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Abstract
Nuclear hormone receptors (NHRs) are ligand-activated transcriptions factors which
transduce the effects of various hormones as well as nutritional and other
environmental signals. They thus function to maintain physiological homeostasis by
integrating the tissue expression of specific target genes to regulate a wealth of
biological processes including reproduction, development, metabolism and
environmental adaptation. Mounting evidence indicates NHRs are the target of
endocrine disrupting compounds (EDCs), exogenous chemicals, often of
anthropogenic origin, which disrupt NHRs and thus the processes under their control.
EDCs can interfere with NHR signalling by activating receptors (agonists), by
inhibiting the actions of the receptor (antagonists), or by disrupting endogenous
hormone synthesis, secretion, transport or metabolism. Much of the focus to date has
been on the risk of EDCs to reproductive functions, via estrogen and androgen NHRs
in humans, and also in aquatic organisms. However environmental pollutants also
have the potential to interact with other NHRs, particularly in aquatic environments,
and cause dysregulation of other critical physiological processes, including energy
homeostasis, immune functions and the stress response.
To address this possibility a reporter gene assay was developed, allowing the high-
throughput screening of pollutants for their interactions with piscine NHRs with
critical roles in energy homeostasis, stress reponse and immune functions, namely
the peroxisome proliferator-activated receptors (PPARs) and corticosteroid receptors
(CRs) from European plaice (Pleuronectes platessa) and European flounder
(Platichthys flesus), respectively. Complementary DNA (cDNA) sequences encoding
the ligand-binding domains of PPARs and CRs, critical for receptor-ligand
Vinteractions and receptor activation, were ligated to the DNA-binding domain (DBD)
of the yeast Gal4 transcription activator protein to create experimental expression
plasmid constructs. Co-transfection of these expression plasmids into the fathead
minnow (FHM) cell line with an upstream-activating sequence (UAS)-firefly
luciferase reporter gene plasmid increased luciferase expression in the presence of
known PPAR and CR ligands. Several aquatic pollutants including pharmaceuticals,
industrial by-products and biocides were tested for their potential to disrupt PPAR
and CR functions by interacting with these receptors in an agonistic or antagonistic
manner.
Several fibrates, a group of pharmaceutical compounds used to treat dyslipidemia in
humans by targeting the PPARs, were able to activate plaice Gal4-PPARα and Gal4-
PPARβ in the reporter gene assay, indicative of an interaction with PPAR receptors
in non-target species. Fibrates which did not activate Gal4-PPARα were able to
inhibit the activation of Gal4-PPARα by the PPARα-specific agonist, Wy14643,
suggesting differential effects of fibrates on human and flounder PPARs. In addition
some metabolites of widespread phthalate ester pollutants were also agonists of the
Gal4-PPARα and Gal4-PPARβ constructs. The Gal4-PPARγ construct was
unresponsive to almost all the compounds tested, including the mammalian PPARγ
agonist, rosiglitazone. The exception to this was the phthalate metabolite
monobenzylphthalate, which induced a small increase in firefly luciferase in Gal4-
PPARγ transfected cells. All of the above effects required concentrations of at least
10 µM, which are unlikely to be encountered in the aquatic environment. In contrast
bis(tributyltin) oxide (TBTO), a notorious environmental pollutant, inhibited Gal4-
PPARα and Gal4-CR constructs at concentrations as low as 1 nM and 100 nM,
VI
respectively. These concentrations are lower than those reported in aquatic
environments, or in fish tissues, making TBTO a candidate endocrine disruptor in
fish by inhibiting PPARα and CR signalling. A European flounder cDNA microarray
was used to investigate the trasnscriptional responses of flounder hepatocytes to
TBTO (10 nM) exposure.
Exposure to TBTO and Wy14643, both alone and in combination, indicated a
TBTO-driven downregulation of several potential PPARα-target genes with
functions in the immune system, the proteasome, and lipid metabolism, although,
based on mammalian comparisons, some potential PPARα-target genes were also
upregulated, indicating differences in mammalian and fish PPAR-target genes or
reflecting the complexity of organisms at a higher organisational level than cell-
based assay systems. However, the microarray-based approach was useful in
formulating further hypotheses about the effects of TBTO on PPARα signalling.
Overall, these results indicate that exogenous chemicals entering the aquatic
environment can interfere with NHRs with functions in energy homeostasis, immune
functions and stress, in non-target organisms. The cell-based reporter gene assay is a
useful tool for identifying potential endocrine disruptors which target PPARs and
CRs and would be a useful method in a first tier testing approach, limiting the use of
live animal models and enabling investigation into specific receptors which are
targets of endocrine disrupting compounds. Although more work is required to
confirm the physiological consequences of TBTO inhibition of PPARα, the results
presented here indicate that organisms inhabiting TBTO-polluted environments may
experience suppression of the immune system, an increase in non-functional or
VII
misfolded proteins through suppression of genes involved in the
ubiquitin/proteasome system and a disruption in lipid homeostasis.
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Chapter 1. General Introduction
Since the early 19th century a dramatic increase in production levels of organic and
inorganic compounds has occurred and by the 21st century production levels of
synthetic organic chemicals in the USA alone exceeded 140 billion kg/annum
(Baillie Hamilton, 2002). With such high production levels, it is inevitable that a
fraction of these compounds are released into the environment, and ultimately enter
aquatic ecosystems, and therefore concern has grown over the potential for these
compounds to cause toxic effects in aquatic species. Over the last ten to fifteen years
it has further become apparent that large numbers of these man-made chemicals can
interact with the endocrine systems of aquatic organisms by specifically interacting
with various endogenous hormone signalling pathways. This diverse group of
chemicals has become known as endocrine disruptors and many different endocrine-
disrupting compounds, particularly small lipophilic contaminants, are able to exert
effects via interactions with cellular receptors for endogenous hormones. One of the
largest and most studies classes of these cellular receptors are the nuclear hormone
receptors.
1.1.1 Nuclear Hormone Receptors (NHRs)
The nuclear hormone receptors (NHRs) are a superfamily of transcription factors,
regulating the expression of genes involved in key physiological processes such as
cell growth, cell differentiation, development, reproduction, metabolism and
homeostasis (Francis et al, 2003). To date 48 NHRs have been identified in humans,
including those which are activated by thyroid hormones (thyroid receptor), sex
steroid hormones e.g. testosterone (androgen receptors) and estradiol (estrogen
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receptors), fatty acids (PPARs), vitamin D3 (vitamin D receptor), cortisol
(glucocorticoid receptor), aldosterone (mineralocorticoid receptor) and retinoic acid
(retinoic acid receptor) (le Maire et al, 2010). Some nuclear receptors remain as
‘orphan’ receptors, so-called because endogenous ligands have not yet been
identified.
Nuclear hormone receptors are classified based on their sequence similarities and
their positions in a phylogenetic tree connecting all known NHR sequences (Laudet,
1997; Nuclear Receptors Nomenclature Commitee, 1999). Thus, all NHRs
discovered to date are placed into one of six evolutionary groups of unequal size. The
distribution of receptors into six subfamilies correlates with their ability to bind DNA
as monomers, heterodimers or homodimers, and to some extent with their ligand-
binding specificities (Laudet, 1997). For example many nuclear hormone receptors
which are able to heterodimerise with the retinoid X receptor (RXR) belong to the
first or fourth subfamily while members of subfamily 3 are almost exclusively
homodimeric, and bind to palindromic response elements.
- 3 -
Table 1-1. The 48 human nuclear hormone receptors (adapted from le Maire (2010)).
Subfamily
/Group NRNC Name
Abbreviati
on
Ligand(s) M,D,H*
1
A
NR1A1 Thyroid hormone receptor α TRα
Thyroid hormone H
NR1A2 Thyroid hormone receptor β TRβ
B
NR1B1 Retinoic acid receptor α RARα
Retinoic acid HNR1B2 Retinoic acid receptor β RARβ
NR1B3 Retinoic acid receptor γ RARγ
C
NR1C1 Peroxisome proliferator-activated receptor α PPARα
Fatty acids (α, β, γ),
leukotriene B4 (α),
fibrates (α),
prostaglandin J2
(γ),
thizaolidinediones
(γ)
HNR1C2
Peroxisome proliferator-
activated receptor β/δ PPARβ/δ
NR1C3 Peroxisome proliferator-activated receptor γ PPARγ
D
NR1D1 Rev-ErbAα Rev-ErbAα
Heme M, D
NR1D2 Rev-ErbAβ Rev-ErbAβ
F
NR1F1 RAR-related orphan receptorα RORα Cholesterol (α),Cholesteryl
sulphate (α),
retinoic acid (β),
Orphan (γ)
MNR1F2 RAR-related orphan receptorβ RORβ
NR1F3 RAR-related orphan receptorγ RORγ
H
NR1H3 Liver X receptor α LXRα Oxysterols,
T0901317,
GW3965
H
NR1H2 Liver X receptor β LXRβ
NR1H4 Farnesoid X receptor FXR Bile acids,fexaramine H
I
NR1I1 Vitamin D receptor VDR
Vitamin D, 1,25-
dihydroxyvitamin
D
H
NR1I2 Pregnane X receptor PXR Xenobiotics, 16α-
cyanopregnenalone H
NR1I3 Constitutive androstane
receptor CAR
Xenobiotics,
phenobarbital H
2
A
NR2A1 Hepatocyte nuclear factor 4α HNF4α
Fatty acids D
NR2A2 Hepatocyte nuclear factor 4γ HNF4γ
B
NR2B1 Retinoid X receptor α RXRα
Retinoic acid (α, β,
γ) DNR2B2 Retinoid X receptor β RXRβ
NR2B3 Retinoid X receptor γ RXRγ
C
NR2C1 Testicular receptor 2 TR2
Orphan D, H
NR2C2 Testicular receptor 4 TR4
E
NR2E1 Homologue of theDrosophila tailless gene TLX Orphan M, D
NR2E3 Photoreceptor cell-specific
nuclear receptor PNR Orphan M, D
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Table 1-1 cont…
Below the nuclear hormone receptors are discussed in more detail with particular
reference to PPARs (NR1C1, NR1C2 and NR1C3) and CRs (NR3C1 and NR3C2).
Subfamily/
Group NRNC Name Abbreviation Ligand(s)
2 F
NR2F1
Chicken ovalbumin upstream
promoter-transcription factor
I
COUP-TFI Orphan
D, H
NR2F2
Chicken ovalbumin upstream
promoter-transcription factor
II
COUP-TFII Orphan
D, H
NR2F6 V-erbA-related EAR2 Orphan M
3
A
NR3A1 Estrogen receptor-α ERα 17β-estradiol (α, β),
tamoxifen (α),
raloxifene (α), various
syntetic compounds (β)
D
NR3A2 Estrogen receptor-β ERβ
B
NR3B1 Estrogen-related receptor-α ERRα
Orphan (α), DES (β, γ),
4-OH tamoxifen (β, γ) M, DNR3B2 Estrogen-related receptor-β ERRβ
NR3B3 Estrogen-related receptor-γ ERRγ
C
NR3C1 Glucocorticoid receptor GR
Cortisol,
dexamethasone,
RU486
D
NR3C2 Mineralocorticoid receptor MR
Aldosterone, cortisol,
dexamethasone,
Spironolactone
D
NR3C3 Progesterone receptor PR
Progesterone,
medroxyprogesterone
acetate, RU486
D
NR3C4 Androgen receptor AR Testosterone,Flutamide
D
4 A
NR4A1 Nerve Growth factor IB NGFIB Orphan M, D, H
NR4A2 Nuclear receptor related 1 NURR1 Orphan M, H
NR4A3 Neuron-derived orphan
receptor 1 NOR1 Orphan
M
5 A
NR5A1 Steroidogenic factor 1 SF1 Phosphatidylinositol M
NR5A2 Liver receptor homolog-1 LRH-1 Phosphatidylinositol
6 A NR6A1 Germ cell nuclear factor GCNF Orphan D
Mi
sc.
A NR0B1
Dosage-sensitive sex
reversal, adrenal hypoplasia
critical region, on
chromosome X, gene 1
DAX1 Orphan
NR0B2 Small heterodimer partner SHP Orphan H
* M – Monomer; D – Homodimer; H – RXR heterodimer
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1.1.2 Structure of NHRs
All nuclear hormone receptors share a common domain structure, comprising an N-
terminal A/B domain, a central DNA-binding C-domain, linked via a hinge region to
a C-terminal ligand-binding E domain and the role of each domain in overall receptor
function has been well defined (Figure 1-1).
Figure 1-1. Schematic diagram of domain architecture of NHRs and the roles assigned to each
of the domains.
1.1.3 A/B domain
The A/B domains of NHRs, unlike the DNA-binding domains and ligand-binding
domains are relatively low in sequence conservation, even between different isotypes
of the same receptor. For example the A/B domains of PPARβ and PPARγ from the
amphibian Xenopus laevis share an amino acid identity of 11% and 21%
respectively, with PPARα (Escher and Wahli, 2000), while the two glucocorticoid
receptors of the marine medaka (Oryzias dancena) share an amino acid identity
within their A/B domains of 17%, and an amino acid identity of  less than 45% is
generally observed between GR1 of this species and the GRs of other teleost GRs
(Kim et al, 2011). As well as differing in sequence, the A/B domains of NHRs differ
considerably in length. For example the N-terminal domain of the mineralocorticoid
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receptor (MR) consists of 602 residues, while the glucocorticoid receptor (GR) and
the estrogen receptor α (ERα) are 420 residues and 184 residues, respectively
(Lavery and McEwan, 2005).
Regardless of the sequence diversity a common function for the A/B domain has
been suggested following the identification of an activation function (AF-1) within
this region of many receptors, including the glucocorticoid receptors (Sturm et al,
2010), the androgen receptor (Chamberlain et al, 1996), the progesterone receptor
(Meyer et al, 1992), the estrogen receptor (Tora et al, 1989; Lees et al, 1989) and the
PPARs (Werman et al, 1997; Juge-Aubry et al, 1999).  A second activation function
(AF-2) is present within the ligand-binding domain of receptors, whose role in
receptor activation is dependent on a conformational change in helix 12 of the ligand
binding domain (LBD), induced by interactions with an activating ligand. In some
NHRs deletion of AF-2 has been reported to lead to a constitutively active receptor,
leading researchers to conclude that the AF-1 functions in a ligand-independent
manner (Hollenberg et al, 1987; Tora et al, 1989). Furthermore, deletion of the A/B
domain of NHRs leads to a significant reduction in transactivation of the receptors
(Hi et al, 1999; Sturm et al, 2010), indicating a synergy between the AF-1 in the A/B
domain and AF-2 in the ligand-binding domain in full receptor activation.
Despite their importance in gene regulation, little is known about the mechanisms in
which AF-1 functions. The structure of the A/B domain of several NHRs has been
solved and all appear to be largely unstructured or intrinsically disordered (Baskakov
et al, 1999; Kumar et al, 2001; Chandra et al, 2008), suggesting that the activation
domains of these receptors may require a high degree of flexibility in order to
function effectively (Garza et al, 2009).
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It has been proposed that interactions of A/B domains with co-regulatory proteins
give structure to the domain via an ‘induced-fit’ model (Kumar et al, 2004; Kumar
and Litwack, 2009), and these interactions correlate in vivo with enhanced
transcription of both co-transfected and endogenous genes (Warnmark et al, 2001;
Copik et al, 2006). The strength of co-regulatory protein interaction may be further
modulated via phosphorylation status (Passilly et al, 1999; Nordzell et al, 2004;
Garza et al, 2010).
1.1.4 DNA-binding domain
Linked to the carboxyl end of the A/B domain is a highly conserved region in the
vast majority of NHRs, the DNA-binding or C-domain. A comparison of the C-
domains of glucocorticoid receptors from several teleost species and the human GR
sees a similarity of no less than 80% (Kim et al, 2011) while between the three
PPAR subtypes (α, β and γ) an amino acid identity of between 78 and 86% is
observed (Dreyer et al, 1993). The DNA-binding domain is composed of two zinc
finger structures, each of which is expressed by a separate exon (Huckaby et al,
1987; Luisi et al, 1991). A prerequisite for the regulation of target genes by NHRs is
the binding of the NHR to a specific DNA sequence, termed a response element,
within the promoter region of target genes and this contact is mediated by the central
DNA-binding domain of NHRs.
Most nuclear receptors bind to DNA either as homodimers or as heterodimers with
RXR. The former group includes the classic steroid hormone receptors, such as
glucocorticoid receptors, estrogen receptors, progesterone receptors and androgen
receptors, while the latter group includes the vitamin D receptor, the thyroid
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hormone receptor and the peroxisome proliferator-activated receptors. In general
homodimers recognise and bind to DNA sequences arranged as inverted repeat (IR)
response elements, while receptors which heterodimerise with RXR bind to direct
repeat (DR) response elements. Some receptors are also capable of binding to everted
repeat sequences (ER) with various spacers separating the two half-sites
(Mangelsdorf and Evans, 1995; Figure 1-2).
Figure 1-2. (A) Schematic diagram representing direct repeat (DR), inverted repeat (IR) and
everted repeat (ER) hormone response elements (HRE), with each half-site of the HRE
separated by ‘N’ base pairs. (B) The dimerization and recognised response element for a
selection of human NHRs. He, heterodimer; Ho, homodimer; (RXR), indicates the receptors
which heterodimerise with RXR; K, G/T; R, A/G; N, A/T/C/G.
The recognition of specific hormone response elements by nuclear hormone
receptors explains much, but not all, of their ability to alter gene transcription in a
targeted manner and several residues within the DBD of receptors are implicated in
the recognition of specific HREs (Umesono and Evans, 1989; Danielsen et al, 1989;
Nguyen et al, 2001; Khorasanizadeh and Rastinejad, 2001).
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The ability of NHRs to bind to specific response elements is also determined in part
by the spacing between the two half-sites of the HRE; for example, while
PPAR/RXR heterodimers recognise DRs with 1 base pair spacing (DR1), the vitamin
D receptor/RXR heterodimer binds preferentially to DRs whose half sites are
separated by 3 (DR3) or 4 (DR4) base pairs (Nishikawa et al, 1994; Quack and
Carlberg, 2000; Tugwood et al, 1992).
Nuclear hormone receptors dimerise in a way that is specific to each dimer complex,
resulting in optimal spatial arrangements for DNA binding. In the absence of a
response element receptors have a limited capacity to dimerise due to the lack of
dimerization contacts and the relatively small surfaces involved. In the presence of
DNA, these monomers become aligned into dimers, resulting in a continuous surface
with many DNA interaction-surfaces (Luisi et al, 1991; Zhao et al, 2000). To date,
examination of protein-DNA complexes reveal discrete protein-protein interactions
between the RXR and its partner monomers which ensure a precise match to the
spacing between the direct repeats (Khorasanizadeh and Rastinejad, 2001).
Structurally, the C-domain consists of two ‘zinc finger’ such that four conserved
cysteine residues are co-ordinately bound by a central divalent zinc ion (Figure 1-3).
Each of the zinc fingers have been shown to have a distinct function. A proposed
function for the second zinc finger is that of nuclear localization; Yu et al (1998)
showed that deletion of the second zinc finger of the orphan nuclear receptor TR2
resulted in a receptor which was evenly distributed between the nucleus and the
cytoplasm compared to a receptor which was exclusively nuclear when the second
zinc finger was intact, suggesting the presence of a nuclear localisation signal within
the second zinc finger. The second zinc finger region of PPARα has also been
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implicated in nuclear localisation of the receptor, with a partial deletion of this region
resulting in cytoplasmic localisation (Iwamoto et al, 2011).
Figure 1-3. The DNA-binding domains of the NHRs are composed of two zinc finger structures,
with each zinc molecule co-ordinated by four conserved cysteine residues. The P-box is involved
in recognition of the response element of DNA to which NHRs bind, while the D-box has been
implicated in dimerization (top; adapted from (Kumar and Thompson, 1999)). An alignment of
the zinc finger regions of different NHRs (bottom) show the four conserved Cys residues
(highlighted in red).
Thus, as well as mediating the binding of receptor dimers to hormone response
elements within the promoter region of target genes, the DNA-binding domain is also
functional in roles concerning localisation of the receptor to the nucleus and in
receptor dimerization.
1.1.5 Hinge region
The hinge region (D-domain) of nuclear hormone receptors is located between the
DNA-binding domain and the C-terminal ligand-binding domain and shows little
conservation amongst various receptors. Studies in which D-domains are mutated or
excluded demonstrate varying functions of this domain, depending on the receptor
being studied. Within the β1 thyroid hormone receptor mutation of the D-domain
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results in an E-domain unable to bind T3 hormone, and unable to release co-
repressor proteins except at very high T3 concentrations (Lin et al, 1991; Safer et al,
1998). Similarly, a natural PPARα D-domain variant is associated with enhanced
recruitment of the nuclear co-repressor NcoR, and a defective release of the co-
repressor in the presence of PPARα ligands (Liu et al, 2008). Thus the hinge region
appears to function in the proper association of coregulatory proteins with the ligand-
binding region in several nuclear hormone receptors.
In contrast, a deletion of eight residues within the hinge region of the androgen
receptor resulted in a stronger response in the presence of androgen hormone, which
could be inhibited with anti-androgen compounds (Haelens et al, 2007). The
dimerization function of the thyroid hormone receptor appears to rely on the hinge
region since the ligand-binding domain alone of thyroid receptor is unable to
homodimerise or heterodimerise with the RXRα, while the inclusion of the D-
domain allowed both homodimerisation and heterodimerisation (Miyamoto et al,
2001). In contrast to the thyroid hormone receptor, the D-domain of RXRα does not
have to be present in order for the receptor to dimerise (Miyamoto et al, 2001).
1.1.6 Ligand-binding domain
The ligand-binding domain (LBD) of nuclear hormone receptors, in which a ligand-
dependent activation function (AF-2) is present, is found at the C-terminal end of
nuclear hormone receptors and, as its name suggests, is involved in binding of ligand
molecules to the receptor. Additionally the LBD contacts both co-repressor and co-
activator proteins when in the inactive and active conformations, respectively, and
together with the DNA-binding domain has a role in receptor dimerization.
Structure of the ligand-binding domain
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The ligand-binding domains of nuclear hormone receptors have highly conserved
tertiary structures, and are composed of 11 or 12 α-helices arranged in an antiparallel
3-layer α-helical sandwich, together with the presence of two β-strands forming a β
hairpin structure (Renaud et al, 1995; Bourguet et al, 1995; Brzozowski et al, 1997;
Egea et al, 2000), although 4 β-strands have been described in the the glucocorticoid
receptor (Bledsoe et al, 2002), PPARβ (Xu et al, 1999) and the thryroid α receptor,
forming a mixed β-sheet (Wagner et al, 1995).
Figure 1-4. The topology of the 12 α-helices found in the ligand-binding domain of the retinoid X
receptor (RXRα). Slight variations on this structure occur, for example Helix 2 does not exist in
the retinoic acid receptor (RAR) γ and helix 12 together with the C-terminus is postioned
perpendicularly to the same region in the RXRα. The β-sheet hairpin structure is represented
by the two green arrows.Adapted from (Renaud et al, 1995).
Interactions between nuclear hormone receptors and their ligands occur within the
ligand-binding domain and the 3-D structures of such interactions have been solved
by x-ray crystallography for several receptors including the estrogen receptor
(Brzozowski et al, 1997), the glucocorticoid receptor (Xu et al, 1999; Bledsoe et al,
2002), RAR-γ (Renaud et al, 1995), PPARβ (Xu et al, 1999), and RXRα (Egea et al,
2000). The overall structure of the ligand-binding domain of NHRs allows for the
- 13 -
presence of a hydrophobic pocket into which ligands can dock; all-trans retinoic acid,
when bound to RAR-γ is found to bury into a pocket formed by residues located in
helices 1, 3, 5, the β-turm, loop 6-7, helix 11, loop 11-12 and helix 12 (Renaud et al,
1995) while the ligand-binding pocket of the glucocorticoid receptor is composed of
residues from helices 3, 4, 5, 6, 7, 10 and 12 as well as residues from β-strands 1 and
2 (Bledsoe et al, 2002). Receptors which bind with high affinity to a specific ligand
generally have smaller ligand-binding pockets than more promiscuous receptors. For
example both PPARβ and PPARγ have very large binding pockets of approximately
1300 Å3, of which only 40% of the latter is occupied by rosiglitazone, a PPARγ
agonist (Nolte et al, 1998; Xu et al, 1999) and the highly promiscuous pregnane X
receptor has a ligand-binding pocket of 1150 Å3. This is in comparison to the ligand-
binding pockets of the thyroid hormone receptor and the estrogen receptors which
show high affinities for the thyroid and estrogen hormones, respectively, and which
have ligand-binding cavities of 600 Å3 (thyroid hormone receptor) (Ribeiro et al,
2004) and 450 Å3 (estrogen receptor) (Brzozowski et al, 1997).
Helix 12 and AF-21.1.6.1
Agonist and antagonist ligands have been described for many NHRs, each of which
make contact with the ligand-binding domain at the ligand-binding pocket
(Brzozowski et al, 1997; Bledsoe et al, 2005). The importance of the C-terminal α-
helix in regulating the transcriptional activities of NHRs was underlined upon the
discovery of a ligand-dependent activation function (AF-2) in this region (Nagpal et
al, 1993; Barettino et al, 1994; Kraus et al, 1995; Bevan et al, 1999).
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In their unliganded state, or when bound to antagonist molecules, nuclear hormone
receptors are bound by co-repressor proteins which dissociate upon binding of
agonists, allowing co-activator binding and receptor activation. It appears that the
choice of co-regulatory protein, which is controlled by ligand-binding, is the ‘switch’
between a transcriptionally active receptor and one with no transcriptional activity.
The interaction of co-activators with nuclear hormone receptors requires the most C-
terminal helix (helix 11/12) to be in a specific conformation, which is obtained upon
agonist binding. Binding of the potent agonist estradiol to the estrogen receptor
results in a conformational change in helix 12, which results in the exposure of a
conserved residue on this helix important in the efficient recruitment of co-activator
proteins (Figure 1-5) (Henttu et al, 1997). Additionally, a hydrogen bond network
within the mineralocorticoid receptor is required to stabilise the receptor and to re-
orientate helix 12 to enable cofactor recruitment (Bledsoe et al, 2005).  The
antagonist spironolactone fails to make these hydrogen bonds, and thus lacks the
ability to stabilise the receptor in order to re-orientate helix 12.
Figure 1-5. Binding of agonist (purple) + co-activator (red), and antagonist (blue) to the estrogen
receptor α (ERα). Binding of agonist ligands leads to a conformational change in helix 12
(yellow) of the ER compared to the conformation when bound to antagonist molecules.
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Interestingly co-repressor and co-activator proteins interact with nuclear hormone
receptors on largely overlapping surfaces of the ligand-binding domain, within a
hydrophobic groove situated between helices 3 and 4 (Nagy et al, 1999; Perissi et al,
1999; Marimuthu et al, 2002; Benko et al, 2003) and thus the question was raised as
to how co-repressor proteins can bind to receptors when helix 12 is not in the correct
orientation for co-activator binding. Several authors have reported the presence of
multiple short interaction motifs (LxxLL) within co-activator proteins which bind to
receptors through contacts with helices 3, 4 and 12 (Heery et al, 1997; Darimont et
al, 1998). Similar, but longer, motifs have been described for co-repressor proteins
(LxxxIxxx; L/I motif) (Nagy et al, 1999; Perissi et al, 1999; Webb et al, 2000) and it
is hypothesised that the longer motif within the co-repressor proteins allows binding
to nuclear hormone receptors in a way which does not require helix 12 to be in the
active conformation (Nagy et al, 1999; Perissi et al, 1999).
In summary, in their un-liganded form most NHRs are in an inactive conformation
by the binding of co-repressor proteins to a hydrophobic groove in their ligand-
binding domain. Upon binding of agonists to the ligand-binding pocket, a network of
bonds between the ligand and the receptor stabilise the receptor and re-orientate helix
12 to the ‘active’ conformation. This latter conformational change favours the
dissociation of co-repressor proteins and the binding of co-activator proteins,
rendering the receptor transcriptionally active.
Receptor dimerization1.1.6.2
The ligand-binding domain, along with the DNA-binding domain, has a function in
receptor dimerization. While dimerization within the DNA-binding domain is
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important for contact with DNA (see 1.1.4 above), dimerization at the ligand-binding
domain stabilises the receptor-DNA complex.
Several residues within helices 7, 9 and 10 of the ligand-binding domain have been
shown, through mutation analysis, to function in receptor dimerization. The crystal
structures of RXRα in a homodimer complex and as a heterodimer with PPARγ has
been resolved and shows an unusual pi-helix (π-helix) conformation within helix 7,
caused by an additional glutamate residue at position 352 of the receptor (Gampe et
al, 2000a and b). This unusual geometry results in the residue bulging out from helix
7 towards its partner monomer, improving the fit at the monomer-monomer interface.
This additional glutamate residue, and the subsequent conformation of helix 7,
appears to be unique to members of the nuclear receptor subfamily 2 (NR2) of which
RXRα, the orphan receptor hepatocyte nuclear factor 4 (HNF4), and COUP-TFI are
members. Indeed the π-helix conformation within helix 7 of HNF4α has also been
described, the deletion or mutation of which fails to form homodimers, neither with
wild-type HNFα nor with other mutated HNFα receptors and interferes with receptor
interactions with co-factor proteins (Eeckhoute et al, 2003).
The Identity box (I-box)1.1.6.3
Helices 9 and 10 of nuclear hormone receptors have been implicated in dimerization
(Gampe et al, 2000a; Dhe-Paganon et al, 2002). A 40 amino acid region within
helices 9 and 10 of the ligand-binding domains of RXR, RAR and TR, termed the
identity box (I-box), has been shown to be critical for heterodimerisation (Perlmann
et al, 1996). Within HNF4α, two residues one from each of helix 9 and 10, were
shown to have a charge compatibility and the resulting reciprocal interactions were
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important in stabilization of HNF4α homodimer complex (Bogan et al, 2000). This
charge compatibility appears to be important in mediating dimerization not only of
homodimers, but also of heterodimers; the residues within RXRα and PPARγ,
corresponding of those in helices 9 and 10 of HNF4α, were mutated to result in a
single charge reversal in either RXRα or PPARγ. As a consequence of these
mutations, heterodimer formation of either receptor with its wild-type partner was
blocked, but could be reinstated by reversing the charge of the residue in the
corresponding wild-type partner (Chan and Wells, 2007). Additionally Nurr-1 and
RXRα heterodimerisation is inhibited following an amino acid substitution in one of
the proteins (Perlmann et al, 1996), which further indicates the importance of
interactions between residues on helix 9 and helix 10 of ligand-binding domains
within nuclear hormone receptors.
1.2 Peroxisome proliferator-activated receptors (PPARs)
PPARs are members of the nuclear hormone receptor superfamily with functions in
lipid, carbohydrate and protein metabolism, adipogenesis, development and the
inflammatory response. To date PPARs in mammalian species have been extensively
studied because they are targets for several pharmaceutical agents including
hypolipidemic, non-steroidal anti-inflammatory and insulin sensitizing drugs
(Forman et al, 1997; Lehmann et al, 1997; Rocchi et al, 2001). More recently the
PPARs have been implicated in the human obesity epidemic, hypothesised to be
targets of compounds which pollute the environment (Evans et al, 2004; Grün and
Blumberg, 2006; Grün et al, 2006; Janosek et al, 2006; Desvergne et al, 2009;
Janesick and Blumberg, 2011). Many nuclear hormone receptors, including the
PPARs, are found in other species such as fish, birds and amphibians (Krey et al,
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1993; Ruyter et al, 1997; Diot and Douaire, 1999; Andersen et al, 2000; Boukouvala
et al, 2004; Leaver et al, 2005), although in general their interactions with
endogenous and xenobiotic compounds, and their physiological roles is less studied.
Peroxisome proliferator-activated receptors share the domain structure common to
almost all members of the nuclear hormone receptor superfamily, and function as
heterodimers with the retinoid X receptor to alter the transcription of their target
genes. Three PPARs (PPARα, PPARβ and PPARγ) have been identified, each the
product of a separate gene and each with a distinct tissue distribution.
1.2.1 PPARα
PPARα, in accordance with its function in fatty acid oxidation in mitochondria and
peroxisomes, is highly expressed in tissues with high rates of β-oxidation such as the
liver, heart, muscle and kidney. This is true in both mammalian (Braissant et al,
1996) and fish species, suggesting a conserved role for PPARα. Brown trout (Salmo
trutta) and sea bream (Sparus aurata) show high PPARα expression in the liver and
heart, with an increased expression also found in the white muscle of the former
species and the red muscle of the latter (Leaver et al, 2005; Batista-Pinto et al, 2005).
PPARα is highly expressed in the liver, proximal tubules of the kidney and in cells of
the intestine of zebrafish (Ibabe et al, 2002).
Fatty acids were first identified as ligands of Xenopus PPARα by Keller et al (1993),
who hypothesised that since known PPAR ligands shared a similar structure to fatty
acids, and that high-fat diets and fatty acid analogues induced peroxisomal β-
oxidation of fatty acids, a role associated with PPARs, that fatty acids may be the
endogenous ligands of these receptors. Indeed co-transfection experiments with
- 19 -
PPARα and RXRβ demonstrated the co-operative activation of the acyl CoA oxidase
promoter which contains a peroxisome-proliferator response element (PPRE) when
the receptors were linked as heterodimers in the presence of fatty acids. Furthermore
a direct interaction between fatty acids and PPARs has been demonstrated (Kliewer
et al, 1997; Murakami et al, 1999), suggesting that activation of the PPAR-RXRβ
heterodimer by fatty acids is due to the interaction of PPARs with fatty acids and not
a consequence of fatty acid interactions with the RXR heterodimer partner. This is a
valid point considering 9-cis retinoic acid, the ligand for RXR, also led to acyl Co-A
oxidase promoter activation (Keller et al, 1993), suggesting that both PPAR and
RXR ligands can regulate the expression of PPRE-containing target genes via the
activation of the PPAR-RXR heterodimer. Within several fish species fatty acids are
ligands for PPARα, and activate PPARα of Japanese medaka (Oryzias latipes),
gilthead sea bream and European plaice (Pleuronectes platessa) (Leaver et al, 2005;
Kondo et al, 2010).
In addition to fatty acids themselves, various oxidised derivatives of fatty acids have
also been shown to activate PPARα. Several transcription activation assays and gel
shift studies indicate that derivatives of fatty acid metabolism, such as eicosanoids,
are endogenous ligands for mammalian PPARs. Derivatives of arachidonic acid,
including 20-hydroxyeicosatetraenoic acid (20-HETE) and several
epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs) are
able to activate PPARα and PPARγ, as demonstrated in transactivation assays (Ng et
al, 2007). Furthermore each of these compounds binds directly to PPARα, permitting
a heterodimeric PPARα-RXRα complex to form, which can subsequently bind to a
PPRE (Ng et al, 2007). The eicosanoid 8S-HETE, produced as a result of
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arachidonic acid entering the lipoxygenase pathway, has also previously been shown
to interact with Xenopus (Krey et al, 1997; Kliewer et al, 1997) and mouse (Forman
et al, 1997; Thuillier et al, 2002) PPARα.
The finding that fatty acids and their derivatives are able to activate PPARs has led to
speculation of the existence of an autoregulatory feedback loop (Göttlicher et al,
1992; Krey et al, 1997). PPARs, upon binding to ligands and heterodimerising with
RXRα, upregulate genes involved in fatty acid oxidation and therefore by activating
the PPAR receptors fatty acids and eicosanoids could mediate their own
neutralisation and degradation. As yet the relative importance of the roles of fatty
acids versus their oxidised derivatives in vivo has not been determined, and will
depend on the physiological concentrations of each of these potential ligands in each
tissue.
A number of synthetic PPARα agonists have been discovered or developed. Indeed
the initial identification of PPARα was as the receptor for the hypolipidemic drug
clofibrate (Issemann and Green, 1990). Since then several other members of the
fibrate class of drugs, as well as the PPARα-specific ligand Wy14643, have been
developed, in some cases specifically as ligands of PPARα (Willson et al, 2000).
Several fibrates have since been tested in transcription assays for their ability to
activate PPARα, β and γ following transient transfection. Forman et al (1997) found
a strong activation of PPARα, a weak activation of PPARγ and no effect on PPARβ
when cells transfected with murine PPARs were treated with ciprofibrate,
gemfibrozil and clofibrate. Fibrates are also activating ligands of amphibian and fish
PPARs; interactions of bezafibrate and ciprofibrate with PPARβ and PPARγ of
Xenopus laevis, respectively, has been demonstrated (Krey et al, 1997), and fibrates
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administered to hepatocyte cells of Atlantic salmon (Salmo salar) and rainbow trout
(Oncorhynchus mykiss) resulted in an increased expression and activity of the PPAR
target gene acyl-CoA oxidase (Donohue et al, 1993; Ruyter et al, 1997).
Prior to the discovery of the peroxisome proliferator-activated receptors, it was well
established that treatment of rodents with various drugs, of which clofibrate was the
archetype, caused a proliferation of peroxisomes which was associated with increases
in the peroxisomal β-oxidation of fatty acids (Lazarow and De Duve, 1976; Lazarow,
1978). Since the discovery of the PPARs and the finding that PPARα is highly
expressed in tissues with high rates of fatty acid β-oxidation, a well-established role
for PPARα in fatty acid metabolism has been defined. Peroxisomal β-oxidation genes
which are targets of PPARα include acyl CoA oxidase (ACO) enzyme, which
functions in the firstand rate-limiting step in the peroxisomal β-oxidation pathway
(Tugwood et al, 1992; Varanasi et al, 1996; Lambe et al, 1999) and enoyl-CoA
hydratase/3-hydroxyacyl Co-A dehydrogenase bifunctional enzyme and ketoacyl-
CoA, which function in the second step and the third steps (Zhang et al, 1992;
Hansmannel et al, 2003).
Similarly, activation of PPARα mediates several steps in the microchondrial β-
oxidation pathway via the transcriptional regulation of genes involved in this
pathway, including those with a function in the transport of fatty acids into the
mitochondria and the major enzymatic steps in the β-oxidation pathway. For example
carnitine palmitoyl transferase expressed in the liver (CPT1a) and muscle (CPT1b) is
involved in the translocation of long chain fatty acids across the mitochondrial
membrane and an analysis of its promoter region reveals the presence of a functional
PPRE (Brandt et al, 1998; Napal et al, 2005). Accordingly, hamsters treated with a
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potent PPARα agonist saw a 2.3-fold increase in the transcription of CPT1
expression in muscle as well as hepatic effects (Minnich et al, 2001). PPARα has
been shown to interact with the PPRE-containing promoter region of the medium
chain acyl-CoA dehydrogenase gene, which encodes the enzyme responsible for the
initial step in mitochondrial β-oxidation (Gulick et al, 1994). Expression levels of
both genes and proteins involved in both peroxisomal and mitochondrial fatty acid
oxidation are induced upon activation of PPARα, and many of these genes have been
shown to contain a peroxisome proliferator response element (PPRE) (Zhang et al,
1992; Hansmannel et al, 2003).
The role of PPARα in peroxisome proliferation and peroxisomal and mitochondrial
fatty acid β-oxidation is demonstrated further by animal models in which PPARα is
non-functional. Rodents with a disrupted PPARα gene fail to increase the number
and size of hepatic peroxisomes when treated with Wy14643 or clofibrate.
Furthermore the increase in expression of peroxisomal β-oxidation genes including
acyl-CoA oxidase, bifunctional enzyme and 3-ketoacyl CoA thiolase, observed upon
treatment with peroxisome proliferators, is abolished in PPARα-null mice (Lee et al,
1995). This failure to upregulate fatty acid β-oxidation genes in PPARα knockout
mice is associated with the accumulations of lipids in the liver and heart and changes
in serum cholesterol (Peters et al, 1997). These results explain the efficacy of fibrate
drugs in correcting, at least partially, dyslipidemia (Mukherjee et al, 1998; Fruchart
and Duriez, 2006).
Taken together the evidence suggests that the physiological role of PPARα is to
upregulate the oxidation of fatty acids for energy during periods of fasting or
starvation.
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1.2.2 PPARβ
PPARβ has been shown to be widely expressed amongst rodent tissues (Jones et al,
1995; Braissant et al, 1996). The findings in mammalian species agree with those in
fish species where zebrafish, brown trout and sea bream show a widely expressed
PPARβ distribution. In addition to being the more widely expressed isotype, PPARβ
was found to be more abundant than PPARα in several tissues from both brown trout
and sea bream (Leaver et al, 2005; Batista-Pinto et al, 2005).
Like PPARα, fatty acids have been demonstrated to activate PPARβ (Xu et al, 1999;
Fyffe et al, 2006), albeit in a differential manner (Yu et al, 1995). The authors
showed that linoleic acid was able to preferentially activate human PPARα over
PPARβ and that PPARγ was not activated by this fatty acid. In accordance with this,
an overlap in ligand recognition amongst the three PPAR isotypes does occur,
however both poly- and monounsaturated fatty acids are able to activate PPARα at a
concentration up to 10-fold lower than that required for PPARβ and PPARγ
activation (Krey et al, 1997). In fish species PPARβ is activated by some fatty acids,
although like mammals, the extent of its activation is less than that of PPARα
(Leaver et al, 2005). Also like PPARα, and depending on species, PPARβ is also
activated by some fibrate drugs, although generally to a lesser extent than PPARα
(Krey et al, 1997). Several PPARβ subtype-specific synthetic ligands are available,
for example GW501516 (Oliver et al, 2001), and there is some evidence that these
also activate PPARβ in fish (Leaver et al, 2007).
The physiological role of PPARβ is less well established than for other PPARs.
Although PPARβ is widely expressed, it appears to be the predominant isotype
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within skeletal muscle (Muoio et al, 2002) and as such has been implicated in the
response of this tissue to exercise (Muoio et al, 2002; Sprecher, 2007). Target genes
for PPARβ appear to be in many cases the same as those for PPARα, and an in vivo
human study, supported by in vitro cell culture experiments, has demonstrated the
ability for the potent PPARβ-selective agonist GW501516 to decrease serum
triglyceride levels and enhance HDL, while upregulating the expression levels of
carnitine palmitoyltransferase-1, CD36 and ABCA1 mRNA (Sprecher, 2007). These
results suggest a role for PPARβ, similar to PPARα in driving increases in fatty acid
oxidation, but targeted to skeletal muscle, rather than liver.
1.2.3 PPARγ
Within mammals PPARγ exists as two forms originating from alternatively spliced
transcripts (PPARγ1 and PPARγ2). PPARγ2 is mostly expressed in adipose tissue
and organs with immune related functions (Braissant et al, 1996), whereas PPARγ1
is more widely expressed but generally at considerably lower level than other
PPARs. The organs involved in immune function include the kidney, the spleen and
the thymus. In accordance with this, a strong PPARγ expression is found within the
trunk kidney of brown trout suggesting that PPARγ may play a similar role in this
species as it does in mammals (Batista-Pinto et al, 2005). However, studies with
different fish species suggest a differential expression of PPARγ between species.
Zebrafish tissues show little or no expression of PPARγ (Ibabe et al, 2002), while
almost all tissues of sea bream expressed PPARγ, with levels appearing greater in the
intestine and adipose tissue, and at a level similar or greater than the expression of
PPARβ (Leaver et al, 2005). There is no evidence of alternative PPARγ polypeptides
corresponding to the two mammalian forms in fish.
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In mammals fatty acids are activators of PPARγ, similar to PPARα, and the
eicosanoid, 15-deoxy-D12, 14-prostaglandin J2 (15d-J2) has been identified as a
possible specific endogenous agonist (Kliewer et al, 1995; Forman et al, 1995). A
number of other lipid molecules have also been suggested as agonists and include
lysophospholipids (McIntyre et al, 2003). Synthetic high affinity agonists include the
thiazolidinediones (TZDs), which include troglitazone, pioglitazone, rosiglitazone
and ciglitazone, and were identified as potentially useful drugs on the basis of
stimulating the activation of rodent and human PPARγ in transient transfection
assays (Lehmann et al, 1995; Lambe and Tugwood, 1996). Furthermore TZDs have
been shown to induce a conformational change in PPARγ analogous to those
produced by agonists of other nuclear hormone receptors (Berger et al, 1996) and
inducing interactions of the CREB-binding protein (CBP) co-activator with PPARγ
(Mizukami and Taniguchi, 1997). TZDs have subsequently been used to treat non-
insulin dependent diabetes mellitus (NIDDM). In addition to improving insulin
sensitivity, these drugs have been reported to improve the lipid profiles of patients
with NIDDM and have antioxidative, anti-inflammatory and antiapoptotic properties
(Betteridge, 2007).
The identification of high affinity agonists for mammalian PPARγ has enabled the
discovery of a well-defined function for this receptor in adipose tissue, and more
specifically in adipogenesis. Cultured fibroblasts expressing PPARγ and treated with
PPARγ activators have been demonstrated to differentiate into adipocytes in a dose-
dependent manner (Tontonoz et al, 1994). In undifferentiated preadipocyte cells
PPARγ expression is undetected (Chawla et al, 1994). However, upon addition of
differentiation media or upon treatment with a PPARγ-activating ligand PPARγ
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expression is quickly induced, concurrent with a differentiation of preadipocytes into
mature adipocyte cells (Chawla et al, 1994). Much work has focussed on mammalian
adipocyte differentiation and function and a complex system of signalling and
transcriptional cascades has emerged (Farmer, 2006). Nevertheless the central and
essential role of PPARγ in the differentiation and maintenance of adipocytes is
firmly established (Lowe et al, 2011).
Various PPARγ target genes have been identified, several of which function in
adipogenesis or are expressed in differentiated adipocytes. Importantly, following the
addition of PPARγ agonists, an increase in the expression of genes integral to the
adipocyte phenotype are increased, including the adipocyte fatty acid binding protein
(aP2), lipoprotein lipase, acyl-CoA synthase and fatty acid transport protein (Martin
et al, 1998; Thompson et al, 2004). The modulation of PPARγ has physiological
consequences with particular relevance to type II diabetes. It has been demonstrated
that accumulation of fatty acids in skeletal muscle is strongly associated with insulin
resistance in type II diabetes (Ferrannini et al, 1983) and that glucose uptake within
skeletal muscle in response to insulin is reduced in a dose-dependent manner with the
levels of free fatty acids (Boden et al, 1994). Since PPARγ promotes the uptake of
free fatty acids into adipose tissue and thus away from skeletal muscle, known as
‘free fatty acid steal’, this action is likely to indirectly improve insulin sensitisation
and glucose uptake in skeletal muscle. Indeed rosiglitazone (a thiazolidinedione) is
able to improve the fatty-acid mediated resistance of insulin by increasing the uptake
of fatty acids in adipocytes and reducing the uptake into the liver and skeletal muscle
by 40% and 30%, respectively (Ye et al, 2004).
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In addition to removing free fatty acids another mechanism, involving the
modulation of adipocytokine levels, has been proposed that is likely to modulate
glucose usage in skeletal muscle. Adipocytokines are cytokine proteins released
specifically by adipocytes in response to extracellular stimuli or changes in metabolic
status and include angiotensin, tumour necrosis factor α (TNFα) and adiponectin
(Tarcin et al, 2007). Several lines of evidence support the hypothesis that
adiponectin, the expression of which is regulated by PPARγ, plays a part in insulin
resistance. Levels of adiponectin protein in models of obesity, insulin-resistance and
dyslipidemia, all of which predispose an individual to type 2 diabetes, are
significantly decreased compared to ‘healthy’ individuals and administration of
adiponectin ameliorates both hyperglycaemia and hyperinsulinemia (Arita et al,
1999; Yamauchi et al, 2001). Thiazolidinedione compounds increase the expression
of adipophilin in a concentration dependent manner, an effect associated with a
decrease in plasma free fatty acids, reduced hepatic fat content and an increase in
hepatic insulin sensitivity in patients with type 2 diabetes (Bildirici et al, 2003; Bajaj
et al, 2004). Since TZDs are potent activators of PPARγ it has been speculated that
adiponectin levels are increased in response to the activation of PPARγ. Indeed, a
PPRE has been identified within the human adiponectin gene (Iwaki et al, 2003) and
co-transfection of a dominant negative PPARγ diminished the increase in expression
of adiponectin in response to TZDs (Maeda et al, 2001), providing evidence for the
regulation of an adipocytokine by PPARγ in a manner shown to improve insulin
sensitivity.
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1.2.4 PPARs in Inflammation and Immunity
Expression of PPARs in several cells of the immune system, including macrophages
(Chinetti et al, 1998; Ricote et al, 1998), T and B lymphocytes (Jones et al, 2002)
and dendritic cells (Gosset et al, 2001) have led to their being implicated in
regulation of the immune system.
Several studies have identified PPARα, PPARβ and PPARγ, or their ligands, to have
anti-inflammatory activities via the inhibition of the nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) signalling pathway (Chinetti et al, 1998; Jones
et al, 2002; Planavila et al, 2005). The NFκB family of proteins function as
transcription factors whose activation and nuclear translocation, is associated with an
increase in the transcription of genes encoding important components of the innate
immune response, such as chemokines, cytokines, adhesion molecules, enzymes that
produce secondary inflammatory mediators and inhibitors of apoptosis (Pahl, 1999).
Both PPARα and PPARγ ligands have been demonstrated to induce apoptosis in
macrophage and T and B lymphocytes via inhibition of NFκB signalling (Chinetti et
al, 1998; Jones et al, 2002) while PPARβ has been demonstrated to downregulate the
expression of a NFκB gene in the cardiac cells of rats via direct binding to NFκB
(Planavila et al, 2005). Both PPARα and PPARγ are able to directly interact with the
subunits of NFκB (Delerive et al, 1999; Chung et al, 2000), with the former
interaction occurring within the region which mediates NFκB binding to DNA,
dimerization and interactions with the NFκB inhibitor, IκB,  and thus may inhibit
NFκB activity by blocking DNA-binding, dimerization and release of IκB.
Furthermore PPARα ligands including Wy14643 and fibrates have been found to
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induce the expression of the NFκB inhibitory protein, IκB, in primary smooth muscle
and hepatocyte cells in a PPARα-dependent manner (Delerive et al, 2000).
A mechanism for PPARβ in anti-inflammatory effects has been demonstrated in
monocytes/macrophages. Unliganded PPARβ inhibits anti-inflammatory pathways
by associating with the transcriptional co-repressor B cell lymphoma (BCL)-6,
rendering it unavailable for anti-inflammatory actions, resulting in the upregulation
of inflammatory proteins such as monocyte chemoattractant protein (MCP)-1, MCP-
3 and interleukin-1β (Lee et al, 2003; Takata et al, 2008). Upon activation of
PPARβ, BCL-6 is released, allowing it to function in the repression of pro-
inflammatory proteins.
PPARβ also has important functions within keratinocytes whereas yet unidentified
pro-inflammatory molecules released following skin injury activate PPARβ. In these
cells PPARβ stimulates cell proliferation and inhibits apoptosis, thus aiding wound
healing (Tan et al, 2001). The anti-apoptotic action of PPARβ occurs via
upregulation of two PPARβ target genes, integrin-linked kinase (ILK) and 3-
phosphoinositide-dependent kinase-1 (PDK1) (Di-Poi et al, 2002). These two kinase
proteins phosphorylate and activate the Akt-1, central to the phosphatidylinositol-3
(PI3K) signalling pathway which results in the inhibition of pro-apoptotic regulatory
proteins. The finding that PPARs have anti-inflammatory mechanisms has increased
the interest in PPAR ligands as possible therapies for inflammatory diseases.
1.2.5 PPARs in Development
All three PPAR isotypes, together with the retinoid X receptor (RXR), the
heterodimeric partner of PPARs, are present in the placenta of humans and rats
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(Wang et al, 2002). Utilising PPARγ-null mice a role for this receptor in the
development of the labyrinth layer was suggested (Barak et al, 2001). This labyrinth
of the placenta is involved in the exchange of material between foetus and mother,
and PPARγ-null mice saw labyrinth-layer defects including delayed differentiation
and inappropriate vascular lake formation, impairing material exchange and leading
to embryonic death.
Similar to PPARγ, morphological defects are found in PPARβ-null placentas with all
three layers reduced in size, of which the giant-cell layer (trophoblast) is most
severely affected. Cultured trophoblastic stem cells treated with the PPARβ-specific
agonist L165041 leads to their differentiation to giant cells while cells in which
PPARβ was silenced and treated with L165041 showed a significant decrease in
differentiation (Nadra et al, 2006), implicating PPARβ in the development of the
placental trophoblastic layer.
1.3 Corticosteroid receptors (CRs)
Corticosteroid receptors, of which the glucocorticoid receptor and mineralocorticoid
receptor are members, function as steroid ligand-activated transcription factors and
have been identified in a variety of organisms including humans (Hollenberg et al,
1985; Arriza et al, 1987), rodents (Danielsen et al, 1986), amphibians (Csikos et al,
1995), birds (Kwok et al, 2007) and fish (Colombe et al, 2000; Marsigliante et al,
2000; Sturm et al, 2005; Takahashi et al, 2006; Schaaf et al, 2008; Pippal et al, 2011;
Sturm et al, 2011; Kim et al, 2011). Similar to PPARs the glucocorticoid receptor is
implicated in energy metabolism, as well as a plethora of other physiological
functions including immune responses, the stress response and reproduction, while
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the mineralocorticoid receptor has a well-studied role in osmoregulation, regulating
salt balance in the kidney and intestine.
Like other members of the nuclear hormone receptor superfamily, ligand activation
of the GR and MR induces binding to a glucocorticoid response element (GRE)
within the promoter region of target genes. This receptor-DNA interaction induces
conformational changes within the receptor which allow receptor dimerization and
stabilization of heterodimeric complex, leading to the altered transcription of target
genes (Härd et al, 1990; Luisi et al, 1991; Baumann et al, 1993). More recently,
glucocorticoid receptor-mineralocorticoid receptor heterodimers have been described
which use an alternative dimerization interface to the one used for homodimerisation,
and induce a distinct transcriptional response pattern from that obtained with
glucocorticoid receptor or mineralocorticoid receptor homodimers (Trapp et al,
1994; Savory et al, 2001; Nishi et al, 2004).
1.3.1 Glucocorticoid receptor (GR)
Within humans alternative splicing of the primary glucocorticoid receptor transcript
gives rise to two, highly homologous protein isoforms, termed hGRα and hGRβ,
which differ in their carboxy-termini (Hollenberg et al, 1985). Using riboprobes
specific to hGRα and hGRβ each of these receptor isoforms have been shown to be
widely distributed throughout human tissues (Oakley et al, 1999), with hGRβ being
expressed most abundantly in terminal bronchiole epithelia of the lung, in the
medulla of the thymus and in the lining of the bile duct within the liver (Oakley et al,
1997). Compared to hGRα, hGRβ is expressed at much lower levels and increased
expression of hGRβ is associated with glucocorticoid resistance, for example in
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glucocorticoid insensitive asthma (Hamid et al, 1999; Sousa et al, 2000) and
ulcerative colitis (Honda et al, 2000), potentially due to its function as a dominant
negative inhibitor of hGRα transcriptional activity (Bamberger et al, 1995). hGRβ is
unable to bind glucocorticoids due to an altered ligand-binding domain (Hollenberg
et al, 1985; Oakley et al, 1996), and unlike hGRα has been found to reside
preferentially in the nucleus of cells regardless of glucocorticoid availability (Oakley
et al, 1997). The inhibitory effect of this GR isoform may be due to its competing
with hGRα for their common response element (Bamberger et al, 1995), its ability to
bind to and thus compete for co-activators essential for full GRα transcriptional
activity (Charmandari et al, 2005), or its ability to interact directly with GRα,
forming GRα-GRβ heterodimers and thus hindering the formation of
transcriptionally active GRα homodimer complexes (de Castro et al, 1996; Yudt et
al, 2003).
The expression of the glucocorticoid receptor within teleost fish species largely
reflects that found in mammals. Two glucocorticoid receptors, each the product of
separate genes, have been identified in several teleost fish species (Greenwood et al,
2003; Bury et al, 2003; Kim et al, 2011), each of which are widely expressed. The
two GR receptors (GR1 and GR2) from rainbow trout are expressed in most tissues
including the intestine, liver, spleen, skin, heart and brain (Ducouret et al, 1995;
Takeo et al, 1996; Bury et al, 2003). Within the cichlid fish species Haplochromis
burtoni a higher expression of GR2, compared to either GR1 or MR, has been
described in the heart, liver and spleen, with overlapping levels of expression in the
gill (Greenwood et al, 2003).
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1.3.2 Mineralocorticoid receptor
The expression of the MR has previously been identified in aldosterone-responsive
tissues from humans including the distal parts of the nephron in the kidney,
cardiomyocytes, enterocytes of the colonic mucosa, keratinocytes and sweat glands
(Zennaro et al, 1997). Additionally a high expression of mineralocorticoid receptor
has been identified within the hippocampus of both human and rodent brains (Chao
et al, 1989; Seckl et al, 1991).
Within teleost fish species the mineralocorticoid receptor is widely expressed,
although expression within the brain has been found to be significantly higher than in
other tissues measured (Greenwood et al, 2003; Sturm et al, 2005). This led to the
hypothesis that the mineralocorticoid receptor of teleosts may have roles in some
aspects of their behaviour (Sakamoto et al, 2011). In support of this theory
intracerebroventricular administration of cortisol or 11-deoxycorticosterone (DOC),
the latter being a specific endogenous activator of the teleost MR, to the mudskipper
(Periopthalmus modestus) altered the migratory behaviour of this species (Sakamoto
et al, 2011), indicating the brain MRs to function in the preference for an aquatic
habitat.
1.3.3 Corticosteroid receptor ligands
The adrenal gland in mammals and the homologous interrenal organ of the head
kidney in teleost fish species are important in steroidogenesis, synthesising the
corticosteroid hormones for which the glucocorticoid and mineralocorticoid
receptors have a high affinity. While the adrenal gland produces two corticosteroids,
namely cortisol (corticosterone in rodents) and aldosterone, teleost fish are thought to
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contain only cortisol, with evidence for a mineralocorticoid hormone in teleost
species lacking. Production and secretion of corticosteroid hormones is under the
control of the highly conserved stress axis, involving the hypothalamus-pituitary-
adrenal (HPA) axis in mammals, and the comparable hypothalamus-pituitary-
interrenal (HPI) axis in teleost fish.
In response to stressors including salinity challenge, restraint, chasing and
confinement, an increase in corticotropin-releasing hormone (CRH) from the pre-
optic area of the hypothalamus has been observed in several fish species (Huising et
al, 2004; Doyon et al, 2005; Wunderink et al, 2011). CRH is also found to be
increased in mammals exposed to stress, as demonstrated by an increased expression
of CRH in the hypothalamus of postnatal rats following prenatal undernutrition
(Núñez et al, 2008). The hypothalamic axons of teleost fish species project directly
to the pituitary gland, terminating in the area of the corticotrophic cells of the
anterior pituitary (Flik et al, 2006). Within the cortitrophic cells of the pituitary, and
in response to CRH, the large precursor protein proopiomelanocortin (POMC) is
cleaved to adrenocorticotropic hormone (ACTH), which is released to the general
circulation and binds to the melanocortin-2 receptors (MC2R) on the interrenal cells
of the head kidney (Schiöth et al, 1996; Aluru and Vijayan, 2008). Similarly ACTH
binds to MC2R on the adrenal gland of mammals. In response to ACTH-binding,
interrenal MC2R of rainbow trout increases the mRNA expression levels of
steroidogenic enzymes (Geslin and Auperin, 2004; Aluru and Vijayan, 2008),
resulting in cortisol biosynthesis and release from the interrenal cells of the head
kidney. Similarly MC2R, expressed on the adrenal gland of mammals, appears to
mediate steroidogenesis in response to circulating levels of ACTH since MC2R
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knockout mice have no detectable levels of corticosterone and an unresponsiveness
to ACTH, despite the presence of measurable levels of the latter hormone (Chida et
al, 2007).
To date, evidence for the presence of the mineralocorticoid hormone aldosterone
within teleost fish is lacking. The p450 11β-hydroxylase (aldosterone synthase) is
highly expressed in the rat adrenal gland and when transfected into a cell line confers
the ability of the cells to convert 11-deoxycorticosterone (DOC) to corticosterone,
18-OH corticosterone and aldosterone through a series of hydroxylations (Zhou et al,
1995). Furthermore cells derived from the adrenal cortex of bovine, porcine and frog
species containing aldosterone synthase have also been shown to have aldosterone
synthesising activity, producing aldosterone from DOC (Nonaka et al, 1995).  In
contrast, aldosterone synthase enzyme isolated from the teleost Japanese eel has been
found to lack aldosterone synthesising activity and is unable to convert  DOC into
aldosterone (Jiang et al, 1998).
Despite the absence of aldosterone, it has been suggested that other products of the
steroidogenic pathway, such as DOC and other 11-deoxycorticosteroids, may act as
endogenous activators for the teleost MR following the discovery that some of these
compounds are able to bind the MR and enhance its transcriptional activity in a
transient transfection assay (Colombe et al, 2000; Sturm et al, 2005).
Within tetrapods the glucocorticoids mediate their effects through both the
glucocorticoid and mineralocorticoid receptors and often bind with a higher affinity
to the latter receptor, while mineralocorticoids such as aldosterone bind exclusively
to the mineralocorticoid receptor. Thus in cells expressing both GRs and MRs
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glucocorticoids present at low concentrations are expected to bind to and exert their
effects primarily through the mineralocorticoid receptor, while at higher
concentrations will act via both receptors as the MR become saturated. Several
mechanisms have been identified, both intracellular and extracellular, which limits
the availability of glucocorticoid hormone to mineralocorticoid-responsive tissues,
allowing the preferential binding of the mineralocorticoid hormone to the
mineralocorticoid receptor.
11β-hydroxysteroid dehydrogenase (11β-HSD) is an enzyme with the ability to
convert the active cortisol into its inactive form, cortisone, and vice versa
(Buckingham, 2006). Two forms of 11β-HSD exist, 11β-HSDI and 11β-HSDII,
responsible for activating and inactivating glucocorticoids, respectively. In
aldosterone-responsive cells of the kidneys and the intestines, 11β-HSDII is highly
expressed allowing preferential binding of the mineralocorticoid aldosterone to
mineralocorticoid receptors. The 11β-HSDI isoform is mainly expressed in tissues in
which the mineralocorticoid receptor is sparse but in which there is an abundance of
the glucocorticoid receptor, such as the brain and the heart. This allows the
generation of active glucocorticoids from inert cortisone and 11-
dehydrocorticosterone, respectively, and thus allows glucocorticoids to be used as
the primary ligands in these cells.
Corticosteroid-binding globulin (CBG), a member of the serine proteinase inhibitor
(serpin) protein superfamily binds approximately 95% of total circulating
glucocorticoids (Buckingham, 2006).  According to the free hormone hypothesis
only glucocorticoids unbound by CBG are able to enter cells and activate receptors
and thus by altering the amount of hormone bound by CBG the level of free hormone
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available to cells can be regulated (Breuner and Orchinik, 2002). CBG has also been
suggested to have a degree of control over the localisation of delivery of
glucocorticoids to the vasculature, for example to sites of inflammation (Pemberton
et al, 1988). Corticosteroid-binding globulin is a clade A member of the serpin
superfamily but, unlike most other members of this clade, CBG shows no proteinase
inhibitory functions (Klieber et al, 2007). Instead it has been found that CBGs are a
target for elastase, an enzyme released by neutrophils at sights of inflammation.
Cleavage of CBG by elastase changes its conformation from a stressed state to a
relaxed state, eradicating its steroid-binding ability. Therefore neutrophil release of
elastase can mediate the localised release of steroid hormone from CBG at sights of
inflammation.
P-glycoproteins are membrane bound proteins which are known to actively export
both dexamethasone and cortisol out of cells. Glucocorticoid receptors have been
shown to have a high affinity for the synthetic glucocorticoid, dexamethasone
(Dekloet, 1975) but, unlike corticosterone, its administration to rats does not lead to
its nuclear sequestration in the cells of the hippocampus. Disruption of the gene
encoding P-glycoprotein leads to a greater sequestration of dexamethasone in the
hippocampus of rodents compared to those containing a functional P-glycoprotein
(Meijer et al, 1998), indicative of a role for P-glycoproteins in the active extrusion of
dexamethasone from cells of the hippocampus. Recent evidence suggests that P-
glycoprotein-mediated extrusion of glucocorticoids may also function in the
placental glucocorticoid barrier, (Mark and Waddell, 2006) where disruption of the
barrier results in placental apoptosis (Waddell et al, 2000), retarded foetal growth
and alterations in postnatal phenotype (Smith and Waddell, 2000).
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1.3.4 Function of CRs
Energy homeostasis1.3.4.1
Addison’s disease and Cushing’s syndrome are two conditions resulting from the
abnormal regulation of glucocorticoid levels within animal models, the underlying
causes of these conditions being decreased and increased levels of glucocorticoids,
respectively. Addison’s disease is characterised by impaired stress responses,
lymphoid tissue hypertrophy, weight loss and hypoglycaemia whereas Cushing’s
syndrome results in obesity, the increased breakdown of skeletal muscle mass,
hyperglycaemia, liver steatosis, high cholesterol, immunodeficiency and insulin
resistance. The pathologies of these two conditions highlights the importance of
regulated glucocorticoid levels and also serves to underline the wide range of
metabolic functions which are regulated by glucocorticoids.
In the liver the glucocorticoid receptor controls many aspects of energy metabolism,
particularly protein and carbohydrate homeostasis. Glucocorticoids act as opposing
hormones to insulin, with the ability to induce the transcription of genes involved in
hepatic gluconeogenesis. This has been demonstrated in human subjects infused with
cortisol over a four hour period, in which plasma glucose concentrations were
increased compared to a control group in which no cortisol was administered (Khani
and Tayek, 2001).
Reports of changes in plasma glucose levels as an indicator of the metabolic response
of teleosts to cortisol have been mixed, with an increase reported in rainbow trout
(Oncorynchus mykiss) (Barton et al, 1987), the sea raven (Hemitripterus americanus)
(Vijayan et al, 1996) and coho salmon (Oncorynchus kisutch) (Vijayan and
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Leatherland, 1989), no change reported in rainbow trout (Andersen et al, 1991) and
brook trout (Salvelinus fontinalis) (Tam et al, 1988) and decreased in brook charr
(Salvelinus fontinalis) (Vijayan et al, 1991), and American eels (Anguilla rostrata)
(Foster and Moon, 1986). The inconsistencies in plasma glucose levels in response to
cortisol may be attributed to differences in experimental methods or may be due to
differences between species, developmental stage or nutritional status (Martinez-
Porchas et al, 2009). Nevertheless, the consensus for teleosts is that cortisol enhances
gluconeogenesis, with an increase in the expression of the main gluconeogenic genes
including glucose 6-phosphatase (G6Pase), fructose 1,6-bisphosphatase and
phosphoenol pyruvate carboxykinase (PEPCK) (Vijayan et al, 1996; Dziewulska-
Szwajkowska et al, 2003; Sathiyaa and Vijayan, 2003). Furthermore glucocorticoid
response elements (GREs) have been identified in the promoter regions of PEPCK
and G6Pase (Scott et al, 1998; Vander Kooi et al, 2005), suggesting the regulation of
such genes in response to cortisol is via the glucocorticoid receptor. Indeed, mice
defective in hepatic glucocorticoid receptors are unable to upregulate the expression
of genes coding for PEPCK and G6Pase, and as a result display a hypoglycaemic
state under conditions of starvation (Opherk et al, 2004). Diabetic mouse models
treated with an antisense oligonucleotide against hepatic glucocorticoid receptors in
order to reduce their expression demonstrate a significantly greater inhibition of
insulin-mediated hepatic glucose production and reduction of PEPCK and G6Pase
activity, which resulted in significantly lowered blood glucose level (Liang et al,
2005), suggesting that glucocorticoids and their receptors may play a role in the
hyperglycaemic phenotype of diabetes by upregulating genes involved in the
gluconeogenic pathway. Since the glucocorticoid receptor has been shown to be
upregulated in diabetic mouse models (Liu et al, 2005), downregulation of the
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hepatic receptor, or an inhibition of its activity, may provide one mechanism by
which the glucose profile of diabetics can be improved.
As well as a role in carbohydrate homeostasis, glucocorticoids have a role in lipid
homeostasis as evidenced by Cushing’s syndrome and the metabolic syndrome, two
conditions in which obesity is a hallmark, and in which glucocorticoid levels are in
excess (Walker, 2006). Furthermore the glucocorticoid receptor antagonist RU486
reverses the obese phenotype in rats (Langley and York, 1990), providing evidence
that raised levels of glucocorticoids participate in the obese phenotype via the
glucocorticoid receptor.
Within adipose tissue, overexpression of the enzyme 11β-hydroxysteroid
dehydrogenase 1 (HSD1) and thus an excess of the active form of glucocorticoids,
has been shown to increase abdominal fat deposits (Rask et al, 2002; Lindsay et al,
2003) contributing to the metabolic syndrome and promoting insulin-resistance.
Glucocorticoids have also been shown to increase preadipocyte differentiation in
primary and cell cultures (Gregoire et al, 1998) and the glucocorticoid receptor,
acting as a transcription factor, can cooperate with other transcription factors and
complexes to promote adipocyte differentiation. One such transcription factor whose
expression is upregulated by the glucocorticoid receptor is the peroxisome-
proliferator activated receptor γ (PPARγ), which itself has been shown to promote
adipocyte differentiation (Wu et al, 1996). Thus it would appear that that
manifestation of the metabolic syndrome is mediated in part through increased levels
of 11β-HSD1 together with the cooperative interaction of the glucocorticoid receptor
with other transcription factors that promote adipocyte differentiation. Consequently,
the inhibition of the 11β-HSD1 enzyme has emerged as a potential therapy in the
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treatment of the metabolic syndrome and associated disorders (Tomlinson and
Stewart, 2005).
As with the gluconeogenic pathway in teleosts the cortisol-mediated regulation of
lipid metabolism in fish species is not without conflicting results, the root cause of
which may be due to experimental or species differences (Mommsen et al, 1999).
However, the prevailing evidence indicates a role for cortisol in peripheral and
hepatic lipolysis. For example, an increase in peripheral lipolysis is observed in
response to elevated cortisol levels in European eel and salmon parr (Lidman et al,
1979; Sheridan, 1989) while cortisol implantation in coho salmon caused reductions
in total lipid concentration and triacylglycerol content in both the liver and muscle
(Sheridan, 1986).
In addition to measured effects on lipid levels, effects on enzymes with a function in
lipid homeostasis are reported to occur in response to cortisol. The activity of
hydroxyacyl coenzyme A dehydrogenase (HOAD), an enzyme involved in catalysing
the third step of fatty acid β-oxidation, was shown to be higher in cortisol-treated sea
ravens than in sham treated individuals and in brook charr reared at high stocking
density (Vijayan et al, 1990; Vijayan et al, 1996).
Glucocorticoids have been proposed to function in protein and glucose metabolism in
skeletal muscle. In both Cushing’s syndrome and steroid therapy muscle atrophy (the
loss of skeletal muscle mass) is common. The maintenance of muscular mass
depends on the activation of protein synthesising pathways, such as the
phosphatidylinositol-3 kinase (PI3K)/Akt signalling pathway, which leads to the
promotion of glucose utilisation and protein synthesis while inhibiting protein
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degradation. Several lines of evidence suggest a glucocorticoid-mediated inhibition
of the PI3K signalling pathway thus inducing muscle atrophy. Several mechanisms
as to how glucocorticoids inhibit this pathway have been proposed, including the
inhibition of signalling proteins upstream of PI3K (Wang et al, 2007), an increase in
the ratio of regulatory to catalytic PI3K subunits (Ueki et al, 2002; Brachmann et al,
2005) and, more recently a direct intracellular interaction between glucococorticoid
receptors and the p85 subunit of PI3K (Zhaoyong et al, 2009).
Osmoregulation1.3.4.2
Euryhaline fish species, which includes European flounder (Platichthys flesus), can
tolerate a wide range of salinities from fresh to salt water. The gills, kidneys and the
intestine of fish are the main organs involved in osmoregulation within teleosts. The
gills contain chloride cells which in turn contain high concentrations of the enzyme
sodium-potassium-activated adenosine triphosphate (Na+, K+-ATPase), which
actively transports portassium into the cell while transporting sodium out to maintain
the ionic gradient across the plasma membrane (Mobasheri et al, 2000). Two
catalytic α-subunit isoforms of Na+, K+-ATPase, α1a and α1b, have been identified
in the gills of rainbow trout and Atlantic salmon which are differentially regulated
during seawater transfer. While α1b is upregulated in response to seawater
acclimation, α1a is downregulated, suggesting these isoforms to function in seawater
and freshwater acclimation, respectively (Richards et al, 2003; McCormick et al,
2009). Evidence to date suggests a role for cortisol and the corticosteroid receptors in
the regulation of Na+, K+-ATPase activity. Administration of cortisol to gilthead
seabream (Sparus aurata) and freshwater tilapia (Oreochromis mossambicus) results
in an increase in gill Na+, K+-ATPase activity and increased hypoosmoregulatory
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capacity (Dang et al, 2000; Laiz-Carrion et al, 2002; Laiz-Carrion et al, 2003) while
seasonal increases in circulating plasma cortisol levels in salmon species is
associated with elevated Na +, K+, -ATPase activity and increases in intestinal fluid
absorption, suggesting a role for cortisol during the parr-smolt transformation
(Veillette et al, 1995; Veillette and Young, 2004). The regulation of Na+, K+-
ATPase enzyme activity by corticosteroid receptors may occur via the upregulation
of the Na+, K+-ATPase gene in a corticosteroid receptor-dependent manner,
following the discovery of a functional glucocorticoid response element (GRE)
within the promoter region of the β1 subunit of the human, rat and European eel
Na+, K+-ATPase gene (Derfoul et al, 1998; Kolla and Litwack, 2000; Cutler et al,
2000; Hao et al, 2003).
An increase in the expression of corticosteroid receptors has been reported upon the
transfer of fish species from freshwater to saltwater (Mizuno et al, 2001; Dean et al,
2003; Takahashi et al, 2006; Kiilerich et al, 2006; Yada et al, 2008). Within the
intestine of the Mozambique tilapia (Oreochromis mossambicus), glucocorticoid
receptors are localised to the posterior section where an increase in glucocorticoid
receptor mRNA in freshwater-adapted individuals exposed to seawater has been
reported, subsequent to an increase in plasma cortisol levels (Takahashi et al, 2006).
Chronic cortisol treatment mimicked the effects of seawater adaptation, increasing
glucocorticoid receptor mRNA, suggesting that increases in mRNA levels during
seawater adaptation may be due to chronic release of cortisol from the interrenal
tissue in euryhaline fish species.
Inhibitors of the glucocorticoid receptor can block the effects of cortisol in
osmoregulation with observed decreases in activity and expression of ion
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transporters, an inhibition of intestinal fluid absorption and a decreased tolerance to
hyperosmotic conditions having been reported (Veillette et al, 1995; Veillette et al,
2007; McCormick et al, 2008; Kiilerich et al, 2011).
Although a role for the glucocorticoid receptor in osmoregulation is well
documented, the role of the mineralocorticoid receptor is less clear. Changes in MR
mRNA levels upon exposure to seawater are somewhat conflicting. While an
upregulation of MR mRNA has been reported in the gills of Atlantic salmon and
rainbow trout following seawater exposure (Yada et al, 2008; Nilsen et al, 2008),
Kiilerich et al (2011) reported no change in the expression of gill MR mRNA during
acclimation of rainbow trout to seawater, although an increase in kidney and intestine
MR mRNA has been reported (Yada et al, 2008; Kiilerich et al, 2011). This may
indicate that the response of the MR to hyperosmotic conditions is species- or
developmental stage-specific.
A role for the mineralocorticoid receptor in acclimation to freshwater has been
suggested following the observation that spironolactone, a specific inhibitor of the
MR, could inhibit the proliferation of chloride cells in gill tissue (Sloman et al, 2001;
Scott et al, 2005). The proliferation of chloride cells is believed to contribute to ionic
homeostasis in freshwater fish by enhancing brachial ion uptake and evidence
suggests this proliferation is mediated by cortisol; chronic administration of cortisol
to rainbow trout increased sodium and chloride ion influx in the gills concomitant
with an increase in the number and individual apical surface area of gill chloride
cells per area of filament epithelium (Laurent and Perry, 1990).
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Within mammalian and amphibious species, the mineralocorticoid hormone
aldosterone has been found to increase expression of the serum glucocorticoid kinase
(GSK) gene which has been found to strongly stimulate sodium transport in tight
epithelia via the epithelial sodium channel (ENaC) (Chen et al, 1999; Pearce et al,
2000). Interestingly, the rodent glucocorticoid corticosterone was unable to induce
GSK expression in adrenalectomised rats (Pearce et al, 2000), suggesting the
mineralocorticoid is important in the regulation of GSK expression. Indeed, a
glucocorticoid/mineralocorticoid response element has been found in the promoter
region of the GSK gene (Webster et al, 1993; Maiyar et al, 1997), providing further
evidence that the mineralocorticoid receptor can regulate the expression of this gene.
More recently the expression of SGK in the euryhaline longjaw mudsucker
(Gillichthys mirabilis) and the Killifish (Fundulus heteroclitus) has been shown to be
altered in response to an osmotic challenge (Shaw et al, 2008; Evans and Somero,
2008). Furthermore in response to an increase in SGK, an increase in CFTR, a
chloride-ion channel, was observed in the gills of the killifish (Shaw et al, 2008),
suggesting a common role for SGK across a diverse range of vertebrate species in
osmoregulation.
Inflammatory response1.3.4.3
Like the peroxisome proliferator-activated receptors, glucocorticoid receptors are
well recognised as functioning in the inflammatory response (Necela and Cidlowski,
2004), but this effect has been recognised for longer and is far more pronounced. As
a consequence glucocorticoid hormones are widely prescribed for the treatment of
inflammatory disorders such as rheumatoid arthritis, asthma and dermatitis, and in
autoimmune diseases such as Crohn’s disease (Barnes, 1998). The primary
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mechanism through which glucocorticoids function to reduce the inflammatory
response is to suppress, either directly or indirectly, the activation of pro-
inflammatory cytokine genes (Barnes, 1998). Like PPARs the glucocorticoid
receptor can inhibit the inflammatory response by affecting the actions of NFκB,
including causing upregulation of inhibitor of kappa B-α (IκB-α) (Auphan et al,
1995; Scheinman et al, 1995), competition for essential NFκB co-activator proteins
(Sheppard et al, 1998) and direct protein-protein interactions between NFκB and the
GR (Adcock et al, 1999) (Figure 1-6).
Figure 1-6. Glucocorticoid receptors are hypothesised to inhibit NFκB activity by direct
interactions with the pro-inflammatory transcription factor NFκB, transcription of the NFκB
inhibitor IκB and by competition for NFκB co-activators (e.g. CBP, p300 and SRC-1).
IκB-α functions in resting cells to maintain NFκB in the cytoplasm, thus impeding its
ability to transcribe its target genes. Upon phosphorylation and subsequent
ubiquitination, IκB-α is targeted for proteosomal degradation, leaving NFκB free to
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enter the nucleus and alter gene transcription. In 1995, two independent research
groups reported an increase in IκB-α protein following administration of
glucocorticoids (Auphan et al, 1995; Scheinman et al, 1995). However since these
first reports, several research groups have failed to observe an increase in IκB-α
protein following administration of glucocorticoids (Adcock et al, 1999; Pruett et al,
2003) or the observed increase was at a level insufficient to prevent its targeted
degradation and to prevent the translocation of NFκB to the nucleus (Auwardt et al,
1998). Furthermore a mutant glucocorticoid receptor with the inability to dimerise,
and which does not increase levels of IκB-α, is still able to repress NFκB (Heck et al,
1997). Together these results suggest that the mechanism of glucocorticoid-mediated
increases in IκB levels is restricted to certain cell types and is not a universal
mechanism.
Glucocorticoid receptors have been hypothesised to compete with NFκB for essential
co-activator proteins, thus limiting the amount of co-activators available for NFκB
activation and therefore inhibiting activation of its transcriptional activities
(Sheppard et al, 1998). The p65 subunit of NFκB has been shown to interact with the
co-activators CREB-binding protein (CBP), p300 and SRC-1 and co-regulatory
proteins potentiate the p65-mediated transcription of reporter constructs (Gerritsen et
al, 1997). Previously the glucocorticoid receptor has been observed to repress
transcription of non-GR target genes via competition for limiting amounts of CBP
and this repression was abolished upon expression of increasing levels of CBP
(Kamei et al, 1996). Despite this finding, several lines of evidence suggest that
competition for co-activator proteins is not the mechanism by which the GR
represses NFκB activity. For example while it is true that increasing levels of CBP
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increases the transcription of several NFκB-driven genes in the absence of
glucocorticoids (Sheppard et al, 1998; De Bosscher et al, 2000), an overexpression
of CBP, p300 or SRC-1 and the presence of glucocorticoids does not relieve the
repression (De Bosscher et al, 2000). A lack of specificity in the model is another
shortcoming of this competition model; both CBP and p300 interact with various
transcription factors and thus each of these proteins, along with the glucocorticoid
receptor, could be considered competitors and be expected to transrepress the activity
of NFκB, which is not the case. The third model proposed for glucocorticoid-
mediated inhibition of NFκB is one involving direct protein-protein interactions
between the glucocorticoid receptor and NFκB. Indeed such an interaction between
NFκB and the glucocorticoid receptor has previously been reported (Adcock et al,
1999) which resulted in decreased expression of the NFκB target, interleukin-6 (IL-
6) (Ray and Prefontaine, 1994), a cytokine overexpressed in rheumatoid arthritis
(Papanicolaou et al, 1998). Multiple regions of the GR are required for effective
transrepression of NFκB; GR mutants lacking the DNA-binding domain, and more
specifically either of the zinc finger regions, the steroid-binding domain or part of the
amino-terminal A/B domain are unable to repress NFκB activity (McKay and
Cidlowski, 1998).
CRs in reproductive function1.3.4.4
Within vertebrates the hypothalamic-pituitary-gonadal (HPG) axis controls
reproduction with the actions of the main hormones, including gonadotropin
releasing hormone (GnRH), gonadotrophins and gonadal sex-steroids having been
extensively described. Within fish species, increasing evidence suggests a role for the
corticosteroid hormones in the endocrine control of reproduction.
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Several adverse effects on teleost reproductive performance have been reported in
response to stress. Within females adverse effects included a reduction in
vitellogenesis, oocyte size, impaired zonagenesis and a reduced progeny survival in
Atlantic salmon and rainbow trout in response to thermal and confinement stress,
respectively (Campbell et al, 1994; King et al, 2003). These effects may be related to
cortisol levels since increased cortisol has been reported in response to stress (Barton
and Peter, 1982; Pickering and Pottinger, 1989; Vijayan et al, 1997) and has been
linked to a disruption of the HPG-axis, vitellogenesis, androgen and estrogen
signalling (Teitsma et al, 1999; Pankhurst and Van Der Kraak, 2000; Lethimonier et
al, 2000; Consten et al, 2002; Berg et al, 2004; Berg et al, 2004).
Despite these adverse effects, several lines of evidence also support a positive role
for corticosteroids in fish reproduction. Gonads of both male and female fish species
have the potential to produce corticosteroid hormones such as cortisol, 11-DOC,
corticosterone and 11-deoxycorticosterone, possessing all the enzymes responsible
for their synthesis (Kobayashi et al, 1998; Kusakabe et al, 2002; Kazeto et al, 2003;
Li et al, 2003; Socorro et al, 2007; Zhou et al, 2007). 11-deoxycorticosteroids have
been shown to be important products of ovarian and testicular steroidogenesis
(Colombo et al, 1978; Tesone and Charreau, 1980; Kime et al, 1992) and the
presence of cortisol and 11-DOC in the ovary, sperm and seminal fluid supports the
theory of gonadal steroidogenesis (Scott et al, 1991a; Scott et al, 1991b).
Corticosteroid receptors have been found to be expressed within both male and
female fish gonads. In rainbow trout the glucocorticoid receptor has been detected in
the ovary (Takeo et al, 1996; Milla et al, 2006) while both the glucocorticoid and the
mineralcorticoid receptors have been detected in the testes of trout and other species
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(Takeo et al, 1996; Park et al, 2007; Filby and Tyler, 2007; Milla et al, 2008).
Furthermore, 11β-HSD2 expression, which prevents the elicit activation of the
mineralocorticoid receptor by catabolising cortisol, is found in both male and female
reproductive organs, particularly from gametogenesis to the final stages of
maturation, and displays activity in the testes (Kusakabe et al, 2003). A role for the
corticosteroid hormones in oocyte maturation has been suggested since treatment
with luteinizing hormone (LH) leads to in vitro follicular and interrenal synthesis of
DOC and cortisol (Colombo et al, 1973; Truscott et al, 1978; Sundararaj et al, 1979).
More recently administration of the human chorionic gonadotropin, used extensively
to induce ovulation in fishes, was demonstrated to increase corticosteroid production
which was associated with oocyte maturation (Mishra and Joy, 2006). In agreement
with a role for corticosteroid hormones in oocyte maturation, 11-DOC has been
found to be the most effective hormone, both in vivo and in vitro, in germinal vesicle
breakdown (GVBD), a measure of oocyte final maturation, in the cyprinid species
Chalcalburnus tarichi (Unal et al, 2008) and in brook trout (Duffey and Goetz,
1980). This latter effect may be species-dependent however since corticosteroid
hormones are relatively ineffective, except at high concentrations, in inducing oocyte
maturation in Coho salmon and are not effective in rainbow trout (Jalabert et al,
1972; Sower and Schreck, 1982). However corticosteroids have been shown to
enhance the actions of gonadotropin and steroids on the induction of GVBD in
rainbow trout (Jalabert, 1975). Associated with oocyte maturation is the biological
process of oocyte hydration, characterised by an increased oocyte volume and oocyte
swelling due to water influx and the entry of inorganic ions (Greeley et al, 1991;
Finn et al, 2002). Injection of a high dose of cortisol was demonstrated to increase
hydration in muscle and ovarian tissues in the Nile tilapia (Oreochromis nilotica),
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and while sodium ion content was found to decrease in muscle an increase in ovarian
sodium content was observed (Babiker and Ibrahim, 1979). More recently, and in
agreement with this previous study, Milla et al (2006) reported an increase in the wet
mass of rainbow trout oocytes in response to incubation with cortisol, concurrent
with an increase in the mRNA levels of GR2, suggesting cortisol may function via
GR2 in the control of oocyte hydration of rainbow trout.
Corticosteroids have also been implicated in male reproduction, and more
specifically in spermatogenesis. Cortisol at 0.1-100ng/mL has been shown to induce
spermatogonial mitosis by increasing levels of 11-ketotestosterone, the primary
androgenic hormone in fish species, in the testes of Japanese eel (Ozaki et al, 2006).
In immature bronze featherback fish (Notopterus notopterus), cortisol administration
increased the testicular-somatic index (a measure of sexual maturity in fish species)
and the onset of spermatogenesis (Shankar and Kulkarni, 2000). In contrast, higher
levels of cortisol (100ng/mL) have been shown to inhibit the effect of 11-
ketotestosterone on spermatogenesis (Ozaki et al, 2006), suggesting excess cortisol
to be deleterious to male reproduction. Indeed following stress or administration of
cortisol, male gonadal development was inhibited, characterised by smaller gonads,
retarded spermatogenesis and a lower sperm quality (Campbell et al, 1992).
Furthermore in common carp administration of RU486, the glucocorticoid receptor
inhibitor, was able to prevent the effects of cortisol on gonadal development and
spermatogenesis delay (Goos and Consten, 2002), demonstrating cortisol is likely
acting via the GR to mediate these effects.
An adverse effect on all components of the HPG axis in immature common carp
(Cyprinus carpio) has been reported following long-term exposure to dietary cortisol
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(Consten et al, 2001). A decrease in brain GnRH content, mRNA levels of LH and
FSH in the pituitary, and plasma levels of LH was reported, as was a decrease in
testicular androgen secretion. Although it could not be determined whether the
effects on gonadotropins was a direct effect on the pituitary or the hypothalamus or
whether the reduced expression and release was due to a decrease in testicular
androgen release, a reduced expression of GnRH in the brain suggests the effect is
likely due to decreased secretion of GnRH.
In addition to cortisol a role for DOC as a regulator of spermiation, the reproductive
stage when hydrated sperm are released from the testis to the vas deferens, in the
rainbow trout has been suggested. This suggestion came following several
observations; firstly DOC is up to 50-times higher in mature males than in immature
males, increasing rapidly at the end of the reproductive cycle, and secondly the
expression of MR, although higher in immature individuals than in mature
individual, increases rapidly during the period of spermiation, immediately after the
increase in plasma DOC (Milla et al, 2008).
Thus it appears that corticosteroids, of which cortisol is the primary example in fish
species, exerts both positive and negative effects on fish reproduction (Figure 1-7).
Higher levels of cortisol appear to inhibit vitellogenesis in female species, while
disrupting gonadal development and spermatogenesis in males. A disruption of the
hypothalamic-pituitary-gonadal axis is observed in both males and females. In
females, evidence suggests a positive role for cortisol in oocyte maturation while in
males spermatogenesis may be positively influenced. This information implies a role
for corticosteroid hormones in the endocrine control of fish reproduction and some of
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the effects may be mediated by activation of the glucocorticoid and/or
mineralocorticoid receptors.
Figure 1-7. The implications of corticosteroids in female and male teleost reproduction. DOC –
11-deoxycorticosterone; 11-DC – 11-deoxycortisol; GnRH – gonadotropin-releasing hormone. +
- indicates a positive influences of corticosteroids; - indicates a negative influences of
corticosteroids; -? – indicates a suspected negative effect of corticosteroids. See text for details.
Figure adapted from Milla et al (2009).
1.4 Endocrine disruption in aquatic organisms
Endocrine disruptors can be defined as exogenous substances which interfere with
the endocrine system either by:
1. Mimicking the actions of a naturally-produced hormone, producing a similar
response from the target receptor (agonist; )
2. Blocking the hormone receptor in target cells, preventing the actions of
endogenous hormones (antagonist; )
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3. Altering the synthesis, transport, metabolism and excretion of endogenous
hormones, thus disrupting hormone homeostasis
Figure 1-8. A diagrammatic representation of agonistic and antagonistic actions by endocrine
disruptors. Endocrine disruptors (represented in green) can disrupt signalling pathways by a)
binding to a receptor and mimicking the actions of a naturally produced hormone or b) block
the hormone receptor, thus preventing the actions of endogenous hormones (represented in
orange).
Behavioural, developmental, and reproductive effects have been reported in aquatic
organisms in response to exposure to anthropogenic compounds which pollute
aquatic environments. Such compounds include human pharmaceuticals, agricultural
and industrial by-products.
1.4.1 Heavy metals
The increased use of heavy metals, such as cadmium and copper, in agricultural,
chemical and industrial processes has resulted in their accumulation in the
environment. Mounting evidence over the last decade suggests these metals to be
endocrine disruptors in aquatic organisms.
(a)
(b)
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Cadmium, widely used in pesticides including fungicides and insecticides and in
commercial fertilizers, is a well-documented endocrine disruptor. The predator-
avoidance behaviour of rainbow trout is eliminated upon a 7 day exposure to 2µg/L
cadmium (Scott et al, 2003), characterised by a decrease in feeding and swimming
and an increase in latency between first feed and sheltering time compared to
unexposed control fish. These observations may be due to the effect of cadmium on
cortisol synthesis. In response to alarm substance (the chemical signal released from
epidermal cells of injured fish to warn others of danger), plasma cortisol levels in
fish are rapidly elevated (Rehnberg and Schreck, 1987). However, brown trout
(Salmo trutta) from the cadmium-contaminated Eagle River, Colorado, when placed
under confinement stress, display a delayed elevation of plasma cortisol levels
compared to fish from uncontaminated waters of the same river (Norris et al, 1999).
Furthermore, raised cortisol levels could not be sustained suggesting that cadmium
exposure impacts upon the hypothalamo-pituitary-interrenal (HPI) axis, resulting in a
delayed or dampened response to stressors. Indeed, it has recently been demonstrated
that cadmium suppresses ACTH-stimulated cortisol secretion in head kidney slices
of rainbow trout, in parallel with decreased levels of steroidogenic enzymes
important for corticosteroid biosynthesis (Sandhu and Vijayan, 2011).
Reproductive abnormalities have also resulted from the exposure of organisms to
heavy metals. A significant decrease in the number of ovarian granulosa cells as well
as a decrease in the binding of follicle stimulating hormone (FSH) and luteinising
hormone (LH) to their receptors on the surface of granulosa cells has been reported
in female rats exposed to either cadmium, lead or a combination of both
(Nampoothiri and Gupta, 2006). The authors also found the membrane composition
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of granulosa cells to be affected by exposure to cadmium as demonstrated by the
decrease in cholesterol and phospholipids content and an increase in the fluidity of
the membrane. This could be one explanation for the decrease in hormone binding
since an alteration in the fluidity of the membrane could result in a conformational
change in the membrane bound receptors, preventing the binding of the gonadotropin
hormones. Not only does cadmium inhibit the binding of gonadotropin hormones to
their receptors, thus inhibiting cholesterol uptake, but it also interferes with the
progesterone biosynthesis pathway as demonstrated by the failure of the cytochrome
P450 side-chain-cleavage (P450scc) enzyme  to convert cholesterol to pregnenolone
in the presence of cadmium in cultured human placental cells (Kawai et al, 2002).
Mercury, which enters the aquatic environment via atmospheric deposition from
sources such as coal power plants, is found in fish predominantly in its most toxic
form, methylmercury (Bloom, 1992). Studies concerning aquatic organisms have
shown methylmercury to be an endocrine disruptor, altering the expression of genes
within the liver, including those related to reproduction (Klaper et al, 2006). One
such gene is that encoding for vitellogenin, a protein associated with egg growth and
normally produced only in females. However a 142.8-fold increase in the levels of
vitellogenin mRNA in male fathead minnows (Pimephales promelas) exposed to
dietary methylmercury has been reported, while in females a downregulation in
vitellogenin expression was reported (Klaper et al, 2006). The downregulation of
vitellogenin mRNA in females could potentially reduce egg production and hence
affect reproductive success in fathead minnows. As well as genes associated with
reproduction, apoptotic genes are upregulated in female fathead minnows (Klaper et
al, 2006). Ovarian follicular apoptosis increased after exposure to methylmercury,
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resulting in a decrease in the production of 17-β estradiol which subsequently led to
impaired reproduction (Drevnick et al, 2006). The effects of methylmercury on
reproduction are unlikely to be specific to female fish since male Wister rats exposed
to methylmercuric chloride experience a decrease in testicular weight and sperm
production and an increase in spermatocyte and spermatid (Homma-Takeda et al,
2001).
1.4.2 Pesticides
Pesticides encompass a wide range of chemicals including bactericides, fungicides,
insecticides, herbicides and molluscicides. Many of these are classed as persistent
chemicals, surviving in the environment long after their use has ceased. An example
of such a chemical is the pesticide dichloro-diphenyl-trichloroethane (DDT), which
is still detected in human breast milk and fat despite having been banned in the UK,
USA and many other countries since the 1970s and 1980s. Traces of DDT can still
be detected in individuals, irrespective of whether it was ever used in the country in
which the individuals reside. This has been found to be the case in many areas of the
Arctic where traces of DDT as well as hexachlorobenzene (HCB), and
hexachlorocyclohexane (HCH) have been found in the indigenous people of the
Russian Arctic areas, transported with the northward flow of rivers, oceans and
atmospheric currents (Webster, 2004).
Many persistent organic pollutants have been shown to bring about adverse health
effects in mammals, as well as in aquatic organisms. A link has been made between
rotenone, a compound used in pesticides, and the development of Parkinson’s
disease-like symptoms in rats (Betarbet et al, 2000). Parkinson’s disease is a
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neurodegenerative disorder characterised by the death of dopaminergic neurons in
the brain. Betarbet et al (2000) noted that constant administration of rotenone to rats
resulted in the disruption of complex I, a part of the mitochondria electron transport
system noted to be disrupted in Parkinson’s disease patients (Keeney et al, 2006).
This disruption of complex I was accompanied by the degeneration of dopamine-
producing circuits and the appearance of Lewy bodies, abnormal protein deposits
that aggregate in nerve cells and that are characteristic of Parkinson’s disease. In
vitro primary dopaminergic cell cultures exposed to rotenone have been shown to
lose neurons in a progressive concentration and time-dependent manner while non-
dopaminergic neurons and glial cells were less affected, demonstrating the
importance of dopaminergic neurons in the sensitivity to rotenone pesticide exposure
(Radad et al, 2008). In the human population more than 90% of cases of Parkinson’s
disease are considered to be sporadic, having no relation to genetic mutation. Further
to this there is a strong correlation between the development of the disease and rural
living, farming and well-water drinking, giving weight to the hypothesis that
pesticide exposure increases the risk for the development of Parkinson’s disease.
Organotins, which includes tributyltin chloride (TBTC), tributyltin oxide (TBTO)
and bis(triphenyltin) oxide (TPTO), are compounds which have been in use since the
1950s as agricultural fungicides, rodent repellents and molluscicides, as well as being
a component of antifouling paint used to treat marine vessels. Organotins are one of
the most widely recognised endocrine disruptors in the aquatic environment and have
been shown to induce irreversible sexual abnormalities in exposed aquatic organisms
(Wibe et al, 2001; Garaventa et al, 2007). Although less studied in the human
population, organotins have been suggested to act as obesognes, disrupting normal
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adipocyte cell differentiation and resulting in a predisposition to obesity and related
metabolic disorders (Kanayama et al, 2005; Grün and Blumberg, 2006; Grün et al,
2006).
Within the aquatic environment molluscs appear particularly susceptible to endocrine
disruption by organotin compounds, with pseudohermaphroditism having been
widely reported (Camillo et al, 2004; Pellizzato et al, 2004; Santos et al, 2006; Lee
et al, 2009). Pseudohermaphroditism is the superimposition of male characteristics,
such as a penis and vas deferens, on female organisms (imposex) (Garaventa et al,
2007). The mechanism by which organotins result in imposex has remained largely
elusive despite the existence of several hypotheses to explain the phenomenon,
including the inhibition of the P450-mediated aromatase enzyme which catalyses the
conversion of androgens into estrogens (Bettin et al, 1996), the inappropriate release
of the neuropeptide Ala-Pro-Gly-Trp-NH2 (APGW amide), a suspected penis-
morphogenic factor (Oberdörster et al, 2005) and through interactions with the RXR
and/or PPARγ receptors (Nishikawa et al, 2004; Kanayama et al, 2005; Grün et al,
2006; Nishikawa, 2006; Castro et al, 2007).
1.4.3 Pharmaceuticals
Many human pharmaceutical products enter the aquatic ecosystem via their
incomplete removal from wastewater treatment plants and several have been shown
to disrupt endocrine systems within fish and other aquatic species. Particular
emphasis has been put on the effects of synthetic sex steroid hormones, such as those
present in contraceptives pills, due to their potential to disrupt reproductive functions
in non-target organisms at environmentally relevant concentrations.
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One of the first observations of reproductive dysfunction in the aquatic environment
was in the wild roach (Rutilus rutilus) inhabiting UK rivers (Jobling et al, 1998). A
high number of roach testes contained numerous female germ cells and oocytes, and
experiments on rainbow trout initially indicated that alkylphenol detergent pollutants
may be the cause (White et al, 1994). However subsequent wider investigations
showed that in most cases the actual environmental concentrations of these
compounds were likely insufficient to cause these effects and both natural and
synthetic estrogens were to blame (Desbrow et al, 1998). Concentrations of the
synthetic estrogen compound 17α-ethinyloestradiol (EE2) have been measured in
UK freshwater systems at concentrations up to 3.4 ng/L (Williams et al, 2003). At
concentrations of 3-5 ng/L a disruption in the development of the testes in genetically
male zebrafish exposed to EE2 was observed, together with development of
feminized gonads, inhibiting reproduction (Nash et al, 2004; Fenske et al, 2005). The
inhibition of male gonadal differentiation may be due to the effects of estrogen on
the doublesex and mab-3 related transcription factor 1 (Dmrt1) and anti-müllerian
hormone (AMH) genes, the expression of which are correlated with the period of
early gonadal differentiation (Schulz et al, 2007). Sex-dependent differences in the
expression of these genes have been described in zebrafish previously, with an
overexpression in males compared to females. This overexpression is inhibited by
exposure to EE2, and was associated with an inhibition of male gonadal sex
development (Schulz et al, 2007). A similar downregulation of Dmrt1 and AMH has
been described in fathead minnow (Pimephales promales) following exposure to
EE2 (Filby et al, 2007).
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The induction of vitellogenin, an egg yolk protein expressed in females of almost
every oviparous species including fish, amphibians, reptiles, birds, most invertebrates
and the platypus (het Schip et al, 1987; Brown et al, 1997; Babin, 2008), has become
a molecular marker for exposure to estrogenic endocrine disrupting compounds
(EDCs) in male fish species, while the inhibition of vitellogenesis in female species
can provide an indication of disruption in the female reproductive axis (Kime et al,
1999). A number of studies have used vitellogenin levels in male organisms to
demonstrate the presence of estrogenic chemicals in the aquatic environment. For
example rainbow trout placed downstream of sewage-treatment works and exposed
to sewage effluent had vitellogenin levels 500-100,000 fold greater than fish
upstream of sewage effluent (Purdom et al, 1994), while European flounder from the
polluted Mersey Estuary, UK, displayed vitellogenin levels up to a million times
greater than control fish from the relatively unpolluted Alde River estuary (Allen et
al, 1999).
In addition to synthetic sex steroids, synthetic glucocorticoids administered in large
quantities as anti-inflammatories, have been detected in surface waters and effluents
in the ng/L range (Chang et al, 2007; Schriks et al, 2010). Within fish, relatively low
concentrations (1 µg/L) of individual glucocorticoids can cause effects (Kugathas
and Sumpter, 2011) and the effect of a mixture of glucocorticoids, as occurs in the
environment, is unknown. Therefore synthetic glucocorticoids released to the
environment may function as endocrine disruptors in non-target organisms.
1.5 Chemical Pollution and Environmental Risk Assessment
Many pollutants, including industrial byproducts (bisphenol A, polychlorinated
biphenyls and alkylphenols), plant-derived phytoestrogens (isoflavones and lignans)
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and pesticides (DTT and methoxychlor), have been described as xenoestrogens,
mimicking the endogenous estrogen hormone 17β-estradiol and exerting effects by
binding to the endogenous estrogen receptor (Korach et al, 1988; White et al, 1994;
Kuiper et al, 1998; Yadetie et al, 1999; Matthews et al, 2000; Tollefsen et al, 2002;
Uchida et al, 2010).
As well as estrogenic activities bisphenol A is able to disrupt endocrine functions in
rodents by impairing the binding of thyroid hormone to the thyroid receptor, in part
by recruiting the co-repressor N-CoR to the receptor (Moriyama et al, 2002).
Similarly binding of the synthetic glucocorticoid dexamethasone to the
glucocorticoid receptor and subsequent GR-mediated transcription of the
phosphoenolpyruvate carboxykinase (PEPCK) gene is inhibited following exposure
of rat hepatoma cells to non-toxic doses of arsenic (Kaltreider et al, 2001). Since
nuclear translocation of the GR was unaffected, the authors deduced that the
inhibitory effect of arsenic is due to its ability to interact directly with the
glucocorticoid receptor thus blocking the access of dexamethasone to the ligand-
binding site.
This brief list of examples summarizes a potentially much broader picture where
many different pollutants, particularly small lipophilic contaminants, are able to exert
effects via interactions with NHRs, emphasising the need for an establishment of
methods to predict such interactions, improve risk assessment methods and thus limit
the risk of exposure to organisms.
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1.5.1 Environmental Risk Assessment (ERA)
ERA is defined as the procedure by which the likely or actual adverse effects of
pollutants and other anthropogenic activities on ecosystems and their components are
estimated with a known degree of certainty using scientific methodologies (Depledge
and Fossi, 1994) and is the foundation for many national and international regulatory
actions.
Well established methods are used to regulate the discharge of chemicals to the
environment. In general these methods compare the dose response of single
chemicals in laboratory toxicity tests on various organisms, to the predicted or
measured environmental concentrations and thus provide discharge limits to
minimize environmental effects (van Leeuwen and Vermeire, 2007). Such
approaches can be criticised because they only consider chemicals in singlicate and
they rely on standardised, usually short-term tests, neither of which scenario is usual
in the environment. For aquatic systems fish have traditionally been used as the test
organisms. In the United States the main test species have been fathead minnows and
bluegill sunfish (Lepomis macrochirus) while within the UK much toxicity work has
been performed with rainbow trout (Mason, 2001). The use of fish species to test the
many hundreds of thousands of chemicals used by man requires an enormous
number of tests on living organisms. Guidelines for fish toxicity testing, issued by
the environmental protection agency (EPA) and the Organisation for Economic Co-
operation and Development (OECD), which oversees the developoment of
environmental risk assessment methods, specifies the use of at least seven fish (EPA
prefer 10) at each test concentration and in controls, with at least five concentrations
tested for each compound. Additionally the EPA recommends duplicate tanks per
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test concentration, thus requiring a minimum of 70 fish per pollutant compound
assessed. Thus with the many compounds requiring assessment the use of live
animals has very negative ethical, logistic and financial implications. For these
reasons more complex testing strategies have been proposed. Hutchinson (2008) has
suggested an Intelligent Testing Strategy designed to prioritize chemicals for toxicity
testing with the aim of reducing the number of tests and consequently the number of
animals required. These types of strategies initially gather chemical information to
establish likely persitence and bioaccumulative effects then assess toxicity using a
“tiered” approach. Thus, the first tier of toxicological testing may include in vitro or
in cellulo tests designed to establish whether a particular chemical is likely to have a
specific toxic mode of action. In this regard the US Environment Protection Agency
(EPA) launched the ToxCast screening programme in 2007 with the aim of
developing an approach to predict potential toxicity and prioritize the many
thousands of chemicals requiring further testing (www.epa.gov/ncct/toxcast/
[Accessed 27 Feb 2012]). Furthermore, in response to the finding that a variety of
compounds can disrupt the endocrine system of animals in laboratory studies, the
EPA instigated, as a first tier testing regime, the assessment of interaction of
chemicals with mammalian NHRs including the estrogen receptor, androgen receptor
and thyroid hormone receptor (http://www.epa.gov/endo/index.htm [Accessed 28
Feb 2012]). Further high throughput screening assays to detect pollutant interactions
with a range of human NHRs, including PPARs and CRs are also under development
in the USA (Huang et al, 2011). These tests are primarily aimed at assessing the risks
of environmental chemicals to humans and to date tests targeted to aquatic organisms
are lacking, although the OECD are currently in the early stages of reviewing
possibilities for developing high-throughput in vitro tests for environmental
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endocrine disruptor screening targeted to fish
(www.oecd.org/dataoecd/22/8/48343294.pdf).
1.5.2 Pollutants in the Aquatic Environment
The requirement for high-throughput in vitro screening methods targeted to aquatic
organisms comes from the finding that many compounds of anthropogenic origins
have been detected in aquatic environments. The compounds used in the studies
presented within this thesis have been detected in waters, sediments and/or the
tissues of fish sepcies (Table 1-2, 1-3 and 1-4).
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Table 1-2. Reported concentrations (ng/L) of selected pollutants in rivers and sewage effluent. In
each case the place of sampling is provided.
Pollutant Water concentration (ng/L) References
Fibrates (Lipid regulators)
Gemfibrozil
790
(Max conc. in survey of 139 USA streams) Kolpin et al (2002)
66 (UK) Kasprzyk-Hordern et al(2008)
Bezafibrate
Up to 4600 (German effluent) Ternes (1998)Up to 3100 (German rivers and streams)
780 (French rivers) Comoretto & Chiron(2005)
Clofibric Acid
5.5 ( Swiss lake surface water)
Buser and Müller (1998)0.5-7.8 (North sea)
100 (French effluents)
Hernando et al (2006)
24-35 (French Rivers)
Fenofibrate
220-400 (Rio de Janeiro, Brazil) Stumpf et al (1999)
160 (Greece STP effluent) Andreozzi et al (2003)
Phthalates/Monopthalate esters (Plasticizers)
Benzylbutylphthalate
(BBzP)
n.d. – 61 (Tama River, Japan) Suzuki et al (2001)
3.5 (False Creek, Canada) Sura (2007)Dimethylphthalate
(DMP)
Diethylhexylpthalate
(DEHP)
400-1900 (Manchester, UK) Fatoki & Vernon (1990)
18500 (max conc.); 9300 (Mean conc) Yuan et al (2002)
Mono-1-methylhexyl
phthalate
20 (Approx from graph data; False Creek,
Canada) Sura (2007)
Bisphenol A
Bisphenol A
n.d. – 330 (Marine/Estuarine waters,
Netherlands) Belfroid et al (2002)
n.d. – 170 (Freshwaters of Netherlands)
Organotins/Pesticides
TBT compounds
3 – 70 (Port of Osaka, Japan) Harino et al (1999)
n.d. – 0.47 (Xiamen area,China) Wang et al (2008)
2 – 200 (Corsica coast, West Mediterranean) Michel et al (2001)
3200 (Max conc., Singapore coastal water) Basheer et al (2002)
Deltamethrin n.d. – 6.28 (Guanting reservoir, Beijing) Xue et al (2005)
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Table 1-2 cont… Reported concentrations (µg/L) of selected pollutants in rivers and sewage
effluent. In each case the place of sampling is provided.
n.d. – not detected
Table 1-3. Reported concentrations (mg/Kg) of selected pollutants in sediments. In each case the
place of sampling is provided in brackets.
Pollutant Sediment concentration (mg/Kg) Reference
Phthalates/Monopthalate esters (Plasticizers)
Dimethylphthalate (DMP) 0.16 (South Africa river) Fatoki et al (2010)
Benzylbutylphthalate
(BBzP)
1.8 (max conc); 0.2 (Mean conc) (Taiwan
river) Yuan et al (2002)
<0.05 – 3.1 (Taiwan rivers) Huang et al (2008)
Diethylhexylphthalate
(DEHP)
0.5-23.9 (range); 4.6 (Mean conc)
(Taiwan river) Yuan et al (2002)
n.d. – 0.1 (Taiwan river) Huang et al (2008)
Mono-1-methylhexyl
phthalate
0.0004 – 0.0005 (d.w. False Creek,
Canada) Sura (2007)
Organotins/Pesticides
TBT compounds
0.015 – 0.047 (Harbour area, Taranto,
South Italy)
Cardellicchio et al
(1992)
0.0005– 1.3 Harino et al (1999)
2.796 (max conc; Paranaguá Estuarine
Complex, Brazil) Santos et al (2009)
n.d -0.573 (Gulf of Cadiz, Spain) Garg et al (2009)
n.d. – 0.026 (Xiamen area, China) Wang et al (2008)
0.007-0.173 (Mersey Estuary, UK) Harino et al (2003)
0.017 – 0.847 (Sao Paulo, Brazil) Godoi et al (2003)
Deltamethrin
0.013 – 0.291 (Okavango delta,
Botswana) Daka et al (2006)
78.6 – 301 (Guanting reservoir, Beijing) Xue et al (2005)
Bisphenol A
Bisphenol A
0.0012 – 0.022 (Urban area sediment
concentration, Japan) Kitada et al (2008)
n.d. – 0.0068 (Rural area sediments,
Japan)
n.d. – not detected
Pollutant Water concentration (ng/L) References
Synthetic Surfactants
Perfluorooctanoic
Acid
0.1 – 456.41 (River and Pond Surface waters,
Japan) Saito et al (2004)
1.90 – 447.74 (Coastal surface waters, Japan)
1.7 – 178 (Svitava and Svratka river, Czech
Republic) Kovarova et al (2012)
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Table 1-4. Reported concentrations of selected pollutants in tissues of fish species. The common
species name and place of sampling is given in brackets .
Pollutant Tissue concentration Reference
Fibrates (Lipid regulators)
Gemfibrozil 210 ng/ml (Rainbow trout blood plasma;Sweden) Brown et al (2007)
Phthalates/Monopthalate esters (Plasticizers)
Dimethylphthalate
(DMPh)
n.d. – 0.17 mg/Kg (muscle of Nile tilapia;
Taiwan)
n.d. – 1.8 mg/Kg (muscle of greenback
mullet; Taiwan)
Huang et al (2008)
Benzylbutylphthalate
(BBzPh)
n.d. – 0.4 mg/Kg (muscle of Nile tilapia;
Taiwan)
n.d. – 26.8 mg/Kg (muscle of greenback
mullet)
n.d. – 28.2 (muscle of freshwater minnow;
Taiwan)
Organotins/Pesticides
TBT compounds
2.91 µg/g (muscle of sheepshead
minnow)* Ward et al (1981)4.19 µg/g (whole body burden of
sheepshead minnow)*
0.120 mg/Kg (average; Japanese sea
perch)
Harino et al (2000)
0.138 mg/Kg (average; white croaker)
0.157 mg/Kg (average; yellowtail)
0.166 mg/Kg (average; Bandfish)
0.182 mg/Kg (average; Silver whiting)
0.128 mg/Kg (average; Butter fish)
0.052 mg/Kg (File fish)
0.167 mg/Kg (Triped puffer)
0.011 mg/Kg (average; Grey mullet)
0.020 mg/Kg (average; Japanese barbel)
0.022 mg/Kg (average; Bluegill)
Bisphenol A
Bisphenol A
2-75 ng/g (European flounder liver,
Netherlands)
Belfroid et al (2002)n.d. – 11 ng/g (European flounder muscle,Netherlands)
1-5 ng/g (Muscle of common bream,
Netherlands)
0.69 – 3.01 ng/g (Perch muscle, Sweden)
Sternbeck & Forsgren
(2007)
1.44 - 4.74 ng/g (Cod muscle, Sweden)
<0.24 ng/g (Salmon muscle, Sweden)
<0.24 – 1.77ng/g (Cod liver, Sweden)
Synthetic Surfactants
PFOA
0.1-0.63 ng/ml (Chub (Leuciscus
cephalus) blood plasma; Svitava and
Svratka rivers, Czech Republic)
Kovarova et al (2012)
n.d. – not detected
* Indicates concentrations derived from controlled laboratory studies
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European legislation provides for measures against chemical pollution of surface
water. In 2000, the Water Framework Directive (WFD) was introduced by the
European Commision (EC) (European Union, 2000). Article 16 of this directive,
“Strategies against pollution of water”, required a list of priority substances to be
selected from those presenting a significant risk to the aquatic environment, together
with a proposal for their control in in order to reduce emissions, discharges and
losses of all substances. Additionally a subset of priority hazardous substances
(PHS), i.e. priority substances which are toxic, persistent and liable to bio-
accumulate and other substances or groups of substances of high concern was to be
identified (Annex X of the directive). The first list of such substances was adopted on
20 November 2001 (European Union, 2001) and consisted of 33 substances, 10 of
which were identified as PHS and a further 15 of which were subject to a review for
identification as possible PHS. Today, following reviews in 2008 (European Union,
2008) and a recently proposed amendment of the list in 2011 (European
Commission, 2011), the list of priority substances consists of 48 substances, of which
21 are listed as priority hazardous substances (Table 1-5).
For substances in surface waters (river, lake, transitional and coast) environmental
quality standards (EQS) have been set such that the concentrations stated are not
expected to cause deleterious effects in aquatic organisms, provided they are not
exceeded (European Union, 2008). Two types of EQS are set for priority substances:
annual average concentrations and maximum allowable concentrations. The former
protects against long-term chronic pollution problems, and the latter short-term acute
pollution. Member States are responsible for monitoring the concentrations of
priority substances in surface waters as part of their monitoring programmes and in
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addition are authorised to set their own EQS for chemicals of concern and other
chemicals. In addition to surface water EQS, 11 of the 48 priority substances have
designated biota EQS. Table 1-6 provides, where available, the EQS for the
compounds used within the present study.
Table 1-5. List of priority substances in the field of water policy. Taken from COM(2011)/876
(European commission, 2011).
Number Priority Substance Name Identified
as PHS Comments
1 Alachlor
2 Anthracene 
3 Atrazine
4 Benzene
5 Brominated diphenylethers  Only Tetra, Penta, Hexa andHeptabromodiphenylether
6 Cadmium and its compounds 
7 Chloroalkanes, C10-13 
8 Chlorfenvinphos
9 Chlorpyrifos (Chlorpyrifos-
ethyl)
10 1,2-dichloroethane
11 Dichloromethane
12 Di(2-ethylhexyl)phthalate(DEHP) 
13 Diuron
14 Endosulfan 
15 Fluoranthene Indicator of other, more dangerous PAHs
16 Hexachlorobenzene 
17 Hexachlorobutadiene 
18 Hexachlorocyclohexane 
19 Isoproturon
20 Lead and its compounds
21 Mercury and its compounds 
22 Napthalene
23 Nickel and its compounds
24 Nonylphenols  Includes isomers 4-nonylphenol and 4-
nonylphenol (branched)
25 Octylphenols Including isomer 4-(1,1’,3,3’-tetramethylbutyl)-phenol
26 Pentachlorobenzene 
27 Pentachlorophenol
28 Polyaromatic hydrocarbons(PAH) 
Including benzo(a)pyrene, benzo(b)fluoranthene,
benzo(g,h,i)perylene, benzo(k)fluoranthene,
indeno(1,2,3-cd)pyrene,and excluding
anthracene, fluoranthene and napthalene
29 Simazine
30 Tributyltin compounds  Including tributyltin-cation
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Table 1-5 cont….
Table 1-6. Environmental Quality Standards (EQS) set for several pollutants used in the present
thesis. AA-EQS: environmental quality standard expressed as an annual average value; MAC-
EQS: environmental quality standard expressed as a maximum allowable concentration.
Name AA-EQS MAC-EQS Sediment-EQS
Benzyl butyl
phthalate (1)
20 µg/L (Freshwater)
20 µg/L (Saltwater)
100 µg/L (Freshwater)
100 µg/L (Saltwater) n/a
Dimethyl
phthalate (1)
800 µg/L (Freshwater)
800 µg/L (Saltwater)
4000 µg/L (Freshwater)
4000 µg/L (Saltwater) n/a
Tributyltin
compounds
(2)
0.0002 µg/L (Inland surface water)
0.0002 µg/L (Other surface water)
0.0015 µg/L (Inland surface
water)
0.0015 µg/L (Other surface
water)
n/a
Deltamethrin
(3)
0.0003 µg/L (Water column)
n/a 0.33 µg/Kg (dry
weight)9, 6, 4, 2, 1 ng/L following 3, 6, 12,
24, 48 hrs after release, respectively
(Water column after release from
aquaculture facilities)
Number Priority Substance Name Identified
as PHS
Comments
31 Trichlorobenzenes
32 Trichloromethane (Chloroform)
33 Trifluralin 
34 Dicofol 
35 Perfluorooctane sulfonic acid
and its derivatives (PFOS)

36 Quinoxyfen 
37 Dioxins and dioxin-like
compounds 
Includes 7 polychlorinated dibenzo-p-dioxins
(PCDDs), 10 polychlorinated dibenzofurans
(PCDFs), 12 dioxin-like polychlorinated
biphenyls (PCB-DL)
38 Aclonifen
39 Bifenox
40 Cybutryne
41 Cypermethrin Includes the eight isomers contributing to CAS52315-07-8, and therefore also CAS 67375-30-8
42 Dichlorvos
43 Hexabromocyclododecanes(HBCDD) 
This includes 1,3,5,7,9,11-
Hexabromocyclododecane,
1,2,5,6,9,10- Hexabromocyclododecane, α-
Hexabromocyclododecane, β-
Hexabromocyclododecane and γ-
Hexabromocyclododecane
44 Heptachlor and heptachlor
epoxide 
45 Terbutryn
46 17α-ethinylestradiol
47 17β-estradiol
48 Diclofenac
The inclusion of these substances is without
prejudice to Regulation (EC) 726/2004,
Directive 2001/83/EC and Directive 2001/82/EC
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Table 1-6 cont…
Name AA-EQS MAC-EQS Sediment-EQS
Fluorooctane
sulfonic acid
(FOSA) and
its
derivatives (2)
6.5 × 10-4 µg/L (Inland surface
water)
1.3 × 10-4 µg/L (Other surface
water)
36 µg/L (Inland surface
waters)
7.2 µg/L (Other surface
waters)
9.1 µg/Kg (wet
weight)
(1) UK Non-statutory EQS (Proposed by Environment Agency)
(2) European commission (2011)
(3) Scottish Environment Protection Agency (SEPA), (2005).
1.6 Thesis aims and objective
Until recently the focus of endocrine disrupting compounds in the aquatic
environment was on their interactions with the estrogen and androgen receptors of
fish species, reflecting the importance of these receptors in reproductive functions.
However, knowledge on the interactions of potential EDCs with other members of
the NHR superfamily in aquatic organisms is lacking, despite involvement in
numerous critical physiological processes. The objectives of the research presented
here was to develop methods to screen environmental pollutants for their potential to
interact with the PPARs of European plaice and the corticosteroid receptors of
European flounder, both of which have roles in regulating energy homeostasis, stress
and immune function. The choice of organisms was based on several considerations.
Firstly, European flounder and plaice are already two of the choice species in
determining the biological responses of fish to aquatic pollutants as part of the
Oslo/Paris convention for the Protection of the Marine Environment of the North-
East Atlantic (OSPAR) initiative (ICES, 2011). Several publications to date have
also used European flounder and European plaice as indicator species to assess the
health of estuarine habitats (Amara et al, 2009) or to identify biomarkers which
reflect the exposure to environmental contaminants in coastal marine habitats
(Eggens et al, 1995; Skouras et al, 2003), reflecting the sensitivity of these species to
environmental contaminants. Secondly, benthic organisms which include plaice and
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flounder are subjected to contaminants not only from the water column but also from
sediments where pollutants can bind to sediment particles, accumulate to high
concentrations and can persist for long periods of time and therefore the use of plaice
and flounder as model organisms allows sediment concentrations, as well as water-
column concentrations, to be considered.
The specific objectives of the current thesis were:
i. To optimise the transfection of plasmid DNA into an established fish cell line by
assessing three different transfection reagents and a range of DNA to reagent
ratios (Chapter 2)
ii. To prepare expression plasmids in which the ligand-binding domains of
European plaice PPARs are ligated downstream of the Gal4 DNA-binding
domain (Chapter 3)
iii. To test the expression constructs prepared in (ii) by co-transfection of a fish cell
line with an expression plasmid in which the luciferase reporter gene is
downstream of a Gal4-upstream activating sequence, treatment of transfected
cells with known PPAR agonists, and measurement of the resulting luciferase
activity (Chapter 3).
iv. To test a range of environmental contaminants with the Gal4-PPAR LBD
expression constructs in a series of luciferase assays to identify pollutants which
interact with plaice PPAR ligand-binding domains (Chapter 4).
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v. To evaluate the transcriptional responses of European flounder hepatocytes to
TBTO, and attempt to determine PPAR-specific responses to TBTO and a
PPARα ligand (Chapter 5).
vi. To isolate corticosteroid receptors from European flounder and characterise the
isolated receptors in terms of phylogenetic analysis and receptor expression
throughout tissues of the European flounder (Chapter 6).
vii. To prepare expression plasmids for corticosteroid receptors in which the ligand-
binding domains of European flounder corticosteroid receptors are ligated
downstream of the Gal4 DNA-binding domain (Chapter 7).
viii. To test the corticosteroid receptor expression plasmids in (a) luciferase assays
and (b) hormone binding assays, with known corticosteroid ligands and to test a
range of environmental contaminants with the Gal4-corticosteroid receptor LBD
expression constructs in a series of luciferase assays (Chapter 7).
- 75 -
Chapter 2. Optimisation of transfection methods and
measurement of luciferase activities
2.1 Introduction
The introduction of foreign nucleic acids into eukaryotic cells using non-viral
methods is defined as transfection. The capacity to efficiently transfect and express
encoded proteins in eukaryotic cells in vivo using non-viral methods is an attractive
prospect in gene therapy strategies for diseases such as cystic fibrosis (Welsh, 1999;
Ferrari et al, 2002). In addition, successful transfection of foreign DNA into a variety
of eukaryotic cell lines in vitro has provided researchers with a relatively simple
means of studying promoter sequences, protein-protein interactions, protein-ligand
interactions and trans-acting proteins e.g. transcription factors.
The introduction of negatively charged molecules, such as the phosphate backbones
of DNA and RNA, into eukaryotic cells is problematic due to their negatively
charged membranes. To overcome this, transfection vehicles are used to create
neutral or overall positively charged molecules, thus facilitating the crossing of DNA
across the cell membrane. These vehicles include both physical and chemical
methods.
2.1.1 Physical methods of transfection
Physical methods of transfection facilitate the crossing of cell membranes by
bringing molecules into closer proximity to the membrane and/or by temporarily
disrupting the cell membrane (Wells, 2004). One such physical method of
transfection in which the membrane is temporarily disrupted is that of electroporation
(or electropermeabilisation), involving the application of an external electric field to
cell membranes, resulting in the formation of hydrophilic pores through which
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molecules can pass into the cell. The first application of this method was used to
successfully transfect circular plasmid DNA carrying the thymidine kinase (TK)
gene into TK-deficient mouse L cells (Neumann et al, 1982). Since then
electroporation has been used in vitro to transfect mammalian cells with a variety of
molecules including anti-cancer drugs (Mir, 2009) and fluorescent dyes (Mir et al,
1988). More recently results of in vivo clinical trials involving the use of
electroporation to increase the uptake of chemotherapeutic drugs in tumours have
been published with the results indicating electroporation to be a potentially
promising development in the treatment of cancers (Mir et al, 1997). Electroporation
is not limited to mammalian cells; the electro-transformation of bacterial cells with
plasmid DNA is a widely used technique in molecular biology, with several strains
of E.coli having been successfully transformed in this manner (Dower et al, 1988;
Sawahel et al, 1993).
As well as electroporation, the direct insertion of DNA into cells by microinjection
has been described as a method of transfection (Capecchi, 1980). This method offers
the advantages of quantifying how much DNA is delivered to cells, the intracellular
localisation of delivery and the minimisation of DNA degradation by nuclease
activity in intracellular vesicles. This method however is impractical when
transfecting a large number of cells.
A more recent development in transfection techniques is the particle bombardment,
or gene gun, technique. This involves the accelerated delivery of DNA, coated with
high density metal particles such as gold or tungsten, into cells using acceleration
instruments. This technique has the advantage of low levels of cell damage and the
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potential for in vivo transfection. However, the requirement for specialist machinery
makes the initial costs of this technique an expensive option.
2.1.2 Chemical methods of transfection
Most chemical methods of transfection rely on the formation of a particle containing
the DNA of interest complexed to a chemical, the formation of which relies on the
interactions between the negatively charged DNA molecules with a positively
charged moiety on the transfection reagent. Complexes are then internalised by cells
using a variety of routes, most of which are not clearly understood. Three commonly
used classes of reagents are cationic organic polymers, calcium phosphate and
cationic lipids, each of which is described briefly below.
Cationic organic polymers2.1.2.1
One of the first chemical reagents to be used for transfection of mammalian cells was
diethylaminoethyl (DEAE) dextran, a high molecular weight cationic polymer. Due
to relatively low transfection efficiencies, toxicity, non-biodegradability and
reproducibility, this method has been largely superseded. More recently a variety of
highly branched cationic organic polymers have been found to form complexes with
DNA and these complexes can be efficiently taken up by cells. The mechanism of
uptake is not fully understood but may involve endocytosis.
Calcium Phosphate2.1.2.2
Calcium phosphate was first used to transfect adenovirus 5 DNA into the human KB
cell line (Graham and van der Eb, 1973) and since then has been widely used to
transfect many different mammalian cell lines including CV1, BHK-21 and HeLa
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cells (Strain and Wyllie, 1984; Zhang and Kain, 1996; Howcroft et al, 1997). The
popularity of this method is due to the availability and inexpensive cost of the
reagents. Using this method DNA is mixed with calcium chloride and added to a
buffered saline/phosphate solution to form a precipitate. Addition of the precipitate
to cells in culture allows DNA to enter the cells via endocytosis or phagocytosis. One
of the major disadvantages of the calcium phosphate precipitation method is, like the
DEAE-dextran method, the relatively low transfection efficiencies and the low
reproducibility between experiments.
Cationic lipids2.1.2.3
Perhaps the most widely used transfection reagents are cationic lipids, of which there
are several available. The cationic head groups of these compounds interact with the
DNA of interest and the hydrophobic lipid tails then from a micelle. The resulting
“liposomes”, small complexes containing the DNA, are then thought to fuse with
cellular membranes, thus resulting of delivery of DNA to the cell cytoplasm.
The successful transfection of fish cell lines using a variety of methods has been
described previously (Leaver et al, 2005; Romøren et al, 2005; Schiøtz et al, 2011),
and optimal conditions for transfection can vary widely for different cell types
(Yamano et al, 2010) and thus must be optimised for the cell line and reagent of
choice. The ratio of DNA for transfection-to-transfection reagent is one consideration
for optimisation, since this determines the overall charge of the DNA-reagent
complex being transfected, and ultimately the ability of DNA to cross the cell
membrane, a critical step in successful transfection. Taking this into consideration,
the present chapter focuses on the transfection of the fathead minnow (FHM) cell
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line using three transfection reagents. A variety of DNA to reagent ratios are
assessed with the aim of identifying the most suitable transfection reagent and the
optimal conditions for use in subsequent experiments.
2.2 Materials and Methods
2.2.1 Harvesting of a fish cell line
Maintaining the FHM cell line2.2.1.1
A cell line derived from the mass of tissue posterior to the anus of the northern
fathead minnow (Pimephales promelas), designated as the FHM cell line (Gravell
and Malsberger, 1965), was used in transient transfection assays. Cells were
maintained in 1× Leibovitz’s L-15 medium (Invitrogen) supplemented with 10%
(v/v) fetal bovine serum (Biosera), 50 units/mL penicillin and 50 µg/mL
streptomycin (Invitrogen) and passaged 1:3 once per week before reaching full
confluence.
Seeding FHM cells2.2.1.2
FHM cells were harvested and seeded into 96-well assay plates (Corning) 24 hours
prior to transfection. Cells were washed twice with 1× Dulbecco’s phosphate-
buffered saline (DPBS; Invitrogen) before being dissociated from the surface of the
flask by addition of 0.5 % trypsin/EDTA (Invitrogen). Cells were then resuspended
in a volume of 1 × Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen)
containing 4.5g/L glucose, 10% (v/v) charcoal/dextran treated fetal bovine serum
(Fisher Scientific) 50 units/mL penicillin and 50 µg/ml streptomycin (Invitrogen),
herein referred to as complete media, and a cell count using the trypan blue exclusion
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test for cell viability carried out. 100 µl cell suspension was diluted with an equal
volume of with 0.4% trypan blue solution (Sigma Aldrich) and two chambers of an
improved Neubauer hemocytometer filled with the solution by capillary action. The
cells within each 0.1mm3 chamber were counted and the number of cells averaged
over the two chambers. The average number of cells was then multiplied by 1000 to
calculate the number of cells per mL suspension, and multiplied again by the volume
of cell suspension to give the total number of cells. The suspension was diluted with
complete DMEM media to a cell density of 2 × 106 cells/mL. 100 µl of cell
suspension was added to the wells of 96-well assay plates (2 × 105 cells per well) and
incubated overnight at 22°C in an atmosphere of 4% carbon dioxide (CO2), ready for
transfection the following day.
2.2.2 Transfection of FHM cells
Lipids have been demonstrated to be the endogenous activators of PPARs and thus,
to avoid any possible interference by lipid-based transfection reagents three
commercially available polycationic transfection reagents were each tested at varying
reagent to DNA ratios for their efficiency to transfect plasmid DNA into FHM cells.
Transfection efficiencies were assessed by measuring levels of a constitutively
expressed Renilla luciferase protein, present in the transfected
pGL4.75[hRluc/CMV] plasmid.
The manufacturers recommended ratios of Genejammer (Agilent) and Satisfection
(Agilent) reagents to DNA was used as a starting point in the transfection of FHM
cells. Both half and double the recommended ratio were also tested for each of the
two reagents. The Polyfect transfection reagent (Qiagen) has been optimised for the
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transfection of a variety of mammalian cell lines, each of which uses a different
Polyfect to DNA ratio. Therefore for the transfection of the fish cell line a range of
ratios covering those used for transfection of mammalian cell lines was used.
In total three DNA plasmids were co-tranfected into the FHM cells, seeded 24 hours
previously into 96-well plates. These plasmids were:
• A plasmid containing the Renilla luciferase gene (pGL4.75[hRluc/CMV]), to
be used as an indicator of transfection efficiency
• A plasmid containing the entire coding region of PPARα2, isolated from
plaice (Pleuronectes platessa)
• A plasmid into which the mouse Cyp4A6z peroxisome proliferator response
element (PPRE) linked to the minimal mouse thymidine kinase promoter was
cloned upstream of a firefly luciferase gene (pGL4.10TKPPRE)
Transfected cells were subsequently treated with Wy14643 (Sigma), an activator of
PPARα2, or a control treatment of ethanol vehicle, in order to assess the interaction
between PPARα2 and the PPRE of the reporter construct in response to a peroxisome
proliferator.
Transfection of plasmid DNA using different reagents2.2.2.1
According to the manufacturers handbook, the use of Polyfect reagent has been
optimised for transfection of DNA into COS-7, NIH/3T3, HeLa, 293, and CHO cell
lines derived from mammalian species, but no information is available for the
transfection of fish cell lines. Therefore, transfection of DNA into the fathead
minnow (FHM) cell line required optimisation. Manufacturer’s protocol
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recommended altering both the quantity of DNA transfected and also the ratio of
Polyfect reagent to DNA.
Nine DNA mixtures were prepared for transfection. Each transfection mix contained
the pcDNA3-PPARα2 plasmid, the pGL4.75[hRluc/CMV] internal control reporter
plasmid and the reporter plasmid pGL4.10[TK/PPRE] in a ratio of 1:0.4:1,
respectively. Three different amounts of DNA (40, 60 and 80ng) were used in three
transfection mixes each. DNA was diluted to a total volume of 12 µl with DMEM
containing no antibiotics or serum, vortex mixed and centrifuged briefly. A volume
of Polyfect reagent (Qiagen) was then added to each tube, giving varying volume to
weight (v/w) ratios of Polyfect reagent:DNA (Table 2-1).
Tube contents were again mixed and briefly centrifuged before being incubated at
room temperature for 10 minutes to allow for a complex between the Polyfect
reagent and DNA to form. 80 µl of complete DMEM was then added to each tube.
Media in which FHM cells were seeded 24 hours prior to transfection was removed
and replaced with 60 µl fresh complete DMEM. The nine DNA/transfection reagent
mixes were aliquoted to four wells each (20 µl transfection mix per well). In addition
to transfected cells, mock transfected cells into which no DNA was transfected was
included as a negative control in order to quantify background levels of
luminescence and to these cells 20 µl DMEM only was added.
Cells were incubated at 22°C in a 4% CO2 incubator for a further 24 hours before
treatment.
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Table 2-1. The nine transfection mixes prepared using Polyfect transfection reagent. Each
contained the P. platesa PPARα2, pGL4.75[hRluc/CMV] and pGL4.10[TK/PPRE] at a constant
ratio of 1:0.4:1, respectively. Polyfect reagent (Qiagen) was added before each of nine
transfection mixes was split between 4 wells containing FHM cells.
Transfection Mix 1 2 3 4 5 6 7 8 9
ppPPARα2 (ng/well) 16.67 25 33.33
pGL4.75[hRluc/CMV]
(ng/well) 6.67 10 13.33
pGL4.10[TK/PPRE]
(ng/well) 16.67 25 33.33
Total DNA (ng/well) 40.0 50.0 80.0
Polyfect reagent
(µl/well) 0.25 0.625 1.25 0.25 0.625 1.25 0.25 0.625 1.25
Polyfect (µl):DNA (µg) 6.25:1
15.6:
1
31.25:
1 4.2:1
10.5:
1
20.8:
1
3.13:
1 7.8:1
15.6:
1
For transfection of FHM cells using Genejammer and Satisfection reagents cells
were harvested and seeded twenty four hours prior to transfection as described in
2.2.1.2 above.
To transfect cells with Genejammer reagent, a total of 2.5 µg plasmid DNA
containing pcDNA3-PPARα2 plasmid, pGL4.75[hRluc/CMV] and
pGL4.10[TK/PPRE] in a 1:0.5:1 ratio, respectively, was diluted with DMEM
(containing no serum or antibiotics), to a final concentration of 100 ng/µl. In separate
tubes 25 µl DMEM (containing no serum or antibiotics) was combined with
Genejammer transfection reagent (Table 2-2) and incubated at room temperature for
5 minutes. A volume of DNA (100 ng/µl) was then added to the mixture to give
varying Genejammer reagent:DNA ratios, and incubated for 15 minutes at room
temperature. Each transfection mix was then distributed between four wells each (5
µl per well).
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For transfection with Satisfection reagent (Agilent), Satisfection reagent was added
to three tubes and the volume made up to 37.5 µl with DMEM media containing no
additives. In separate tubes plasmid DNA was combined in a ratio of 1:0.5:1 pCMV-
PPARα2, pGL4.75[hRluc/CMV] and pGL4.10[TK/PPRE], respectively, and diluted
to final concentrations of 20 ng/µl and 40 ng/µl. 37.5 µl of DNA (either 20 ng/µl or
40 ng/µl) was added to each reagent/DMEM mix. The contents of all three
transfection mixes were mixed and incubated at room temperature for 15 minutes
before 15 µl of each transfection mixes was added to each of four wells of an assay
plate. Mock transfected control wells in which no plasmids were transfected were
also included on the assay plate and to these 15 µl complete DMEM was added. The
assay plate was then incubated in a 4 % CO2 incubator at 22°C overnight.
Table 2-2. Three DNA mixes each were prepared for transfection using Genejammer (Agilent)
and Satisfection reagent (Agilent). Each contained the P. platesa PPARα2,
pGL4.75[hRluc/CMV] and pGL4.10[TK/PPRE] at a constant ratio of 1:0.5:1, respectively. DNA
was added to Genejammer reagent (Agilent) or Satisfection reagent (Agilent), diluted with
DMEM media, before each of the transfection mixes was split between 4 wells containing FHM
cells.
Genejammer Satisfection
Transfection Mix 1 2 3 4 5 6
ppPPARα2 (ng/well) 20 20 40 60 60 120
pGL4.75[hRluc/CMV]
(ng/well) 10 10 20 30 30 60
pGL4.10[TK/PPRE]
(ng/well) 20 20 40 60 60 120
Total DNA (ng/well) 50 50 100 150 150 300
Polyfect reagent (µl/well) 0.15 0.3 0.15 0.22 0.44 0.22
Reagent (µl):DNA (µg) 3:1 6:1 1.5:1 1.5:1 3:1 0.75:1
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2.2.3 Application of treatment solution to transfected cells
Twenty four hours following transfection of FHM cells with pCMV-PPARα2,
pGL4.75[hRluc/CMV] and pGL4.10[TK/PPRE] using either Polyfect reagent
(Qiagen), Genejammer reagent (Stratagene) or Satisfection reagent (Stratagene),
cells were treated with Wy14643 or ethanol vehicle.
Dilution of treatment into complete DMEM media2.2.3.1
Cells were treated with [[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-
pyrimidinyl]thio]-acetic acid (Wy-14643), a compound previously shown to activate
both mammalian and piscine, PPARα. A 5 molar stock solution of Wy-14643
compound was prepared in ethanol absolute and 5 µl diluted into 1 ml complete
DMEM, giving a final concentration of 25 µM. A vehicle control treatment was also
prepared, in which ethanol was diluted into DMEM at a concentration of 5 µl/mL.
Treatment of transfected cells2.2.3.2
Transfection mixes were aspirated from the wells of the assay plates and 75 µl of
diluted treatments added such that cells transfected with different reagents and at
different ratios were each treated in duplicate with both Wy-13643 and ethanol.
Following treatment the assay plate was incubated at 22 °C, 5% CO2 for 24 hours.
2.2.4 Luciferase Assay and Data Normalisation
Measurement of Firefly Luciferase2.2.4.1
Cells were assayed for luciferase activity using the Dual-Glo™ Luciferase Assay
System (Promega), following the manufacturer’s instructions. Briefly 75 µl of Dual-
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Glo™ Luciferase Reagent was added to each experimental well in the assay plate,
and the contents of each well pipetted up and down four times to mix before being
incubated at room temperature for ten minutes to allow complete cell lysis. The
Dual-Glo™ Luciferase Reagent acts as a substrate for firefly luciferase, producing a
luminescent signal which, after the ten minute incubation period, was quantified
using the Wallac 1420 Victor 2 multilabel counter (Perkin Elmer).
Measurement of Renilla Luciferase2.2.4.2
Subsequent to obtaining firefly luciferase values, 75 µl of Dual-Glo™ Stop & Glo®
Reagent was added to each well of the assay plate, mixed and incubated as before.
The Dual-Glo Stop & Glo reagent quenches firefly luminescence signal by at least
10,000-fold while providing the substrate for the Renilla luciferase enzyme. Renilla
luminescence signal was measured using the same procedure as described for firefly
luciferase.
Subtraction of Background Luminescence & Data Normalisation2.2.4.3
Neither firefly nor Renilla luciferase enzyme is endogenously expressed in the FHM
cell line, and therefore firefly luminescence and Renilla luminescence readings from
mock-transfected cells in which no DNA had been transfected was an indication of
background noise levels. Firefly and Renilla luciferase values from non-transfected
cells were each averaged and subtracted from firefly and Renilla luciferase values
from transfected cells, respectively.
To account for differences in transfection efficiency between wells on an assay plate
the ratio of firefly to Renilla luminescence was calculated. Since the results below
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are based on one transfection experiment only, statistical differences were not
calculated and thus the results are based only on graphical trends.
2.3 Results
2.3.1 Polyfect reagent
Transfection efficiency2.3.1.1
The efficiency with which DNA is transfected into cell lines using Polyfect reagent is
dependent on the overall net charge of the reagent-DNA complex, which in turn is
dependent on the ratio of Polyfect reagent to negatively charged DNA. Therefore in
optimising the transfection of FHM cells, various Polyfect to DNA ratios were used,
altering both the amount of DNA transfected and the volume of Polyfect reagent
used for transfection. Transfection efficiencies of different Polyfect to DNA ratios
were determined by measuring the luciferase signal from the constitutively expressed
Renilla luciferase gene, present in the transfected internal control plasmid
pGL4.75[hRluc/CMV] (Figure 2-1). The efficiency with which plasmid DNA was
transfected into FHM cells was dependent on the ratio of Polyfect to DNA, with
Renilla luciferase values increasing with increasing Polyfect to DNA ratios,
regardless of the amount of DNA transfected. A two-fold increase in the ratio of
Polyfect reagent to DNA resulted in a 2.4-fold, 1.5-fold and 1.9-fold increase in
Renilla luciferase signal when transfecting 40ng, 60ng and 80ng DNA, respectively.
Increasing the ratio of Polyfect to DNA five-fold resulted in a fold- increase in
Renilla luciferase of 23.6, 17.4 and 12.2 when transfecting 40, 60 and 80ng DNA,
respectively. Maximum Renilla luciferase signal was obtained at a reagent to DNA
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ratio of 31.25:1 while the lowest transfection efficiencies were observed at ratios of
6.25:1 and lower (Figure 2-1).
The effect of increasing the amount of DNA transfected while maintaining a constant
ratio of Polyfect reagent to DNA was investigated. Doubling the amount of DNA
transfected per well from 40ng to 80ng while maintaining the ratio of reagent to
DNA at 15.6 µl to 1 µg resulted in a 1.45-fold increase in Renilla luciferase signal,
suggesting that the amount of DNA transfected as well as the ratio of reagent to
DNA could be optimised to give maximum transfection efficiency.
Figure 2-1. The effect of altering the Polyfect reagent to DNA ratio (µl to µg) on transfection
efficiency. Varying ratios of Polyfect:DNA were used to transfect FHM cells before cells were
assayed for Renilla luciferase signal, used as a measurement of transfection efficiency. Graph
shows mean + SD of 1 experiment in which each transfection mix was used to transfect 4 wells
each.
2.3.2 Genejammer Reagent & Satisfection Reagent
Transfection efficiency2.3.2.1
For both Satisfection and Genejammer transfection efficiencies were assessed using
ratios of reagent to DNA at the manufacturers recommendations and at both double
and half that of the recommended amount. Doubling the ratio of Genejammer reagent
- 89 -
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
3:1 (50ng) 6:1 (50ng) 1.5:1 (100ng) 1.5:1 (150ng) 3:1 (150ng) 0.75:1
(300ng)
Genejammer Reagent Satisfection Reagent
M
ea
n
 
R
en
ill
a 
Lu
c
to DNA from 3:1 to 6:1 gave an increase in Renilla luciferase signal of 2.3-fold,
while halving the ratio from 3:1 to 1.5:1 caused Renilla luciferase signal to decrease
by half (Figure 2-2), suggesting transfection efficiency is proportional to the ratio of
reagent:DNA.
Increasing the ratio of Satisfection transfection reagent to DNA did not change
Renilla luciferase signal, while halving the ratio resulted in a two-fold increase in the
signal from the control reporter (Figure 2-2).
Figure 2-2. The effect of altering the Genejammer and Satisfection reagent to DNA ratio (µl to
µg) on transfection efficiency. Varying ratios of reagent:DNA were used to transfect FHM cells
before cells were assayed for Renilla luciferase signal, used as a measurement of transfection
efficiency. Graph shows mean + SD of 1 experiment in which each transfection mix was used to
transfect 4 wells.
2.3.3 Transactivation of PPARα by Wy-14643
Transfection of PPARα2 and the experimental reporter pGL4.10[TK-PPRE] plasmid
into FHM cells using Polyfect reagent, and subsequent treatment of transfected cells
with 25 µM Wy-14643 saw an increase in reporter gene activity of between 3.09-fold
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and 5.83-fold over treatment with ethanol vehicle, when normalised for transfection
efficiency (Figure 2-3).
Transfection of DNA with Satisfection reagent and treatment of transfected cells
with Wy14643 resulted in increases in firefly luciferase activity ranging between 3.2
and 3.8-fold over ethanol vehicle. Those cells transfected with Genejammer reagent
and subsequently treated with Wy14643 or ethanol and assayed for luciferase
luminescence signal saw the lowest fold-increases in firefly luciferase signal with
signal more similar to those observed with ethanol vehicle. Compared to ethanol
increases of between 1.3 and 1.7-fold were observed. Genejammer reagent was
excluded as the transfection reagent of choice for future transfections due to the
relatively low fold-induction in firefly luciferase when transfected cells were treated
with a PPARα2 activator.
Figure 2-3. Firefly luciferase signal measured from cells transfected with Polyfect, Genejammer
or Satisfection reagent at various reagent:DNA ratios and treated with the PPARα agonist
Wy14643. The graph shows firefly luciferase activity, normalised for transfection efficiency, as a
fold induction over treatment with ethanol vehicle. Data are the mean + SD of 1 experiment in
which each Wy14643 and ethanol vehicle treatment was applied in duplicate.
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2.4 Discussion
An assessment of the efficiency of three commercially available transfection reagents
to transfect a cell line derived from the fathead minnow (Pimephales promelas) has
been carried out. Transfection efficiency was increased with both Polyfect and
Genejammer reagents with increasing ratios of reagent:DNA, while no obvious
pattern was observed with Satisfection reagent. An increase in normalised firefly
luciferase was noted in all transfected cells treated with Wy14643, in comparison to
those treated with ethanol vehicle, suggesting PPARα to interact with the PPRE-
containing firefly luciferase reporter gene construct (pGL4.10[TK-PPRE]) in
response to PPARα ligands.
2.4.1 Ratio of reagent:DNA and transfection efficiency
As expected the efficiency of transfection using both Polyfect reagent and
Genejammer was found to decrease with decreasing ratios of reagent to DNA.
Decreases in transfection efficiencies are likely due to the lower concentrations of
transfection reagents present, which may have resulted in the presence of excess,
uncomplexed DNA which, by itself, has low transfection efficiency. Therefore in
order to ensure efficient transfection of DNA in future experiments, a Polyfect to
DNA ratio greater than 6.25 µl:1 µg should be used since efficiencies above this ratio
were considered acceptable for the intended use in this study. GeneJammer
transfection reagent, although providing an adequate level of transfection efficiency,
was discounted from future use due to the very low inductions in firefly luciferase
when transfected cells were treated with Wy14643 compared to ethanol (Figure 2-3).
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Cells transfected with Satisfection reagent gave the lowest Renilla luciferase signal,
when compared to Polyfect or GeneJammer reagent, suggesting this reagent to be the
least effective in the transfection of FHM cells, perhaps due to sub-optimal
transfection conditions (e.g. DNA:reagent ratio). Due to this low transfection
efficiency Satisfection was also omitted as the transfection reagent of choice in
future experiments.
Maintaining a constant Polyfect reagent to DNA ratio while doubling the amount of
DNA in the transfection mix resulted in a doubling in the efficiency of transfection.
It has previously been reported that increasing the amount of DNA while maintaining
a constant transfection reagent to DNA ratio increases the number of rabbit corneal
cells transfected up to a point, after which the number of rabbit corneal cells
transfected with plasmid DNA decreases (Hudde et al, 1999). The authors
hypothesised that the decrease in transfection efficiency was due to the toxicity of the
dendrimer-DNA complex. In transfecting the FHM cell line as described above,
maintenance of a Polyfect to DNA ratio of 15.6:1 while doubling the amount of
DNA transfected per well from 40ng to 80ng resulted in an increase in transfection
efficiency, suggesting that no dentrimer-DNA complex toxicity was occurring at
80ng DNA used in these experiments.
2.4.2 Activation of PPARα2 by Wy14643 and interactions with
a PPRE
PPARα-transfected cells treated with Wy14643 saw an increase in normalised firefly
luciferase compared to ethanol vehicle treated cells. This increase in reporter gene
expression in the presence of Wy14643 agrees with previous findings that PPARα2
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from plaice is activated by this compound. In addition these results indicate that
PPARα2 from plaice, when activated by Wy14643, interacts with the peroxisome
proliferator response element to drive expression of firefly luciferase, thus suggesting
the pGL4.10[TK-PPRE] reporter construct to be functional and suitable for use in
studies involving peroxisome proliferator-activated receptor α.
Previously Wy14643 has been shown to be a selective agonist of plaice PPARα,
having no effect on PPARβ and PPARγ from the same species in transfection assays
(Leaver et al, 2005). The levels of firefly luciferase activity in the present assay,
although higher than vehicle controls, were lower than the levels of reporter gene
protein observed by Leaver et al (2005) who observed a 35-fold increase in
chloramphenicol acetyltransferase (CAT) compared to ethanol vehicle treatment.
This is most likely due to differences in experimental protocol and assay technique;
Leaver et al (2005) assayed for CAT protein levels using an enzyme-linked
immunosorbent (ELISA) assay system while in the present study, an indirect
measurement of luciferase protein levels was carried out based on enzyme activity,
but may also be due to the use of different cell lines or differences in transfection
efficiencies.
Differences in fold inductions of luciferase activity in the presence of Wy14643 was
observed when different transfection reagents were used with the lowest fold
inductions observed with GeneJammer reagent-transfected cells. Both Satisfection
reagent and Polyfect reagent-transfected cells gave similar fold-inductions in
response to Wy14643. Taking into consideration both the efficiency of transfection
and the fold increase observed in transfected cells, Polyfect reagent was chosen as
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the reagent of choice for future transfection experiments. In addition a reagent to
DNA ratio of 10.5 µl:1 µg was selected as the future ratio for use in transfection.
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Chapter 3. Development and validation of a luciferase
reporter gene assay
3.1 Introduction
Peroxisome proliferator activated receptors (PPARs) are members of the nuclear
hormone receptor superfamily and function as heterodimers with the retinoid X
receptor (RXR). Gel retardation assays have revealed that binding of mouse PPARα
and mouse RXRα to the peroxisome proliferator-response element of the acyl CoA
oxidase gene, a PPAR target gene, is weak when these two receptors are in isolation
(Issemann et al, 1993). When combined however, a much stronger interaction with
the PPRE of acyl-CoA oxidase is observed. Peroxisome proliferator-activated
receptors from the rat, expressed in insect cells and subsequently purified, show a
loss of activity to bind to DNA, a loss which can be restored upon addition of in
vitro-translated RXRα (Gearing et al, 1993). In searching for compounds which
activate or repress PPAR activity the formation of this heterodimeric complex with
RXR presents challenges, not least because it has been found that both clofibric acid,
an activator of PPARα, and 9-cis retinoic acid, a ligand of RXRα, can activate the
expression of acyl-CoA oxidase gene (Kliewer et al, 1992). Thus not only can the
PPAR/RXR heterodimer complex be activated by both PPAR and RXR ligands, it
appears that PPARs cannot function without the presence of RXR.
3.1.1 A reporter gene assay to identify PPAR-interacting
compounds
The identification of compounds which interact with PPARs is hindered by the
interference of compounds that interact with the RXR, the heterodimeric partner of
PPARs. The removal of RXR from a cellular system is not an option due to the
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requirement of RXR for proper PPAR functioning. In order to overcome these
problems a fusion protein, consisting of the Gal4 DNA-binding domain and the
PPAR ligand-binding domain was generated for use in a reporter gene assay. This
fusion protein was not dependent upon the formation of an active PPAR/RXR
heterodimer complex for transcription of the reporter gene, but instead depended
only on the activity of the activation function 2 (AF2) within the PPAR ligand-
binding domain following binding of this domain by an activating compound,
allowing PPAR activators and antagonists to be identified with no interference or
influence from the retinoid X receptor.
The Gal4-PPAR/UAS assay system3.1.1.1
The yeast transcription activator protein Gal4 activates the transcription of target
genes by binding to upstream activating sequences (UAS) within their promoter
region. Similar to NHRs, the Gal4 transcriptional regulator is composed of several
distinct domains, including a DNA-binding domain and two transcriptional
activation domains, termed ARI and ARII (Lohr et al, 1995). Furthermore the Gal4
DNA-binding domain has been found to be functional within a variety of cell lines
other than yeast; when the DNA-binding domain of yeast Gal4 protein was
cotransfected into mammalian cells alongside the Gal4 UAS linked upstream of the
mouse mammary tumour virus (MMTV) promoter, the Gal4 protein was capable of
activating the transcription of the MMTV promoter (Kakidani and Ptashne, 1988).
Several authors have described the use of Gal4 fusion proteins in cellular assay
systems to study the human steroid hormone receptors, with literature documenting
the activities of mutated estrogen receptors (Bush et al, 1996), the assessment of the
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estrogenic activity of various chemicals (Balaguer et al, 1996) and the modulation of
the progesterone receptor (Rudakoff et al, 1999).
The present work took advantage of i) the functionality of the Gal4 DNA-binding
domain as a fusion protein with an activation function-containing protein and ii) its
functionality in cell types other than yeast. A fusion protein was created for use in a
fish cell line for the development of a cellular transient transfection assay to identify
both activators and repressors of the peroxisome proliferator-activated receptors. The
fusion protein consisted of amino acids 1-147 of the Gal4 gene, encoding the Gal4
DNA-binding domain (Gal4-DBD). The Gal4-DBD was fused in-frame to the
ligand-binding domain of PPARs with the expression of the whole construct being
driven by the cytomegalovirus (CMV) immediate early promoter (Figure 3-1(A)). A
second plasmid construct contained five Gal4 UAS sequences, to which the
Gal4DBD could bind. These sequences were upstream of a TATA box which itself
was upstream of a reporter gene, which in this case was firefly luciferase (Figure
3-1B).
Figure 3-1. Schematic representations of the two constructs used in the Gal4-UAS assay system.
A: the Gal4-PPAR construct in which the ligand-binding domain of PPARs were cloned
downstream of the Gal4DBD whose expression was driven by the CMV promoter. B: The
Gal4UAS-luc construct containing 5 Gal4UAS sequences upstream of a TATA box which itself
was upstream of a firefly luciferase enzyme.
The PPAR ligand-binding domain contains an AF2 in which the ligand-induced
reorientation of helix 12, and subsequent release of corepressor proteins and binding
of coactivator proteins, is critical to its activation (Moras and Gronemeyer, 1998).
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Thus although the DNA-binding domain of the Gal4-PPAR fusion construct can
interact with the upstream activating sequences of the Gal4UAS-luc construct, this
complex remains transcriptionally inactive until binding of a ligand to the ligand-
binding domain of the PPAR, leading to AF2 activation and ultimately an increase in
luciferase expression. The cascade of steps which ultimately results in an increase in
the transcription of the firefly luciferase reporter gene is show in Figure 3-2. The use
of the Gal4-PPAR fusion protein described above has a single major advantage over
using full-length PPAR receptors in that the activity of the peroxisome proliferator-
activated receptors can be assessed while uncoupled from its endogenous
heterodimeric RXR partner. Furthermore it is foreseen that the assay can be adapted
relatively easily to study other members of the hormone receptor superfamily.
Figure 3-2. Schematic diagram of the Gal4-UAS assay system. A: The Gal4-PPAR and the
Gal4UAS-luc constructs are co-transfected into a fish cell line. The fusion protein remains
transcriptionally inactive due to the association of the PPAR LBD with corepressor proteins.
Transfected cells are treated with a compound of interest. B: An interaction between the
treatment compound and the PPAR ligand-binding domain leads to a conformational change in
the Gal4-PPAR construct, a dissociation of corepressor proteins and the recruitment of the
transcriptional machinery, leading to an increase in the transcription of the firefly luciferase
reporter enzyme.
- 99 -
Luciferase genes as reporter proteins3.1.1.2
Luciferase genes are widely used reporter genes due to their sensitivity and the
relative ease in measuring the levels of the luciferase protein. Renilla luciferase is a
36kDa protein isolated from the sea pansy (Renilla reniformis) and differs from
firefly luciferase both in its substrate and its cofactor requirements. In addition
whereas firefly luciferase produces a greenish yellow light in the 550-570nm range,
Renilla luciferase produces a blue light of 480nm. These differences in substrate,
cofactor requirements and light output are characteristics which allow these enzymes
to be used in the same assay system. Due to their wide usage several commercially
available reagents, containing the substrates for luciferase proteins, are available
which enables the quantification of luciferase protein levels in cell cultures.
Generally, after producing luminescence, luciferase proteins undergo spontaneous
inactivation producing the characteristic “flash”-type kinetics in which a very rapid
decrease in luciferase signal occurs over a short time period. In order to overcome
such a problem, several research groups have developed reagents in which the rate of
luciferase inactivation is slowed by slowing the rate of catalysis, generating lower
level of luciferase luminescence from samples but producing luminescence levels
which remain stable over several hours. The most widely used commercial
application of such reagents is the Dual-Glo® assay system developed by Promega.
This has the advantage of allowing luciferase protein to be assayed over a longer
time period. Despite the advantages of these reagents the costs can be prohibitively
expensive, limiting the number of experiments which can be performed. Furthermore
the compositions of commercial reagents are not available. However, literature
documenting a formulation for non-commercial firefly and Renilla luciferase assay
buffers (Dyer et al, 2000) along with several patents (Wood, 1994; van Lune and
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Bruggeman, 2006) provide several methods for attenuating and prolonging luciferase
signals. One finding is that the inclusion of a compound which competes with or
which slightly inhibits the firefly luciferase enzyme can help sustain firefly luciferase
signal for longer time periods. These compounds include thiol reagents such as
coenzyme A (CoA) at concentrations between 0.1 and 1 mM and dithiothreitol
(DTT) between 20 and 100 mM (Wood, 1994). Further to this, a patent exists (van
Lune and Bruggeman, 2006) which describes the inclusion of phosphate and
ammonium ions in a luciferase buffer, resulting in the sustainability of firefly
luciferase signal with satisfactory results obtained in a reaction mixture comprising at
least 250 mM Tris, accompanied with at least 125 mM phosphate. Using the
information from these sources to produce non-commercial, “homemade” luciferase
buffers would provide considerable cost-savings over commercial reagents.
The aims of this chapter were:
(i) to isolate, by polymerase chain reaction (PCR), the LBD of plaice PPARs
from the full receptors and clone the LBD into the pBIND plasmid, thus
creating the Gal4-PPAR LBD construct.
(ii) to test the response of the Gal4-PPAR LBD construct to known PPAR
ligands. This aim will be fulfilled through the measurement of luciferase
enzyme activity from FHM cells transfected with the Gal4-PPAR LBD
construct, a reporter gene construct (Gal4UAS-luciferase plasmid) and an
internal control plasmid (Renilla luciferase plasmid) and subsequently treated
with Wy14643, GW501516, Bromopalmitate or Rosiglitazone, i.e. known
PPAR agonists.
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(iii) to use available patents and current literature to formulate and test non-
commercial luciferase buffer preparations as a cheaper alternative to the
commercially available Dual-Glo® luciferase assay system (Promega), while
limiting the steps involved in luciferase measurements, thus also making the
assay time-efficient.
3.2 Materials and Methods
3.2.1 Construction of the Gal4-PPAR expression plasmid
Three cDNA sequences, each encoding a separate peroxisome-proliferator activated
receptor called PPARα2, PPARβ and PPARγ, have previously been isolated from
plaice (Pleuronectes platessa) and cloned into the pcDNA3 vector (Invitrogen)
(Leaver et al, 2005). Accession numbers for each PPAR isotype from P.platessa are
AJ539467.1, AJ536468.1 and AJ243956.2 for PPARα, PPARβ and PPARγ,
respectively.
Amplification of PPAR ligand-binding domains3.2.1.1
Ligand-binding domains of PPARs were amplified and cloned into the pBIND
cloning vector, containing the Gal4-DBD. Amplification and cloning was performed
such that the ligand-binding domains of PPARs were cloned downstream and in-
frame with the Gal4-DBD.  Corresponding to amino acids 153 to 474, 206 to 510 and
196 to 532 for PPARα, PPARβ and PPARγ respectively, the ligand-binding domains
of PPARs were amplified by polymerase chain reaction (PCR). For each PPAR, a
pair of primers was designed around the nucleotide sequences corresponding to the
amino acids above (Table 3-1). Each forward and reverse primer included
recognition sequences for restriction enzymes BamHI (5’ -GGATCC- 3’) and KpnI
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(5’ -GGATCC- 3’), respectively, at their 5’ ends. The recognition sequences for
these enzymes were selected due to their being present within the multiple cloning
region of the pBIND plasmid into which the PPAR ligand-binding regions are to be
cloned but absent in the ligand-binding domains of all three PPAR isotypes,
confirmed using DNA restriction mapper tool, NEBcutter V2.0 (Vincze et al, 2003).
Incorporation of these restriction enzyme recognition sequences into primers will
allow their subsequent incorporation into the amplified PCR products and the
directional cloning of the ligand-binding domains into the pBIND cloning vector,
downstream of and in-frame with the Gal4 DNA-binding domain.
Table 3-1. Primer sequences used to amplify the ligand-binding domains of PPARs from
Pleuronectes platessa. Recognition sequences of BamHI and KpnI are highligted in red.
PCR primer
name
Primer sequence (5’ 3’)
pBINDppαF TT GGATCC GA ATG TCC CAC AAC GCC ATT CGG TTT
pBINDppαR AA GGTACC TCA CTT CAG TAC ATG TCC CGG TAT
pBINDppβF TT GGATCC GA ATG TCC CAT GAT GCG ATC CGA TAC
pBINDppβR AA GGTACC GA ACA CTA ATA CAT GTC TTT GTA G
pBINDppγF TT GGATCC GC ATG TCA CAC AAC GCT ATT CGT TTT
pBINDppγR AA GGTACC CTC TAA TAC AAG TCC TTC ATG ATC
PCR reactions were prepared in 20 µl volumes each containing 5 ng template DNA
(pcDNA3- PPARα, pcDNA3-PPARβ or pcDNA3-PPARγ), 1× Pfu polymerase
buffer (Promega), 250 µM deoxynucleotide triphosphate (dNTP) mix, 250 nM each
of forward and reverse primer and 2.5 units Pfu polymerase enzyme (Promega).
Reactions were cycled in a thermal cycler (Biometra T gradient) using the following
conditions: one minute at 95°C (initial denaturation), followed by 20 seconds at 95°C
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(denaturation), 20 seconds at 50°C (primer annealing) and 15 seconds at 72°C
(extention). The denaturation, annealing and extention steps were cycled 30 × with a
final extention step of three minutes at 72°C completing the cycle. A sample of each
amplification product was loaded onto a 1× TAE, 1 % agarose, 0.5 µg/ml ethidium
bromide gel and electrophoresed at 75 V for 30 minutes alongside a 1 kb DNA
ladder (Fermentas). Ethidium bromide-stained DNA was visualised by exposure of
the gel to UV light. Products of 974, 915 and 1014 base pairs were expected for the
ligand-binding domains of PPARα, PPARβ and PPARγ, respectively.
Precipitation and restriction digestion of DNA from PCR reactions3.2.1.2
PCR products were precipitated out of enzymatic reactions using ethanol. To each
PCR reaction 1/10 volume of 3 M sodium acetate (Sigma) and 2.5 volumes of
ethanol absolute were added, reactions mixed thoroughly, incubated at -20°C for 1
hour and centrifuged at 16,000 × g for 15 minutes. The supernatant was discarded
and the DNA pellet washed with 150 µl 70 % ethanol before a second centrifugation
and decantation of the supernatant, leaving behind a pellet of purified DNA, which
was dried at room temperature for 15 minutes.
Individual DNA pellets were resuspended in digestion reactions containing final
concentrations of 1× multicore buffer (Promega), 5 units BamHI restriction enzyme
(Invitrogen) and 5 units KpnI restriction enzyme (Invitrogen). pBIND vector (1µg;
Promega) was digested in the same way. Reactions were incubated at 37 °C for one
hour followed by inactivation of restriction nucleases by heating at 75 °C for 15
minutes. The digested pBIND vector was dephosphorylated, removing the 5’
phosphate from the linearised vector to avoid any possibility of self-religation, using
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1 unit of shrimp alkaline phosphatase enzyme (Boehringer Mannheim) and 1×
dephophorylation buffer (Boehringer Mannheim). The reaction was incubated at
37°C for 15 minutes before the alkaline phosphatase enzyme was denatured by
heating at 65 °C for 15 minutes. Products were then purified using the
chloroform/phenol extraction method. This method involves the dilution of reactions
to 100 µl with milliQ water before the addition of 100 µl phenol and 100 µl
chloroform, and vortexed vigorously. Tubes were centrifuged at 16,000 × g for 2
minutes and the DNA-containing aqueous upper phase removed. To the aqueous
phase 200 µl of chloroform was added and the centrifugation and removal of the
upper phase process repeated. Ethanol precipitation then followed as previously
described above.
Ligation of digested PCR products into digested pBIND vector3.2.1.3
Ligation of the amplified and digested ligand-binding domains into the pBIND
vector was done in a 10 µl reaction volume. Each of the precipitated DNA pellets
were resuspended in 1 µl of the restriction-digested, dephosphorylated pBIND
vector, 1× T4 DNA ligase buffer (Fermentas) and 0.5 µl (15 Weiss units) T4 DNA
ligase enzyme (Fermentas). The volume was made up to 10 µl with Milli-Q water
(Millipore) and ligation reactions incubated at room temperature overnight before
transformation into chemocompetent Escherichia coli (E.coli) cells.
Transformation of pBIND-putative PPAR LBD into Top10 E.coli3.2.1.4
Ligated DNA was transformed into Top10 chemocompetent E.coli cells. 100 µl of
chemocompetent cells were thawed on ice and 5 µl of each ligation reaction added
per treatment. Reactions were incubated on ice for 20 minutes before cells were
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transformed by heat shocking in a waterbath at 42 °C for one minute, and replacing
on ice for a further 20 minutes. Five hundred microlitres of Luria-Bertani (LB) media
was added to each tube of transformed cells and subsequently incubated at 37 °C for
one hour with agitation (~150 rpm).
Transformants were spread on selective LB agar plates (100 µg/ml ampicillin).
Selection is based on the presence of the beta lactamase gene, conferring ampicillin
resistance in the pBIND vector and thus in successfully transformed E.coli cells.
Plates were incubated overnight at 37 °C overnight before four colonies from each
plate were used to inoculate 4 ml cultures (LB media, supplemented with 100 µg
ampicillin), followed by a further overnight incubation at 37°C with agitation (~150
rpm).  Plasmid DNA was purified from cultures using the GenElute™ Plasmid
Miniprep Kit (Sigma), following manufacturer’s instructions. DNA was eluted from
columns using 100 µl Milli-Q water (Millipore).
A sample of each eluate was subjected to a restriction digest as described in 3.2.1.2,
the products of which were electrophoresed for 30 minutes at 75V on a 1× TAE, 1%
agarose, 0.5 µg/ml EtBr gel alongside a DNA ladder to confirm the insertion of DNA
fragments of expected size into the pBIND vector. At least one clone per ligation
showed the expected restriction pattern, consisting of one DNA band at 6kb
corresponded to the pBIND vector and a second band about 1000bp corresponded to
the inserted PPAR ligand-binding domain.
Sequencing of the isolated plasmids3.2.1.5
Plasmids were sequenced to confirm the identity of the insert using an autosequencer
(CEQ8800, Beckman Coulter) in which capillary electrophoresis is used to separate
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and detect dye-labelled DNA fragments (Swerdlow and Gesteland, 1990).
Sequencing reactions were carried out in a 5µl volumes and each reaction contained
275 to 350 ng of plasmid DNA template, heated to 96°C for 1 minute before cooling
rapidly on ice. The amount of template per reaction was dependent on the total size
of plasmid plus insert as recommended in the sequencing protocol. Additionally 0.5
µM sequencing primer (Table 3-2) and 2 µl sequencing mix (GenomeLab DTCS
Quick Start Kit, Beckman Coulter) was included. The strategy used for sequencing
each pBIND-putative PPAR LBD construct is detailed in Figure 3-3. Reactions were
placed in a thermocycler (Biometra TGradient) and cycled 35 times in the following
sequence before post-reaction cleanup: 96 °C for 1 minute, 50 °C for 10 seconds and
60 °C for 4 minutes.
Table 3-2. Sequences of primers used in the sequencing of pBIND vectors containing putative
ligand binding domains of PPARα, PPARβ and PPARγ.
Name of Sequencing Primer Primer sequence (5’ 3’)
PPARα LBDseqR CCG GTG AGT ATG ACC TTC GCC
PPARα LBDseqR2 GCC GCC ACG TGC CAC CAG GAG GCC
PPARα LBDseqR3 TGG AGC TGC AGC GCC TGG AGA ATG
PPARβ LBDseqR GCC TGT CAG GTA CTG CGG GCC
PPARβ LBDseqR2 TTT GGG CTC CAT GAT CTC ACT GAA
PPARβ LBDseqR3 GAG CGT TCT CAG TAA CCA GCT GAC
PPARγ LBDseqR GGT CTT CCC AGA GAG GAT GGC
PPARγ LBDseqR2 GGT CAT CTT CTG GAG CAG CTT GGC
pBINDseqF CTT CAG TGG AGA CTG ATA TGC
pBINDseqR CAC TGC ATT CTA GTT GTG GT
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Figure 3-3. The annealing position of primers used to sequence the pBIND vectors containing
putative PPARα (A), PPARβ (B) and PPARγ (C) ligand-binding domains. Lines represent the
sense (5’  3’) and antisense (3’  5’) DNA strands of the plasmid. Red lines represent the
pBIND vector sequence and black lines represent the PCR product ligated into the pBIND
vector. Arrows indicate the direction in which sequencing will advance with numbers under
primer names indicating the nucleotide positions within each ligand-binding domain to which
the primer will anneal.
Post-reaction sequencing cleanup3.2.1.6
To stop the sequencing reactions and precipitate DNA, 20 µl 150 mM sodium acetate
(Sigma), 10 mM EDTA (Sigma), 1 µl glycogen and water was added along with 60
µl ice cold ethanol. Reactions were mixed thoroughly and centrifuged at 16,000 × g
for 10 minutes in a microcentrifuge. The supernatant was pipetted off and the
remaining DNA pellet washed with 150 µl 70% ethanol and centrifuged for 2
minutes before the ethanol was removed and the DNA pellet left to dry. Once all
traces of ethanol was removed the DNA pellet was resuspended in a 35 µl volume of
sample loading formamide solution (SLS formamide; GenomeLab), transferred to a
sequencing plate and covered with a single drop of mineral oil (Beckman coulter).
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The raw sequence data output was analysed using the Lasergene SeqMan programme
(DNASTAR). Confident changes were made to the raw sequences where required
and putative PPAR ligand-binding domain sequences compared to database entries
for the European plaice PPAR ligand-binding domain sequences. Sequences were
also analysed to confirm that the DNA insert in each construct was in the same open
reading frame as the upstream yeast Gal4 DNA-binding domain found in the pBIND
vector.
3.2.2 Testing the Gal4-PPAR LBD constructs in a
transactivation assay
Following confirmation that the fragments ligated into the pBIND vector were the
ligand-binding domains of PPARα, PPARβ and PPARγ, the response of the fusion
proteins to well characterised PPAR ligands was assessed in a transient transfection
assays.
Seeding of FHM cells3.2.2.1
FHM cells, isolated from fathead minnow (Pimephales promelas) (Gravell and
Malsberger, 1965) were seeded to 96 well assay plates in DMEM (supplemented
with 10% charcoal/dextran treated FBS, 50 units per ml penicillin and 50 µg/ml
streptomycin) as described in 2.2.1.2.
Transfection of FHM cells3.2.2.2
Transfection occurred 24 hours after seeding of FHM cells. Cells were transfected
with 25ng Gal4-PPARαLBD, Gal4-PPARβLBD, Gal4-PPARγLBD or pBIND
plasmid containing the Gal4 DNA-binding domain only, together with the 10ng
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internal reporter plasmid pGL4.75[hRluc/CMV] and 25 ng of the experimental
reporter pGL4.31[luc2P/Gal4UAS/hygro]. For each well to be transfected DNA was
diluted with DMEM, with serum and antibiotics absent, to a final volume of 3 µl.
After mixing and brief centrifugation to collect DNA/DMEM mix in the bottom of
the tube a volume of Polyfect reagent (Qiagen) was added to give a final Polyfect to
DNA ratio of 10.5 µl:1 µg and transfection mixes incubated at room temperature for
10 minutes. Media in which cells were seeded was replaced with 60 µl 1 ×
Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen) containing 4.5g/L
glucose, 10% (v/v) charcoal/dextran treated fetal bovine serum (Fisher Scientific) 50
units/mL penicillin and 50 µg/ml streptomycin (Invitrogen) before 20 µl transfection
mix was added to wells of the assay plate.
Transfected cells were incubated for 24 hours prior to treatment.
Treatment of transfected cells with mammalian PPAR agonists3.2.2.3
Treatments were selected upon the basis that they had previously been shown to be
mammalian and, in some cases, piscine PPAR activators (Leaver et al, 2005). Each
compound was prepared in ethanol absolute at 200× the concentration to which the
transfected cells would be exposed. Compounds and concentrations were as follows:
4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy14643; Sigma) prepared
at 5 mM concentration, 2-methyl-4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-
thiazol-5-yl)-methylsulfanyl)phenoxy-acetic acid (GW501516) prepared at 2 mM
concentration, Bromopalmitate prepared at 2 mM concentration, Rosiglitazone
prepared at 5 mM and fatty acids at 20 mM.
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In 5mL bijoux tubes each compound was diluted into complete DMEM at a
concentration of 5 µl per mL, giving final assay concentrations of 2 µM (GW501516
and bromopalmitate), 5 µM (Wy14643 and rosiglitazone) or 100 µM (fatty acids). In
addition an ethanol vehicle control treatment was prepared using, per mL of DMEM,
5µl ethanol absolute. Diluted treatment compounds were mixed thoroughly before
being added to transfected cells. Transfection mixes were removed from each well of
the assay plate and cells washed once with 1 × DPBS (Invitrogen), after which 75 µl
of treatment compounds added to cells. Treatments were administered in such a way
that each Gal4-PPAR construct/empty Gal4 plasmid was treated in triplicate with
each compound.
Cells were then incubated with treatment compounds for a further 24 hours at 22°C,
5% CO2 before assaying for luciferase activity.
3.2.3 Luciferase assay, data normalisation and statistical
analysis
To assay for luciferase activity in transfected cells treated with known mammalian
PPAR agonists, the Dual-Glo® ™ luciferase assay system (Promega) was used, as
described in the manufacturer’s instruction manual. Both firefly and Renilla
luciferase activites were measured. Renilla luciferase values were used to normalise
for variabilities in transfection efficiencies between wells. This normalisation was
achieved by dividing each firefly luciferase value by its corresponding Renilla
luciferase value. Values from replicate wells were then averaged and expressed as
mean normalised firefly luciferase activity. In each case data shown are the means of
three independent experiments. The effects of treatments on transactivation were
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tested by one way analysis of variance (ANOVA), followed by Dunnet’s post hoc
test to identify where significant differences lay. An assumption of ANOVA is that
data are sampled from a population with equal variances. Therefore before carrying
out ANOVA, homogeneity of variances was tested using the F-max test and where
necessary data were log transformed to improve homogeneity. Results were
considered statistically significant when the probability value (P) was less than 0.05
(P <0.05).
3.2.4 Formulation and testing of “homemade” luciferase
buffers
A draw-back in using the Dual-Glo® ™ luciferase assay system is that it is
prohibitively expensive and the exact compositions of the buffers which allow
extension and quenching of the luciferase signal are not available. However, a report
of “homemade” luciferase buffers (Dyer et al, 2000) together with the valuable
information available in several patent descriptions has been combined to formulate
two buffers as an alternative to the Dual-Glo®™ luciferase assay reagents. The
firefly reagent formulated contained, in addition to the required pH buffering and co-
factors, high concentrations of phosphate, DTT and co-enzyme A, which partially
inhibit firefly luciferase activity, leading to attenuation of light output but with a
more stable luminescence signal over an extended time course. The Renilla reagent
contained sodium azide and was buffered to pH 5.1, conditions which abolish
(quench) firefly luciferase (Dyer et al, 2000), but still enable the measurement of
Renilla luciferase activity.
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Cells transfected with Gal4-PPARα and treated with Wy14643 (see 3.2.2), served to
compare luciferase measurement methodologies between the Dual-Glo®™
luciferase assay system and the alternative luciferase assay buffers comparing the
following parameters:
• Overall levels of firefly and Renilla luciferase signal
• Stability of firefly and Renilla luciferase signal over time
• The effectiveness of quenching firefly activity during the Renilla luciferase
measurement
For each of the three conditions mentioned above, twelve wells were transfected with
Gal4-PPARα, six of which were treated with Wy14643 and six with ethanol vehicle.
In measuring luciferase activity half the wells of each treatment were assayed using
the Dual-Glo luciferase assay system and the remaining half assayed using the
“homemade” luciferase buffers.
Measurement of Firefly Luciferase Activity3.2.4.1
Twenty four hours after treatment of transfected cells with 25 µM Wy14643 or 0.5%
ethanol vehicle, a 2× concentrated volume of “homemade” firefly luciferase buffer or
Dual-Glo® luciferase reagent was added to wells, the volumes of which were equal
to the 75 µl volume of media already present in the wells. The final composition of
the homemade buffer in wells was as follows; 1× passive lysis buffer (Promega),
16mM dithiothreitol (DTT; Sigma), 2mM magnesium sulphate, 25mM Tris
Phosphoric acid (pH 8.0), 0.5mM Adenosine triphosphate (ATP; Sigma), 100 µM
coenzyme A (CoA; Sigma), 1mM EDTA and 190 µM beetle luciferin (Promega).
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The contents of the wells were pipetted up and down to mix and a 10 minute
incubation given before measurement of luciferase activity on the Wallac 1420
Victor 2 multilabel counter (Perkin Elmer). One of the aims of this experiment was
to measure the stability of firefly luciferase signal over time and therefore firefly
luciferase activity was monitored in several wells every 20 minutes for 1 hour.
Renilla Luciferase Measurement3.2.4.2
Following measurement of firefly luciferase, a 75 µl volume of 3× concentrated
“homemade” Renilla luciferase buffer or 75 µl of Dual-Glo® Stop & Glo® reagent
(Promega) was added. The final composition of the “homemade” Renilla luciferase
reagent was 0.55M sodium chloride, 3.33mM EDTA, 0.33mg/mL BSA (Sigma),
0.67mM sodium azide (Sigma), 100mM sodium phosphate buffer (pH 5.1) and 1 µM
coelenterazine (Promega). Several wells to which “homemade” Renilla luciferase
buffer was added, was done so with coelenterazine absent with the volume of
coelenterazine being replaced by MilliQ water. The purpose of these wells was to
test the effectiveness of the Renilla buffer in quenching firefly luciferase signal, prior
to measurement of Renilla luciferase luminescence. Coelenterazine acts as a
substrate for Renilla luciferase protein, and upon its oxidation by Renilla luciferase,
leads to the production of a measurable light emission. In the absence of
Coelenterazine there is no light emission due to the activities of Renilla luciferase
protein, therefore any luminescence produced after addition of Renilla buffer with no
coelenterazine present will be due to the activity of firefly luciferase. In these wells
minimal light emission is expected if the Renilla buffer is a good firefly luciferase
quench. Following addition of Renilla luciferase buffer (with or without
coelenterazine), or Stop & Glo® reagent, the contents of the wells were pipetted up
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and down to mix and a 10 minute incubation given. Renilla luciferase activity was
measured on the Wallac 1420 Victor 2 multilabel counter (Perking Elmer).
3.3 Results
3.3.1 Construction of the expression plasmid
Amplification of the ligand-binding domain from Pleuronectes platessa3.3.1.1
PPAR cDNA
Using primer pairs designed to the 5’ and 3’ end of the ligand-binding domains of
each PPAR subtype, the polymerase chain reaction (PCR) was expected to amplify
DNA fragments of 969, 915, and 1014 base pairs using the full open-reading frame
of PPARα, PPARβ and PPARγ as a template, respectively. Analysis of PCR products
using agarose gel electrophoresis revealed a single DNA product from each reaction.
Furthermore these products were within the expected size range for the PPAR
ligand-binding domains.
Cloning of PCR-amplified DNA fragments into the pBIND vector3.3.1.2
(Promega)
Before sequencing the putative ligand-binding domain products to confirm their
identities, fragments were cloned into the pBIND vector (Promega) by means of a
restriction digest and ligation reaction as described in 3.2.1.2 and 3.2.1.3. Following
transformation of ligation product into Top10 E.coli cells, selection of colonies and
purification of plasmid DNA, a restriction digest was carried out on a sample of each
plasmid to confirm which, if any, of the plasmid preparations contained the putative
ligand-binding domains. In five of the twelve samples, two bands were visible
following restriction digest reactions, corresponding to the expected size of the
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ligand-binding domain inserts and the 6 kb size of the pBIND vector. This was
indicative that the ligation reactions had been successful and that each product
amplified by PCR was present in at least one plasmid preparation.
Sequencing of the pBIND-PPAR ligand-binding domain plasmid3.3.1.3
The five plasmid preparations which produced two fragments when subjected to a
restriction digest (α1, α4, β2, β3 and γ3) were sequenced to confirm a) that the DNA
inserts in the pBIND vectors are the ligand-binding domains of the PPARs and b)
that the ligand-binding domain sequence and the Gal4 DNA-binding domain of the
pBIND vector were in the same continuous reading frame. Assembly of the raw
sequencing files for each plasmid resulted in a single continuous contig for each
PPAR isotype. The sequences for each PPAR isotype from P.platessa are available
from the Genbank database and comparisons of the cloned sequences with the
sequences from the database revealed identical sequences. Importantly sequencing
also confirmed that the Gal4 DNA-binding domain and the PPAR ligand-binding
domains were in a continuous, single frame (Figure 3-4).
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Figure 3-4. Nucleotide and deduced amino acid sequences of Gal4-PPARα (A), Gal4-PPARβ (B)
and Gal4-PPARγ (C) contigs produced from sequencing reactions described in 3.2.1.5. The
DNA-binding domain of the Gal4 protein is underlined. The start and stop codons of the PPAR
ligand-binding domains are boxed with the stop codon being indicated by an asterisk. The
BamHI (GGATCC) and KpnI (GGTACC) enzyme recognition sites are highlighted in bold and
italics.
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3.3.2 Response of Gal4-PPAR LBD expression constructs to
known PPAR ligands
Previously isolated from European plaice, transient co-transfection of native full-
length PPARα with a reporter construct in which the peroxisome proliferator
response element (PPRE) of mouse Cyp4A6z was attached upstream of a
chloramphenicol acetyltransferase (CAT) reporter gene, has been shown to increase
transcription of the CAT reporter gene following exposure to the synthetic PPARα-
specific activator Wy14643 (Leaver et al, 2005). FHM cells transfected with Gal4-
PPARαLBD and subsequently exposed to 25 µM Wy14643 showed similar
behaviour to the full-length native receptor, inducing luminescence signal from the
luciferase reporter construct 50-fold (Figure 3-5). Additionally, the induction in
reporter gene expression by Wy14643 was specific to those cells transfected with
Gal4-PPARαLBD, with inductions from Gal4-PPARβLBD- and Gal4-PPARγLBD-
transfected cells being within the same range as that observed after ethanol vehicle
treatment.
As well as Wy14643, GW501516 also increased Gal4-PPARαLBD mediated
inductions in reporter gene expression, increasing luciferase activity by 20-fold.
Developed as a selective modulator of PPARβ, GW501516 was also able to increase
reporter gene expression following transfection of the Gal4-PPARβLBD construct.
The induction of luciferase luminescence from cells transfected with Gal4-
PPARβLBD and subsequently treated with GW501516 was almost 2-fold greater
than that from Gal4-PPARαLBD-transfected cells, with an induction of almost 37-
fold being observed in the presence of Gal4-PPARβLBD.
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Bromopalmitate, previously shown to be an activator of PPARβ in Atlantic salmon
(Leaver et al, 2007) was able to induce transactivation of Gal4-PPARβ and Gal4-
PPARα 32-fold and 35-fold, respectively.
Previously, native PPARα and PPARβ from both sea bream (Sparus aurata) and
plaice have been shown to respond to fatty acids, suggesting these compounds to be
potential endogenous activators of piscine PPARs (Leaver et al., 2005). In FHM cells
transfected with the Gal4-PPARα construct all of the tested fatty acids, with the
exception of linoleic acid (18:2n-6), significantly induced reporter gene expression.
In cells transfected with Gal4-PPARβ there was no response after oleic (18:1n-9),
linoleic (18:2n-6), linolenic (18:3n-3), arachidonic (20:4n-6) or docosahexaenoic
acid (22:6n-3) treatments, whereas strong responses were observed with palmitoleic,
γ-linoleic (γ18:2), stearidonic (18:4n-3) and eicosapentenoic acid (20:5n-3). N-oleoyl
ethanolamine (OEA) and N-linoleyl ethanolamine (LEA) were effective agonists of
both PPARα and PPARβ. None of the fatty acids tested provoked a response with
Gal4-PPARγ.
FHM cells transfected with Gal4-PPARαLBD and Gal4-PPARβLBD, showed
positive responses to treatment with activating compounds of the PPARα and PPARβ
receptors. In contrast transfection of the Gal4-PPARγLBD construct and subsequent
treatment with the compound rosiglitazone, a member of the thiazolidinedione class
of mammalian PPARγ ligands, failed to induce an induction in reporter signal. In
response to all compounds tested luciferase luminescence signal from Gal4-PPARγ-
transfected cells remained at levels similar to those observed in the presence of the
ethanol control treatment.
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Figure 3-5. Transactivation of Gal4-PPAR constructs in response to PPAR activators. FHM
cells were transiently transfected with with Gal4-PPAR constructs, firefly luciferase reporter
plasmid pGL4.31 and an internal Renilla luciferase reporter used to correct for transfection
efficiencies (pGL4.75). Post-transfection cells were treated with 25 µM Wy14643, 10 µM
GW501516, 25 µM Bromopalmitate, 10 µM Rosiglitazone or 0.5% ethanol vehicle. Results are
expressed as arbitrary units of firefly luciferase normalised to Renilla luciferase. Data represent
the the mean ± SEM from three independent experiments. Asterisks indicate whether activities
significantly differed (P<0.01) from those in ethanol-treated cells.
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Figure 3-6. Transactivation of Gal4-PPAR constructs in response to fatty acids.FHM cells were
transiently transfected as described in the legend of Figure 3-5. Post-transfection cells were
treated with 100 µM of palmitoleic acid (16-1), oleic acid (18-1), linoleic acid (18-2), stearidonic
acid (18-4), arachidonic acid (20-4), eicosapentenoic acid (20-5), docosahexaenoic acid (22-6),
oleoylethanolamide (OEA or linoleoylethanolamide (LEA). Results are expressed as the fold
increase over ethanol control of normalised firefly luciferase activity. Asterisks indicate whether
activities significantly differed (P<0.01) from those in ethanol-treated cells.
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Within this assay system the Renilla luciferase internal control reporter is
constitutively expressed, and therefore the levels of luminescence from this enzyme
can give an indication of transfection efficiency. The mean values obtained from
measurement of Renilla luciferase luminescence reveals no significant differences in
transfection efficiency between all four Gal4 constructs (Figure 3-7), indicating that
the lack of activity from Gal4-PPARγ did not originate due to low transfection
efficiency of the construct into the FHM cell line.
Figure 3-7. Levels of constitutively expressed Renilla luciferase luminescence. 10ng of plasmid
DNA containing the Renilla luciferase gene (pGL4.75) was cotransfected with Gal4-PPAR and
Gal4UAS-luc plasmids into FHM cells which were subsequently treated and assayed for firefly
and Renilla luciferase activity. Data represents the the mean ± SEM from three independent
experiments.
3.3.3 Dual-Glo® reagents  vs. “Homemade” luciferase buffers
Stability of Firefly Luciferase Signal3.3.3.1
The homemade firefly luciferase buffer, formulated using information from both
patents and the non-commercial luciferase assay buffer described by Dyer et al
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(2000) was compared to that of the Dual-Glo® assay system for its ability to sustain
firefly luminescence signal.
Over a time period of 60 minutes, luminescence obtained using the Dual-Glo®
luciferase reagent was very stable, losing only 10% of its luminescence by 60
minutes compared to time 0 (Figure 3-8). In comparison, the firefly luciferase signal
obtained using the “homemade” firefly luciferase buffer was approximately 3.4-fold
less stable, losing 34% luminescence over the 60 minutes. This was not deemed to be
problematic due to the time scales involved in the measurements of luciferase
activities in the experimental procedure described above. Specifically, measurement
of firefly luciferase activity should occur 10 minutes after the addition of the firefly
luciferase buffer (indicated as time 0 in Figure 3-8), with the multilabel counter used
to measure luminescence taking approximately 2-3 minutes to read a full 96-well
tissue culture plate in which assays are performed. Since the loss of activity over the
60 minute time period appears to be linear, with approximately 10% loss of signal
every 20 minutes, it is predicted that in the time it takes to measure the luminescence
from one whole assay plate, the loss of activity should be very small (approximately
1.5%).
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Figure 3-8. Comparison between Dual-Glo® Luciferase reagent (Promega) and homemade
firefly luciferase buffer in sustaining the firefly luciferase signal over time. Cells transfected
with Gal4-PPARα and treated with Wy14643 were assayed for luciferase activity 24 hours after
treatment. Luciferase buffers were added and a 10 minute incubation given before the first
measurement of firefly luciferase luminescence (T0). Firefly luciferase activity was measured
thereafter every 20 minutes up to 1 hour.
Renilla luciferase buffer as a Firefly luciferase Quench3.3.3.2
The next parameter of the assay to be tested was the ability of the “homemade”
Renilla luciferase buffer to quench firefly luciferase activity. A sequential assay
system in which firefly and Renilla luciferase activities are to be measured from the
same sample requires that, prior to measurement of Renilla luciferase, firefly
luciferase activity is completely quenched to allow Renilla luciferase activities to be
quantified accurately. From Figure 3-9 it is evident that after addition of
“homemade” Renilla luciferase buffer (T20), firefly activities produced from
addition of both Dual-Glo® and “homemade” firefly luciferase reagents are
quenched completely. Firefly activities measured after addition of Dual-Glo
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luciferase reagent is quenched to 1.4% of its maximum (from 3391 units to 48 units)
while firefly activities measured after addition of homemade firefly luciferase buffer
is quenched to 0.24% of its original value (from 7422 units to 18 units). Mock
transfected wells in which no DNA was transfected but in which firefly luciferase
values were measured showed mean firefly luciferase values of 13 ± 3 units,
indicating that the Renilla luciferase buffer quenches firefly signal down to a level
which is very near that of background noise. Therefore the homemade Renilla
luciferase buffer functions very well to quench firefly luciferase activities.
Figure 3-9. The functionality of homemade Renilla luciferase buffer as a quencher of firefly
luciferase signal obtained by addition of Dual-Glo® reagent (Promega) or homemade firefly
luciferase buffer. Cells transfected with Gal4-PPARα and treated with 25 µM Wy14643 were
assayed for luciferase activity 24 hours after treatment. Firefly luciferase buffers were added
and a 10 minute incubation given before measurement of firefly luminescence (T0). Homemade
Renilla luciferase buffer with coelenterazine absent was then added, a 10 minute incubation
given and luciferase activity measured (T20).
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Firefly and Renilla Luciferase signals3.3.3.3
Using both the homemade luciferase buffers, with coelenterazine included in the
Renilla buffer, and the Dual-Glo® luciferase assay system, the levels of firefly and
Renilla luciferase were compared between the two systems (Figure 3-10). The levels
of firefly luciferase produced from use of the homemade luciferase buffer were
approximately twice that of the Dual-Glo® luciferase reagent, in those cells
transfected with Gal4-PPARα and treated with Wy14643. Levels of firefly luciferase
produced from cells transfected with Gal4-PPARα and treated with ethanol vehicle
was very low (5 and 29 units produced from Dual-Glo and Homemade firefly
luciferase buffers, respectively) due to the inability of this compound to activate
PPARα and consequently the repression of the AF2 function within the ligand-
binding domain of this receptor and the inability of the Gal4-PPARα construct to
transcribe the luciferase reporter gene. Upon quenching of the firefly luciferase
signals by addition of Dual-Glo® Stop & Glo® (Promega) or Renilla luciferase
buffer, Renilla luciferase luminescence is then produced due to the actions of this
luciferase protein on its coelenterazine substrate which is present in the reagents. The
Stop & Glo® reagent produces approximately 3-fold more Renilla signal than the
homemade Renilla buffer (Figure 3-10), however the signal from the homemade
buffer is still greater than 10-fold higher than that of background Renilla
luminescence. Over the forty minute time period that Renilla luminescence was
measured a decrease of 14% was observed when using the Dual-Glo® luciferase
assay reagents while a decrease of approximately 25% was observed when using the
“homemade” luciferase buffers. Similar to measurement of the firefly luciferase
signal, the time taken to measure Renilla luciferase luminescence is a fraction of that
measured above and therefore the decrease in Renilla luminescence over that time is
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likely to be negligible. The results, taken together suggest that both the homemade
firefly and Renilla luciferase buffers appear to function and are suitable for use in
future luciferase reporter experiments.
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Figure 3-10. Firefly and Renilla luciferase luminescence obtained using either the Dual-Glo®
luciferase reagents (Promega) or homemade luciferase buffers. Firefly reagents were added and
a 10 minute incubation given before measurement of luciferase activity (T0). Renilla luciferase
reagents were then added (indicated by the red dotted line) and a 10 minute incubation given
before measurement of Renilla luciferase activities (T20). Renilla luciferase was then measured
at 20 minute time intervals up to 60 minutes to assess the stability of Renilla luciferase signals.
Data represents the mean ± SD of triplicate measurements made in a single experiment.
3.4 Discussion
3.4.1 Activation of Gal4-PPAR constructs by known PPAR
agonists
Wy14643 as an activator of piscine PPARα3.4.1.1
A Gal4-PPAR/Gal4UAS-luc assay was developed and validated using compounds
previously shown to activate full-length native peroxisome proliferator-activated
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receptors. The isolation of three PPAR isoforms from two marine fish species, the
plaice (Pleuronectes platessa) and gilthead seabream (Sparus aurata), has previously
been reported (Leaver et al, 2005). In testing each of these full-length receptors in a
cell-based transactivation assay Wy14643 was found to increase the expression of
the chloramphenicol acetyltransferase (CAT) reporter, under the control of the
peroxisome proliferator-response element, in cells transfected with plaice and
seabream PPARα. In these assays Wy14643 had no effect on the expression levels of
CAT activity in cells transfected with PPARβ and PPARγ, despite these receptors
having the ability to interact with the PPRE. As well as fish PPARα, PPARα from
rodents has been found to be affected by Wy14643 in vivo; mice viable for PPARα,
when fed a diet containing Wy14643 showed proliferation in the number and size of
hepatic peroxisomes, typical of an activation of PPARα mice (Lee et al, 1995). This
proliferation of peroxisomes in the liver was absent in mice in which PPARα was
disrupted, suggesting the effects of Wy14643 to be mediated by PPARα. From this
previous data in which PPARα from various species has been shown to be activated
by Wy14643, the Gal4-PPARα construct appears to function similarly to native
PPARα.
GW501516 activates both PPARα and PPARβ3.4.1.2
The Gal4-PPARα and Gal4-PPARβ construct was able to increase expression of the
firefly luciferase reporter gene in the presence of GW501516. GW501516 was
developed, through combinatorial chemistry and structure-based drug design, as a
potent subtype-selective PPARβ agonist, interacting with the ligand-binding domain
of the human PPARβ to increase expression of a reporter construct within a reporter
assay system (Oliver et al, 2001). GW501516 was able to increase the expression of
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firefly luciferase reporter protein in those cells transfected with the Gal4-PPARβ
construct, confirming an interaction with the ligand-binding domain of PPARβ in
fish species as well as mammals. In their study Oliver et al (2001) reported that
GW501516 had no effect on other nuclear hormone receptors, including human
PPARα, which would appear to contrast with the findings with Gal4-PPARα in this
study, which was activated by GW501516. It has been found that GW501516 is 1000
times more selective for PPARβ than for PPARα, with EC50 values of 0.001µM and
1.1µM, respectively, in transactivation assays (Sznaidman et al, 2003). While Oliver
et al (2001) used a maximum concentration of 1 µM GW501516 in their
transactivation assays, a maximum concentration of 10 µM was used with the Gal4-
PPAR constructs above. While 1 µM is approximately equal to the reported EC50 of
GW501516 with PPARα, 10 µM is approximately 10-fold higher than the reported
EC50 of this compound for PPARα and therefore an effect on PPARα will more
likely be expected.
Fatty acids as PPAR agonists3.4.1.3
Fatty acids, when tested at 100 µM, activated both PPARα and PPARβ of flounder.
This concentration is similar to that shown to activate mammalian and amphibian
PPARs (Gӧttlicher et al, 1992; Krey et al, 1997). In line with mammals a number of
fatty acids induced transactivation of plaice Gal4-PPARα, the most active of which
were the fatty-acid like compounds OEA and LEA. In mammals OEA and LEA are
potent agonists of PPARα and appear to control feeding and fat-induced satiety
through PPAR interactions (Artmann et al, 2008; Schwartz et al, 2008; Dipasquale et
al, 2010). The finding that OEA also activates PPARα of plaice indicates the
potential for a similar function in fish species.
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None of the fatty acids tested were able to activate the Gal4-PPARγ. A previous
study on native plaice PPARs indicated that docosahexaenoic acid (22:6; DHA)
activated PPARγ in preference to PPARα and PPARβ (Leaver et al, 2005). However,
neither plaice Gal4-PPARγ nor Gal4-PPARβ was affected by DHA. DHA has been
reported to activate mouse RXR (de Urquiza et al, 2000), indicating that in the
previous study on fish, DHA may have been acting on RXR, the endogenous
heterodimeric partner for transfected PPAR.
Plaice PPARγ is unresponsive to mammalian PPAR agonists3.4.1.4
Peroxisome proliferator-activated receptor γ from mammals has been shown to be
the target for the thiazolidinedione class of compounds (Lehmann et al, 1995; de Vos
et al, 1996). This finding has been of particular interest due to the anti-diabetic and
insulin-sensitising effects of these agents. Rosiglitazone (BRL49653) is a member of
the thiazolidinedione class of compounds and in an assay system similar to the one
described here were able to activate murine PPARγ at a concentration of 10 µM, and
with EC50 values of 30 nM and 100 nM for PPARγ1 and PPARγ2 isoforms,
respectively (Lehmann et al, 1995). These findings are in contrast to those found
here in which 10 µM Rosiglitazone failed to increase the expression of firefly
luciferase reporter in cells transfected with the Gal4-PPARγ construct. PPARγ has
recently been isolated from olive flounder (Paralichthys olivaceus) and its response
to Rosiglitazone characterised (Cho et al, 2009). In these studies, PPARγ was found
to have weak transactivity for Rosiglitazone compared to murine PPARγ, suggesting
differences do exist in the sensitivity of PPARγ from fish and mammalian species.
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One reason for this difference in sensitivity has been suggested by Maglich et al
(2003) and Willson et al (2000). Four conserved residues within the ligand-binding
region of mammalian PPARs have been indicated as being important in ligand-
receptor interactions and alignments between the human PPAR receptors and the
orthologs in several fish species including plaice, salmon and fugu, reveal fish to
have identical residues to their human counterparts at these key positions within
PPARα (Maglich et al, 2003). Within PPARβ of fish species, three of the four
residues are identical to the human residues, however as Maglich et al (2003) states
this single amino acid change would still be likely to allow binding of ligands to the
receptor. In contrast to PPARα and PPARβ, PPARγ within fish species have two
amino acid alterations at these key residues compared to the human PPARγ  isoform;
His323 is changed to Iln and Tyr473 to Met. The thiazolidinediones make specific
hydrogen-bonding interactions with these four conserved residues (Ser289, His323,
His449 and Tyr473) as well as with the Glycine residue at position 286 (position refers
to human PPARγ). In fish species including plaice, flounder, fugu and salmon two of
these five residues are altered (Figure 3-11). These changes in key residues within
PPARγ may be enough to prevent binding of ligands to the PPARγ receptor in fish
species, thus reducing their sensitivity to the thiazolidinediones and other PPARγ
ligands.
Importantly, from previous studies and from the experiments reported here, it is
apparent that fish PPARγ does not have high levels of constitutive activity. In the
Gal4 assay, reporter gene activity driven by plaice PPARγ was very low and at
background levels. The low constitutive activity of piscine PPARγ, the high degree
of conservation amongst fish species and the lack of response to fatty acids or
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mammalian subtype specific ligands suggests that if endogenous and other ligands
for piscine PPARγ exist, they are likely to have some significant structural
differences compared to fatty acids.
Figure 3-11. Alignment of the partial ligand-binding domains of mammalian and mouse PPARγ.
Residues important in the interaction between thiazolidinediones and the PPARγ ligand-binding
domain are shown in boxes. Those that are not conserved between human and piscine PPARγ
are indicated by a red arrow.
Human ------------------------------EQS-----KEVAIRIFQGCQFRSVEAVQEI 296
Mouse ------------------------------EQS-----KEVAIRIFQGCQFRSVEAVQEI 324
Plaice -QQQASVLTATHRGLTEHHMGSDYGVWGTTSISGQEPQNALELRFFQSCQSRSAEAVREV 351
Flounder -QQQASVLTAAHGGLTEVHMGSDYGVWGMTSISGQEPQNALELRFFQSCQSPSAEAVREV 351
Fugu QQQLAPALAPGLAGLTEAHCGSDG------NIS-----DELELRFFNSCQSRSVEAVREV 337
Salmon --------------------------RQRSVLPPEEPAEELELSVFRRIQFRSAEAVQEV 362
.     . : : .*.  *  *.***:*:
Human TEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSL 356
Mouse TEYAKNIPGFINLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSL 384
Plaice TEFAKSIPGFTDLDLNDQVTLLKYGVIEVLIIMMSPLMNKDGTLISYGQIFMTREFLKSL 411
Flounder TEFAKSIPGFTDLDLNDQVTLLKYGVIEVLIIMMSPLMNKDGTLISYGQIFMTREFLKSL 411
Fugu TEFAKSIPGFIDLDLNDQVTLLKYGVIEILIIMMAPLMNKDGTLISYGQIFMTREFLKSL 397
Salmon TEFTKSIPGFTELDMNDQVILLKYGVIEVMTTMLAPLMNKDGTLFAYGQIFMTREFLKSL 422
**::*.**** :**:**** ****** *::  *::.******.*:: ** **********
Human RKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQA 416
Mouse RKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQA 444
Plaice RKPFCQMMEPKFEFSVKFNTLELDDSDMALFLVVIILSGDRPGLLNVKPIEQLQETVLHS 471
Flounder RKPFCQMMEPKFEFSVKFNTLELDDSDMALFLVVIILSGDRPGLLNVKPIEQLQETVLHS 471
Fugu RKPFGQMMEPKFEFSVKFNTLELDDNDMTLFLAVIILSGDRPGLLNVKPIERLQETVLHS 457
Salmon RKPFCEMMEPKFEFAAKFNLLELDDSDMALFFAVIILSGDRPGLVNVKPIEDLQETVLQA 482
**** ::*******:.*** *****.*:::*:.***********:****** :*:.:*::
Human LELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL 476
Mouse LELQLKLNHPESSQLFAKVLQKMTDLRQIVTEHVQLLHVIKKTETDMSLHPLLQEIYKDL 504
Plaice LELQLKLNHPDSLQLFAKLLQKMTDLRQIVTDHVHLIQLLKKTEVDMCLHPLLQEIMKDL 531
Flounder LELQLKLNHPDSLQLFAKLLQKMTDLRQIVTDHVHLIQLLKKTEIDMCLHPLLQEIMKDL 531
Fugu LELQLKISHPDSLQLFAKLLQKMTDLRQIVTDHVHFIQLLRKREVDMCLHPLLQEIMKDL 517
Salmon LELQLKTIHPDCPQLFAKLLQKMTDLRQLVANHVRHIHLLKKQELQMCLHPLLQEIMRDL 542
******  **:. *****:*********:*::**: :::::* * :*.******** :**
Human Y 477
Mouse Y 505
Plaice Y 532
Flounder Y 532
Fugu Y 518
Salmon Y 543
*
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3.4.2 Evaluation of the Gal4-PPAR assay system
The use of cell-based assay systems as a replacement for animal testing is an
attractive prospect, both in terms of ethical considerations and as a means of
overcoming many of the limitations in using live animal models. The replacement of
animals with cells or tissues in vitro is also in keeping with the internationally
accepted Three Rs concept, which aims to Replace animal models with non-animal
methods where possible, Reduce the number of animals used in experiments while
obtaining comparable levels of information and Refine methods of testing so as to
minimise or alleviate potential pain, suffering or distress and, where the use of
animals persists, enhance animal welfare (Flecknell, 2002). These considerations are
especially important in the context of assessing the risk from chemical released to the
environment, and the use of in vitro receptor interaction assays may provide a first
tier of assessment, allowing the prioritisation of chemicals for toxicological testing
on animals. The development of the Gal4 transient transfection assay provides
several advantages including high throughput screening of a number of relevant
aquatic pollutants, allowing the specific responses of receptors to be tested and
allows dosing of compounds at controlled concentrations and without interference
from in vivo complexities such as other receptors, hormones, signalling pathways,
bioaccumulation and depuration.
The use of fish cell lines in transfection experiments to evaluate environmental
samples has been previously described. The zebrafish embryo-derived cell line,
ZEM2S, transfected with a luciferase reporter constructs containing the aryl
hydrocarbon response element (AHRE), the metal response elements (MRE) or the
electrophile response elements (ERE) within its promoter region, saw an increase in
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luciferase activity following treatment of transfected cells with aryl hydrocarbon
compounds, cadmium, zinc, mercury and aluminium ions, and mercury, lead,
arsenic, copper and cadmium ions, respectively (Carvan et al, 2000).  The fathead
minnow cell line employed in the present study has been previously reported to be a
valuable tool for the study of in vitro cytotoxicity following the finding that in vitro
toxicity studies with 49 chemicals correlated well with fish lethality data (Brandão et
al, 1992). Furthermore the FHM cell line has recently been used to confirm
transactivation data, previously obtained from transfected mammalian cells, for
rainbow trout glucocorticoid receptors (Sturm et al, 2011), thus confirming the
presence of co-regulatory proteins and other elements of the transcriptional
machinery essential for the transcriptional activity of nuclear hormone receptors
within this cell line.
The use of cell based assay also holds several advantages over other methods, e.g.
computer-based in silico methods, which have been used to predict the toxicological
effects of anthropogenic compounds via nuclear hormone receptors in mammals and
other vertebrates (Jacobs, 2004; Vedani et al, 2007; Wu et al, 2009; Wu et al, 2010).
One advantage over in silico predictive methods is that, while an interaction between
a pollutant of interest and an endogenous receptor can be predicted, it is difficult to
say whether the chemical will have agonistic or antagonistic effects upon the
receptor. Furthermore several in silico studies have used experimental data from
binding assays to validate the predicted in silico binding affinities due to the
uncertainties associated with these methods (Wu et al, 2009; Wu et al, 2010; ), and
thus in silico methods may be better used in conjunction with in vitro studies rather
than as an alternative method. In silico methods have been applied to identify ligands
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of PPARα, β and γ, using a virtual docking-system in compounds were docked into
the ligand-binding domains of PPARα, β and γ and a scoring system applied taking
into account steric, hydrogen bonding, hydrophobicity, continuum electrostatics, and
entropy terms to assign a score to the ligand reflecting the quality of the complex
(Schapira et al, 2003). The authors of this study demonstrated that isotype selectivity
was poorly represented, with PPARβ-selective agonists being identified as agonists
of all three PPAR subtypes while out of seven PPARγ-selective agonists, five, four,
and three were present in the top 1% PPARγ, PPARα, and PPARβ focused libraries,
respectively. These results indicate that in vitro cell-based assay systems have the
advantage of being able to discriminate between isotype-selective ligands of PPAR
receptors, as demonstrated in the results of the current study.
In relation to the specific Gal4-NHR system employed in the present studies, the use
of the Gal4 DNA-binding domain and its upstream-activating sequence (UAS)
provides several advantages in itself. Previously a variety of receptor response
elements, including the promoter region of receptor target-genes (Klotz et al, 1996;
Tarumi et al, 2000) or the specific receptor response element (Legler et al, 1999;
Rogers and Denison, 2000; Seinen et al, 1999; Yoon et al. 2001), have been
incorporated into the reporter construct. The use of these promoter regions and
response element constructs have been shown to display reduced responsiveness to
the reporter gene through activation by non-NHR specific processes and the cross-
talk with other signalling pathways. For example the PPAR/RXR heterodimer has
been shown to inhibit transactivation activities of the estrogen receptor by binding to
the estrogen response element (ERE) (Keller et al, 1995). Thus, the introduction of
hybrid receptor and reporter constructs minimises the problem of cross-reactivity
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described above since the Gal4-NHR ligand binding domain fusion recognises and
activates the Gal4 DNA response element-reporter gene construct, which is not
known to be bound by other factors within animal cells. The Gal4-PPAR expression
constructs used in the present study utilised only the ligand-binding domain of the
nuclear hormone receptors studied. Interactions between the ligand-independent AF1
in the A/B domain and the ligand-dependent AF2 in the ligand-binding domain of
several nuclear hormone receptors have been described previously, and thus the
omission of the whole amino terminus of the receptor may influence its
transcriptional abilities in vitro. Using human PPARα in assay systems a comparison
has previously been made between the full-length receptor and a truncated receptor,
the latter using only the ligand-binding domain (Berbaum and Harrison, 2005). The
authors reported that although there was a reduced affinity for co-activator proteins
with the truncated receptor no difference in the potencies for agonists in cell-free and
cell-based assays was observed. These results indicate that the expression plasmid
used in the current study will be suitable for use in identifiying compounds which
interact with PPAR receptors and that the use of a truncated receptor should not
interfere with the potencies of such compounds.
3.4.3 Suitability of the “Homemade” luciferase assay buffers
Firefly and Renilla luciferase buffers have been formulated using data available in
patents and in the description of the non-commercial buffers described by Dyer et al
(2000). Firefly luciferase acts upon the substrate luciferin, oxidising it to oxyluciferin
and light energy in the presence of cofactors such as ATP, oxygen and magnesium
ions. For this reason beetle luciferin, ATP and magnesium sulphate were included in
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the firefly luciferase buffer, the latter of which provided the necessary magnesium
ions.
A common problem reported in measuring luminescence from luciferase-luciferin
reactions is the “flash”-type kinetics associated with this reaction, characterised by
an initial “flash” of light emission, which decays rapidly to a constant low level
luminescence (Djouadi et al (1998); Figure 3-12).
Figure 3-12. The “flash”-type kinetics associated with luciferase-luciferin reactions. Figure
taken from Djouadi et al (1998).
Experimental difficulties can arise when we consider the delay that can occur
between commencing the luciferase-luciferin reaction and starting the measurement
of luminescence, by which time light levels may have already started to deteriorate.
An early solution to this problem was to use an arsenate buffer, which inhibited the
luciferase-luciferin reaction, altering the time-course of the reaction (DeLuca et al,
1979). More recently, it has been reported that coenzyme A (CoA) and dithiothreitol
(DTT) can stabilise the luminescence signal of the luciferase-luciferin reaction,
prolonging the signal and thus avoiding the “flash”-type kinetics associated with the
reaction. CoA has been shown to stabilise light emission by converting
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dehydroluciferyl-adenylate (L-AMP), a side product of the bioluminescence reaction
and a potent inhibitor of the reaction, to dehydroluciferyl-coenzyme A (L-CoA),
reducing the inhibitory actions of L-AMP (Fraga et al, 2005). As well as DTT and
CoA having been identified as stabilisers of luminescence in luciferase-luciferin
reactions, high concentrations of phosphate and ammonium ions, have also been
shown to have a similar effect (van Lune and Bruggeman, 2006). From these results
dithiothreitol (DTT) and coenzyme A (CoA) along with high concentrations of
ammonium and phosphate ions, present as Tris-phosphoric acid, were included in the
firefly luciferase buffer. This appeared to have a stabilising effect, with only a 34%
loss of luminescence over a 60 minutes period. This is not perceived to be
problematic in the current assay system because of the small lapse in time (10
minutes) between the addition of substrate and measurement of firefly luciferase, in
which time only a 5% loss in luminescence signal is observed.
Within the experiments described above the firefly luciferase reagent contained a
lysis buffer. One of the aims in the development of these alternative assay buffers
was to limit the number of steps, and thus time, involved in the measurement of
luciferase activities. A patent detailing a lysis reagent consisting of octoxynol
(Triton-X 100), BSA and DDT has been described (Wood, 1997) and a concentrated
lysis reagent thought to contain these components was available from Promega,
which was added to the homemade firefly luciferase reagent in order to combine the
cell lysis step and firefly luciferase reaction into one. In a further step to reduce assay
time, measurements of luciferase activities were carried out in the presence of media
which had been spiked with treatment compounds, in a similar method to that
described for the Dual-Glo® luciferase assay system. Therefore the culture media
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and any treatment compounds added made up 50% of the environment of the firefly
luciferase reaction and one-third of the environment of the Renilla luciferase
reactions. The effects of many of the treatment compounds on luciferase protein and
other components of the assay system were largely unknown and therefore in
subsequent experiments, the methodology was modified so that media and treatments
were removed and cells washed prior to determination of luciferase activities. As the
specific inhibition of firefly luciferase by long-chain fatty acids in the µM range has
been reported previously (Matsuki et al, 1999), this additional step was considered a
necessary precautionary measure for subsequent experiments, especially when fatty
acids were being tested as potential PPAR activators.
Within this assay system Renilla luciferase activities were used to normalise for
differences in transfection efficiencies between wells on an assay plate. In vitro,
Renilla luciferase catalyses the oxidative carboxylation of coelenterazine in the
presence of oxygen, producing Renilla luminescence, oxyluciferin and carbon
dioxide (Hori et al, 1973). Coelenterazine was therefore present in the Renilla
luciferase buffer. One of the requirements of the Renilla luciferase buffer was that it
should quench the firefly luciferase signal down to background levels. Information
contained within a patent show many reagents, including high concentrations of
sodium chloride and sodium phosphate as well as EDTA quench beetle luciferase
activity (Sherf et al, 1998). Additionally, it was stated that superior quenching was
obtained with a combination of these reagents, several of which were included in the
Renilla luciferase buffer formulated by Dyer et al (2000). The formulation of the
“homemade” Renilla luciferase buffer described and used here was based roughly on
that described by Dyer et al (2000) and included sodium chloride, sodium phosphate
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and EDTA, shown by Sherf et al (1998) to effectively quench firefly luciferase
activity by 91.7%, 90% and 99.87%, respectively. Using the Renilla luciferase
buffer, firefly luciferase was quenched by more than 99%, and the Renilla luciferase-
coelenterazine reaction was simultaneously activated, suggesting this buffer to be
very effective in the dual-reporter assay system.
3.5 Conclusions
In order to find compounds that interact with the peroxisome proliferator-activated
receptors (PPARs) a system is required in which PPARs are tested in isolation from
their endogenous heterodimeric partner, the retinoid X receptor (RXR). A luciferase
assay is described here which makes use of the interactions between the Gal4 DNA-
binding domain and the Gal4 upstream-activating sequences to initiate transcription
of the firefly luciferase reporter gene following compound interactions with the
PPAR ligand-binding domain. The Gal4-PPARα and Gal4-PPARβ constructs
increased transcription of the firefly luciferase protein in response to known
mammalian PPARα and PPARβ agonists, respectively, leading to the conclusion that
these constructs are appropriate to detect compounds which interact with PPARα and
PPARβ. The Gal4-PPARγ construct was unresponsive to mammalian PPARγ
agonists. The unresponsiveness of full-length piscine PPARγ to compounds which
activate mammalian PPARγ has previously been described, and therefore the
unresponsiveness described for the Gal4-PPARγ construct is not likely to be due to
the truncation of the receptor.
Luciferase proteins are widely used as reporters, but their use has previously been
hindered by the rate of their inactivation, which quickly reduces luminescence signal
over a matter of seconds. Several commercial reagents have been described in which
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the luminescence signal can be stabilised for longer time periods, allowing
luminescence signal to be assayed over several hours. These reagents can be
prohibitively expensive and therefore information from available literature was used
to develop alternative firefly and Renilla reagents, the former of which initiated the
luciferase-luciferin reaction and stabilised firefly luminescence signal for longer than
was required to assay its activity and the latter of which both quenched firefly
luciferase activity while generating Renilla luciferase activity.
Both the Gal4-PPAR/Gal4UAS-luc assay system and the reagents used to assay for
luciferase protein can be combined to give a method for the high throughput
screening of compounds which can interact with the ligand-binding domain of
PPARs, separate from the influence of RXR.
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Chapter 4. Response of piscine PPARs to
environmental contaminants
4.1 Introduction
The production of synthetic organic and inorganic compounds has been increasing
dramatically since the early 20th century, and in the USA alone production levels
now exceed 140 billion kg/annum (Baillie Hamilton, 2002). This inevitably leads to
a release of a fraction of the produced chemicals to the environment, with significant
volumes ultimately entering aquatic ecosystems. Some of these pollutants have been
shown to be endocrine disruptors in aquatic organisms via interactions with nuclear
hormone receptors (NHRs). At present the interactions of pollutants with the
estrogen receptor is relatively well studied, reflecting the importance of this receptor
in reproductive function (Fent et al, 2006; Mortensen and Arukwe, 2007; Tollefsen
et al, 2008). However much less is known of the effects of anthropogenic compounds
on other nuclear hormone receptors (NHRs), many of which are known to function in
endocrine and cellular signalling.
The peroxisome proliferator-activated receptors (PPARs) have been isolated from a
variety of organisms, including mammals, fish and amphibian species (Lee, 1991;
Göttlicher et al, 1992; Schmidt et al, 1992; Krey et al, 1993; Tontonoz et al, 1994;
Kliewer et al, 1994; Aperlo et al, 1995; Andersen et al, 2000; Leaver et al, 2005) and
function as regulators of energy homeostasis (Latruffe and Vamecq, 2002; Dressel et
al, 2003; Wang, 2010). An emerging hypothesis concerning PPARs is that they are
the targets of environmental pollutants known as ‘obesogens’, hypothesised to play a
role in the increasing precedence of the metabolic syndrome and obesity in the
human population, due to their interactions with the human PPARs. Such obesogenic
compounds include phthalate plasticisers, bisphenol A and organotins (Desvergne et
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al, 2009; Grun, 2010), all of which have been detected in the aquatic environment.
Despite little being known about the interactions of such compounds with piscine
PPARs or their physiological effects, some evidence exists to suggest that
compounds which activate mammalian PPARs also interact with piscine PPARs,
with a variety of physiological consequences. Examples of such effects are described
in adult zebrafish and in Grass carp (Ctenopharyngodon idella) in which cholesterol
levels are decreased in response to the pharmaceuticals bezafibrate and fenofibrate,
respectively (Du et al, 2008; Velasco-Santamaria et al, 2011). Additionally plasma
triacylglyceride, total whole body and liver lipid levels and tissue eicosapentanoic
and docosahexanoic acid content was reportedly decreased in grass carp (Du et al,
2008), suggesting large alterations in lipid profiles in response to exogenous
compounds. Since cholesterol is the precursor for all steroidogenic hormones it
might be expected that steroid hormone synthesis would be decreased in response to
decreasing levels of cholesterol. Indeed 11-ketotestosterone is decreased by
bezafibrate and clofibric acid in the zebrafish (Runnalls et al, 2007; Velasco-
Santamaria et al, 2011) and exposure of goldfish (Carassius auratus) to gemfibrozil
also saw a reduction in testosterone (Mimeault et al, 2005) The purpose of the study
described in this chapter was to assess a selection of persistent environmental
pollutants for their ability to interact with PPARs from plaice (Pleuronectes
platessa), a flatfish species which lives in close association with marine benthic
sediments. Fourteen widespread pollutants, which are detected in benthic sediments
were assessed, and included byproducts of the manufacturing industry, human
pharmaceuticals and pesticides. The transient transfection assay developed in
Chapter 3 was used within this study to identify:
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i) pollutants with the ability to agonise the Gal4-PPAR LBD construct
transfected into FHM cells, by increasing luciferase enzyme activity.
ii) pollutants with the ability to antagonise Gal4-PPAR LBD constructs
transfected into FHM cells, identified as a decrease in luciferase enzyme
activity when treatment is in combination with a PPAR agonist.
4.2 Materials and Methods
The Gal4-PPAR constructs described in Chapter 3 were used to test for agonistic and
antagonistic effects of pollutants in cell-based transactivation assays.
4.2.1 Seeding and tranfection of FHM cells
FHM cells were harvested from near-confluent cell culture flasks and seeded at 2 ×
105 cells per well of 96 well plates before transfection 24 hours later with with Gal4-
PPARα, Gal4-PPARβ, Gal4-PPARγ or pBIND plasmid,
pGL4.31[luc2P/GAL4UAS/Hygro] and pGL4.75[hRluc/CMV] as described in
3.2.2.1 and 3.2.2.2.
As a control, an experiment to assess the potential impact of environmental
contaminants on PPAR-independent transcription within FHM cells was carried out
using the Checkmate™ Positive Control vectors pBIND-Id and pACTmyoD
(Promega). The Id and myoD proteins interact to generate a functional transcriptional
complex and, when co-transfected together with pGL4.31[luc2P/GAL4UAS/Hygro],
induce firefly luciferase proteins in a non-PPAR dependent manner. Per well 60ng
DNA was transfected per well using 12.5ng pBIND-Id, 12.5ng pACTmyoD, 25ng of
pGL4.31[luc2P/GAL4UAS/Hygro] and 10ng internal control vector
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pGL4.75[hRluc/CMV] was transfected with 0.63 µl Polyfect reagent as described
previously.
Cells were incubated with transfection mixes for 24 hours prior to treatment with
compounds of interest.
4.2.2 Treatment of transfected FHM cells
Following transfection, cells were treated with various pollutants of the aquatic
environmental. These compounds included fibrates (Gemfibrozil, Fenofibrate,
Clofibric Acid, Bezafibrate and Ciprofibrate), phthalates and their metabolites
(dimethylphthalate, benzylbutylphthalate, 1-monobenzyl-phthalate and mono-1-
methylhexylphthalate), surfactant compounds (perfluorooctanoic acid and
fluorooctane sulphonic acid), deltamethrin, bisphenol A and tributyltin oxide. The
compounds were tested for their ability to interact with the PPAR-ligand binding
domain as receptor agonists, i.e. chemicals capable of increasing the transcriptional
activity of PPAR, or as receptor antagonists, i.e. molecules that are capable of
blocking the action of an agonist. In experimental designs addressing antagonistic
action, pollutants were tested in combination with pharmacological inducers of
PPAR. Antagonism of Gal4-PPARγ could not be addressed due to the lack of known
activators of the Gal4-PPARγ construct. Based on results obtained in Chapter 3,
Wy14643 was used as an agonist for Gal4-PPARα, while GW501516 was used as an
agonist for Gal4-PPARβ. Compounds with antagonistic activitity on the PPAR will
fully or partially reverse the stimulating effects of the above agonists on the
transcription of the firefly luciferase gene, leading to lower luminescence compared
to those cells treated with agonists alone.
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Stock solutions of compounds were prepared in absolute ethanol at 200 times the
exposure concentration. Directly prior to to the treatment of cells, stock solutions
were diluted 1 in 200 into DMEM (supplemented with 10% charcoal/dextran treated
FBS (Fisher Scientific), 50 units/mL penicillin and 50 µg/mL streptomycin
(Invitrogen)). For antagonism experiments both the chosen agonist and the treatment
compound of interest were diluted 1 in 200 into supplemented DMEM. Initially, two
arbitrary concentrations, designated as ‘high’ and ‘low’, was chosen for each
compound in activation experiments (see the legend of figure 4.1, figure 4.4 and
figure 4.6 for concentrations), while a single concentration, equal to the ‘high’
concentration used in activation experiments, was chosen for inhibition experiments.
Initial experiments with TBTO revealed cell toxicity at micromolar concentrations
and therefore nanomolar concentrations of TBTO were used. On the day following
transfection of cells, media was aspirated from the assay plate and cells washed once
with 1× DPBS (Invitrogen) before addition of treatment compounds diluted in
DMEM (75 µl/well). Each treatment was run in triplicate within each experiment.
Control treatments included an ethanol vehicle treatment (0.5% or 1% ethanol for
agonism and antagonism experiments, respectively). Wy14643 and GW501516 were
used at final concentrations of 25 µM and 10 µM, respectively.
Cells were incubated with treatment compounds for a further 24 hours at 22°C, 5%
CO2, before being assayed for luciferase activity.
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4.2.3 Luciferase activity, data normalisation and statistical
analysis
Luciferase Assay4.2.3.1
Firefly and Renilla luciferase activities were measured using the non-commercial
luciferase assay buffers described in Chapter 3. Twenty four hours post-treatment,
media containing treatment compounds was aspirated from assay plates and cells
washed twice with 1× DPBS. Concentrated 5× Passive lysis buffer (Promega) was
diluted down to a 1× concentration with MilliQ water (Millipore) and 75 µl added to
cells. Cells were incubated with lysis buffer at room termperature for 10 minutes to
allow for complete cell lysis, before adding 75 µl of 2× concentrated luciferase
buffer to the lysate. The reagents making up the luciferase buffer and their final assay
concentrations were as described in 2.2.4.1, except that the lysis reagent in the buffer
was replaced by water because in these, and subsequent experiments, lysis and
measurement of firefly luciferase activity was performed separately. The cell lysate
and firefly luciferase buffer was mixed by pipetting up and down and firefly
luciferase activity measured on Wallac 1420 Victor 2 multilabel counter (Perking
Elmer).
Renilla luciferase was then measured using the non-commercial buffer described in
2.2.4.2. 75 µl of 3× concentrated Renilla luciferase buffer was added to lysate
containing firefly luciferase buffer, mixed by pipetting and Renilla luciferase activity
measured on Wallac 1420 Victor 2 multilabel counter (Perking Elmer).
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Data Normalisation & Statistical Analysis4.2.3.2
As previously described, Renilla luciferase values were used to normalise firefly
activities for differences in transfection efficiency between wells. For each well, the
firefly luciferase value was divided by the corresponding Renilla luciferase value and
the mean of replicate wells was calculated.
Experiments were repeated independently at least three times (i.e. with different
flasks of cells seeded on different days). Data is reported as the mean fold inductions
in firefly luciferase activites compared to ethanol vehicle controls. To test for
statistically significant differences between ethanol control treatment and treatment
with environmental pollutants a one way ANOVA was carried out followed by
Dunnet’s post hoc test. Where necessary data were log transformed to improve
homogeneity of variances. Results were considered statistically significant when the
probability value (P) was less than 0.05 (P <0.05).
4.3 Results
4.3.1 Environmental pollutants as Gal4-PPARα agonists
Of the tested compounds four were able to induce PPARα transcriptional activity,
reflected by an increase in firefly luciferase activities of between 2-fold and 58-fold
over ethanol controls (Figure 4-1).
Activation by Fibrates4.3.1.1
Of the five fibrates tested (Gemfibrozil, Bezafibrate, Ciprofibrate, Fenofibrate and
Clofibric Acid), two elicited a response from the Gal4-PPARα construct (Figure
4-1). At 100 µM, the presence of ciprofibrate and gemfibrozil increased firefly
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luciferase luminescence 5.4-fold and 57-fold, respectively. A 2-fold increase in
luciferase luminescence was seen in the presence of 100 µM Clofibric acid, however
this was not statistically significant. The lower concentrations of of 10 µM failed to
induce firefly luciferase activity. Bezafibrate and Fenofibrate at concentrations of 10
µM and 100 µM were not agonists of PPARα, indicated by similar firefly luciferase
activities as observed with ethanol vehicle controls.
Phthalate metabolites4.3.1.2
In addition to fibrates, the major metabolites of two phthalate compounds were
shown to activate the Gal4-PPARα construct (Figure 4-1). At concentrations of 100
µM, both 1-monobenzylphthalate and mono-1-methylhexylphthalate increased
reporter gene activity by 2-fold and 16.6-fold, respectively, over treatment with
ethanol vehicle alone. No effect was observed at the lower 10 µM concentration.
Two parent phthalate compounds which were also tested (benzylbutylphthalate and
dimethylphthalate) had no effect on the transcription of firefly luciferase at
concentrations up to 25 µM.
Perfluorochemicals chemicals, Pesticides & Bisphenol A4.3.1.3
In the present study neither fluorooctane sulfonic acid (FOSA), perfluorooctanoic
acid (PFOA), deltamethrin, TBTO nor bisphenol A at the concentrations tested
induced any increase in firefly luciferase activity when incubated with the Gal4-
PPARα (Figure 4-1).
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Figure 4-1. Activation of PPARα by aquatic contaminants. FHM cells were transfected and
treated as described in materials and methods. Cells were treated with two concentrations per
contaminant: Fluorooctanesulfonic acid, perfluorooctanoic acid, dimethylphthalate,
benzylbutylphthalate, bisphenol A and deltamethrin were tested at 10 μM (LOW) and 25 μM
(HIGH). Mono-1-methyl-hexyl-phthalate, 1-mono-benzylbutylphthalate, gemfibrozil,
bezafibrate, ciprofibrate, fenofibrate and clofibric acid were tested at 10 μM (LOW) and 100
μM (HIGH). Bis(tributyltin)oxide (TBTO) was tested at 10 nM (LOW) and 50 nM (HIGH).
Data are the means ± SEM of three independent experiments. Results are expressed as the fold
increase over ethanol control of normalised firefly luciferase activity. Asterisks represent
statistically significant differences to activities in ethanol controls ( P<0.01).
4.3.2 Environmental Pollutants as antagonists of Gal4-PPARα
Antagonism of Gal4-PPARα by pollutant compounds reduced luciferase activity by
up to 61.7%, compared to treatment by Wy14643 alone (Figure 4-2). Three
compounds, (Bezafibrate, Fenofibrate and bis(tributyl tin) oxide (TBTO)), had
statistically significant antagonistic effects. Antagonism of Gal4-PPARα by
Bezafibrate and Fenofibrate was unexpected as fibrates have been described
previously as activators of PPARα in mammalian and amphibian species. The
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inhibition of Gal4-PPARα by TBTO is previously undescribed and antagonism
occurred at concentrations 2000-fold lower than that of fibrates.
Figure 4-2. Antagonism of Gal4-PPARα by aquatic contaminants. Transfected FHM cells were
treated with Wy14643 alone or in combination with aquatic contaminant, the concentration of
which is indicated above. Data are represented as the mean ± SEM of 3 independent
experiments and are expressed as the percentage of normalised firefly luciferase luminescence
with respect to treatment with Wy14643 (25 µM) alone, set arbitrarily to 100%. Asterisks
represent statistically significant differences to the treatment without inhibitor (* P<0.05, **
P<0.01).
Inhibitory effects of TBTO were further assessed over a range of concentration (1nM
to 50nM) and were shown to significantly inhibit Wy14643-mediated luciferase
activity at concentrations as low as 1nM (Figure 4.3).
Additionally, in order to assess whether this apparent antagonistic effect was due to
specific interactions with the PPAR ligand-binding domain or due to non-specific
effects on transcription, the effects of TBTO on luciferase activities were observed in
FHM cells transfected with a positive control two hybrid construct system (pBIND
ID and pACTmyoD, Promega) as described in 4.2.1. In these cells TBTO failed to
reduce firefly luciferase activity (Figure 4.3), suggesting TBTO decreases luciferase
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activity in Wy14643-treated Gal4-PPARα transfected cells in a PPAR dependent
manner.
Figure 4-3. Concentration dependent effects of TBTO on plaice PPARα. FHM cells transfected
with Gal4-PPARα were treated with Wy1463 either alone (Control) or in combination with
various concentrations of TBTO. As an internal control, cells transfected with pBIND-Id and
pACTmyoD, which resulted in constitutive luciferase expression, were included to test for
general effects of TBTO on gene expression. Means ± SEM of three independent experiments
are shown. Data are expressed as the percentage of normalised firefly luciferase luminescence
observed in control treatments with Wy14643 (Gal4-PPARα transfected cells) or 0.5% ethanol
(pBIND-Id/pACTmyoD-transfected cells) alone. Asterisks represent statistically significant
differences to control treatments at P<0.05 (*) or P<0.01 (*).
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4.3.3 Response of Gal4-LBDβ to environmental pollutants
Agonism of PPARβ4.3.3.1
Bezafibrate, a member of the fibrate class of pharmaceutical compounds, has
previously been described as a dual agonist of PPARα and PPARβ (Peters et al,
2003). Bezafibrate failed to activate plaice PPARα, but at both 10 and 100 µM
concentrations this compound increased Gal4-PPARβ-dependent transactivation by
2.4- and 59.8-fold, respectively, compared to ethanol vehicle.
Similar to the Gal4-PPARα construct the monophthalate esters mono-1-
methylhexylphthalate and 1-monobenzylphthalate, at 100 µM, were able to
significantly induce transcriptional activation of Gal4-PPARβ by 2.9- and 2.3-fold,
respectively (Figure 4-4).
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Figure 4-4. Activation of PPARβ by aquatic contaminants. FHM cells were transfected and
treated as described in materials and methods. Cells were treated with two concentrations per
contaminant: Fluorooctanesulfonic acid, perfluorooctanoic acid, dimethylphthalate,
benzylbutylphthalate, bisphenol A and deltamethrin were tested at 10 μM (LOW) and 25 μM
(HIGH). Mono-1-methyl-hexyl-phthalate, 1-mono-benzylbutylphthalate, gemfibrozil,
bezafibrate, ciprofibrate, fenofibrate and clofibric acid were tested at 10 μM (LOW) and 100
μM (HIGH). Bis(tributyltin)oxide (TBTO) was tested at 10 nM (LOW) and 50 nM (HIGH).
Data are the means ± SEM of three independent experiments. Results are expressed as the fold
increase over ethanol control of normalised firefly luciferase activity. Asterisks represent
statistically significant differences to activities in ethanol controls ( P<0.01).
Antagonism of Gal4-PPARβ4.3.3.2
None of the compounds tested were able to significantly reduce the luciferase
activity in GW501516-treated cells transfected with Gal4-PPARβ (Figure 4-5)
although a slight (non-significant) inhibition by Bisphenol A (42.5% inhibition) and
TBTO (27.3% inhibition) was observed.
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Figure 4-5. Antagonism of Gal4-PPARβ by aquatic contaminants. Transfected FHM cells were
treated with GW501516 alone or in combination with aquatic contaminanats, the concentrations
of which are indicated above. Data are represented as the mean ± SEM of 3 independent
experiments and are expressed as the percentage of normalised firefly luciferase luminescence
with respect to treatment with GW501516 alone, set arbitrarily to 100%.
4.3.4 Activation of Gal4-PPARγ by environmental pollutants
Aquatic contaminants incubated with Gal4-PPARγ at low concentrations had no
effect on the expression of firefly luciferase reporter gene. At high concentrations
only one compound, 1-monobenzylphthalate, was able to increase expression of
firefly luciferase over that observed with ethanol to a statistically significant level,
although this increase was small at 1.72-fold (Figure 4-6).
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Antagonism of Gal4-PPARγ by the pollutant compounds could not be determined
since no sufficiently potent plaice PPARγ agonist was identified throughout this
study.
Figure 4-6. Activation of PPARγ by aquatic contaminants. FHM cells were transfected and
treated as described in materials and methods. Cells were treated with two concentrations per
contaminant: Fluorooctanesulfonic acid, perfluorooctanoic acid, dimethylphthalate,
benzylbutylphthalate, bisphenol A and deltamethrin were tested at 10 μM (LOW) and 25 μM
(HIGH). Mono-1-methyl-hexyl-phthalate, 1-mono-benzylbutylphthalate, gemfibrozil,
bezafibrate, ciprofibrate, fenofibrate and clofibric acid were tested at 10 μM (LOW) and 100
μM (HIGH). Bis(tributyltin)oxide (TBTO) was tested at 10 nM (LOW) and 50 nM (HIGH).
Data are the means ± SEM of three independent experiments. Results are expressed as the fold
increase over ethanol control of normalised firefly luciferase activity. Asterisks represent
statistically significant differences to activities in ethanol controls ( P<0.01).
4.4 Discussion
4.4.1 Fibrates
Several environmental pollutants, some of which have been reported to activate
mammalian PPARs, were tested with the plaice Gal4-PPAR chimerae. Fibrates,
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pharmaceutical agents used to treate dyslipidemia in humans and shown to function
primarily via PPARα (Schoonjans et al, 1996; Staels et al, 1997), were amongst the
compounds tested. Fibrates have been widely detected in the aquatic environment
(Ternes, 1998; Buser and Müller, 1998; Andreozzi et al, 2003; Sanderson et al, 2003;
Fent et al, 2006), with their incomplete removal from sewage influent being the main
route of entry into such environments. Measurements of fibrate concentrations in
sewage, following its treatment at a sewage treatment plant (STP), have shown that
of initial concentrations detected in the sewage influent 66%, 54%, 55% and 50% of
clofibric acid, gemfibrozil, fenofibric acid and bezafibrate, respectively, remains in
the effluent (Stumpf et al, 1999). Thus there is some concern as to their effects on
aquatic organisms, including fish species, which may come into contact with fibrate
compounds.
Studies in mice and humans have shown clofibrate and fenofibrate to be at least an
order of magnitude more potent for PPARα than for PPARβ or PPARγ while
bezafibrate is an agonist of all three PPAR subtypes at similar potency (Willson et al,
2000). With regards to fish, evidence exists to suggest fibrates are also able to
activate PPARs in several species. Donohue et al (1993) have previously shown that
treatment of Rainbow trout hepatocytes with clofibric acid, from which clofibrate is
metabolised, was effective in inducing the activity of the PPARα target gene fatty
acyl-CoA oxidase (FACO), while the activity of the same enzyme also increased in
culture hepatoctes from Atlantic salmon after treatment with clofibric acid and
bezafibrate (Ruyter et al, 1997). In vivo, Yang et al (1990) and Du et al (2004),
respectively showed that intraperitoneal injection with ciprofibrate and a diet
containing fenofibrate, increased hepatic acyl-CoA oxidase activity in Rainbow trout.
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In plaice neither clofibric acid, the metabolite of clofibrate, nor fenofibrate appear to
interact with the ligand-binding domain of any of the PPARs. Although this appears
contradictory to results obtained in rainbow trout and Atlantic salmon cell cultures,
the concentrations of fibrates used in these latter experiments were in the ranges of
0.25mM to 3mM and therefore between 2.5 and 30-fold higher than the
concentrations used here. Whether higher concentrations of fibrates could have
induced the activities of the Gal4-PPAR constructs is unknown and was not tested
due to higher concentrations not being considered relevant in an environmental
context.
While bezafibrate is able to activate all three PPAR subtypes in mammalian species,
it appears to be selective for PPARβ in plaice, having no effect on PPARα or PPARγ
at concentrations up to 100 µM. Similarly bezafibrate has been shown to be selective
for PPARβ in the African clawed frog (Xenopus laevis) (Krey et al, 1997).  Thus,
data from this and earlier studies suggest that fibrates target PPARs, not just in
humans but in other vertebrates including mammals, fish and amphibians. Although
it appears that at least some of the fibrate drugs have the potential to exert toxic
effects in plaice via PPAR-mediated pathways, the concentrations required to do so
(>10 µM) far exceed measured concentrations of individual fibrates, which have
been reported to be between 0.02 µM and 0.2 µM in various sewage treatment
effluents (Krey et al, 1997; Ternes, 1998; Buser and Müller, 1998; Andreozzi et al,
2003; Sanderson et al, 2003). Measured or predicted environmental concentrations
(PECs) of pharmaceuticals are often at least an order of magnitude lower than those
levels shown to cause any effect in aquatic organisms (Corcoran et al, 2010). Despite
this it has to be considered that in most exposure studies, organisms are exposed to
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only one compound, while the situation within the environment is much more
complicated. The finding that several fibrates can have an effect on fish PPARs
suggests that the additive effects of these pharmaceuticals in the environment should
be considered. Previously additive effects of chemicals in fish have been shown
(Brian et al, 2005; Cleuvers, 2003; Thorpe et al, 2003) while some pharmaceuticals
have been shown to modify the toxicity of others (Hasselberg et al, 2008).
It is expected that organisms will be chronically exposed to low-concentrations of
these pharmaceutical drugs. Additionally plaice are a predatory benthic species,
spending much of their time in contact with bottom sediments where they feed on
invertebrate species including crustaceans, molluscs and worms. Many pollutants
have been shown to bind to particles within sediments where they accumulate to
much higher concentrations than are found in the water column (Peck et al, 2004;
Martinez-Llado et al, 2007; Zeng et al, 2008). Thus the possibility exists that plaice
may come into contact with higher concentrations of fibrate compounds than have
been reported in the water column, by contact with the bottom sediments. In feeding
on other organisms an opportunity exists for fibrates to bioaccumulate within plaice
and other omnivorous fish species where they feed on organisms contaminated with
fibrates.
One unexpected result of the experiments described above is the inhibition of the
ligand-binding domain of PPARα by some fibrates, despite these pharmaceutical
compounds being manufactured for their ability to activate PPARα. Notably the
fibrates causing antagonism had no agonistic effects on PPARα when given alone.
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4.4.2 Phthalates
Phthalates are compounds used in the manufacture of plastics, serving to soften PVC
products and are also found in cosmetics, perfumes, industrial paints and solvents,
and certain drugs. Phthalate compounds have been widely reported in the aquatic
environment (Fatoki et al, 2010) and measured environmental concentrations can be
similar to those causing reproductive disruption in laboratory experiments in some
animals (Oehlmann et al, 2009). Previous studies concerning the interactions of
phthalates with PPARs found interactions with all three subtypes. Diethylhexyl
phthalate (DEHP) has been shown to induce PPARα-dependent activation of fatty
acid catabolism in the liver of mice (Feige et al, 2010) and to disrupt the
reproductive system of male zebrafish (Danio rerio), most likely via PPAR
signalling pathways (Uren-Webster et al, 2010). Results from transactivation assays
support an interaction between PPARs and phthalates, with both benzylbutyl
phthalate and di-n-butylphthalate able to increase reporter gene expression when
incubated with all three mouse PPAR subtypes (Lapinskas et al, 2005).
Despite phthalates having been shown to affect organisms in a PPAR-dependent
manner, parent phthalates are usually subjected to biotic degradation within the
environment. Abiotic degradation pathways, including hydrolysis and photo
degradation have minor roles in the degradation of phthalate compounds compared to
biotic degradation by microbes, both aerobic and anaerobic, and the metabolic
pathway in aquatic organisms (Staples et al, 1998). Degradation by microbes and
within higher aquatic organisms, results in parent phthalate metabolites being
hydrolysed to a monoester phthalate and the corresponding alcohol (Barron et al,
1995), the former of which can be excreted or enter a further biotransformation
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pathway. The monoester metabolites of phthalates have also been suggested as
agonists of PPARs; the major metabolite of DEHP, mono(2-ethylhexyl) phthalate
(MEHP), activated all three PPAR subtypes in a transactivation assay (Lapinskas et
al, 2005) while monobenzyl phthalate, the monoester phthalate of benzylbutyl
phthalate, has been shown to increase the expression of PPARα in COS cells, with a
half-maximal response (EC50) at 21 µM (Hurst and Waxman, 2003).
Much of the literature documenting the effects of phthalates and their metabolites on
PPARs is focused on the mammalian receptors, while little information is available
concerning the effect of these compounds on fish PPARs. In this study both parent
phthalate compounds (dimethyl phthalate and benzylbutyl phthalate) and their
monoester metabolites (mono-1-methylhexyl phthalate and 1-monobenzyl phthalate)
were tested with the Gal4-plaice PPAR constructs to assess the potential impact of
these compounds on fish PPARs. Both dimethyl phthalate and benzylbutyl phthalate
failed to increase reporter gene expression when incubated with PPAR constructs. In
contrast, mono-1-methylhexyl phthalate and 1-monobenzyl phthalate had effects on
both Gal4-PPARα and Gal4-PPARβ while 1-monobenzyl phthalate was able to
activate Gal4-PPARγ, however these effects were only seen with phthalate monester
concentrations of 100µM. Within the aquatic environment parent phthalate
compounds have been detected at levels up to 33.5 µgL-1 in UK rivers (Fatoki and
Vernon, 1990) while levels of up to 97.8 µgL-1 (0.25µM) have been detected in
German surface waters (Fromme et al, 2002). Within sediments, concentrations of
phthalates tend to be higher; within German sediments concentrations of DEHP
ranged from 0.21-8.44 mg kg-1 (0.54-21.61 µM) while concentrations of dibutyl
phthalate (DBP) was between 0.06-2.08 mg kg-1 (0.21-7.473 µM). The presence of
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monoesther phthalate metabolites within environmental samples are much less
reported, however MMP, MBP and MEHP have been detected in the Tama River,
Tokyo at concentrations of  30-34 (0.17-0.19 nM), 10-480 (0.039-1.87 nM), and 10-
1300 (0.037-4.68 nM) ng L-1, respectively (Suzuki et al, 2001). These
concentrations would be unlikely to have an effect on the activation of PPARs in
plaice in the environment, and therefore the threat of phthalate compounds to energy
homeostasis in this species is small.
4.4.3 FOSA & PFOA
Previous studies on fish PPARs have shown PFOA to transactivate the PPAR/RXR
heterodimers (Leaver et al, 2005) and in mice and humans both PFOA and PFOS act
as weak agonists in a similar Gal4-PPAR assay to that used here (Takacs and Abbott,
2007). Perfluoro-based chemicals have been described as activators of human and
mouse PPARα (Shipley et al, 2004) with fluorooctane sulfonic acid (FOSA) having
an EC50 of approximately 13-15 µM. PFOA has been shown to increase the mRNA
levels of the PPARα target gene acyl-CoA oxidase (ACO) in the livers of Japanese
medaka (Yang, 2010), suggesting PFOA to activate PPARα.
However, plaice Gal4-PPAR was not affected by PFOA or FOSA, which suggests
that these compounds may be targeting RXR in fish. Even in mice the effects of
PFOA on PPAR-target genes appear to be, to some extent, independent of PPARα.
Rosen et al (2008) showed that PFOA can regulate the expression of genes involved
in amino acid homeostasis and fatty acid β-oxidation, functions typically modulated
via PPARα, in PPARα-null mice, indicating that other mechanisms of action should
be investigated.
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4.4.4 Bis(tributyl tin)oxide (TBTO)
Organotins have previously been widely used as antifouling biocides for ships and
fishing nets as well as agricultural fungicides and rodent repellents, and although
banned by International Maritime Organisation (IMO) since 2003, their persistence
means they remain a common contaminant of aquatic environmnents, both in
sediments and fish tissues (Antizar-Ladislao, 2008). Previous reports into the effects
of organotin compounds on aquatic organisms has been largely focussed on female
gastropods, in which the imposition of male sex organs on females (imposex) in
response to TBT has been found (Rilov et al, 2000; Hung et al, 2001; Gravel et al,
2006). More recently the masculinisation of fish species in response to TBT has also
been reported (McAllister and Kime, 2003; Shimasaki et al, 2003). The mechanism
by which imposex occurs remains largely elusive but several theories have been
suggested, such as the inhibition of the P450-mediated aromatase enzyme
responsible for catalysing the conversion of androgens, e.g. testosterone, to female
sex hormones such as estradiol and estrone (Bettin et al, 1996) and the inappropriate
release of the neuropeptide Ala-Pro-Gly-Trp-NH2 (APGWamide) (Oberdörster and
McClellan-Green, 2000). More recently a third target for organotin compounds has
been suggested – the retinoid X receptor (RXR) (Kanayama et al, 2005; Grün et al,
2006; Nishikawa, 2006; Castro et al, 2007). Kanayama et al (2005) first discovered
that tributyltin and triphenyltin were potent activators of the RXR/PPARγ receptor
complex in mammals, being high affinity ligands for both proteins. The PPARγ/RXR
heterodimer is involved in adipogenesis and in the storage of lipids in adipocytes
(Chawla et al, 1994; Martin et al, 1998) and organotin compounds have been shown
to induce adipogenesis both in vitro and in vivo, further confirming a role for the
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RXR/PPARγ heterodimer in mediating the effects of organotins (Kanayama et al,
2005; Grün et al, 2006; Kirchner et al, 2010). With the discovery that organotins are
high affinity ligands for both the RXR and the PPARγ receptors in mammals and are
able to induce imposex in invertebrates, came the hypothesis that organotins promote
imposex via binding to the RXR receptor. PPAR receptors have been shown to have
evolved relatively late in the evolution of receptors (De Mendonca et al, 1999) and
may not even be present in invertebrate organisms and thus the target receptor for
organotins in promoting imposex in gastropods is more likely to be the retinoid X
receptor, which evolved earlier in time, being present even in insects and nematodes
(Nishikawa, 2006). Indeed, it has been shown that injection of 9-cis retinoic acid, the
natural ligand of RXRs in humans, into female rock shells (Thais clavigera) and into
the neogastropod Nucella lapillus, is sufficient to induce imposex in these organisms
and is also able to increase the penis length in male T. clavigera (Nishikawa et al,
2004; Castro et al, 2007). Despite organotin compounds having no resemblance,
neither in structure nor chemical properties, to known RXR and PPAR ligands
(retinoids and thiazolidinediones, respectively) tributyl tin (TBT) has been shown to
bind to the human retinoid X receptor and promote the recruitment of PGC-1α, a
PPARγ coactivator peptide (le Maire et al, 2009). In contrast TBT interacts poorly
with PPARγ, leading to a poor recruitment of PGC-1α (le Maire et al, 2009). Further
to this the crystal structure of RXRα bound to TBT has been resolved, providing
unambiguous evidence that TBT interacts with the RXR, rather than PPARγ (le
Maire et al, 2009). This agrees with the findings here in which TBTO was found not
to interact with the Gal4-PPARγ construct. Little evidence is available describing the
interaction of TBT with PPARα and PPARβ in fish species, although an increase in
the mRNA expression of all three PPAR subtypes in Atlantic salmon (Salmo salar)
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has been found when fed a diet containing tributyltin (Pavlikova et al, 2010).
Furthermore, an increase in whole body lipid content has been measured in chinook
salmon (Onchorynchus tshawytscha) fed a TBT-contaminated diet, consistent with
the hyposthesis that TBT acts as an obesogen and as a PPARγ/RXR agonist (Meador
et al, 2011). In the studies here TBTO was found to antagonise the activation of
Gal4-PPARα by the model activator Wy14643 at low nanomolar, environmentally
relevant concentrations. Thus results from earlier studies and those presented here
indicate that TBTO may function as an agonist of the RXR receptor while
antagonising PPARs.  In PPARα/β-null mice, an RXR homodimer complex has been
shown to compensate for PPARs by binding to PPREs (IJpenberg et al, 2004). Thus
PPAR inhibition by TBTO may be ameliorated by the activation of other signalling
pathways.
Tributyltin has been detected in aquatic environments worldwide with sediment
concentrations ranging from ng/g to µg/g (Godoi et al, 2003; Harino et al, 2003;
Santos et al, 2009; Garg et al, 2009) while concentrations within the water column
have been reported at concentrations from 200ng/L in the Mediterranean Sea
(Michel, 2001) to 3.20 µg/L in Singapore (Basheer et al, 2002). Organisms
inhabiting TBT-contaminated environments have been shown to accumulate the
compound within their tissues, with most research focussed on molluscs and
crustaceans due to their being important seafood resources. Marine bivalves have
been shown to accumulate TBT to high levels due to efficient transfer of TBT into
their tissues via the pump activity used during filter feeding (Laughlin et al, 1986).
Additionally the low efficiency of their metabolic systems causes TBT to be
degraded slowly (Lee, 1991). Within fish species, TBTO and related organotin
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compounds have been found to accumulate to the µg kg-1 range (Hoch, 2001;
Antizar-Ladislao, 2008). These concentrations are comparable to the concentrations
which were shown to inhibit PPARα - 10 nM is equivalent to approximately 6 µg L-
1
.
4.5 Conclusion
In conclusion plaice PPARα and PPARβ exhibit both similarities and differences to
their mammalian counterparts. Some fibrates act as activators of plaice PPARs as
they do in mammals, whilst other fibrates which are agonists of mammalian PPARs
are not effective in activating fish PPARs, but in the current study were antagonists
of PPARα. In addition to fibrates phthalate compound metabolites were also agonists
of all three plaice PPAR subtypes. However, these aforementioned compounds were
effective at concentrations higher than that recorded in the aquatic environment. Of
the environmental pollutants tested, only TBTO had effects at environmentally
relevant concentrations. Although environmental concentrations of TBT have been
decreasing in many parts of the world following legislation to limit their use, they are
still detectable in sediments and fish tissues in quantities (Antizar-Ladislao, 2008)
that would, based on the results reported here, inhibit ex vivo piscine PPARα. Given
the potency of this contaminant and its persistent and ubiquitous presence in
estuarine environments, these effects should be further studied in vivo, to establish
what, if any, are the physiological consequences and knock-on ecological effects of
exposure.
Other than the compounds mentioned above, no other compound tested had any
agonistic or antagonistic effects on Gal4-PPAR LBD constructs from plaice.
- 167 -
Chapter 5. Transcriptomic response of European
flounder hepatocytes to TBTO
In Chapter 4 it was shown that fenofibrate, bezafibrate and TBTO inhibit the
transcriptional activity of peroxisome-proliferator activated receptor alpha (PPARα).
In an environmental context, the study of TBTO is perhaps most relevant since, as
discussed in chapter 4, the concentrations at which TBTO is able to inhibit PPARα
activity are found within the environment, while the necessary concentrations of
fibrates are unlikely to be encountered. As a preliminary investigation into this
apparent PPARα antagonism by TBTO, and to identify genes whose expression has
the potential to be regulated by PPARα, a transcriptomic approach was taken,
comparing the resulting gene expression profiles using a flounder cDNA microarray.
5.1 Microarray
DNA microarrays are used as a means of measuring the expression of many genes in
parallel. First used to measure the expression of 45 cDNAs from the small flowering
plant Arabidopsis thaliana (Schena et al, 1995), the use of microarray technology for
expression profiling has since developed to allow measurement of thousands of
genes in parallel and platforms have been developed for many organisms including
several piscine species.
As part of the GENIPOL consortium a European flounder cDNA array has been
developed, consisting of 3336 unique genes (Williams et al, 2006). This array has
been enriched with transcripts induced by a wide range of model toxicants, including
a polycyclic aromatic hydrocarbon (PAH), a mixture of polychlorinated bipheyls
(PCBs), a peroxisome proliferative agent, a heavy metal, an organic hydroperoxide
and estrogen, by using a cDNA library derived from mRNA obtained from the livers
of individuals following intraperitoneal injection with the aforementioned
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compounds (Diab et al, 2008). Previously this array has been used to determine the
responses of flounder to disease (Aeromonas salmonicida) aquatic toxicants (17β-
estradiol, cadmium and cadmium salts, polycyclic aromatic hydrocarbons and a
chlorinated hydrocarbon pesticide) and hormone (Williams et al, 2006; Williams et
al, 2007; Falciani et al, 2008; Diab et al, 2008).
Using a reporter gene assay designed to identify compounds which interact, either as
agonists or antagonists, with the peroxisome proliferator activated receptors,
bis(tributyl tin) oxide (TBTO) was identified as an aquatic contaminant with the
potential to inhibit the alpha subtype of these receptors (Chapter 4). Within the
present study, a preliminary study into this apparent antagonism of PPARα was
carried out using a microarray-based approach. The transcriptomic responses of
European flounder hepatocytes to the PPARα-specific agonist Wy14643, TBTO or a
combination of both compounds was measured in order to identify
(i) Genes whose expression is altered upon PPAR activation with Wy14643
(ii) Genes whose expression is altered upon exposure to TBTO
(iii) Genes whose expression is upregulated by Wy14643 but downregulated
by a combination of Wy14643/TBTO, thus indicative of a PPARα
inhibition.
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5.2 Materials and Methods
5.2.1 Hepatocyte isolation and treatment
Isolation of liver hepatocyte cells5.2.1.1
A single male juvenile flounder (Platichthys flesus), obtained from the Forth estuary
and acclimated in seawater for six months in an aquarium, was killed by a blow to
the head and the liver removed. The liver was immediately washed in chilled
phosphate buffered saline (1×) and chopped into fine dice which were then placed
into 1× Hanks’ Balanced Salt Solution (HBSS; Gibco), supplemented with 200 units
kanamycin, 100 units penicillin, 100 µg streptomycin, 1g bovine serum albumin and
5mM EDTA and incubated on ice for 30 minutes with gently agitation. Liver
fragments were allowed to settle before HBSS was removed, liver pieces washed
twice with HBSS supplemented as above but excluding EDTA, and incubated at
15°C for 3 hours in HBSS supplemented with 200 units kanamycin, 100 units
penicillin, 100 µg streptomycin, 1g bovine serum albumin and 0.2g collagenase type
IV (Sigma).
Digested liver pieces were passed through a course filter (250µm) before being
filtered through a 100µm filter into a sterile 50 ml centrifuge tube. The solution was
centrifuged at 100 ×g for 2 minutes at 4°C, supernatant removed and the pellet
containing hepatocyte cells resuspended in Leibovitz’s L15 medium (Invitrogen)
supplemented with 10% fetal bovine serum, 200 U kanamycin, 100 U penicillin and
100 µg streptomycin. A second centrifugation was then done at 100g for 5 minutes at
4°C before supernatant was removed and the pellet resuspended in a 20 mL volume
of L15 media, supplemented as described above.
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Seeding of Hepatocytes and treatment5.2.1.2
Using a hemocytometer, the density of hepatocyte cells in 20 ml suspension was
determined and adjusted to 5 × 105 cells per ml by addition of L15 medium. Cells
were then seeded into 6-well tissue culture plates in a volume of 2 mL per well (1 ×
106 cells) and incubated for 2 hours at 15°C before being treated.
Four different treatments were administered to cells in total volumes of 5 µl and each
treatment was in triplicate. Treatments and the final treatment concentrations used
were as follows:
• 0.25% Ethanol (vehicle)
• 25 µM Wy14643
• 10 nM TBTO
• 10 nM TBTO + 25 µM Wy14643
Each treatment was prepared by diluting concentrated stock solutions in absolute
ethanol. Concentrated stocks of Wy14643 were prepared at 10mM and 20 mM
concentrations and TBTO was prepared at 4 µM and 8 µM concentrations.
Treatments were added directly to the media in which cells were seeded in a total
volume of 5 µl. The 10 nM TBTO + 25 µM Wy14643 treatment was achieved by
addition of 2.5 µl of 20mM Wy14643 and 2.5 µl 8 µM TBTO to the media while 10
nM TBTO and 25 µM Wy14643 treatments were achieved by addition of 5 µl 4 µM
TBTO and 5 µl 10 mM Wy14643, respectively. Tissue culture plates were then
swirled gently to achieve a homogenous treatment mixture. An additional a control
treatment of ethanol vehicle was administered by addition of 5µl ethanol to cell
culture media. Treatment levels were chosen based on the results of Chapter 3. Thus
a concentration of 25 µM Wy14643 was shown to maximally increase PPARα
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transactivation in a transient transfection assay, while 10 nM TBTO was shown to be
the concentration at which the maximal transactivation by 25 µM Wy14643 was
halved, and therefore these concentrations were considered suitable to study gene
expression changes.
Treated cells were incubated for a further 40 hours at 15 °C before being harvested
for RNA extraction.
5.2.2 Extraction, amplification and labelling of RNA from
treated hepatocytes
Extraction of RNA from treated hepatocyte cells5.2.2.1
Hepatocyte cells and media were collected by aspiration from each well of the tissue
culture plates following 40 hours of incubation and placed into 2ml microcentrifuge
tubes. Cells were pelleted by centrifugation for 2 minutes at 100 × g and 4 °C,
supernatant removed and cell pellets resuspended in 500 µl TRIpure isolation reagent
(Roche). TRIpure isolation reagent was used to extract RNA as described in the
TRIpure isolation reagent protocol. Briefly, cells were incubated with TRIpure
reagent for 5 minute to allow for complete cell lysis, after which chloroform was
added and the mixture shaken vigorously for 15 seconds. The tubes were then
incubated at room temperature for a further 15 minutes before being centrifuged at
12,000 × g for 15 minutes to effect phase separation. The top aqueous phase was
transferred to a fresh tube and isopropanol added to precipitate RNA. After mixing,
the sample was incubated for 10 minutes at room temperature and centrifuged for 15
minutes at 12,000 ×g. Supernatant was removed, being careful not to disturb the
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visible RNA pellet, and the pellet washed in 75% ethanol. After removal of ethanol,
the pellet was left to dry slightly before being resuspended in 15 µl of MilliQ water.
RNA concentrations and purity was assessed spectrophotometrically on a Nanodrop
ND1000 spectrophotometer, while RNA integrity was confirmed electrophoretically
using a 1% agarose, 1× TAE, 0.5 µg EtBr gel to resolve 1 µg of each RNA sample
after denaturation at 75 °C for 5 minutes.
RNA amplification5.2.2.2
Spectrophotometric analysis revealed RNA yields which were less than that required
for direct labelling for microarray experiments and therefore messenger RNA was
amplified using the Amino Allyl MessageAmp™ II aRNA amplification kit
(Ambion). Amplification of mRNA using this kit is based on the RNA amplification
protocol developed by Van Gelder et al (1990) in which RNA is first used in reverse
transcription with a modified oligo(dT) bearing the phage T7 RNA polymerase
promoter to create first strand cDNA. Following second strand synthesis and cleanup
the obtained cDNA is used as a template for in vitro transcription (IVT) with T7
RNA polymerase, producing many copies of antisense RNA for each mRNA in the
original sample.
For first strand cDNA synthesis 1 µg total RNA was combined with 1 µl Oligo(dT)
and incubated at 70 °C for 10 minutes before placing on ice. A mastermix of
reagents, sufficient for each reaction was prepared using, per 20 µl reaction, 1× First
strand buffer, 4 µl dNTP mix, 10 units RNase inhibitor and 1 µl Arrayscript™
reverse transcriptase enzyme. All reagents were provided with the Amino Allyl
MessageAmp™ II aRNA amplification kit (Ambion). Reactions were mixed and
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centrifuged briefly before being incubated at 42 °C for 2 hours. Following incubation
reactions were placed on ice ready for second strand cDNA synthesis.
A second strand cDNA synthesis mastermix was prepared containing, for a single
reaction, 1× second strand buffer, 4 µl dNTPs, 2 µl DNA polymerase and 1 µl RNase
H and milliQ water to a volume of 80 µl. 80 µl of the mastermix was added to the
first-strand cDNA synthesis reaction, mixed and incubated for 2 hours at 16 °C.
cDNA was then purified using cDNA filter cartridges provided with the
amplification kit. Briefly 250 µl cDNA binding buffer was added to each tube and
the contents mixed gently. The sample was then placed onto the centre of the
cartridge and centrifuged for 1 minute at 10,000 ×g. The flow through was discarded
and the cartridge washed with wash buffer. Excess wash buffer was removed with a
further centrifugation at 10,000 ×g for 1 minute and cDNA eluted with 20 µl milliQ
water heated to 55 °C.
Eluted cDNA was then used for in vitro transcription to aminoallyl-labelled
amplified RNA (aRNA). A mastermix for in vitro transcription was prepared,
containing per reaction, 2.5 µl 50mM aminoallyl-labelled UTP, 3.5 µl 50mM
unlabelled UTP, 12 µl ATP, GTP, CTP mix (25 mM each), 1× T7 buffer and 4 µl T7
enzyme mix. The mastermix was vortexed and briefly centrifuged before 26 µl was
added to purified cDNA, mixed and incubated for 18 hours at 37°C. After 18 hours
aRNA was purified using aRNA filter cartridges supplied with the Amino Allyl
MessageAmp™ II aRNA amplification kit and eluted in 60 µl milliQ water,
preheated to 55°C. Concentrations of aRNA were checked spectrophotometrically on
Nanodrop ND1000 spectrophotometer.
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Labelling of aRNA with Cy-dyes5.2.2.3
Cyanine reagents have previously been shown to be readily conjugated to antibodies,
avadin, modified DNA and other amino-group containing molecules (Mujumdar et
al, 1993; Yu et al, 1994) and have been shown to be useful in the labelling of nucleic
acid substrates for microarray experiments (Kimura et al, 2005; Staal et al, 2005). A
pooled reference design (Novoradovskaya et al, 2004) was employed for the
microarray experiments. Thus a sample of each aRNA sample was labelled with Cy3
dye, while a pool of all aRNA samples was labelled with Cy5 dye. A single vial of
Cy3 and Cy5 dyes (GE Healthcare) were each resuspended in 38 µl high-purity,
anhydrous dimethyl sulfoxide (DMSO; Sigma) and brought to room temperature in
the dark.
For labelling with Cy3 dye, 3 µg of aRNA was added to 1.5ml centrifuge tubes and
made up to a 10 µl volume with MilliQ water. The sample was placed on a dri-block
(Techne) at 70°C for 2 minutes and cooled to room temperature. 3 µl 0.5M sodium
bicarbonate (Sigma) was added to each tube together with 2 µl of Cy3 dye. For
labelling with Cy5 dye an aRNA pool was made using 250 ng of aRNA from each
sample, giving a total of 24 µg aRNA for labelling. aRNA was made up to a volume
of 80 µl with milliQ water, which was subsequently split into 8 × 10 µl aliquots (3
µg/aliquot). Sodium bicarbonate and Cy5 dye was added to each reaction as
described for the Cy3 reaction. Dye-labelling reactions were incubated at 25°C for 1
hour, after which labelled aRNA was purified from unincorporated dyes by column
purification using Illustra Autoseq G50 dye terminator spin columns (GE Healthcare)
following manufacturer’s instructions.After pooling of Cy5 labelled aRNA, dye
incorporation was meausured on Nanodrop ND1000 spectrophotometer. Additionally
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0.4 µl of each dye-labelled aRNA product was electrophoresed on a thin 1% agarose,
0.5× TAE gel. Following electrophoresis the gel was scanned on a Typhoon Trio
scanner (GE Healthcare).
5.2.3 Microarray hybridisation, washing and scanning
The array used in these experiments was the GENIPOL European flounder 13K
cDNA microarray, (EMBL ArrayExpress Accession no. A-MAXD-12), which has
been described in detail elsewhere (Williams et al, 2006; Diab et al, 2008). This
array consists of 13,000 cDNAs spotted in duplicate. After contig clustering, the
13000 cDNAs represent 3336 unique genes. The array design along with accession
numbers is available through EMBL ArrayExpress
(http://www.ebi.ac.uk/microarray- as/aer/lob?name=adss&id=1308203622).
Microarray slide Presoak and Pre-hybridisation5.2.3.1
A sodium borohydride pre-soak of the microarray slides was performed to block the
glass surface, preventing binding of labelled aRNA to the glass platform thus
reducing non-specific fluorescence. A pre-soak has previously been shown to reduce
auto fluorescence on glass slides with and without DNA arrays, the reduction of
which remained unaltered for up to 6 months (Raghavachari et al, 2003).  A 2× SSC,
0.05% SDS, 0.25% sodium borohydride pre-soak buffer was prepared and preheated
to 42°C before twelve European flounder 13K microarray slides were incubated with
mild agitation (~125 rpm) for 30 minutes at 42°C. Slides were rinsed in 2× SSC
twice before being transferred to pre-hybridisation buffer. The pre-hybridisation
buffer was prepared fresh containing 25% deionised formamide, 5× SSC, 0.1% SDS
and 10mg/ml BSA (fraction V; Sigma) and was preheated to 42°C before slides were
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incubated at 42°C in pre-hybridisation buffer for 2 hours. Following pre-
hybridisation slides were dipped twice in milliQ water, followed by a dip in ethanol
and dried by centrifugation at 2000 rpm for 10 minutes at room temperature. Pre-
hybridised slides were then used immediately for hybridisation with labelled aRNA.
Hybridisation of labelled aRNA to microarray slides5.2.3.2
Hybridisation buffer was prepared using 1.2× ULTRAhyb® ultrasensitive
hybridisation buffer (Ambion), 1.2× saline-sodium citrate (SSC) buffer (Sigma),
0.89mg/ml polyadenylic acid (PolyA; Sigma), 0.44mg/ml single stranded Herring
sperm DNA (Sigma) and 2.2mg/ml UltraPure BSA (Ambion). The volume of
hybridisation buffer was aliquoted into 1.5ml microcentrifuge tubes, enough for 1 per
hybridisation to be performed, with 225 µl per tube. Hybridisation buffer was kept at
60°C until required. For hybridisations, Cy3-labelled aRNA and pooled aRNA
labelled with Cy5 dye was combined such that 40 picomoles of each dye were
present and the volume made up to 25 µl with MilliQ water. The samples were then
denatured at 95°C for 3 minutes, centrifuged briefly and added to a 225 µl volume of
hybridisation solution and incubated in the dark at 60°C until ready for hybridisation.
Hybridisation reactions were done on a Lucidea™ SlidePro Hybridiser (Amersham
Biosciences). Once samples were injected, chambers were heated to 70°C for 10
minutes followed by heating at 42°C for hybridisation and washing stages. The
hybridisation stage was carried out for 17 hours with a pulse mix of 25 µl at 5 µl per
second every 15 minutes. Following the hybridisations, wash stages were carried out.
The first of these flushed 800 µl of 1× SSC, 0.1% SDS solution over each slide at 8
µl per second. A second wash consisted of 800 µl of 0.3× SSC, 0.2% SDS being
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flushed over each slide, also at 8 µl per second, after which slides were transferred to
an EasyDip container containing the second wash buffer preheated to 45°C. Slides
were washed twice for 3 minutes each in an orbital incubator set at 45 °C with
shaking at 125 rpm. A further three washes of 2 minutes each in 0.2× SSC buffer
were carried out before slides were dipped for 20 seconds in 0.1× SSC and
centrifuged at 500×g for 5 minutes at room temperature to dry. Throughout all
manual wash steps and the final drying stage caution was taken to avoid exposure of
the slides to light sources, thus preventing degredation of the fluorescence signal
from Cy3 and Cy5 dyes.
Microarray slides were scanned using the Axon 4200A Scanner and GenePix®
software version 6.1. To calculate the optimum conditions at which Cy5 and Cy3
dyes are detected, the red and green lasers were selected and an auto-PMT for a
single array on each slide carried out to fine the optimum scan conditions. The full
slide was then scanned using the calculated PMTs.
5.2.4 Microarray analysis
Following hybridisation and scanning, images were first analysed by Bluefuse
software (BlueGnome Ltd, UK) which was used to identify features, fuse replicates
and quantify Cy3 and Cy5 fluorescent signals from each feature. Bluefuse data were
then analysed in Genespring GX7.3.1. (Agilent). To normalise data, all features with
less than 0.01 fluorescence units were first discarded, then a Lowess per spot, per
chip normalisation was carried out. Features whose sequence data formed contigs
(Williams et al., 2006) were treated as on-chip replicates in Genespring.
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Pair wise T-tests were carried out using Genespring GX7.3.1 to identify list of genes
whose expression was changed between particular treatments. Genes were
considered as significantly altered at P<0.05. To test the hypothesis that TBT
reversed the WY16463-dependent effect on gene expression, a list comprising genes
which were significantly changed after comparison of WY16463 alone and
WY16463 plus TBT was first generated. To further explore the central hypothesis,
lists of genes whose expression increased after WY16463 and decreased after TBT
treatment were also generated.
5.3 Results
An overview of the genes whose expression changed in each treatment is provided in
Table 5-1. These lists were generated by T-tests of selected pairwise comparisons,
designed to explore the hypothesis that TBTO antagonises the effects of Wy14643
on PPARα. Application of false discovery correction (Bonferroni and Hochberg)
returned very few genes in any of the comparisons, and therefore it is likely that the
uncorrected lists contain false positives.
Gene ontology (GO) analysis of these lists (Figure 5-1) provided further lists of
physiological processes which were over-represented in up- or down-regulated
outputs from each of the treatment comparisons. In both TBTO and Wy14643,
“proteolysis” was increased and “xenobiotic metabolism” decreased, otherwise, in
terms of GO biological process categories, there were few overlaps between
treatments.
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Figure 5-1. Overview of gene expression changes in hepatocyte treatments. Lists of genes whose
expression is upregulated (UP) or downregulated (DOWN) is represented by blue nodes when
comparing Wy14643 treatment with Wy14643 +TBT, yellow nodes when comparing TBT with
vehicle control (Ethanol) and green nodes when comparing Wy14643 with vehicle control.
Numbers linking nodes indicate the numbers of genes common to the two lists. Red arrows link
to statistically over-represented Gene Ontology (GO) categories in each of the lists, as calculated
by Genespring GX from the total number of representative genes on the array (No. Array), and
the number of genes in an output list (No. List).
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In Chapter 4, it was hypothesised that TBTO inhibited the actions of Wy14643 and
therefore those genes downregulated by exposure to Wy14643 and TBTO in
combination might be expected to be upregulated by treatment with Wy14643 alone
and potentially downregulated by TBTO alone, and thus an overlapping pattern of
expression would be expected. This was not reflected in GO categories, although the
subset of 9 genes showing increased expression in Wy14643 and decreased
expression in TBTO with Wy14643, was the largest overlapping group of any pair of
output lists.  To explore these results at the gene level, further manual annotation of
the output lists was performed. The original microarray annotation was achieved
automatically using BLASTtoGO and resulted in identification and annotation of
between 60 and 70% of features (Williams et al, 2006). It was possible to identify
and annotate approximately a futher 10% of these genes by manual comparison with
Genbank/EMBL EST databases, followed by BLASTX to non-redundant protein
databases.
Genes whose expressions were altered by the treatments with Wy14643 and TBTO,
either alone or in combination, are listed in Table 5-1. Thus, after additional manual
annotation, 14 genes were identified whose expressions were upregulated by
Wy14643 and who were also downregulated by treatment with Wy14643 in
combination with 10nM TBTO (Table 5-2), compared to the original 9 found after
automatic annotation. Additionally, of the 20 genes shown to be downregulated by
treatment with TBTO alone, 4 were also downregulated by TBTO in Wy14643
treatment. Of these overlapping genes those with a function in mitochondrial
oxidative phosphorylation and proteasomal-dependent protein degradation formed
the largest functional groups, with all genes in these groups being downregulated by
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TBTO in Wy14643 treatment. Genes with functions in carbohydrate metabolism and
protein biosynthesis were also similarly affected, being largely decreased. One such
gene decreased by TBTO in Wy14643, glyoxylase 1, was also increased by
Wy14643 alone. Genes involved in lipid metabolism, a function associated with
PPARα, were of particular interest and showed both increases and decreases
depending on the gene, when treated with a combination of TBTO and Wy14643.
Notably, GO biological process “fatty acid β-oxidation”, the archetypal target of
PPARα action (Cook et al, 2000) was decreased in this group (Figure 5-1). The
genes in this β-oxidation group whose expression decreased included PPARβ and
mitochondrial delta 3,5-delta 2,4-dienoyl-CoA isomerase. Notably, a flounder gene,
glutathione S-transferase A1 was similarly changed and has been implicated in fatty
acid metabolism and is a potential PPARα target (Leaver et al, 1997). Two other
potential mammalian PPARα target genes, L-3- hydroxyacyl-Coenzyme A and G0s2
G0/G1 switch gene 2 (Zandbergen et al, 2005; Zhang et al, 1992) were upregulated
following treatment with Wy14643 and TBTO.
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Table 5-1. Genes whose expressions are changed by treatment with 25 µM Wy14643 + 10nM
TBTO, Wy14643 alone and TBTO alone in P.flesus hepatocytes. Upregulated genes are
indicated in red while downregulated genes are indicated in green
BLAST FOLD
change P value Function
Genes whose expressions are significantly altered by treatment with a combination of
Wy14643 + TBTO compared to Wy14643 alone
Aquaporin 8 2.536 0.0349 water balance
Pre-mRNA splicing factor ATP-
dependent RNA helicase PRP16 2.226 0.0157
RNA processing
Survival motor neuron domain
containing 1 2.684 0.0272
Bile acid binding protein (FABP10) 2.182 0.000829
lipid transport and
metabolism
Retinol binding protein II, Cellular
(CRBP-II) 1.215 0.0235
TBT-binding protein 2  (lipocalin) 1.325 0.0134
L-3-hydroxyacyl-Coenzyme A
dehydrogenase, short chain 1.839 0.0201
G0s2 G0/G1 switch gene 2 2.475 0.038
Alpha amylase 1.091 0.0237 Carbohydrate metabolism
Trafficking protein particle complex
subunit 1 2.155 0.0219
protein transport and
secretion
component of oligomeric golgi
complex 4 1.903 0.011
similar to RAB5 interacting protein 2 2.065 0.00437
Vesicle-associated membrane protein 8
(endobrevin) 1.706 0.00259
SLC6A8 neurotransmitter transporter,
creatine 1.987 0.0393 creatine uptake
slc35d1 UDP-glucuronic acid/UDP-N-
acetylgalactosamine transporter 2.241 0.00514 chondroitin sulphate synth
heat shock protein gp96 1.807 0.0327
stress
copper/zinc superoxide dismutase 1.229 0.00853
POMP proteasome maturation protein 1.8 0.0205 proteasome
IgE receptor gamma 1.764 0.0144 Immune
Protein phosphatase 6, catalytic subunit 1.759 0.0397 cell cycle
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Table 5-1 cont…
Blast FoldChange P value Function
RNA polymerase II, polypeptide H 1.489 0.0358 Transcription
similar to SMT3 suppressor of mif two
3 homolog 2 1.441 0.0244 Sumoylation
calmodulin 1 1.379 0.0341 Ca signalling
FAM162A family with sequence
similarity 162, member A 1.85 0.0276
apoptosis
NOD3 protein; CARD15-like 1.329 0.000829
glutamate carboxypeptidase (Darmin) 2.267 0.0485 metabolism
60S ribosomal protein L11 1.071 0.0216
Translation
40S ribosomal protein S11 (poor seq) 1.1 0.0197
ATPase inhibitor, mitochondrial
precursor 0.852 0.0138
Mitochondrial electron
transport and oxidative
phosphorylation
H+ transporting F1 ATP synthase
epsilon subunit 0.73 0.0184
NADH dehydrogenase B14.5b chain 0.722 0.0145
NADH dehydrogenase subunit 4 0.597 0.0428
NADH dehydrogenase (ubiquinone) 1
alpha subcomplex 4 0.764 0.045
NADH-ubiquinone oxidoreductase
subunit B17.2 0.576 0.0192
cytochrome b-c1 complex subunit
Rieske, mitochondrial 0.527 0.00778
cytochrome c oxidase 0.576 0.0404
slc25a12 solute carrier family 25
member 12 0.76 0.0216
Mitochondrial
Mitochondrial ribosomal protein L22 0.626 0.0117
UXT protein 0.605 0.0261
Glutaredoxin 0.814 0.0265 Redox homeostasis
SPC18 protein, signal peptidase
complex (18kD) 0.666 0.0182 Protein Processing
calreticulin 0.83 0.0208
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Blast FoldChange P value Function
C100 chaperonin subunit 2 0.713 0.0127
Protein processing
dolichyl-diphosphooligosaccharide-
protein glycosyltransferase subunit 4 0.704 0.00619
ERP27 endoplasmic reticulum protein
27 0.81 0.00344
proteasome subunit beta 7 0.789 0.00885
Proteasome and
Ubiqutination
PSMA8 proteasome subunit, alpha
type, 8 0.715 0.0157
Proteasome subunit beta type 1
precursor (EC 3.4.25.1) 0.603 0.00189
Proteasome beta-subunit C5 0.693 0.0175
FBXO48 F-box protein 48 0.638 0.013
Thioredoxin-like 1 (proteosomal
protein) 0.79 0.0215
possible de-ubiquitinylating peptidase 0.71 0.0405
Vitamin K epoxide reductase complex
subunit 1 0.857 0.00739
blood coagulation
similar to coagulation factor 10;
coagulation factor X 0.81 0.0454
PPAR beta 0.524 0.0492
lipid transport and
metabolism
TBT-binding protein 1 (lipocalin) 0.758 0.0467
APOD apolipoprotein D 0.725 0.00682
inter-alpha (globulin) inhibitor H4
isoform 1 0.766 0.0162
Delta3,5-delta2,4-dienoyl-CoA
isomerase, mitochondrial 0.804 0.0169
Probable ergosterol biosynthetic
protein 28 0.751 0.00735
inositol(myo)-1(or 4)-
monophosphatase 1 0.618 0.00315
glutathione S-transferase A1 (rho class) 0.511 0.0428
Table 5.1 cont…
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Table 5-1 cont…
Blast FoldChange P value Function
Glyoxalase 1
0.63 0.0081
Carbohydrate metabolism
Fructose-1,6-bisphosphatase 1 0.808 0.0419
Fucosidase, alpha-L-1, tissue 0.634 0.037
xylulokinase homolog 0.785 0.0279
protein phosphatase 1, regulatory
(inhibitor) subunit 0.653 0.0242
carboxymethylenebutenolidase
homolog 0.776 0.0498
Other metabolism
pnpo pyridoxine 5'-phosphate oxidase 0.623 0.00595
Spermidine/spermine N1-
acetyltransferase 0.618 0.029
histidine ammonia lyase 0.593 0.0458
Copper homeostasis protein cutC
homolog 0.744 0.0316
Warm-temperature-acclimation-related
protein (65kDa) 0.75 0.0117
chloride channel protein 0.596 0.0188 ion balance
slc29a3 nucleoside transporter 0.682 0.0263 nucleoside transport
GTP cyclohydrolase 1 0.414 0.0254 tetrahydrofolatebiosynthesis
Vitronectin 0.801 0.00659
Cell adhesion, Growth,
Motility
Hgfac hepatocyte growth factor
activator 0.622 0.0356
Hyaluronic acid binding protein 2 0.621 0.0221
Developmentally regulated GTP
binding protein 1 0.793 0.034
Receptor-binding cancer antigen
expressed on SiSo cells 0.428 0.0393
Epithelial protein lost in neoplasm 0.73 0.0106
sorcin isoform b 0.72 0.0411 Calcium binding
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Table 5-1 cont…
Blast FoldChange P value Function
isg12-like 0.882 0.0104
immune function
isg12-like 0.804 0.033
isg12-like 0.766 0.0397
Ifit interferon-induced protein with
tetratricopeptide repeats 0.754 0.0416
MHC class IIb antigen 0.858 0.0157
myeloid differentiaton factor 88,
myD88 0.671 0.039
Heterogeneous nuclear
ribonucleoprotein A/B 0.733 0.0174
RNA processing
nucleolar protein family A, member 2 0.717 0.0138
processing of precursor 5, ribonuclease
P/MRP subunit 0.673 0.0325
Splicing factor 3 subunit 1 0.609 0.0123
NOL12 nucleolar protein 12 0.791 0.0461
nucleolin 0.879 0.00196
Density-regulated protein 0.72 0.011
Aspartyl-tRNA synthetase 0.698 0.00292
Elongation factor 2 0.843 0.0467
Protein Biosynthesis
60S ribosomal protein L7a 0.924 0.0107
60S ribosomal protein L28 0.793 0.00968
60S ribosomal protein L13a 0.758 0.0482
eukaryotic translation initiation factor 5 0.71 0.00756
ATPase family, AAA domain
containing 1 0.851 0.00312
Unknown function
ATPase family, AAA domain
containing 4 0.486 0.000748
Transmembrane protein 93 0.715 0.0235
rhamnose binding lectin STL2 0.711 0.0317
Oral cancer overexpressed 1 0.677 0.0205
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Table 5-1 cont…
Blast FoldChange P value Fuction
Unknown Function
LIM motif-containing protein kinase 2
(Limk2) 0.515 0.0051
EF hand containing family 1A (Smhs2) 0.652 0.0384
Cytochrome b5 domain containing 2 0.584 0.0374
Genes whose expression is upregulated by exposure to 25 µM Wy14643
IDH3A isocitrate dehydrogenase 3 (NAD+) alpha 1.664
Mitochondrial electron
transport and oxidative
phosphorylation
NADH-ubiquinone oxidoreductase 30 kDa subunit 1.505
cytochrome b-c1 complex subunit Rieske,
mitochondrial 1.549
cytochrome c oxidase subunit VIb precursor 1.443
brain protein 44-like; HSPC040 protein 1.281 mitochondrial
importin 9 1.709
protein processing
intraflagellar transport protein 20 1.295
Reticulon-1 1.322
prefoldin 1 1.944
COMM domain containing 7 1.863 Transcription
CLEC4E C-type lectin domain family 4 member E 1.831 immune
PPDPF pancreatic progenitor cell differentiation and
proliferation factor 1.354
Cell adhesion, Growth,
Motility
transducer of ERBB2, 1b (tob1b), 1.256
CRIPT cysteine-rich PDZ-binding protein 1.486
Microtubule aggregate protein 3.552
Vitronectin 1.526
glyoxalase 1 1.203 carbohydrate metabolism
PPAR gamma 1.518 lipid transport and
metabolism
Vacuolar ATP synthase subunit H (V-ATPase H
subunit) 1.266 ATP synthesis
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Table 5-1 cont…
Blast Fold Change Function
anticoagulant protein C precursor (PROC) 1.431 blood coagulation
similar to basic leucine zipper and W2 domains 1 1.199 transcription
Heterogeneous nuclear ribonucleoprotein A/B 1.285
RNA processing
splicing factor arginine/serine-rich 3 1.361
splicing factor, arginine/serine-rich 2 (SC-35) 1.421
PRPF8 PRP8 pre-mRNA processing factor 8 1.205
Proteasome (Prosome, macropain) subunit, beta type, 8 1.32
Proteasome and
UbiqutinationFBXO48 F-box protein 48 1.486
ubiquitin specific peptidase 50 1.315
Chymotrypsinogen 2 1.182
proteolysis
elastase 2-like protein 1.17
elastase 2 precursor 1.16
pancreatic elastase 1 1.094
Ribosomal Protein S3A 1.154
Protein Biosynthesis
18S ribosomal RNA gene 1.314
Genes whose expressions are downregulated by treatment with 10nM TBTO
acetyl-Coenzyme A acyltransferase 2 (mitochondrial) 0.718 Lipid metabolism
Liver glycogen phosphorylase 0.668
carbohydrate metabolismprotein phosphatase 1, catalytic subunit, gamma
isoform 0.653
proteasome, 26S, non-ATPase regulatory subunit 6 0.405 proteasome
PABPC3 poly(A) binding protein, cytoplasmic 3 0.43 RNA processing
hepcidin precursor 0.841
immune
CLEC10A C-type lectin domain family 10, member A 0.506
alpha-2-macroglobulin 0.702
fetuin B 0.409 ossification
Derlin-2 (Degradation in endoplasmic reticulum
protein 2) 0.675 Protein processing
18S ribosomal RNA 0.64 protein biosynthesis
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Table 5-2. Genes, or genes which are similar, whose expression is downregulated by treatment
with Wy14643/TBTO combination and also either upregulated or downregulated in response to
Wy14643 and TBTO alone, respectively.
BLAST Function
Genes upregulated by Wy14643 alone and downregulated by Wy14643 + TBTO
NADH-ubiquinone oxidoreductase 30 kDa subunit
Mitochondrial electron transport and
oxidative phosphorylation
cytochrome b-c1 complex subunit Rieske,
mitochondrial
cytochrome c oxidase subunit VIb precursor
CLEC4E C-type lectin domain family 4 member E immune
Vitronectin Cell adhesion, Growth, Motility
glyoxalase 1 carbohydrate metabolism
Heterogeneous nuclear ribonucleoprotein A/B RNA processing
Proteasome (Prosome, macropain) subunit, beta
type, 8 Proteasome and Ubiqutination
FBXO48 F-box protein 48
18S ribosomal RNA gene Protein Biosynthesis
Genes dowregulated by Wy14643 + TBTO treatment and downregulated by TBTO alone
protein phosphatase 1, catalytic subunit, gamma
isoform Carbohydrate Metabolism
proteasome, 26S, non-ATPase regulatory subunit 6 proteasome
CLEC10A C-type lectin domain family 10, member
A Immune
18S ribosomal RNA Protein Biosynthesis
5.4 Discussion
The liver is an organ in which PPARα is highly expressed in fish species (Leaver et
al, 2005) and is also the main organ of biotransformation of contaminants, making it
an ideal organ in which to study gene expression changes by an anthropogenic
compound. Here we have preliminarily identified several European flounder genes
whose expression in hepatocytes is altered after exposure to a PPARα agonist,
Wy14643, in combination with TBTO and compared to those exposed to Wy14643
alone. Additionally several genes have been identified as being upregulated by
Wy14643 and downregulated by TBTO in isolation. Although this evidence is
preliminary and requires confirmation by quantitative PCR (rt-qPCR), this is the first
indication that TBT inhibits the effects of Wy14643 in European flounder.
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5.4.1 Differential gene expression changes between species
Wy14643, a PPARα-specific agonist (Leaver et al, 2005; Seimandi et al, 2005), has
previously been shown to alter 6.5% of all genes within wild-type mouse liver
(Anderson et al, 2004). Of the 815 Wy14643-regulated genes only 2 were regulated
in a PPARα-independent manner, being regulated by Wy14643 in PPARα-null
mouse models. Regarding PPARα-regulated genes several species-specific
differences have previously been noted; a mostly divergent set of genes has been
found to be regulated by PPARα in mouse and human hepatocytes (Rakhshandehroo
et al, 2009) and fewer genes have been found to be affected by treatment with
Wy14643, with a lesser maximal response, in human hepatoma cells compared to rat
hepatoma cells (Vanden Heuvel et al, 2003). This latter effect is likely due to the
greater abundance of PPARα in rodent liver than in human liver, but other qualitative
differences between species, such as the presence or absence of transcriptional
activators/repressors, the existence of dominant negative PPARα variants, and
differences in the PPRE sequence of target genes, have been suggested as possible
factors contributing to the differences in response to peroxisome proliferators
(Holden and Tugwood, 1999). Thus, despite the number of clear parallels which exist
between the flounder data described here and the many studies on PPAR effect in
rodents and humans, it may not be feasible to directly compare results from other
species in order to fully elucidate the effects of contaminants which are suspected to
disrupt PPARα in flounder.
5.4.2 Alterations in proteome maintenance genes
Wy14643, being a highly potent PPARα agonist, was expected to upregulate the
expression of PPARα target genes in the hepatocytes of European flounder. In total
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50 genes were upregulated within hepatocyte cells of European flounder, three of
which were components of, or associated with the proteasome. Of the genes whose
expression decreased following treatment with Wy14643 plus TBTO, 7 genes were
associated with the proteasome, and two of these (PSMB8 and FBOX48) were
identical to genes increased in the Wy14643 only treatment. PSMB8 was also
decreased in the TBTO only treatment. Previously genes encoding proteins which
function in the maintenance of the proteome, including components of the
proteasomal protein degradation pathway, have been reported to be upregulated in
response to treatment with Wy14643 in mouse hepatocytes (Anderson et al, 2004;
Ren et al, 2010) and also upregulated in response to ciprofibrate, another PPARα
agonist, in a primate species (Cariello et al, 2005). The hypothesis that PPARα is
important in the regulation of proteasome maintenance genes was strengthened by
the finding that PPARα-null mice display defects in the expression of proteins that
protect the proteome from chemical damage. Thus, the patterns of expression of
these genes are consistent with a hypothesis that TBTO antagonises the activity of
PPARα in regulating proteosomal genes in flounder.
5.4.3 Mitochondrial oxidative phosphorylation
As well as changes in the expression of genes encoding proteins involved in the
proteasome and in ubiquitination, changes in the expression of genes encoding
proteins with a function in mitochondrial oxidative phosphorylation were also highly
represented. All of the genes in this category displayed the same pattern of
expression across treatments. They were increased in Wy14643 (4 genes), and
decreased by TBTO in Wy14643 treatment (8 genes). Three of these genes were the
same in both lists. The increased expression of oxidative phophorylation genes by
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both PPARα and PPARβ has been consistently observed in mammalian studies
although, an indirect mechanism has been inferred (Kelly and Scarpulla, 2004).
Many of the regulatory functions of hormone receptors are mediated via their
interactions with co-activators and co-repressors. PPAR gamma co-activator 1α
(PGC-1α), so called due to its first being identified as a PPARγ-interacting protein
(Puigserver et al, 1998), is a co-activator whose interactions with all three PPAR
subtypes has since been described. Vega et al (2000) demonstrated a ligand-
influenced interaction between PGC-1α and PPARα, which increased the expression
of mitochondrial fatty-acid oxidation (FAO) genes, while transient transfection
assays have revealed PGC-1α to be a potent co-activator for all three PPAR subtypes
(Røst et al, 2009). The identification of a peroxisome proliferator response element
(PPRE) within the promoter region of the human PGC-1α gene (Schuler et al, 2006)
has also led to the suggestion of a feedback loop between PGC-1α and PPARs with
PPARs increasing the expression of PGC-1α, which in turn increases the expression
of PPAR-target genes via its function as a co-activator (Hock and Kralli, 2009). Thus
PPARs may indirectly modulate the expression of proteins involved in mitochondrial
oxidative phosphorylation by increasing the expression of PGC-1α, which itself has
been shown to modulate the expression of genes involved in oxidative
phosphorylation via interactions with other transcription factors (e.g. nuclear
respiratory factor (NRF) 1 and GA binding protein (GABP)) (Wu et al, 1999).
5.4.4 TBT-binding proteins (TBT-bp)
The lipocalin protein family functions in the transport of small hydrophobic
molecules (Flower, 1996). Two lipocalin-like proteins, tributyltin-binding protein
(TBT-bp) 1 and TBT-bp 2, were found to be differentially regulated in response to
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the addition of TBTO in Wy14643 treatments. An upregulation of TBT-bp2 was
observed when compared to treatment in which TBTO was absent. Although a small
upregulation of TBT-bp2 was observed in treatments with TBTO with Wy14643
treatments, there was no indication that this gene was upregulated in European
flounder hepatocytes treated with TBTO alone. TBT-bp1 was found to be
downregulated after treatment with TBTO in Wy14643. This pattern of expression in
which TBT-bp2 is upregulated and TBT-bp1 downregulated, has previously been
found in Japanese flounder (Paralichthys olivaceus) injected with tributyltin (Nassef
et al, 2011). Furthermore medaka exposed to TBT (Nassef et al, 2011) and K.
marmoratus exposed to Bisphenol A (Lee et al, 2007) also showed a downregulation
of TBT-bp1 while an upregulation was seen in medaka in response to TCDD (Volz
et al, 2005). Therefore it appears that the response of European flounder to TBTO
may reflect that of other fish species. Although the mechanisms relating to the
downregulation of TBT-bp1 following TBT exposure is currently unknown, it has
been suggested that the response of TBT-bp1 may be dependent on the exposure
chemical (Nassef et al, 2011). TBT injected intraperitoneally in Japanese flounder
and dab (Limanda Yokohamae) was found to accumulate within blood serum at a
higher concentration than muscle, liver, spleen, bile and kidneys (Oshima et al,
1998), and this accumulation has been found to correlate with the appearance of TBT
binding proteins (Shimasaki et al, 2002). It has since been suggested that TBT-
binding proteins might be secreted into the skin mucus of fish as a complex with
TBT as a means of excretion, thus protecting fish species from the toxicological
effects of such a compound (Satone et al, 2008).
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5.4.5 Lipid metabolism and transport
As discussed in Chapter 1 one of the main functions of PPARα is in regulating lipid
metabolism. Genes involved in lipid transport and metabolism were both upregulated
and downregulated by the presence of TBTO in Wy14643 treatments, several of
which were identified as PPARα target genes. Consideration of these genes indicates
that their patterns of expression are not entirely consistent with the hypothesis that
TBTO antagonises the activity of PPARα. Both, mitochondrial delta3,5-delta2,4-
dienoyl-CoA isomerase (a β-oxidation enzyme) and glutathione-S-transferase A1,
have been suggested as PPAR-targets, with their expression increasing in response to
an activation of PPARs (Berger et al, 2002; Leaver et al, 2007; Williams et al, 2008).
Since they are both decreased by TBTO in Wy14643 treatment, this pattern of
expression would be consistent with the TBTO antagonism hypothesis. Another β-
oxidation gene, acetyl-Coenzyme A acyltransferase 2 (mitochondrial ACAT2) is
reduced in TBTO treated hepatocytes. However, two potential PPARα targets are
also present in the list of genes increased by TBTO in Wy16463 treatment. These are
L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain (HADH, a short chain
fatty acid β-oxidation enzyme) andG0/G1 switch gene 2 (G0S2). HADH catalyses the
third step in the mitochondrial β-oxidation of short chain fatty acids and a
peroxisome proliferator response element has previously been found in the promoter
region of the rodent gene (Zhang et al, 1992). Previously HADH has been found to
be upregulated in response to TBTO in thymocytes of rats (Baken et al, 2007). G0S2
has previously been identified in mouse hepatocytes as a PPARα-target gene,
containing a functional peroxisome proliferator-response element (PPRE) and being
upregulated by the PPARα agonist Wy14643 (Zandbergen et al, 2005). In addition
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the G0S2 gene has also been shown to be a direct target of PPARγ, increasing in
expression during adipocyte differentiation (Zandbergen et al, 2005).
Although these results are clearly equivocal, it is also true that TBTO may have other
effects than the antagonsim of PPARα. For example in mammals organotins are
potent agonists of RXR (Cui et al, 2011), the heterodimeric partner of PPARs, and of
PPARγ.  Although effects on PPARγ by TBTO has not been examined, since no
potent agonist has been discovered for this receptor from fish species, in treatment
with Wy14643 alone, PPARγ was found to be one of the genes upregulated. Also the
HADH gene, as well as being a PPARα target, has been shown to be upregulated in
response to the liver X receptor (LXR) ligand T0901317 (Hu et al, 2005), suggesting
HADH to be regulated by more than one nuclear hormone receptor. Furthermore the
LXR also partners with RXR to form a heterodimer, indicating other potential
mechanisms of regulation.
5.4.6 TBT downregulates the expression of genes involved in
immune functions
TBTO in rodents has been previously shown to be an immunotoxicant, decreasing
the thymus volume and the expression of genes with a function in cell division,
pointing to immunosuppression via cell cycle arrest (Baken et al, 2008). A reduction
in thymus volume has also been reported after TBTO exposure in European flounder,
leading to the suggestion that the immunocompetence of the animals may be
compromised (Grinwis et al, 1998; Grinwis et al, 2009).
In flounder hepatocytes in response to treatment with TBTO only, of the twenty
genes downregulated, three have immune function. Six immune function genes were
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also downregulated in the treatment with TBTO in Wy14643. These genes were also
well represented in the treatment with TBTO in Wy14643.
One of the TBTO down-regulated genes, alpha 2 macroglobulin (α2M) is an
important acute-phase proteins whose hepatic expression has been found to be
modified by PPARα agonists in a PPARα-dependent manner, being significantly
downregulated in rats treated with the PPARα agonist fenofibrate (Carmen González
et al, 2009). Despite no PPRE having been identified within the promoter region of
α2M, Carmen González et al (2009) suggested that PPAR may be negatively
regulating α2M through negative regulation of STAT3 or NF-kB. Furthermore it has
also been suggested that PPARβ may have a role in the regulation of α2M
expression; Kino et al (2007) found that GW501516, a PPARβ agonist, interfered
with interleukin-6 (IL-6)-induced acute phase response by inhibiting the
transcriptional activity of STAT3 thus inhibiting α2M expression. Within the study
here a small downregulation of α2M was noted in response to TBTO, possibly due to
PPAR mechanisms. This decrease in α2M expression, although small, is unexpected
since TBTO is thought to inhibit both PPARα and PPARβ and would therefore
diminish PPAR-dependent inhibition of pathways leading to α2M downregulation.
However, in agreement with a downregulation of α2M, the expression of α2M of the
small abalone (Haliotis diversicolor) was found to be downregulated upon exposure
to TBT (Jia et al, 2011).
5.5 Conclusions
Several genes have been discussed whose expression is altered by TBTO in the
presence of Wy14643. Although the results are not entirely clear with respect to
some of the known effects of PPARs, for example fatty acid β-oxidation, the
products of the most highly represented classes of genes belong to several functional
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groups including those involved in the maintenance of a healthy proteome,
mitochondrial oxidative phosphorylation, excretion of toxins and lipid homeostasis.
These groups are consistently decreased in expression by TBTO, increased by
Wy14643 and decreased by TBTO in Wy14643-treated cells. Several of these genes
have been described previously as PPARα-target genes or genes indirectly regulated
by activated PPARs. Due to the constraints of time, confirmation of the changes in
gene expression, for example by application of rt-qPCR, was not done and thus these
results should be regarded tentatively. However the overall pattern of gene
expression indicates that TBTO has the potential to alter normal gene expression
patterns in European flounder via PPARα. Of the genes amenable for further study,
glutathione S-transferase A1 (GSTA1) would be the most informative due to its prior
characterisation from flounder/plaice (Leaver et al, 1993; Henson et al, 2000) and
the presence of a PPAR-binding PPRE within its promoter region (Leaver et al,
1997; Leaver et al, 2005), indicating that it is likely regulated by PPARs.
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Chapter 6. Isolation of corticosteroid receptors from
European flounder (Platichthys flesus).
6.1 Introduction
Corticosteroid receptors, of which the glucocorticoid (GR) and the mineralocorticoid
receptor (MR) are distinguished, are members of the superfamily of nuclear hormone
receptors and mediate the effects of the corticosteroid hormones. These steroid
hormones, produced by the adrenal cortex in tetrapods and the homologous interrenal
cells of the head kidney of teleost fish (Phillips and Mulrow, 1959) have been
implicated in a wide range of physiological functions such as energy metabolism,
anti-inflammatory and immune responses (Amsterdam et al, 2002; Stolte et al,
2008), development (De Jesus et al, 1991), osmoregulation (McCormick, 2001;
Kiilerich et al, 2011) and reproduction (Brann and Mahesh, 1991; Milla et al, 2009).
Mammals possess two main corticosteroid hormones, the glucocorticoid cortisol
(corticosterone in rodents) and the mineralocorticoid aldosterone. While cortisol and
corticosterone can bind to and activate both GR and MR, aldosterone is, at
physiological levels, limited to binding to MR only. In teleost fish, the glucocorticoid
cortisol is the main product of interrenal cells, and has traditionally been regarded as
the main functional corticosteroid hormone (Mommsen et al, 1999). The ability to
synthesise aldosterone may have evolved relatively recently in the lineage leading to
the tetrapods given that this mineralocorticoid is absent in teleosts (Jiang et al, 1998),
elasmobranchs (Simpson and Wright, 1970; Nunez and Trant, 1999), and agnathans
(Bridgham et al, 2006). The emergence of aldosterone as a mineralocorticoid appears
to be due to a modification of cytochrome P450 hydroxylase enzyme which is found
in all jawed vertebrates and whose ancestral function appeared to be the
hydroxylation of DOC in cortisol synthesis. Only in tetrapods does this enzyme have
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the ability to hydroxylate corticosterone to aldosterone (Nonaka et al, 1995; Bülow
and Bernhardt, 2002). Several authors have described the inability of this enzyme
from teleosts to synthesis aldosterone (Jiang et al, 1998; Nelson, 2003). Despite the
lack of aldosterone, an MR has been identified and characterised in rainbow trout
(Colombe et al, 2000; Sturm et al, 2005) and other teleost species (Greenwood et al,
2003; Stolte et al, 2008; Pippal et al, 2011). In addition two glucocorticoid receptors
have been identified in several teleosts (Greenwood et al, 2003; Bury et al, 2003;
Stolte et al, 2006; Stolte et al, 2008).
Since these receptors have a role in a wide range of physiological processes in fish
species a disruption of their transcriptional abilities, for example by environmental
contaminants, might be expected to negatively impact fish species in polluted
environments. European flounder (Platichthys flesus) is a sentinel species used to
monitor the biological effects of contamination in inshore/estuarine waters of the
OSPAR maritime area. The aim of this study was to isolate cDNAs for corticosteroid
receptors from flounder as a necessary first step in determining the effects of
environmental contaminants on corticosteroid receptor function in flounder. Three
corticosteroid receptors from this species and their tissue distributions are described
here for the first time.
6.2 Materials and Methods
6.2.1 Total RNA isolation from tissues of European flounder
For the purpose of receptor isolation total RNA was extracted from eight tissues of a
single juvenile male European flounder (Platichthys flesus) obtained from the Forth
estuary and acclimated to seawater in an aquarium for six months. The fish was
killed by a single blow to the head, after which samples of the brain, gills, heart,
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small intestine, kidneys, liver, white muscle and gonads were removed and
homogenised in 10 volumes of TRIpure isolation reagent (Roche). Six hundred
microlitres of homogenate were centrifuged for 2 minutes at 16,000 ×g to remove
any remaining lumps of tissue and 500 µl of the resulting supernatant transferred to a
clean tube. RNA isolation was continued as described in the TRIpure isolation
reagent instruction manual (Roche), with RNA finally being resuspended in MilliQ
water (Millipore) to a final concentration of 1mg/mL.
RNA concentration and purity were determined spectrophotometrically on Nanodrop
ND1000 spectrophotometer. In addition, the integrity of total RNA samples was
confirmed. 1 µg total RNA from each tissue was heated at 75°C for 2 minutes and
loaded onto a 1 × TAE, 1% agarose, 0.5 µg/ml EtBr gel for electrophoresis at 75V
for 30 minutes. RNA was visualised by exposure of the gel to UV light and RNA
integrity confirmed by the presence of 28S and 18S rRNA bands at an intensity ratio
of approximately 2:1 (28S:18S).
RNA samples and excess tissue homogenates were stored at −70°C until further use.
Reverse transcription6.2.1.1
Total RNA isolated from each tissue, was reverse transcribed using either the
commercially available SMART™ (Switching Mechanism At 5’ end of the RNA
Transcript) RACE cDNA amplification kit (Clontech) or an  oligo(dT)-anchor primer
according to an in-house protocol. Furthermore two separate reverse transcription
reactions were prepared using the SMART™ RACE cDNA amplification kit
(Clontech), one of which would allow subsequent rapid amplification of 3’ cDNA
ends (3’ RACE) and the other which would allow rapid amplification of 5’ cDNA
ends (5’ RACE).
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Regardless of which method of reverse transcription was used, an oligo(dT) primer
was included in each reaction (see Table 6-1). The oligo(dT) portion of the primer
compliments the polyA tail at the 3’ end of mRNA molecules. An anchor sequence is
included at the 5’ end of both the in-house RACE RT oligo(dT) and the 3’ RACE
CDS primer A (Clontech). Reverse transcription from the polyA tail of these
oligo(dT)-anchor primers results in first-strand cDNA with the anchor sequence
incorporated into the 5’ end, the presence of which is important in subsequent 3’
RACE. In order to be used for 5’ RACE, first-strand cDNA requires a similar anchor
sequence incorporated into the 3’ end of reverse transcription products. Reverse
transcription using the SMART™ RACE cDNA kit (Clontech) to produce 5’ RACE
ready cDNA makes use of both the terminal transferase activity of the Moloney
murine leukemia virus reverse transcriptase (MMLV RT) enzyme and a so-called
‘template-switch’ oligonucleotide primer during first-strand cDNA synthesis (Matz
et al, 1999). MMLV RT is capable of adding 3-5 non-template residues,
preferentially dC, to the 3’ end of the reverse transcription product. The SMART
template switch oligonucleotide primer, included in the reverse transcription
reaction, hybridises to the dC residues via a terminal stretch of guanosine residues,
and serves as an extended template for reverse transcription, the end product of
which is first strand cDNA with the additional SMART sequence at the 3’ end.
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Table 6-1. Oligo(dT) primers used during reverse transcription of total RNA into first-strand 3’
RACE ready cDNA. V = A, G or C; N = A, T, C, G
Primer Name Primer sequence
In-house RACE RT oligo (dT) CAG CTG CAG GTA CCG GAT CCT C GAG AAG C (T)19
3’ RACE CDS primer A (Clontech) AAG CAG TGG TAT CAA CGC AGA GTA C(T)30 V N
5’ RACE CDS Primer (Clontech) (T) 25 V N
Per reaction 1 µg total RNA and oligo(dT)-anchor primer at a concentration of 1 µM
was used. Additionally, 1 µM of SMART II oligonucleotide (5’- AAG CAG TGG
TAT CAA CGC AGA GA CGC GGG -3’), the ‘template-swich’ oligonucleotide
described above, was included in the reaction aiming to produce 5’ RACE ready
cDNA. Reactions were then made up to 5 µl with water and incubated at 70°C for 5
minutes before being rapidly cooled on ice for 2 minutes. 1× first strand buffer, 1mM
of each dNTP and either 1 µl M-MLV RT(-)H point mutant reverse transcriptase
enzyme (Promega) for use with the In-house oligo(dT) and 3’ CDS primer A
(Clontech) or 1 µl Powerscript reverse transcriptase (Clonech) for use with the 5’
CDS primer were. A 2mM concentration of dithiothreitol (DTT) was also included in
the reverse transcription yielding 5’ RACE-ready cDNA. Reactions were gently
mixed and placed in a thermocycler (Biometra Tgradient) at 42°C for 90 minutes
after which each 10 µl reaction was diluted to 110 µl by the addition of Tricine
EDTA buffer. Reverse transcriptase enzyme was inactivated by heating at 70° for 10
minutes and first-strand cDNA stored at -20°C until further use.
6.2.2 Amplification of corticosteroid receptors by PCR
A partial cDNA for GR2 from the European flounder (Platichthys flesus; Genbank
accession number AJ867607.1) has previously been cloned (Lu et al, 2007). When
aligned to GR2 sequences of burton’s mouthbrooder (Astotilapia burtoni) and
gilthead seabream (Sparus aurata) the GR2 of European flounder corresponds to
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amino acids 430-759 of A.burtoni and 434-764 of S.aurata GR2, encompassing the
D-domain and the majority of the ligand-binding E-domain of the receptor, with the
most C-terminal 20 amino acids absent. In databases, no GR1 or MR sequences were
available for P.flesus. To isolate partial sequences of these receptors, a PCR
approach was used, based on the design of primers taking into account available MR
and GR1 from other fish species.
Primer design and Polymerase Chain Reaction (PCR)6.2.2.1
MR sequences from other fish species (Japanese pufferfish, Takifugu rubripes;
zebrafish, Danio rerio; rainbow trout, Onchorynchus mykiss; Burton’s
mouthbrooder, Haplochromis burtoni) were aligned using ClustalW (Larkin et al,
2007) and primers derived from highly conserved regions. Two gene-specific pairs
of MR primers were designed (Table 6-2) that were expected to amplify two
overlapping MR fragments.
A nucleotide sequence for the GR1 of Japanese flounder (Paralichthys olivaceus)
was available within the Genbank database, (Accession no. AB013444). Similar to
the above strategy for MR, two GR1 primer pairs were made in order to amplify
overlapping partial European flounder GR1 sequences. All primers used for PCR
amplification are described in Table 6-2. PCR amplification reactions for each
primer pair was done in 20 µl volumes containing 2.5 µl first-strand cDNA from
kidney, liver and brain for GR1, GR2 and MR, respectively, 200nM forward and
reverse primer each, 200 µM of each dNTP, DNA polymerase enzyme (0.4 µl Pfu
fusion II polymerase (Stratagene), 1 × Advantage II polymerase mix (Clontech) or
Expand long template polymerase (Roche) for GR1, GR2 and MR, respectively) and
a 1× concentration of corresponding polymerase buffer. Single primer and no-
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template controls were included for each reaction, the former of which contained
only a single primer with water replacing the second primer and the latter of which
contained water instead of first-strand cDNA template. No-template controls ensure
contamination of reagents has not occurred and that primers are specific for their
target sequence and do not amplify in a non-specific manner while the single primer
controls ensure the amplified products are not due to the mis-priming of an
individual primer.
Table 6-2. Primer sequences used to amplify partial cDNAs of each of the corticosteroid
receptors from European flounder (Platichthys flesus). The given name of each primer is shown
alongside its nucleotide and amino acid sequence. Primer annealing positions refers to amino
acid positions of European flounder GR1, GR2 and MR, which have been added to the
GenBank database with Accession nos. JF951960, JF951961 and JF951959, respectively.
Cycling conditions for each PCR reaction included an initial denaturation step of 2
minutes at 94 °C followed by 35 cycles of denaturation, primer annealing and
extension steps (Table 6-3). Following each PCR amplification reaction, amplified
products were visualised by agarose gel electrophoresis, as described in 3.2.1.1, and
subcloned into plasmid vectors for further analysis.
Primer
name
Primer sequence (5’ 3’) Amino Acid
sequence (5’3’)
Annealing
Position
P.fGR1F1 ATG-GAT-CAG-GGT-GGA-CTG-AAG-CG M-D-Q-G-G-L-K 1-6
P.fGR1R1 CAG-GTT-ACG-ACA-CCG-TAG-TGG-CAT-C C-H-Y-G-V-V-T 455-461
P.fGR1F2 GTG-GGC-CTA-CAA-GAC-CAG-AA V-G-L-Q-D-Q 364-369
P.fGR1R2 CAC-GCT-GAG-GGT-TTT-ATT-CAC V-N-K-T-L-S-V 771-777
P.fGR2F1 CAC-TAC-GGC-GTT-CTC-ACC-TG H-Y-G-V-L-T 77-82
P.fGR2R1 GTC-CTC-CAA-CCA-TCT-CAT-GC H-E-M-V-G-G 372-377
P.fMRF1 ATG-GAG-AC(CT)-AAA-AGA-TAC-C(AC)A-AGT-T(AGT)C
M-E-T-K-R-Y-Q/P-
S-Y/C/F 1-9
P.fMRR1 A(CT)G-A(AG)T-GTC-C(AG)C-C(GT)G-AAT-TAA-C(AGT)C V-N-S-G-G-H-S 527-533
P.fMRF2 TGG-TAT-CTT-AGG-ACC-CCC-TGT g-i-l-g-P-P 477-482
P.fMRR2 GAC-TCC-ACC-TTT-GGT-ATC-TGG Q-I-P-K-V-E 972-977
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Table 6-3. PCR cycling conditions for amplification of partial GR1, GR2 and MR fragments
using primers detailed previously in Table 6-2.
GR1 GR2 MR
Forward
Primer F1 F2 F3 F4 F5
Reverse
Primer R1 R2 R3 R4 R5
Polymerase
enzyme used
Pfu fusion II
(Stratagene)
Expand
Long
template
(Roche)
Advantage II
mix
(Clontech)
Expand Long
template
(Roche)
Expand Long
template
(Roche)
Cycling Parameters
Denaturation 94 °C20 secs
94 °C
10 seconds
94 °C
20 secs
94 °C
10 secs
94 °C
10 seconds
Primer
annealing
64 °C
30 secs
55 °C
30 seconds
57 °C
30 secs
60 °C
30 secs
59 °C
30 seconds
Extension 72 °C60 secs
68 °C
2 minutes
72 °C
60 secs
68 °C
4 mins
68 °C
2 minutes
Final
extension
72 °C
3 minutes
68 °C
7 minutes
72 °C
5 minutes
68 °C
7 minutes
68 °C
7 minutes
Cloning methods6.2.2.2
Amplicons from PCRs were ligated into one of three different cloning vectors,
selected due to their availability and the method of cloning required.
The Pfu fusion II enzyme produces amplicons with polished ends, reflecting the
enzyme’s 3’  5’ exonuclease proofreading. Accordingly, blunt-ended cloning was
used to subclone the putative GR1 fragment generated with this enzyme.  All other
amplicons were generated with DNA polymerases adding single 3’-Adenine
overhangs, and thus were subcloned into linearised vectors containing single 3’ –
terminal thymidine residues at both ends.
The blunt-end GR1 fragment was purified from the enzymatic reaction using the
QIAquick PCR purification kit (Qiagen), following manufacturer’s instructions,
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followed by ethanol precipitation as described in Chapter 3 (3.2.1.2). The resulting
DNA pellet was resuspended in a ligation reaction containing 0.3 µl EcoRV-digested
pBluescript vector (Stratagene), 1× T4 DNA ligase buffer (Fermentas), 15 weiss
units T4 DNA ligase enzyme (Fermentas) and water to a volume of 10 µl. The ligase
reaction was allowed to proceed at room temperature overnight.
For TA cloning either the pCR®2.1-TOPO (Invitrogen) or pGEM® T-easy
(Promega) cloning plasmid was used. Use of the TOPO TA cloning® method avoids
the need for post-PCR cleanup, allowing PCR enzyme reactions to be used directly
in TA cloning in the case of amplification of a single, discrete band. The putative
GR2 fragment was ligated into this vector in a 6 µl reaction volume in which 4 µl of
the PCR product were incubated with 1 µl of salt solution (1.2M sodium
chloride/0.4M magnesium chloride; Invitrogen) and 10ng of pCR® 2.1-TOPO vector
at room temperature for 30 minutes.
All other products of PCR were cloned into the pGEM® T-easy cloning vector. Prior
to ligation, DNA was first purified from the PCR reaction using ethanol precipitation
or the QIAquick PCR purification kit (Qiagen), following manufacturers protocol.
DNA purified using the latter method was further purified using ethanol
precipitation. Precipitates were then resuspended in a 10 µl ligation reaction
containing 1× Rapid ligation T4 DNA ligase buffer (Promega), 50 ng pGEM® T-
easy vector (Promega) and 3 Weiss units of T4 DNA ligase (Promega) and the
reactions incubated at 4 °C overnight.
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Transformation of chemocompetent E.coli cells with ligation reaction6.2.2.3
product and plasmid purification
Following ligation, an aliquot of each reaction was transformed into
chemocompetent E.coli (prepared in-house from the DH5α strain (described below),
or commercially obtained JM109 high efficiency cells provided with the Promega’s
pGEM® T-easy vector system kit).
In-house E.coli cells were prepared by inoculation of 5ml SOB media with a single
colony of DH5α and incubation overnight at 37°C. A 200ml volume of SOB, pre-
warmed to 37°C, was then inoculated with 200 µl of the starter culture and incubated
at 37°C until the OD600 ≤ 0.4, determined spectrophotometrically using SOB media
only as a blank. Bacterial growth was stopped by placing the flask on ice and the 200
ml volume aliquoted to 50ml sterile centrifuge tubes before incubating on ice for a
further 10 minutes. Cells were pelleted by centrifugation (1000 ×g for 15 minutes at
4 °C) and SOB media discarded. Cells were resuspended in 67ml RF1 (100mM
RbCl, 50mM Magnesium chloride, 30mM potassium acetate, 10mM calcium
chloride, 15% (w/v) glycerol, pH5.8) before pelleting as described above. The
supernatant was discarded and cells resuspended in 16ml RF2 (10mM MOPS, 10mM
RbCl, 75mM calcium chloride, 15% (w/v) glycerol). Cells were incubated on ice for
15 minutes before being aliquoted to sterile pre-chilled tubes, snap frozen and stored
at -70 °C.
For transformation, an aliquot of chemocompetent E.coli cells, thawed on ice (100 µl
per reaction), were mixed with 5 µl of the products of the above ligation reactions
and incubated on ice for 30 minutes before heat shocking for 45 seconds at 42 °C,
followed by incubation of ice for 2 minutes. Luria broth (LB) media was then added
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to transformed cells in a volume of 500 µl (DH5α E.coli) or 950 µl (JM109 high
efficiency E.coli) and the mixtures incubated for 1 hour at 37°C with shaking at 150
rpm.
LB agar plates (90mm diameter containing 20ml agar) supplemented with 0.1 mg/ml
ampicillin were treated with 2µg/plate 5-bromo-2-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal) and 100 µl/plate 10 mM isopryl β-D-1-
thiogalactopyranoside (IPTG). Transformed E.coli cells were then spread and the
inoculated plate incubated overnight at 37 °C. The inclusion of ampicillin provided a
selection for cells transformed with plasmids conferring ampicillin-resistance, while
the use of X-gal allows for a further colorimetric distinction (blue/white screening)
of cells transformed with plasmids containing an insert (white colonies) from those
containing empty vector (blue colonies), based on the cleavage of X-gal by β-
galactosidase, an enzyme encoded by the LacZ gene present in the cloning plasmids.
Cleavage of X-gal results in the production of galactose and 5-bromo-4-chloro-3-
hydroxyindole, the latter of which is further metabolised to the insoluble blue-
coloured product, 5,5'-dibromo-4,4'-dichloro-indigo. Plasmids in which the PCR
product is successfully ligated results in a disruption of the LacZ reading frame and
thus a production of white colonies.
Individual white colonies from each plate were selected, used to inoculate small scale
cultures (4 ml of LB media, supplemented with ampicillin at 0.1mg/ml), which were
grown overnight at 37°C and 150 rpm agitation. Plasmid DNA was isolated from
cultures using the GenElute™ Plasmid Miniprep kit (Sigma), following
manufacturer’s instructions, with plasmid DNA being eluted in 50 µl MilliQ water.
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The obtained plasmid preparations were characterised by restriction mapping using
enzymes releasing the insert. Plasmids derived from pGEM® T-easy and pCR®2.1-
TOPO vectors were digested with EcoRI, using 2 µl plasmid preparation, 2 units of
EcoRI enzyme (Invitrogen), 1× MULTI-CORE™ digestion buffer (Promega) and
water to a volume of 10 µl. Plasmids derived from pBluescript were digested by
HindIII and EcoRV, using 2 µl plasmid preparation, 1.3 units HindIII enzyme
(Invitrogen), 1.3 units EcoRV enzyme (Invitrogen), 1× REact 2 digestion buffer
(Invitrogen) and water to make the volume to 10 µl. Reactions were incubated at 37
°C for 1 hour before 5 µl of digested plasmid product was electrophoresed at 75V on
a 1 × TAE, 1% agarose, 0.5 µg/mL EtBr gel alongside a 1 kb DNA ladder (Biogene),
and the gel exposed to UV light in order to visualise digestion products. Plasmid
preparations in which digestion yielded two DNA bands of the expected sizes, one
corresponding to the plasmid and the other to the corticosteroid receptor fragment,
were sequenced to confirm the identity of the insert.
6.2.3 Rapid Amplification of 3’ and 5’ cDNA ends (3’ RACE &
5’ RACE)
RACE-PCR was performed in order to amplify the 5’ and 3’ ends of each
corticosteroid receptor cDNA, facilitating the isolation of the full open-reading frame
of GR1, GR2 and MR from European flounder. As described in 6.2.1.1, reverse
transcription reactions were done using either a modified oligo(dT) with an anchor
sequence attached, designed to produce a reverse transcription product with the
anchor incorporated at the 5’ end, suitable for 3’ RACE, or with both an oligo(dT)
and a template switch oligonucleotide in which products of reverse transcription
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would have the template switch oligonucleotide sequence incorporated at the 3’ end,
making it suitable for 5’ RACE.
3’ RACE using in-house oligo(dT) and anchor primer6.2.3.1
For both the MR and GR2, 3’ RACE was carried out using cDNA reverse transcribed
from RNA using the in-house RACE anchor primer using a semi-nested strategy
with primers described in Table 6-4.
First round PCR reactions used 2.5µl RACE-ready liver cDNA, 1 × PCR buffer IV
(Abgene), 200 nM of forward and reverse primer each, 200 µM dNTPs, and 1 unit
DNA taq polymerase (Abgene). The reactions were cycled for 2 minutes at 95°C
followed by 25 cycles of dentaturation, primer annealing and extention steps at 95°C
30 seconds, 55°C (MR) or 62.5°C (GR2) for 30 seconds and 72°C for 2 minutes,
respectively. A final extension of 72°C for 5 minutes completed the PCR
programme. After analysis on a 1% agarose, 1 × TAE, 0.5 µg/mL EtBr gel, no
amplification product was visible and therefore a second round of semi-nested PCR
was performed. The reaction from first round PCR was diluted 1 in 100 with Milli Q
water and 2.5 µl used as the template in a second round of PCR. All reagents and
concentrations described above for first round PCR were the same for semi-nested
PCR. The forward gene specific primers used were located internal to the original
forward primers. Cycling conditions were as described for first round PCR, with the
annealing temperatures altered to 57 °C and 63 °C for 3’ RACE of GR2 and MR,
respectively, to ensure compatibility with the internal forward primers.
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3’ RACE using the SMART RACE cDNA kit (Clontech)6.2.3.2
The SMART™ RACE cDNA amplification kit (Clontech) was used to amplify the
3’ region of GR1, employing a GR1-specific primer.
3’ RACE-ready cDNA, produced from reverse transcription using the 3’ CDS primer
A (see 6.2.1.1) was used in 3’ RACE PCR at a volume of 2.5 µl per reaction together
with 1 × Advantage II PCR buffer, 200 µM dNTP mix (Clontech), 1 × Universal
primer mix (oligo(dT) kit primer), 200 nM gene specific forward primer and 1 ×
Advantage II polymerase mix (Clontech). The reaction was cycled using a
touchdown cycling programme as recommended in the SMART™ RACE kit
protocol. Touchdown PCR involves an increased annealing temperature at the
beginning of the cycling programme such that annealing is at, or just above, the
expected annealing temperature. During cycling the annealing temperature is
decreased in increments to a temperature at which primers will anneal in a manner
which is least permissive of  non-specific binding, thus increasing the likelihood of
amplifying the targeted sequence (Don et al, 1991; Hecker and Roux, 1996). Here,
cycling was performed using 5 cycles combined annealing/extention step at 72 °C for
3 minutes, following an initial denaturation step at 94 °C for 30 seconds and
followed by 5 cycles of denaturation, annealing and extention steps at 94 °C for 30
seconds, 70 °C for 30 seconds and 72 °C for 3 minutes, respectively. The programme
was completed using 25 cycles of denaturation, annealing and extention steps at 94
°C for 30 seconds, 68 °C for 30 seconds and 72 °C for 3 minutes.
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Table 6-4. Gene specific primers and primers designed to anneal to the anchor sequence at the
3’ extremity of cDNA used in first and second-round PCR to amplify 3’ RACE products for
GR1, GR2 and MR.
5’ RACE PCR6.2.3.3
For each of the three corticosteroid receptors 5’ RACE was undertaken using the
SMART™ RACE cDNA amplification kit (Clontech). A gene specific reverse
primer was designed to be used in PCR reactions with the Universal primer mix
(UPM) contained in the SMART™ RACE cDNA amplification kit (Table 6-5).
Table 6-5. Gene-specific primers used in conjunction with the Universal primer mix to amplify
the 5’ cDNA ends of corticosteroid receptors.
Primer
Name Primer Sequence (5’3’)
Amino acid sequence (5’3’)
& annealing position
P.fGR1 5’R TTG-ATG-TGC-TGG-GGG-AAA-AGG-TTG N-L-F-P-Q-H-I (142-148)
P.fGR2 5’R GCT-GTC-GTA-GCC-GGC-AAA-GAT-GGT-GT T-I-F-A-G-Y-D-S (189-196)
P.fMR 5’R AGT-GGC-GTT-GGA-CTG-CTG-AAA-ACC-A G-F-Q-Q-S-N-A-T (161-168)
Primer Name Primer Sequence (5’ 3’) Amino Acid sequence
(annealing position)
Additional Information
P.fGR13’F
TGC ATG AAG GTC CTG TTA
CTG CTG AGT
C-M-K-V-L-L-L-L-S
(695-703)
Primers used in first-
round RACE PCRP.fGR23’F
CTT TCG GTC TGG GCT GGA
GGT CTT ACC
F-G-L-G-W-R-S-Y
(252-259)
P.fMR3’F
AAC CCT TTG TTG AGC CTA
ATT TC
N-P-L-L-S-L-I
(556-562)
P.fGR2 3’F
nested
GCA TGA GAT GGT TGG AGG
AC
H-E-M-V-G-G
(372-377) Primers used in
second-round semi-
nested PCRP.fMR 3’F
nested
GGC GGC GTT CGA GGA GAT
GAG AGT
A-A-F-E-E-M-R
(895-901)
Universal
primer mix
(UPM;
Clontech)
CTA ATA CGA CTC ACT ATA
GGG CAA GCA GTG GTA TCA
ACG CAG AGT AND
CTA ATA CGA CTC ACT ATA
GGG C
Reverse primer for 3’RACE; sequence used in
PCR of GR1
RACE(+GSP) GCA GGT ACC GGA TCC TCGAGA AG
Reverse primer for 3’ RACE; used in first and
second-round PCR of GR2 & MR
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RACE PCR reactions were prepared in 20 µl volumes, each containing 2.5 µl 5’
RACE-ready cDNA, prepared as described in 6.2.1.1, 1× UPM (Clontech), 200 nM
gene-specific primer, 1× Advantage II PCR buffer (Clontech), 200 µM dNTP mix
and 1× Advantage II polymerase mix (Clontech). PCR reactions were cycled using a
touchdown PCR cycle, starting with a combined annealing and extension
temperature of 72°C, followed by cycles using successively lower annealing
temperatures. Cycling parameters were as follows – 5 cycles at 94°C for 30 seconds
and 72° for 3 minutes, 5 cycles at 94°C for 30 seconds, 70°C for 30 seconds, 72°C
for 3 minutes and 25 cycles of  94°C for 30 seconds, 68°C for 30 seconds and 72°C
for 3 minutes.
Products amplified by 3’ and 5’ RACE were visualised by gel electrophoresis at 75
V for 30 minutes on a 1 × TAE, 1 % agarose, 0.5 µg/ml EtBr gel alongside a 1kB
DNA ladder (Biogene). In order to view any amplified products the gel was exposed
to UV light allowing the visualisation of EtBr stained DNA. Single bands of interest
were obtained for each corticosteroid receptor and therefore DNA within the
remaining reaction volumes was purified, cloned and sequenced to determine their
identity.
Ligation of RACE amplicons into cloning vector6.2.3.4
DNA from 5’ and 3’ RACE reactions were each purified from agarose gel and
subsequently ligated into the pGEM®-T easy cloning vector. Purifications were
performed using either the NucleoSpin extract II PCR clean up gel extraction kit
(Machery Nagel) or the Illustra GFX PCR DNA and Gel band Purification kit (GE
Healthcare). Both kits are based on the principle of binding DNA to a silica
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membrane in the presence of chaotropic salts. The membrane is then washed with an
ethanol-based wash solution to remove salts and other contaminants and DNA is
eluted in a low- or salt- free solution in a small volume. In each case, following
purification, the concentration of eluted DNA was checked spectrophotometrically
using a Nanodrop 1000 spectrophotometer and a 3:1 molar ratio of PCR product to
vector was used in the cloning reactions. The amount of DNA required for ligation
was calculated as follows:
ng insert DNA = mass of vector (50ng) × size of inster (kb) × Insert:Vector molar ratio
size of pGEM®Teasy (3.0kb)
To the vector and insert DNA, Rapid ligation buffer (Promega) and T4 DNA ligase
(Promega) were added to a final concentration of 1× and 3 weiss units, respectively.
Cloning reactions were left overnight at 4°C to produce the maximum number of
transformants before being transformed into chemocompetent DH5α E.coli, which
were then spread on LB agar plates selective for ampicillin resistance and blue/white
screening. White bacterial colonies were selected from each plate and grown further
in LB media before purification of plasmid DNA using the GenElute™ Plasmid
Miniprep kit (Sigma). Transformation, growth of bacterial colonies and plasmid
purifications were performed as described previously in 6.2.2.3. As described in
6.2.2.3 samples of each plasmid preparation were digested with EcoRI enzyme and
those plasmids containing ligated RACE amplicons were sequenced.
Sequencing of plasmids containing putative RACE PCR fragments6.2.3.5
Sequencing and post-reaction cleanup of plasmid DNA was done as described in
3.2.1.5. Primers used for sequencing are detailed in Table 6-6 with the sequencing
strategy, including annealing positions of primers, detailed in Figure 6-1.
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Figure 6-1. Strategy used to sequence PCR fragments of corticosteroid receptors from European
flounder. Primers are indicated by arrows, colour co-ordinated to identify the fragment for
which they were designed to sequence. Numbers associated with primers indicate the amino acid
positions to which they were designed to anneal and correspond to amino acids for GR1 (top),
GR2 (middle) and MR (bottom) sequences in GenBank database.
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Table 6-6. Primers used to sequence PCR fragments and their nucleotide sequences. The positions
to which they are designed to anneal are given in Figure 6-1.
Sequencing primer name Primer sequence (5’3’)
Primers designed to RACE anchor
RACE(+GSP) GCA GGT ACC GGA TCC TCG AGA AG
Primers designed to cloning plasmids
M13R CAG GAA ACA GCT ATG AC
M13F GTA AAA CGA CGG CCA G
T-easy F TAA AAC GAC GCC CAG TGA AT
T-easy R CTC AAG CTA TGC ATC CAA CG
Primers designed to PfGR1
PfGR1F1 ATG-GAT-CAG-GGT-GGA-CTG-AAG-CG
PfGR1R1 CAG-GTT-ACG-ACA-CCG-TAG-TGG-CAT-C
P.fGR1F2 GTG GGC CTA CAA GAC CAG AA
P.fGR1R2 CAC GCT GAG GGT TTT ATT CAC
P.fGR1F3 GAG GAC AAT ATG CCG TTG CT
P.fGR1R3 CGG TGC TGT CGT TTC TGC AAT CTG
P.fGR1F4 CCA AGC CCA GTG GTC AGA CCC ATA AGA T
P.fGR1R4 GCC CAC TTG ACT GCA GAG AT
P.fGR1F5 AAC A CA GAT GGC CAA CAC AA
P.fGR13’F TGC ATG AAG GTC CTG TTA CTG CTG AGT
P.fGR15’R TTG ATG TGC TGG GGG AAA AGG TTG
Primers designed to PfGR2
P.fGR2F1 CAC TAC GGC GTT CTC ACC TG
P.fGR2R1 GTC CTC CAA CCA TCT CAT GC
P.fGR2F2 CCT CAT GAC CAC CCT GAA CA
P.fGR2R2 CAC TGC TCT CTT GAA GAA GAC TTT
P.fGR2F3 CCT CAT GTC TTT CGG TCT GG
P.fGR2R3 TCT TTG CCT GCG CTA AGG AT
P.fGR25’R GCT GTC GTA GCC GGC AAA GAT GGT GT
P.fGR23’F nested GCA TGA GAT GGT TGG AGG AC
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Table 6-6. continued…
Sequencing primer name Primer sequence (5’ 3’)
Primers designed to PfMR
P.fMRF1 ATG-GAG-AC(CT)-AAA-AGA-TAC-C(AC)A-AGT-T(AGT)C
P.fMRR1 A(C/T)G A(A/G)T GTC C(A/G)C C(G/T)G AAT TAA C(G/A/T)C
P.fMRF2 TGG TAT CTT AGG ACC CCC TGT
P.fMRR2 GAC TCC ACC TTT GGT ATC TGG
P.fMRF3 GTG AT(A/G) T(G/C)C T(G/C)A TGG ATA T(A/T/C)G
P.fMRR3 TTG AAC ACC TCC CCG TCA G
P.fMRF4 CAC CAA GAG CCC CAA GAT AA
P.fMRR4 TTC TCT TGG TA(A/G) TAG CTG CC(A/G) TC
P.fMR3’F nested GGC GGC GTT CGA GGA GAT GAG AGT
P.fMR5’R CTG CAG GAC AGG GAT GAG ACC AGC AT
6.2.4 Confirmation of corticosteroid receptor fragments by long
PCR
Individual DNA sequences from all PCR and RACE reactions were assembled into
contigs and using the Lasergene SEQman software (DNASTAR). Original trace files
and raw nucleotide sequences were compared and where necessary confident changes
within the raw nucleotide sequence were made to match the trace file. The corrected
raw nucleotide sequence was translated in all three 5’ to 3’ reading frames to its
corresponding amino acid sequence using the ExPASy DNA to protein ‘Translate’ tool
(Gasteiger et al, 2003). Per receptor, the reading frame with the longest predicted amino
acid sequence uninterrupted by stop codons was selected and using the corresponding
nucleotide sequence, primers were designed to amplify a single fragment covering the
whole open-reading frame.
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Amplification of GR16.2.4.1
For confirmation of the GR1 sequence a forward (5’- GTG GAC GCT GCG TAA TTT
CT -3’) and reverse (5’-TTG TGC TCT TGG AGG AGG AT -3’) primer was made,
designed to the 5’ and 3’ untranslated regions, respectively. These primers were then
used in a 25 µl PCR reaction which included 5 µl cDNA from gills, 0.2 µM forward and
reverse primer each, 200 µM of each dNTP, 1 × polymerase buffer and 1.25 units
PrimeSTAR HS DNA polymerase (Takara). PCR reactions were given an initial
incubation step for 30 seconds at 98°C, before being cycled 20 times at 98°C for
10seconds (denaturation), 55°C for 15 seconds (annealing) and 72°C for 3 minutes. A
final extension at 72°C for 5 minutes completed the PCR. The product resulting from
this first PCR (PCR-1) was diluted 10-fold and used as a template in a subsequent PCR
reaction (PCR-2). PCR-2 was a nested PCR, using a second set of primers designed to
amplify a region within the expected product of the PCR-1. The forward primer (5’-
GAT GGT ACC ATG GAT CAG GGT GGA CTG AAG -3’) was designed to the first
21 nucleotides of the GR1 open-reading frame with the KpnI restriction enzyme
recognition site incorporated (underlined). The reverse primer (5’- GAT GGA TCC
TCA TTT CTG ATG AAA CAG CAG AGG -3’) was designed to the 5’ end of the
GR1 open-reading frame with the BamHI restriction enzyme recognition site
incorporated (underlined). PCR-2  included 5 µl template (1/10 dilution of first PCR
product), 0.2 µM forward and reverse primer each, 200 µM of each dNTP, 1 ×
polymerase buffer and 1.25 units PrimeSTAR HS DNA polymerase (Takara). Cycling
conditions were as described for PCR-1 except denaturation, annealing and extension
steps were cycled 35 times and the extension step reduced by 30 seconds to 2.5 minutes.
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Amplification of GR2 and MR6.2.4.2
The GR2 and MR sequences were confirmed using a single PCR reaction each. The
component of each PCR reaction were as described for the PCR-1 of GR1, except
primers were specific to the corticosteroid receptor being amplified. For GR2 the
forward and reverse primer sequences were 5’- TGT ATC TCC CAG TGA CGA CCAT
-3’ and 5’- AGA CCA CGT GGA TGT TAG CC -3’, and designed to the most 5’ end
of the incomplete open-reading frame and the 3’ untranslated region, respectively. The
forward and reverse primer sequences for the MR were 5’- GAT GGT ACC ATG GAG
ACC AAA AGA TAC CAA AGT TTC -3’ and 5’- GAT GGA TCC TCA CTT CTT
GTG GAA GTA GAT TGT G -3’, respectively. Similar to the GR1 primers the forward
and reverse primer designed to the MR was designed to the 5’ and 3’ end of the open-
reading frame and incorporated the KpnI and BamHI restriction enzyme recognition
sites, respectively. Cycling conditions to amplify GR1 and GR2 were as for PCR-1 of
GR1 except denaturation, annealing and extension steps were cycled 35 times.
Ligation and purification of plasmids containing inserts6.2.4.3
The amplified products of each PCR were visualised by electrophoresis on a 1× TAE,
1% agarose, 0.5 µg/ml EtBr gel and subsequent exposure to UV light. The remaining
reaction volume was purified and subcloned into pGEM® T-easy (Promega) as
described in 6.2.3.4. Ligated plasmids were transformed into chemocompetent DH5α
plasmids, grown, and purified as described in 6.2.2.3. As described in 6.2.2.3 samples
of each plasmid preparation were digested with EcoRI enzyme and of those plasmids
containing the putative corticosteroid receptors, at least three were sequenced per
receptor. Following confirmation of the corticosteroid receptor sequences, they were
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submitted to the Genbank database and assigned accession numbers JF951960 (GR1),
JF951961 (GR2) and JF951959 (MR).
6.2.5 Phylogenetic analysis
Amino acid sequences of corticosteroid receptors from European flounder and other
vertebrates were aligned by ClustalW. Due to the GR2 of European flounder being
incomplete at the 5’ end, all sequences selected for phylogenetic analysis were trimmed
at their 5’ ends so as to align with the first available amino acid of European flounder
GR2. Thus phylogenetic analysis was done on receptors spanning a partial section of
A/B domain and the whole DNA- and ligand-binding domains. GRs and MR of
European flounder were compared to corticosteroid receptors of other mammalian
(chicken, mouse and human), amphibian (frog) and fish (Burton’s mouthbrooder,
zebrafish, Japanese medaka) vertebrates.
Phylogenetic analyses, using Mega4 (Tamura et al, 2007), utilised the neighbour-
joining method (Saitou and Nei, 1987) and the reliability of the nodes of the tree tested
using the bootstap test with 5000 replicates (Felsenstein, 1985).
6.2.6 Real-time quantitative PCR analysis
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was
used to examine the tissue distributions of mRNA of the three corticosteroid receptors
isolated from European flounder.
Five European flounder, obtained from the Forth estuary and adapted in an aquarium to
seawater for six months, were killed and samples of eight tissues were collected from
each individual. Tissues were homogenised in Tri-reagent (Roche) and stored at -70°C
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until proceeding to RNA extraction. Tissues were sampled from the brain, gill, testes
(all five individuals were male), heart, small intestine, kidney, liver and white muscle.
RNA extraction was done as described in 6.2.1 and RNA quantity assessed
spectrophotometrically on a NanodropND1000 spectrophotometer. The ratio of
absorbances at 260nm and 280nm and 230nm and 260nm was also used to assess RNA
purity.  In addition 1 µg RNA was heated at 75°C for 5 minutes and run on a 1%
agarose, 1× TAE, 0.5 µg/ml EtBr gel to assess RNA integrity. Both the 28S and 18S
rRNA bands were visible at an approximate intensity ratio of 2:1 (28S:18S), indicating
good RNA quality, and therefore reverse transcription reactions were proceeded with.
Reverse Transcription6.2.6.1
Reverse transcription reactions were done using either the ImPromII™ Reverse
transcription system (Promega) with a blend of oligo(dT) and random primers or the
High Capacity cDNA reverse transcription kit (Applied Biosystems) using random
primers only.
High Capacity cDNA Reverse Transcription kit6.2.6.2
Reverse transcription using the High Capacity cDNA reverse transcription kit was done
in 20 µl reaction volumes. A mastermix containing reverse transcription buffer, dNTPs,
RT random hexameric primers and Multiscribe™ Reverse transcriptase, all supplied
with the kit, was prepared to give enough reagents for all reverse transcription reactions.
Aliquots of this mastermix were then added to 0.2 ml PCR tubes containing 1 µg total
RNA each, such that per reaction 1× Reverse transcription buffer, 4mM dNTP mix, 1×
Random primers and 50 units Multiscribe™ Reverse transcriptase was present.
Reactions were gently mixed and centrifuged briefly before being placed in a thermal
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cycler (BiometraT gradient) and cycled at 25°C for 10 minutes, 37°C for 2 hours and
85°C for 5 minutes. In addition to reverse transcription reactions, a control reaction in
which a sample of RNAs were pooled in a total of 1 µg and incubated with all above
reagents except for the enzyme was included. This control reaction is to serve as a
control in qPCR, testing for the potential interference from genomic DNA
contamination.
Once reverse transcription was completed each reaction was diluted 10-fold, to 200 µl,
with tricine EDTA and stored at -20°C until further use.
ImPromII™ Reverse transcription system6.2.6.3
Reverse transcription with the ImPromII Reverse transcription system was done in 20 µl
reaction volumes. cDNA was prepared using 1µg of total RNA, denatured at 70°C for 5
min and placed on ice. A volume of reverse transcription mastermix was then added to
total RNA to a volume of 20 µl containing 300 ng of random hexamers, 125 ng of
anchored oligo-dT, 0.5 mM dNTPs, 1× ImProm-II™ Reaction Buffer and 1µL of
ImProm-II™ Reverse Transcriptase (Promega). The synthesis reaction was carried out
at 42 °C for 1 hour and then stopped by heating at 75°C for 10 min. Finally, cDNA
reactions were diluted to 200 µL total volume (dilution 1:10) with MilliQ water and
stored at -20°C until required for QPCR.
Design of qPCR primers6.2.6.4
Primers for qPCR were designed, taking into account amplicon length and target
sequence. In general, amplification efficiencies are increased with shorter amplicons
and therefore primers were designed to give products less than 200 base pairs in length.
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From an alignment of corticosteroid receptors from European flounder a greater amino
acid identity was observed between the DNA-binding C-domains and the ligand-
binding E-domains of the glucocorticoid receptors and mineralocorticoid receptor.
Therefore to minimise the likelihood of primers amplifying non-target corticosteroid
receptor sequences, the forward primer of a pair was designed on the A/B domain which
shows little sequence conservation. In addition primers were either designed over exon
boundaries or the forward and reverse primers of a primer pair designed on two separate
exons. Exon boundaries were identified from an alignment of European flounder CRs
with those of other fish species (zebrafish; fugu, Japanese pufferfish and green spotted
pufferfish), whose sequences, showing exon boundaries, are available from the Ensembl
database (http://www.ensembl.org).  Design of primers over exon boundaries, with the
5’ end of a primer on one exon and the 3’ end of the same primer on the adjacent exon,
allows amplification of products from cDNA template reverse transcribed from
messenger RNA but avoids interference from any contaminating genomic DNA.
Messenger RNA is processed to remove introns in a process called RNA splicing,
leaving behind only exons, however genomic DNA contains both introns and exons, the
introns of which are located between different exons. Therefore primers designed over
exon boundaries are complimentary to cDNA reverse transcribed from mRNA but not
to genomic DNA. Where it was not possible to design primers over exon boundaries,
they were designed on two separate exons, with the forward primer on the exon
encoding the A/B domain and the reverse primer on the adjacent exon which encodes
the 3’ end of the A/B domain and part of the DNA-binding domain. This allowed
products amplified from cDNA to be differentiated from those amplified from
contaminating genomic DNA since the latter product would be greater in length due to
the amplification of intron sequences, absent in product from cDNA template.
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Reference genes are usually included in experimental plans for quantitative RT PCR to
provide a loading control, and differences in the efficiency of reverse transcription. A
requirement of the housekeeping gene is that its expression levels remain unchanged
between treatments, i.e. tissue type in the experiments described here. As a
housekeeping gene that is expressed equally amongst all tissues, demonstrated by gel
electrophoresis, 18S ribosomal RNA (18S rRNA) was used (Figure 6-2).
Figure 6-2. The expression of 18s rRNA expressed across tissues used in qPCR. 1 µg of RNA from
each tissue was electrophoresed on an agarose gel as described in 6.2.6
Primers for European flounder 18S rRNA have previously been designed to amplify a
product of 100 base pairs (Williams et al, 2006) and these primer sequences were used
in the present study. All primers used in qPCR are described below in Table 6-7.
Table 6-7. Primers used in RT-qPCR. Primers were designed to amplify a small fragment of GR1,
GR2 and MR from European flounder. A primer pair was also used to amplify a fragment of 18S
rRNA, the expression of which was to be used as a normalising gene.
Primer Name Sequence
Amino acid
sequence/Annealing
position
Expected
product (no.
base pairs)
P.f18S rRNAF GCC TGA ATA CCG CAG CTA GG
100
P.f18S rRNAR TAG CGG CAC AAT ACG AAT GC
P.fGR1
R1qPCR
CAG GCA GAT CTT ATG GGT CTG
A
Q-T-H-K-I-C-L (440-
446)
102
P.fGR1
F1qPCR GCC AAC TTC TGC AGC TCA TCT
A-N-F-C-S-S-S (414-
420)
P.fGR2
F1qPCR
TGT ATC TCC CAG TGA CGA CCA
T
Y-L-P-V-T-T (1-6)
135
P.fGR2
R1qPCR
CGA GGT AGA ACT TGC AAA GCT
G
S-F-A-S-S-T-S (39-
45)
P.fMR
F1qPCR
CCA ACC CTT TGT TGA GCC TAA
T
N-P-L-L-S-L (556-
561)
150
P.fMR
R1qPCR GGA GGA CGG CTG CCT CAG
L-R-Q-P-S-S (600-
605)
L      Te G       B I       H K    WM
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Real time quantitative PCR (RT-qPCR) reactions6.2.6.5
RT-qPCR reactions were done in 20 µl volumes using, per reaction, 2 µl cDNA, reverse
transcribed from total RNA as described in 6.2.6.1, 70 nM forward and reverse primer
each and 1× ABsolute QPCR SYBR green mix (Thermo). Each plate included several
negative control reactions comprising no template controls in which cDNA was
replaced by water, and no reverse transcriptase controls in which the template was a
pool of RNA run through the reverse transcription transcription protocol but omitting
the enzyme as described in 6.2.6.2. The former control was included to detect potential
unspecific products amplified due to primer dimer formation while the latter was used
to detect potential genomic DNA contamination. A cDNA reference pool dilution series
was also included on each plate in order to calculate the efficiency of the PCR reaction.
Dilutions were done so as to give cDNA dilutions of 1 in 3, 1 in 9, 1 in 27, 1 in 81 and 1
in 243 in water. The undiluted cDNA reference pool was aliquoted in small volumes
and stored at -20°C and dilutions freshly prepared on the day of use. All cDNA samples,
controls and pooled-dilutions were present in triplicate on each plate. Plates were sealed
using Clear Seal lids (KBiosciences) and briefly centrifuged to collect reactions in the
bottom of plate wells. Reactions were then cycled in a mastercycler ep realplex
(Eppendorf) at 95°C for 15 minutes in order to activate the polymerase enzyme
followed by 45 cycles of denaturation at 95°C for 15 seconds, primer annealing at 57°C
for 30 seconds and extension at 72°C for 30 seconds to amplify products of 99, 137, 152
and 100 base pairs for GR1, GR2, MR and 18S rRNA, respectively. Fluorescence was
detected during the 72°C extension step during each of the 45 cycles and crossing points
calculated by the software of the qPCR cycler.
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At the end of the cycling programme the temperature was increased from 65°C to 95°C
in 0.25°C increments every 10 seconds in order to produce a dissociation curve, used to
identify the products of any non-specific amplification. The point at which double
stranded DNA products denatured and separated into single strands was visualised by a
rapid decrease in fluorescence. The presence of multiple products can be detected at this
point since products of different lengths and base composition will have different melt
temperatures. In the case of primers for amplification of GR1, GR2, MR or 18S rRNA
only a single product was detected each time, indicating the primers were specific for
the target sequence. In addition six randomly selected samples per primer pair were run
on a 1× TAE, 1% Agarose, 0.5 µg/ml EtBr gel at the end of cycling and amplified
products visualised by exposure of the gel to UV light. Gel electrophoresis of qPCR
product revealed the presence of only one DNA band around 100-200 base pairs
depending on primers used.
Calculation of Relative Expression Ratios6.2.6.6
Relative expression ratios (R) of each corticosteroid receptor was calculated using the
method of (Pfaffl, 2001) whereby the relative expression of a target gene is calculated
based on the amplification efficiency (E) and the crossing point (CP) deviation of an
unknown sample versus a control and expressed in comparison to a reference gene. The
equation used to derive R was as follows:
R = (Etarget)∆CPtarget(control – sample) / (Eref) )∆CPref(control – sample)
The relative expression of each corticosteroid receptor target was calculated for each
tissue from each of the five fish using, as the control, the reference cDNA diluted 1 in 9.
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For each receptor, expression was compared across tissues using one way ANOVA,
followed by post-hoc comparisons using Tukey’s test.
6.3 Results
6.3.1 Isolation of Corticosteroid receptors from P.flesus
Using both reverse transcription polymerase chain reaction (RT-PCR) and rapid
amplification of cDNA ends (RACE) PCR the full open-reading frame of GR1 and MR
was isolated from the European flounder (Platichthys flesus). A partial sequence for the
GR2 was isolated, extending from the 3’ end of the N-terminal A/B domain through to
the stop-codon of the ORF and into the 3’ untranslated region. Each of these sequences
showed high sequence similarity to the corresponding receptors from other fish species.
PCR and RACE reaction products6.3.1.1
Both GR1 and MR were isolated using two primer pairs each, which generated two
overlapping partial cDNA fragments per receptor. A single cDNA fragment was
isolated using a single primer pair specific to the GR2. The 5’ and 3’ extremities of the
open-reading frames of GR1 and MR were isolated using 5’ and 3’ RACE PCR,
respectively. While 5’ RACE of GR2 produced an incomplete fragment which did not
extend all the way to the start codon, 3’ RACE allowed the full 3’ extremity of this
receptor to be isolated. Assembly of the various fragments, together with longer PCRs
to confirm fragment assembly and sequencing, resulted in the full ORF of GR1 and
MR, and a partial ORF for GR2. The strategy used to isolate cDNAs for each receptor is
shown in Figure 6-3.
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Figure 6-3. The annealing positions of primers used to amplify the GR1 (A), GR2 (B) and MR (C)
from European flounder (Platichthys flesus). Sense and anti-sence DNA strands are represented by
black lines while red lines represent the 3’ and 5’ untranslated regions. Primers are represented by
arrows with arrow heads indicating the direction in which amplification proceeded, with numbers
under primer names indicating the amino acid positions to which the primer is expected to anneal,
with positions complementary to those detailed in GenBank database for GR1, MR and GR2.
Glucocorticoid Receptor 16.3.1.2
For GR1, an open reading frame of 807 amino acids was obtained. This amino acid
sequence, when subjected to a blast search revealed a high sequence identity to the GR1
of other fish species. An 89% sequence identity was found with the glucocorticoid
receptor 1 of Japanese flounder (Paralichthys olivaceus; Accession no. BAA25997),
while an identity of 80% was found with the glucocorticoid receptor of European sea
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bass (Dicentrarchus labrax; Accession no. AAS48459) and 76% with glucocorticoid
receptors from both the Burton’s mouthbrooder (Haplochromis burtoni; Accession no.
AAM27889) and European perch (Perca fluviatilis; Accession no. ACF75335).
Glucocorticoid Receptor 26.3.1.3
The GR2 sequence was obtained by assembling three fragments generated by a single
PCR reaction and 3’ and 5’ RACE. The product of 5’ RACE failed to extend to the
initiation codon of the receptor but did extend past the sequence obtained with PCR to
allow further deduction of the GR2 sequence.
The assembled contig gave a fragment, uninterrupted by stop codons, 423 amino acids
in length and corresponding to a partial A/B domain, the full DNA-binding domain and
the full ligand-binding domain up to the stop codon at the 3’ end of the receptor. A
protein blast search of this sequence revealed it to have a high amino acid identity to the
glucocorticoid receptor 2 of the Japanese medaka (Oryzias latipes; Accession no.
NP_001156605), Gilthead sea bream (Sparus aurata; Accession no. ABF30967) and
Burton’s mouthbrooder (Haplochromis burtoni; Accession no. AAM27887), with
amino acid identities of 87% each.
Mineralocorticoid Receptor6.3.1.4
Assembly of the individually sequenced partial DNA fragments for the MR of European
flounder resulted in the complete open-reading frame being deduced. The MR sequence
was 989 amino acids long and showed high amino acid identity with the
mineralocorticoid receptor of other fish species (90%, 86%, 70% and 69% with the MR
of Burton’s mouthbrooder (Haplochromis burtoni; Accession no. AAM27890) Japanese
medaka (Oryzias latipes; Accession no. NP_001156601) zebrafish (Danio rerio;
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Accession no. ABS00395) and common carp (Cyprinus carpio; Accession no.
CAH03995), respectively).
Structure and Sequence similarity between the corticosteroid receptors of6.3.1.5
European flounder
A highly conserved domain structure, comprised of an N-terminal A/B domain, a
central DNA-binding C domain, a hinge region (D-domain) and a C-terminal ligand-
binding domain E domain, has been described for nuclear hormone receptors, including
the receptors for corticosteroid hormones. Each of the corticosteroid receptors isolated
from European flounder shared this domain architecture with domain regions being
defined according to Greenwood et al (2003) and Bury et al (2003), who has previously
reported the domain architecture for the GR1, GR2 and MR of the cichlid species
Haplochromis burtoni and the GR2 of rainbow trout (Onchorynchus mykiss),
respectively. Sequence identity between each domain of the three receptors was
compared (Figure 6-5) using the needle algorithm (European Bioinformatics Institute;
http://www.ebi.ac.uk), revealing the A/B domains of GR1 and MR to have the least
conservation with an amino acid identity of 14.6%. Since the A/B domain of the GR2
receptor was incomplete the A/B domain of this receptor was excluded from
comparisons. The highest amino acid identity was seen within the DNA-binding
domains, with identities between the receptors of greater than 90%. Within GR1 an
additional 27 nucleotides (9 amino acids) were present between the two zinc fingers of
the DNA-binding domain which were absent in the glucocorticoid 2 and
mineralocorticoid receptors (highlighted in Figure 6-4).
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Within the ligand-binding E-domains the two glucocorticoid receptors, GR1 and GR2,
showed high amino acid identity (89.3%), however less conservation was seen between
the E-domain of the mineralocorticoid receptor and those of the GR1 and GR2, with
identities of 57.1% and 56.7%, respectively.
Figure 6-4. Alignment of deduced amino acid sequences of glucocorticoid 1, glucocorticoid 2 and
mineralocorticoid receptors isolated from European flounder (Platichthys flesus). DNA-binding and
ligand-binding domains are shown. Due to the low sequence conservation within the A/B domain,
this domain is omitted. The 9 amino acid insert found between the two zinc fingers of the the DNA-
binding domain of GR1 is shown boxed in red.
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Figure 6-5. Percent amino acid identity between European flounder corticosteroid receptors as a
function of receptor domains. Receptor domains, defined following Ducouret et al. (1995), were
compared between receptors using the needle algorithm as implemented on the website of the
European Bioinformatics Institute (http://www.ebi.ac.uk/). The full sequence of the A/B domain of
GR2 was not available, precluding comparisons.
6.3.2 Phylogenetic Analysis
To infer evolutionary relationships of GR1, GR2 and MR from European flounder to
those of other vertebrate species a bootstrap-consensus phylogenetic tree was
constructed using the neighbour-joining method and 5000 bootstrap replicates (Figure
6-6).
Within several fish species two glucocorticoid receptors have been identified. When
analysed phylogenetically it was found that these receptors formed two distinct clusters,
with one glucocorticoid receptor per species in each cluster. The glucocorticoid
receptors of European flounder were grouped with those of other fish species with high
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bootstrap support. Additionally the fish mineralocorticoid receptors grouped separately
from the glucocorticoid receptors from the same species and also grouped in a separate
cluster from tetrapod mineralocorticoid receptors (Figure 6-6).
6.3.1 Tissue distribution of Flounder corticosteroids
All three corticosteroid receptors showed a wide distribution throughout the tissues of
European flounder (Figure 6-7). There was a tendency for all three receptors to be
expressed at higher levels within the testes although the mRNA expression levels of
GR1 and GR2 within this tissue were not significantly different to any other tissue. The
high variability in GR2 in the testes of European flounder was due to one single fish
having very large relative levels of GR2 in this tissue compared to other individuals.
The reason for this is unknown and no difference in the stage of maturity in this
individual compared to the others was observed during tissue sampling. In contrast the
mRNA expression of MR within the testes was significantly higher to that in the liver,
kidney and white muscle in which low mRNA levels of this receptor was expressed.
Similarly an increased expression of MR was also observed in the gills and brain, with
the expression levels significantly higher than in the liver, kidney and white muscle.
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Figure 6-6. Phylogenetic tree.. A comparison between the glucocorticoid and mineralocorticoid
receptors of vertebrates. The tree was generated using MEGA version 4 software using the
neighbour-joining method. Bootstrapping, using 5000 replicates, assessed the reliability of the tree
with figures representing the bootstrap value in percentage. Receptor sequences used were
mouseMR (NP_001077375), HumanMR (NP_000892), ChickenMR (ACO37437), FrogMR
(NP_001084074), ZebrafishMR (NP_001093873), Rainbow troutMR (NP_001117955), MedakaMR
(NP_001156601), SticklebackMR (ENSGACP00000022714), PufferfishMR
(ENSTRUP00000037995), MouthbrooderMR (AAM27890) and European flounderMR (not
submitted to database). GR sequences used were Mouthbrooder GR1 (AAM27887), Pufferfish GR2
(ENSTRUP00018413), Stickleback GR2 (ENSGACP00000024074), European flounder GR2 (not
submitted to database), MedakaGR2 (NP_001156605), Rainbow trout GR2 (NP_001117954),
Zebrafish GR (NP_001018547), Rainbow trout GR1 (NP_001118202), Mouthbrooder GR2
(AAM27889), Medaka GR1 (ENSORLP00000001939), Pufferfish GR1 (ENSTRUP00015645),
Stickleback GR1 (ENSGACP00000027400), European flounder GR1 (not submitted to database),
Frog GR (NP_001081531), Chicken GR (NP_001032915), Mouse GR (NP_032199), Human GR
(CAJ65924).
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Figure 6-7. mRNA expression of GR1, GR2 and MR in body tissues of male European flounder
(Platichthys flesus). Quantitative real-time PCR was performed on tissues from sea water adapted
flounder. LI, liver; TE, testes; GI, gills; BR, brain; IN, intestine; HE, heart; KI, kidney; WM, white
muscle. Expression of corticosteroid receptors was normalised to 18S RNA levels and is expressed
as relative to a reference sample. Data are the average and SEM of results from five fish.
Expression levels of GR1 and GR2 did not vary significantly between tissues. For MR expression
levels are significantly different (P<0.05) when columns are not labelled by the same letter.
6.4 Discussion
Corticosteroid receptors have previously been isolated from several fish species
including rainbow trout (Onchorynchus mykiss) (Ducouret et al, 1995; Bury et al,
2003), Burton’s mouthbrooder (Haplochromis burtoni) (Greenwood et al, 2003),
zebrafish (Danio rerio) (Schaaf et al, 2008; Pippal et al, 2011) and the common carp
(Stolte et al, 2008; Stolte et al, 2008). With the exception of zebrafish in which only one
glucocorticoid receptor and one mineralocorticoid receptor has been isolated (Alsop and
Vijayan, 2008), each of these species contains three functional corticosteroid receptors,
comprising a single mineralocorticoid receptor and two glucocorticoid receptors. The
isolation of three corticosteroid receptors from the European flounder (Platichthys
flesus) is described here for the first time. Sequence analysis reveals two of these
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receptors to be glucocorticoid receptors while the third receptor was most similar to a
mineralocorticoid receptor.
6.4.1 Corticosteroid receptor structure
The domain structure of corticosteroid receptors from humans, rodents and fish species
has been described previously (Hollenberg et al, 1985; Danielsen et al, 1987; Carlstedt-
Duke et al, 1987; Rogerson et al, 2003; Rogerson et al, 2004; Pippal et al, 2011).
Within the present study the complete open-reading frames of GR1 and MR, and a
partial sequence for GR2 (missing the first 2/3rds of the N-terminus), from European
flounder have been isolated and analysis of their sequences reveals them to share the
common modular structure previously described. The GR1, GR2 and MR of European
flounder each have an N-terminal A/B domain (partially isolated in the case of GR2), a
DNA-binding C-domain and a C-terminal ligand-binding domain.
A/B domain6.4.1.1
Previously, and in contrast to the DNA-binding and ligand-binding domains, the A/B
domains of corticosteroid receptors from several fish species have been shown to be low
in sequence conservation (≤ 25%) (Greenwood et al, 2003; Sturm et al, 2010). This
limited sequence homology however has been shown not to impact on the functionality
of the A/B domains since those of rainbow trout GR1 and GR2 can be swapped with
little effect on receptor transactivation (Becker et al, 2008; Sturm et al, 2011),
suggesting a functional equivalency.
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DNA-binding domain6.4.1.2
The DNA-binding C domain of corticosteroid receptors consists of two zinc fingers, the
molecular shape of which are determined by the co-ordinate binding of four cysteine
residues to a divalent zinc ion (Freedman et al, 1988; Luisi et al, 1991; Low et al,
2002). Similar to the DNA-binding domains of other fish species, such as rainbow trout
and Haplochromis burtoni in which amino acid identities greater than 90% have been
described (Greenwood et al, 2003; Bury et al, 2003), the C-domain of European
flounder GR1, GR2 and MR was also found to be highly conserved. The highly
conserved sequence and resulting tertiary structure is likely to be optimal for specific
DNA-binding to the hormone response element (HRE) within the promoter region of
target genes, a prerequisite for the regulation of gene expression by steroid hormone
receptors.
Despite a large degree of sequence conservation in the C-domain, the number of amino
acid residues in the interfinger region (the region between zinc finger 1 and 2) has been
found to differ between species.  An extra one amino acid was found within the GR of a
primate species (Brandon et al, 1991), while an additional 4 amino acids have been
found in the interfinger region of human and rat MR (Bloem et al, 1995). Within several
teleost species, in which duplicate GRs have been found, the DNA-binding domains of
GR1 have been found  to contain a nine amino acid insert between the two zinc fingers,
which is absent in GR2. These additional nine amino acids appear to be highly
conserved in the GR1 of fish species, having been described in rainbow trout (Ducouret
et al, 1995; Takeo et al, 1996), Japanese flounder (Tokuda et al, 1999), Burtons
mouthbrooder (Greenwood et al, 2003), brown trout (AY863149), European sea bass
(AY549305) and fugu (Takifugu rubripes). Through amplification and sequencing of
rainbow trout glucocorticoid receptor genomic DNA it has been found that the presence
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of this insert is due to an additional exon, 27 nucleotides (9 amino acids) in length,
located within the intron between exons three and four which code for the two zinc
fingers (Tujague et al, 1998; Lethimonier et al, 2002). The impact of these additional
amino acids on DNA-binding and receptor dimerization, two functions associated with
the zinc finger region, of GR1 has been previously suggested. Modelling of the rat GR
with that of the common carp (Cyprinus carpio), the latter of which contains the 9
amino acid insert, reveals the nine amino acids results in an extention of the loop after
the interfinger α-helix, leading to a loop which protrudes outside of the protein and
which was shown not to interfere with receptor DNA-binding and receptor
transactivation (Stolte et al, 2008). A similar model was predicted using the GR1 of
rainbow trout (Lethimonier et al, 2002; Wickert and Selbig, 2002). Although DNA-
binding and receptor transactivation appears not to be affected by the additional exon
between the two zinc fingers, a suggestion that the association of the GR1 with
coactivator corepressor proteins and may be affected has been suggested (Stolte et al,
2008).
Ligand-binding domain6.4.1.3
The ligand-binding domain, as the name suggests, is responsible for binding of ligand
molecules which results, in the case of the holo (agonist bound) receptor, in a
conformational change in the ligand-binding domain structure, leading to the activation
of the receptor and to an alteration in the transcription of target genes. A role for the
LBD in receptor dimerization has also been shown. Similar to the DNA-binding
domain, and in agreement with the situation in other fish species (Greenwood et al,
2003; Bury et al, 2003), the ligand-binding domain of European flounder GR1, GR2
and MR showed a large degree of amino acid sequence conservation.
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Despite the high sequence similarity, mineralocorticoid receptors and glucocorticoid
receptors of European flounder show a difference in their response to the
mineralocorticoid hormone aldosterone; while the mineralocorticoid receptor is
activated by both glucocorticoids and mineralocorticoids, the glucocorticoid receptor is
inactive in the presence of aldosterone, suggesting a difference in the ligand-binding
region of the corticosteroid receptors which confers ligand-specificity. Previously
several amino acids within the ligand binding domains of the GR and MR have been
suggested to be important in steroid selectivity (Baker et al, 2007). An example of such
an amino acid is the highly conserved serine residue within the mineralocorticoid
receptor, corresponding to the serine residue at amino acid position 949 in human MR
and found within the loop between α-helix 11 and α-helix 12, responsible for
positioning the AF-2 domain for binding of coactivator and corepressor proteins. This
amino acid has been found to be lacking in almost all glucocorticoid receptors, with the
exception of the skate (Raja erinacea) GR (Baker et al, 2007). An alignment of the
corticosteroid receptors of European flounder with the human mineralocorticoid
receptor reveals the serine residue to be conserved in the mineralocorticoid receptors
but lacking in the glucocorticoid receptors (Figure 6-8). Thus we would expect both
GR1 and GR2 of European flounder to be transcriptionally inactive in the presence of
aldosterone. The skate GR is transcriptionally active in the presence of both aldosterone
and cortisol, in which the serine residue is present, suggesting this residue is important
for aldosterone specificity since glucocorticoid receptors lacking this serine residue, or
those in which the serine residue is deleted, are unresponsive to aldosterone (Bridgham
et al, 2006). Additionally, mutants within the loop region can decrease or eliminate
transcriptional activity of the mineralocorticoid receptor, even when the receptor retains
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high affinity for the steroid, indicating this region to be important in defining
transcriptional activity (Hellal-Levy et al, 2000; Hultman et al, 2005).
Figure 6-8. Alignment of the ligand-binding domain of human MR with European flounder
corticosteroid receptors. ClustalW was used to align the sequences. The AF-2 domain is underlined
while the position of the conserved serine residue in the mineralocorticoid receptor, which is absent
in the glucocorticoid receptors, is indicated by an arrow.
Further regions in the ligand-binding domain of the MR have been implicated in the
specificity of this receptor for aldosterone. Using chimeric structures of MR and GR
ligand-binding domains from human receptors in a cell-based reporter assay system,
amino acids 804-874 of the human MR were identified as being crucial for aldosterone
binding specificity (Rogerson et al, 1999). This region was further narrowed down to
amino acids 820-844, where twelve of the sixteen amino acids that differ between the
GR and MR were critical in conferring responsiveness to aldosterone (Rogerson et al,
2007). Of these 25 amino acids described by Rogerson et al (2007), 19 are conserved
between the human MR and European flounder MR, of which eight are also conserved
in GRs and eight differ between MRs and GRs (Figure 6-9). These residues lie on the
surface of the MR molecule and thus are not part of the ligand-binding domain pocket
and quite how they are able to influence the specificity of steroid binding in such a way
is unknown. Nevertheless it has been found that in other receptors, such as the androgen
and the glucocorticoid receptor, the region corresponding to amino acids 820-844 of the
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MR, is critical for binding of natural and synthetic ligands, providing further evidence
that this region may influence ligand specificity in the GR and MR (Vivat et al, 1997;
Robin-Jagerschmidt et al, 2000).
Human MR    820  KHTNSQFLYFAPDLVFNEEKMHQSA 844
P.flesus MR      KHTNGQMLYFAPDLIFNEDRMQQSA
P.flesus GR1     EQCNGNMLCFAPDLVINQERMKLPF
P.flesus GR2     QQCNGNMLCFAPDLVINEERMKLPY
* *  *  *      *      ***
Figure 6-9. A comparison of the sequence of amino acids 820-844 of the human MR which has been
implicated in aldosterone hormone selectivity. Amino acids which are identical within the MR and
GRs are shown in bold while those that are conserved in the MR but differ in GRs are indicated by
an asterisk.
In addition to residues which confer ligand-selectivity, residues of the ligand-binding
domain which make contact with the ligand molecule have been described using
structural analysis of the glucocorticoid and mineralocorticoid receptors (Figure 6-9).
Maximal activation of the MR by aldosterone has been shown to involve an intricate
network of hydrogen-bonds mediated by ligand-binding (Bledsoe et al, 2005). Helix 3
of the ligand-binding domain in the human receptor contains several residues, including
aspargine at position 770 (Asn770) and a serine residue at position 767 (Ser767), which
have been shown to form hydrogen bonds with aldosterone or with other residues of the
MR, thus stabilising and activating the receptor (Bledsoe et al, 2005; Hellal-Levy et al,
2000). In addition to residues in helix 3 of the MR, both aldosterone and
deoxycorticosterone (DOC) have been found to be contacted by helix 10 of the MR via
hydrophobic interactions with the threonine residue at position 945 (Thr945) (Bledsoe
et al, 2005). It has been hypothesised that ligands which promote a hydrogen bonding
network and interact with helix 10 of the MR via Thr945 induce stabilisation of helix 3
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and movement of the AF-2, allowing cofactor recruitment and ultimately activation of
target gene transcription. Since all of the residues described above are conserved in
European flounder MR, it is possible that the same mechanism of receptor activation
occurs for both mammalian and teleost species.
Figure 6-10. The contact points of aldosterone with the ligand-binding domain of MR and the
intramolecular associations. Residues Asn770 and Ser767 of helix 3 (purple) form H-bonds (yellow
dashed lines) with the Glu955 within the loop preceding the AF-2 (red). Asn770 also forms H-bonds
with C18-OH and C21-OH. Thr945 on helix 10 (orange) hydrogen bonds to C20 carbonyl and
C21hydroxyl of aldosterone (yellow). Image taken from Bledsoe et al (2005).
Similar to the MR, a network of hydrophilic and hydrophobic interactions between
ligand molecules and the GRs have been described. Twenty four amino acids within the
ligand-binding domain of the human GR have been described by to interact with
dexamethasone (Bledsoe et al, 2002), likely explaining the high affinity binding of
dexamethasone by the GR. Of these residues only four, corresponding to methionine,
alanine, tyrosine and isoleucine at positions 601, 605, 747 and 735 of the hGR,
respectively, differ in GR1 and GR2 of European flounder. A substitution of residues
from phenylalanine to tyrosine (as in Tyr747 to Phe of GR2) has previously been shown
to have no effect on the rat GR and its affinity for dexamethasone (Ray et al, 1999).
Additionally, each of the substitutions described above for the European flounder GRs
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have been previously described for rainbow trout GRs (Bury et al, 2003) and a
comparison of the substitution positions and residues reveals them to be identical,
suggesting these residues which differ between human and European flounder GRs are
conserved across teleost species.
Several residues in the ligand-binding domain have been demonstrated, through
mutation analysis, to be critical in GR functioning. Glutamine at position 642 of the
human GR (Gln642) has been proposed to interact with the 17α-OH group of steroids
such as cortisol, 9α-fluorocortisol, prednisolone and dexamethasone. This suggestion
was made following the discovery that the affinity of the GR for these steroids
decreased after mutation of Gln642 to alanine, a decrease not observed with steroid
molecules lacking the 17α-OH group (Lind et al, 2000). The elucidation of the crystal
structure of human GR bound to dexamethasone strengthened this suggestion when
Gln642 was indeed found to bind to the 17α-OH group of the dexamethasone molecule
(Bledsoe et al, 2002).
A second residue shown to have an important function in GR ligand binding and
transactivation is the asparagine at position 564 (Asn564) of the human GR (Bledsoe et
al, 2002; Hammer et al, 2003), which forms two hydrogen bonds with the C11-OH
group and the C21-OH group of dexamethasone ligand. Mutation of this residue results
in a loss of binding affinity for dexamethasone as well as a pronounced loss of
transactivation function, suggesting this Asn564 to be important not only for steroid
binding but also for transactivation. The destruction of GR function by mutations in this
residue has been suggested to be due the influence of the residue on interactions of the
GR with coactivator proteins since helix 3, to which Asn564 belongs, together with
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helices 4, 5 and 12, have been shown to form a hydrophobic groove important for
coactivator binding in the related estrogen receptor (Brzozowski et al, 1997).
A high degree of amino acid conservation is seen in the ligand-binding domains of
human and European flounder corticosteroid receptors. Residues which have previously
been identified to have a function in ligand-binding and receptor transactivation are
especially conserved, suggesting a common mechanism in which these receptors
interact with their ligands, ultimately leading to receptor transactivation.
6.4.2 Multiple Corticosteroid Receptors within European
flounder
Steroid hormone receptors within jawed vertebrates evolved, through several
duplication and divergence events, from a single ancient steroid receptor most closely
related to that of the estrogen receptor (ER) (Eick and Thornton, 2011). The estrogen
receptor is thought to have undergone an initial duplication and divergence event to give
rise to the progesterone receptor (PR) which was itself duplicated, and underwent
divergence, to give rise to the corticosteroid receptors (CRs). Following the divergence
of the jawed (gnathostomes) and jawless vertebrates, the ER, PR and CR were
duplicated in a whole-genome duplication event within the gnathostome lineage and
diverged, giving rise to the six steroid receptors currently found in jawed vertebrates
(ERα, ERβ, GR, MR, PR and AR) (Thornton, 2001).
Here, the isolation of a single mineralocorticoid receptor and two glucocorticoid
receptors from European flounder is described. Within fishes the presence of two
separate genes encoding glucocorticoid receptors appears to be unique to, and
widespread amongst, actinopyterygii species, having been isolated from rainbow trout
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(Bury et al, 2003), Burton’s mouthbrooder (Greenwood et al, 2003), green spotted
puffer fugu (Stolte et al, 2006), common carp (Stolte et al, 2008) and sea bass (Terova
et al, 2005; Vizzini et al, 2007). The presence of these two GRs, which are encoded by
separate genes, have been hypothesised to have arisen by a second whole-genome
duplication event, following the divergence of the teleostomi into the actinopterygii and
sarcopterygii lineages, the former of which European flounder belong (Jaillon et al,
2004). Therefore, due to the duplication of the actinopterygii genome, the presence of
two glucocorticoid receptors within European flounder is not surprising. Along with
corticosteroid receptors, other steroid hormone receptors have been identified to occur
in multiple forms in fish species; two androgen receptors have been discovered in the
cichlid fish species Haplochromis burtoni (Vagell et al, 2001; Harbott et al, 2007) while
three estrogen receptors have been identified in the Atlantic croaker (Micropogonias
undulatus) (Hawkins et al, 2000; Hawkins and Thomas, 2004).
Phylogenetic analysis of GR1 and GR2 from European flounder, together with those of
other fish species and several tetrapod species, showed that the glucocorticoid receptors
of flounder cluster with those of other teleost species and separately from those of other
vertebrates. Additionally two separate sub-clusters formed from fish glucocorticoid
receptors, with each sub-cluster containing one glucocorticoid isoform from each
species. A 989 amino acid sequence was isolated from European flounder, with high
amino acid identity with mineralocorticoid receptors of other vertebrate species. The
isolation of mineralocorticoid receptors from fish species has been surprising since fish
are thought to lack aldosterone, the typical mineralocorticoid hormone present within
other vertebrate species (McCormick et al, 2008). Since the discovery of a
mineralocorticoid receptor it has been found that cortisol, typically considered to be a
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glucocorticoid receptor agonist, can act as an activator for both the glucocorticoid and
mineralocorticoid receptors in fish species (Greenwood et al, 2003; Stolte et al, 2008).
Expression of corticosteroid receptors in European flounder6.4.2.1
The tissue expression profiles of the two glucocorticoid receptors and the
mineralocorticoid receptor was determined in nine tissues from European flounder. The
expression of GR1 and GR2 was found to be widely expressed in European flounder,
although there was a tendency for GR1 to be more highly expressed in the gills and the
gonads while GR2 had a tendency for an increased expression in the gonads, although
these higher expressions were not significant. Mineralocorticoid receptor expression
was highest in the brain of European flounder, with an elevated expression also being
observed in the testes and the gills. Studies in rainbow trout and carp have previously
described tissue expression patterns similar to those observed for European flounder;
the two GRs from rainbow trout and carp were expressed ubiquitously across a wide
range of tissues while the MR of rainbow trout was found to be expressed at
significantly higher levels in the brain than in other tissues examined (Bury et al, 2003;
Sturm et al, 2005; Stolte et al, 2008). The lean towards a more pronounced expression
of MR in the brain may reflect a neuroendocrine function for this receptor while a more
pronounced expression of all three corticosteroid receptors in the testes of European
flounder may demonstrate a function in male reproduction. Indeed Milla et al (2008)
has previously demonstrated that MR expression in the testicular tissue and the vas
deferens increases in mature testis during the initiation of sperm production in rainbow
trout and may be involved in male reproduction by altering the ionic concentration of
seminal fluid during the release of sperm. The gills of European flounder displayed a
tendency for higher expression of GR1 compared to other tissues examined, which may
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indicate a role for the corticosteroids and their receptors in osmoregulation, which has
been demonstrated previously in other fish species (Dang et al, 2000; Laiz-Carrion et al,
2002; Dean et al, 2003; Laiz-Carrion et al, 2003; Takahashi et al, 2006).
6.5 Conclusions
Several fish species from which corticosteroid receptors have been isolated have been
shown to differ from other vertebrates in terms of the number of functional
corticosteroid receptors they contain. While a single glucocorticoid receptor and a
mineralocorticoid receptor has been identified in humans and other mammals, fish
species of the actinopterygii lineage have two glucocorticoid receptors and a single
mineralocorticoid receptor. The two glucocorticoid receptors have been shown to be
products of separate genes as opposed to products of alternative splicing of the same
gene. In the present study three sequences from the European flounder which show high
sequence identity with the two glucocorticoid receptors and mineralocorticoid receptor
of other teleost species has been isolated. This is the first report of three corticosteroid
receptors from European flounder. Phylogenetic analysis of deduced European flounder
corticosteroid receptor sequences with the same receptors of other fish and tetrapod
species reveals the European flounder receptors were more similar to those of other
teleost species than to mammalian, avian or amphibian species, which is to be expected.
Expression of the three corticosteroid receptors found a tendency for the receptors to be
expressed more highly in the gills and the testes compared to other fish species.
Additionally the mineralocorticoid receptor was highly expressed in the brain, as
described previously for other fish species. The expression patterns of corticosteroid
receptors in European flounder agree with previous fish species and indicate common
functions to those described for other species, namely osmoregulation, reproduction and
neuroendocrine functions.
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The functionality of the corticosteroid receptors of European flounder is, as yet,
uncharacterised and therefore it cannot be said with certainty that the three receptors
described here are functional. However an analysis of the ligand-binding domain of the
glucocorticoid and mineralocorticoid receptors of European flounder and the
orthologous human corticosteroid receptors reveal that the residues which contact the
ligands and those with a function in positioning of the ligand-dependent activation
function within the LBD for receptor activation are highly conserved. Thus the
European flounder receptors are expected to bind to ligands. Having isolated the full
ligand-binding domains from each of the receptors, the next step will be to characterise
their response to model activators and repressors of corticosteroid receptors in the Gal4-
NHR assay described in Chapter 3. Additionally since these receptors are speculated to
have a large variety of functions within fish species, the response of these receptors to a
persistent environmental contaminant will shed some light on the potential for
endocrine disruption in European flounder via the glucocorticoid and mineralocorticoid
receptors.
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Chapter 7. Corticosteroid Receptors & their interactions
with environmental pollutants
7.1 Introduction
Several lines of evidence exist to suggest that environmental pollutants may impair the
estrogen- and androgen-signalling pathways in fish species. For example, atrazine, a
widely used herbicide has been shown to suppress levels of plasma androgens in male
goldfish (Carassius auratus) while elevating levels of 17β-estradiol (Spanò et al, 2004),
likely due to its aromatase-inducing effects (Sanderson et al, 2001). Moreover, several
environmental pollutants such as perfluoro alkyl acids which are widely used industrial
and commercial chemicals, have been shown to directly interact with the estrogen
receptor to disrupt signalling (Benninghoff et al, 2011). However while a relatively
large number of studies have assessed endocrine disruption via the estrogen and
androgen receptors, relatively little is known about endocrine disruption of other
endocrine axes, such as the corticosteroid receptors.
In Chapter 6 the isolation of two glucocorticoid receptors and a mineralocorticoid
receptor from European flounder (Platichthys flesus) was described. These receptors
mediate the effects of the corticosteroid hormones, produced by the adrenal cortex of
mammals (Nanki et al, 1967) and the homologous interrenal cells of the kidney in
teleosts (Bern, 1967). Tetrapods possess two types of corticosteroids, glucocorticoids
and mineralocorticoids. In mammals, the main glucocorticoid is cortisol (corticosterone
in rodents), which interacts with both glucocorticoid and mineralocorticoid receptors,
while the main mineralocorticoid is aldosterone, which specifically interacts with MR
with no agonistic effects on the GR at physiological concentrations. In contrast, in
teleosts the main corticosteroid is cortisol. Whether or not aldosterone is present in
teleosts has long been a debated subject, with the current consensus being that fish lack
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the aldosterone hormone and the enzyme required for its synthesis (Jiang et al, 1998;
Nelson, 2003). Despite the absence of aldosterone, a homologue of the
mineralocorticoid receptor has been isolated from several teleost species (Colombe et
al, 2000; Greenwood et al, 2003; Stolte et al, 2008; Pippal et al, 2011). In both
mammals and teleost species the glucocorticoid receptor is selectively activated by
cortisol, while the mineralocorticoid receptor is less selective, showing transactivation
in the presence of different gluco- and mineralocorticoids (Sturm et al, 2005).
Apart from their lack of aldosterone, teleosts further differ from mammals in terms of
the number of glucocorticoid receptors they possess. While mammals have only a single
glucocorticoid receptor, two glucocorticoid receptors encoded by distinct genes have
been identified in several teleost species, for example in rainbow trout (Bury et al,
2003), Burton’s mouthbrooder (Greenwood et al, 2003), Green puffer, Japanese
pufferfish and common carp (Stolte et al, 2006; Stolte et al, 2008).
Fish corticosteroid receptors are involved in a wide range of physiological functions and
thus the disruption of corticosteroid signalling might be expected to have a negative
impact on the fitness of individuals, with the potential to disrupt their normal
physiology. Evidence to-date indicates a disruption of corticosteroid signalling in fish
by pollutant compounds, resulting in an inhibited stress response (Cericato et al, 2008;
Hontela et al, 1992). A lack of cortisol elevation has been found to correlate with the
impaired response of interrenal tissue to ACTH (Brodeur et al, 1997). This in turn may
be a result of impaired interrenal steroidogenesis, since a diminished cortisol response
to ACTH has been found in salicylate-exposed trout, congruent with a decrease in the
expression of key proteins involved in corticosteroidogenesis (Gravel and Vijayan,
2006). Furthermore corticosteroid receptors are implicated in osmoregulatory functions
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in fish species and therefore it might be expected that fish inhabiting polluted
environments and which come into contact with pollutants with an inhibitory effect on
corticosteroid receptors, will display a limited capacity to acclimate to different osmotic
conditions. This will likely affect euryhaline species, such as salmonids and European
flounder, which move between osmotic gradients in order to reproduce.
Several compounds have been suggested to bind directly to corticosteroid receptors.
Methylsulfonyl PCBs were shown to antagonise both human and mouse GR by direct
interactions with the receptor, to which it has been shown to have an affinity (Johansson
et al, 1998). Additionally these compounds have been shown to affect dexamethasone-
induced tyrosine aminotransferase activity in a rat hepatoma cell line (Johansson et al,
2005). Gumy et al (2008) demonstrated the ability of an organotin compound to bind
directly to the human glucocorticoid receptor and antagonise its transcriptional activity
while human pharmaceuticals have been implicated in corticosteroid-mediated
endocrine disruption in fish, with ten of the most prescribed corticosteroids in the UK
each able to transactivate the glucocorticoid receptors of trout (Kugathas and Sumpter,
2011).
All the aforementioned studies demonstrate the potential for environmental pollutants to
disrupt corticosteroid receptor signalling in human and other vertebrate species. In the
present study a reporter gene assay based on recombinant fusion proteins combining the
ligand-binding domain of flounder corticosteroid receptors with the DNA binding
domain of the yeast transcription factor Gal4 has been developed to allow screening of
aquatic pollutants for their potential to interact with the ligand-binding domain of
corticosteroid receptors from European flounder. The reporter gene assay was first
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validated by elucidating its response to classical corticosteroid receptors agonists and
antagonists, before selected chemical pollutant were tested.
7.2 Materials and Methods
7.2.1 Constructs expressing the corticosteroid ligand-binding
domains
During the cloning of corticosteroid receptors from European flounder (Platichthys
flesus), cDNAs comprising the putative full-coding sequences of MR and GR1 were
obtained, while a partial cDNA sequence was isolated for GR2. To study the
transcriptional activation of these receptors by cognate hormones, and the potential of
chemicals to interfere with this receptor function, chimeric constructs were made
combining the DNA-binding domain of the yeast transcription factor GAL4 with the
ligand-binding domain of the individual flounder corticosteroid receptors. To this end,
the commercial plasmid pBIND was used, which contains a sequence encoding GAL4
upstream of a multiple cloning site. Using primers containing suitable restriction sites,
cDNAs of receptor ligand-binding domains were generated by PCR and inserted into
pBIND using suitable enzymes.
Polymerase chain reaction7.2.1.1
The polymerase chain reaction was employed to amplify the ligand-binding domains of
each corticosteroid receptor before ligation into the pBIND vector. A primer pair was
designed for each receptor. The forward primer was positioned at the start of the ligand-
binding domain while the reverse primer was positioned at the stop codon of the open-
reading frame and the end of the ligand-binding E-domain. Recognition sequences for
BamHI and KpnI restriction enzymes were placed at the 5’ ends of the forward and
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reverse primers respectively, to allow the directional cloning of ligand-binding domains
into the cloning vector while maintaining the reading frame of the plasmid region
encoding GAL4. Primer pairs are described in Table 7-1.
Table 7-1. Primer sequences used to amplify the ligand-binding domains of corticosteroid receptors
from Platichthys flesus. Recognition sequences of BamHI and KpnI are highligted in red
Primer Name Primer sequence (5’ 3’)
GR1LBDF TT GGATCC TG CCC CAG CTC GTG CCC ACC AT
GR1LBDR AA GGTACC AG TCA TTT CTG ATG AAA CAG CAG AGG CTT G
GR2LBDF TT GGATCC GC ATG CCT CAA TTG TCC CCA CAA TG
GR2LBDR AA GGTACC AG TCATCT CTG GTG AAA GAG GAG GGG CTT GAC
MRLBDF TT GGATCC TT CTG CCG CCC TCC ATC T
MRLBDR AA GGTACC AG TCA CTT CTT GTG GAA GTA GA
Polymerase chain reactions were in 20 µl reaction volumes containing, per reaction, 2.5
µl 3’ RACE ready cDNA, 0.2 µM of each of the forward and reverse primers, 0.2 mM
dNTP, 1× Advantage II PCR buffer (Clontech) and 1× Advantage II polymerase mix
(Clontech). To generate the template 3’ RACE-ready cDNA 1 µg RNA from kidney,
liver and intestine was reverse transcribed using the SMART rapid amplification of
cDNA ends kit (Clontech) for amplification of ligand-binding domains of GR1, GR1
and MR, respectively. Reverse transcription of RNA using this kit is described in
Chapter 5.
Cycling conditions for each receptor included an initial denaturation of 2 minutes at
95°C, followed by 35 cycles of denaturation (95°C for 30 seconds), primer annealing
(65 °C for GR1 and MR and 67°C for GR2 for 30 seconds) and extension (72°C for 2
minutes). A final extension step of 72°C for 5 minutes completed the PCR cycle.
An aliquot of each PCR product was electrophoresed on a 1× TAE, 1% agarose,
0.5µg/mL EtBr gel alongside 1kb DNA ladder, confirming amplification of a product of
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expected size. The remainder of the PCR products were purified from enzymatic PCR
reactions and ligated into the prepared pBIND cloning vector (Promega). Purification of
PCR products and their restriction digest, along with restriction digest of pBIND
plasmid was done using ethanol precipitation as described previously in 3.2.1.2.
Following digestion, DNA was precipitated and a 10 µl ligation reaction prepared for
each receptor. For GR1 receptor 30ng digested GR1 LBD DNA was ligated into 50 ng
digested pBIND vector using 1× T4 DNA ligase buffer (New England Biolabs) and 200
cohesive-end units of T4 DNA ligase (New England Biolabs). The ligand-binding
domain of GR2 was ligated into pBIND using 50ng digested pBIND plasmid, 1× T4
DNA ligase buffer (Promega) and 7.5 weiss units of T4 DNA ligase (Promega) in a
total of 10 µl. The digested ligand-binding domain of the mineralocorticoid receptor
was ligated into the digested pBIND plasmid using 100ng pBIND vector, 35ng putative
ligand-binding domain, 1.5 units T4 DNA ligase enzyme (Promega) and 1× T4 DNA
ligase buffer (Promega).
All reactions were incubated overnight at 4°C before being transformed into
chemocompetent DH5α E.coli cells. Transformants were spread on selective agar plates
and small scale cultures were grown from single colonies and plasmid DNA isolated.
The method used for these procedures was the same as described for transformation of
E.coli Top10 and isolation of plasmid DNA in 3.2.1.4.
Sequencing of pBIND-corticosteroid ligand-binding domain constructs7.2.1.2
Plasmids resulting from the above ligation reactions were characterised by restriction
mapping. A 2 µl sample of each plasmid preparation was incubated with 5 units BamHI,
5 units KpnI, 1× Universal restriction buffer and water to a volume of 10 µl at 37°C for
1 hour. Digested plasmids were then electrophoresed on a 1× TAE, 1% agarose, 0.5
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µg/ml EtBr gel to identify those plasmids in which the digestion released a fragment,
corresponding to the size of the ligand-binding domains of GR1, GR2 and MR. At least
two plasmid preparations per corticosteroid receptor showed this expected band pattern
and were sequenced to confirm the identity and correct insertion of the insert.
Sequencing was carried out as previously described (see 3.2.1.5) using primers detailed
in Table 7-2
Table 7-2. Primers used for the sequencing of the Gal4-corticosteroid ligand-binding domain
plasmids.
7.2.2 Hormone-binding assays
Hormone binding assays with Gal4-corticosteroid receptor ligand-binding domain
constructs were performed in COS-7 cells derived from kidney cells of African green
monkey, which lack endogenous expression of corticosteroid receptors.
Primer Name Primer sequence (5’ 3’) Amino acid
sequence
pBINDseqF CTT CAG TGG AGA CTG ATA TGC n/a
pBINDseqR CAC TGC ATT CTA GTT GTG GT n/a
P.fGR1seqF GCT CCT GGC TCT TTC TCA TG S-W-L-F-L-M
P.fGR1R2 CAC GCT GAG GGT TTT ATT CAC V-N-K-T-L-S-V
pBIND GR1R AA GGTACC AGT CAT TTC TGA TGA AAC AGC AGAGGC TTG L-F-H-Q-K-*
pBIND GR1F TT GGATCC TGC CCC AGC TCG TGC CCA CCA T P-Q-L-V-P-T
P.fGR1seqR2 GCC CAC TTG ACT GCA GAG AT I-S-A-V-K-W
pBIND MRF TT GGATCC TTC TGC CGC CCT CCA TCT L-P-P-S-I
pBIND MRR AA GGTACC AGT CAC TTC TTG TGG AAG TAG A Y-F-H-K-K
P.fMR 3’F GGC GGC GTT CGA GGA GAT GAG AGT A-A-F-E-E-M-R
P.fGR2 5’R GCT GTC GTA GCC GGC AAA GAT GGT GT T-I-F-A-G-Y-D-S
P.fGR2 GSP1 CCT CAT GAC CAC CCT GAA CA L-M-T-T-L-N
P.fGR2 F3 GAT GAG ATT CGG ATG GCC TA D-E-I-R-M-A
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Transfection of COS-7 cells7.2.2.1
COS-7 cells were maintained in DMEM (Invitrogen), supplemented with 100 IU/ml
penicillin, 100 µg/ml streptomycin, 2mM glutamine and 10% denatured fetal calf serum
in a humidified atmosphere with 5% CO2. For transfection media from a flask of
almost-confluent COS-7 cells was emptied and the cells washed twice with 1 × DPBS
(Gibco, Invitrogen). Trypsin/EDTA was added to cells in order to release them from the
flask and subsequently resuspended in DMEM, supplemented with 10%
charcoal/dextran treated FBS.
COS-7 cells were counted using a hemocytometer and the method described for FHM
cells in paragraph 2.2.1.2, and diluted to a final density of 16 × 104 cells/ml. Cells were
then seeded into 24 well plates at a volume of 0.5 ml per well (8 × 104 cells) in DMEM.
Plates were incubated overnight at 37 °C, 5% CO2. The following day media was
aspirated from cells and washed with 1 × DPBS and 0.3 ml DMEM with penicillin
streptomycin and serum added to final concentrations of 50 µg/ml, 50 units/ml and 10%
respectively.
For each plasmid to be transfected, a tranfection mix was prepared. For each 24 well
plate, 7.5 µg plasmid DNA was diluted to a volume of 500 µl with DMEM (free of
serum and antibiotics) and 50 µl polyfect reagent was added. Polyfect-DNA mixture
was incubated for 10 minutes at room temperature to allow the DNA complexes to form
then 3ml DMEM (supplemented with antibiotic and serum as above) was added to the
tube containing the DNA and the Polyfect, and the resulting transfection solution mixed
by gently pipetting. To each well of a 24 well assay plate 142 µl of the transfection
solution was added (300 ng DNA per well) and plates incubated for a further 24 hours
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at 37 °C, 5% CO2 before replacing transfection solutions with fully supplemented
media.
Preparation of tritiated and cold hormone treatments7.2.2.2
Stock solutions of tritiated hormone solutions ([3H]-dexamethasone (6,7-3H(N), Perkin
Elmer, specific activity 2.072 Bq/fmol) and [3H]-cortisol (1,2,6,7(N), Perkin Elmer,
specific activity 2.6788 Bq/fmol)) were diluted to 200-times the final assay
concentration in absolute ethanol. Stock concentrations were then added to DMEM
media containing no supplements in a ratio of 1 µl tritiated hormone:1 µl ethanol:200 µl
DMEM, giving final assay concentrations of 1.56, 3.12, 6.25, 12.5, 25 and 50 nM
tritiated dexamethasone and 0.28, 0.85, 2.56, 7.67, 23 and 69 nM tritiated cortisol. To
measure non-specific hormone binding a second treatment was prepared in which the
tritiated hormone was present with a 500-fold excess of unlabelled hormone. Unlabelled
hormone stocks were diluted into ethanol to 200-times the final assay concentration.
Tritiated hormone and unlabelled hormone, both at 200-times the final required
concentrations, were diluted into a volume of DMEM in a ratio of 1 µl tritiated
hormone:1 µl unlabelled hormone:200 µl DMEM giving the same tritiated hormone
concentrations as described above, each with a 500-fold excess of unlabelled hormone
(0.78, 1.56, 3.12, 6.25, 12.5 and 25 µM dexamethasone and 0.125, 0.425, 1.28, 3.84,
11.5 and 34.5 µM cortisol.
Treatment of transfected COS-7 cells7.2.2.3
Supplemented media supplied to cells during transfection were removed from the assay
plate and cells washed twice with DPBS. Media containing the appropriate
concentrations of radiolabelled and unlabelled hormones were then added to cells in a
volume of 250 µl. All treatments were performed in duplicate within a given
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experimental repeat. Cells were placed in a 37°C incubator for 1 hour after which media
was removed and cells washed twice with DPBS. Radiolabelled hormone retained by
the cell monolayer was then extracted from cells by adding 130 µl of ethanol absolute to
each well, incubating the plate for 5 minutes and removing the ethanol quantitatively
into a 6ml scintillation vial (Perkin Elmer). The extraction was repeated and the second
extract placed into the same vial as the first extract. 4 ml of scintillation fluid was added
to each tube and contents vortex mixed before being subjected to scintillation counting.
Calculating specific binding, Kd and Bmax7.2.2.4
Following scintillation counting, disintigrations per minute (DPM), calculated
automatically by the scintillation counter, were converted to Becquerel (Bq) units by
dividing each DPM value by 60 (1 Bq = 1 DPS and therefore 1Bq=60 DPM). Using the
specific activity of each hormone (2.6788 Bq/fmol for [3H]-cortisol and 2.072 Bq/fmol
for [3H]-dexamethasone), Bq units were then converted to fmol/well by division by the
specific activity and further converted to nanomoles (by multiplying by 4 and dividing
by 0.004). Specific and non-specific binding, as well as the ratio of bound to free
hormone was calculated. Specific binding of the hormone by Gal4-CR-transfected cells
was calculated as the difference between total binding, i.e. cells treated with tritiated
hormone only, and non-specific binding, i.e. cells exposed to tritiated hormone with a
500-fold excess of unlabelled hormone.
Specific hormone binding in receptor transfected cells followed Michaelis-Menton type
saturation kinetics in accordance with the presence of a single binding site; however, the
upper asymptote of replicates differed significantly between experiments, probably
reflecting the differences in transfection efficiency. This was accounted for by fitting a
Michaelis-Menton-type non-linear least squares model of Binding (B) versus substrate
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concentration (Uij) for measuring j in experiment i.  This model allowed for a different
asymptote (Bmax) for each experiment, i, but with a single kinetic parameter (Kd). The
error term (εij) was assumed to be normally distributed:
Bi,j = Bmax,i ([Uij]/([Uij] + Kd)) + εij
Curvilinear regressions according to the above model were calculated using the R
modelling environment (http://www.r-project.org/).
7.2.3 Transactivation assay
Transactivation assays were performed in order to characterise the response of
glucocorticoid and mineralocorticoid receptors to model agonists cortisol,
dexamethasone and aldosterone, respectively. In addition mifepristone (RU486) and
spironolactone were assessed for their ability to antagonise the receptors.
Transactivation assays were carried out in transiently transfected fathead minnow cells
using the same procedures as described for PPAR transactivation assays in 3.2.2.
Seeding and transfection of FHM cells7.2.3.1
Twenty four hours prior to transfection FHM cells were seeded into 96 well black assay
plates with clear bottoms (Corning) at a density of 2 ×105 cells per well as described in
3.2.2.1.
Transfection of plasmid DNA into cells was carried out using Polyfect transfection
reagent (Qiagen). Per well, 60ng DNA was transfected consisting of 10 ng Gal4-
corticosteroid ligand-binding domain, 10ng of control reporter plasmid
pGL4.75[hRluc/CMV] and 40ng experimental reporter plasmid
pGL4.31[luc2P/Gal4UAS/hygro]. DNA was diluted with DMEM, lacking serum and
- 260 -
antibiotics, such that 0.05 µl DMEM was added per 1ng of DNA. After mixing and
brief centrifugation a volume of Polyfect reagent (Qiagen) was added to give a final
Polyfect to DNA ratio of 10.5 µl:1 µg and transfection continued as detailed in 3.2.2.2.
Transfection of cells continued for 24 hours before cells were treated with compounds
of interest.
Treatment of transfected cells7.2.3.2
To study the hormone dependency of the transactivation of Gal4-corticosteroid
constructs, cells transiently transfected as above were treated with different
concentrations of aldosterone, cortisol and dexamethasone. Concentrated ethanolic
stocks of each compound were prepared using absolute ethanol and diluted 1 µl per mL
into complete DMEM media to give final assay concentrations. Antagonism of Gal4-
corticosteroid constructs was assessed by combining receptor agonists dexamethasone
(GR1 and GR2) or aldosterone (MR) at a concentration of 10-6M with different
concentrations of mifepristone and spironolactone, with appropriate single compound
controls. Concentrated stocks of agonists and antagonists were added to DMEM, each at
1 µl per 1000 µl DMEM, to give final stated assay concentrations.
Transfection mixes were removed from wells of the assay plate and cells washed once
with 1× PBS (Invitrogen) before adding 75 µl of media containing treatments to each
well of the assay plate. Each treatment was performed in triplicate within a given
experiment. In addition a control treatment was included in which absolute ethanol was
diluted into complete DMEM at a final concentration of 0.1% or 0.2% for agonism and
antagonism experiments, respectively. A second control was included on plates in
which antagonism was studied, which consisted of dexamethasone or aldosterone only
at a concentration of 10-6M, and was used as a positive control against which all other
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treatments were compared. On each assay plate non-transfected cells were included to
assess for background luciferase.
Cells were incubated with treatments for 24 hours before being assayed for luciferase
activity
Luciferase Assay & Statistical Analysis7.2.3.3
At the end of experiments, media was removed from the plates and cells washed twice
with 1× PBS (Invitrogen). Firefly and Renilla Luciferase activities were measured using
buffers adapted from Dyer et al (2000), as described in Chapter 3.
Statistical analysis was carried out using Graphpad InStat version 3.05 to determine
statistically significant differences between control treatments and hormone treatments
in transactivation experiments. The F-max test was used to confirm the homogeneity of
variances and, where necessary, data were log transformed before performing repeated
measures ANOVA followed by post hoc comparisons with Dunnett’s test. Differences
were considered statistically significant when the probability value (P) was less than
0.05.
7.3 Results
7.3.1 Construction of Gal4-Corticosteroid LBD constructs
From previous isolation of the three corticosteroid receptors (see 0) polymerase chain
reaction with primers specific to the ligand-binding region of GR1, GR2 and MR was
expected to produce products of 756 (MR), 762 (GR2) and 759 (GR1), respectively.
Additionally, when cloned into the pBIND vector containing the DNA-binding domain
of Gal4 protein, the ligand-binding domain of the corticosteroid receptors and the Gal4-
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DBD were expected to be in the same reading frame. Sequencing analysis revealed the
ligated DNA fragments to be the ligand-binding regions of GR1, GR2 and MR and that
all three DNA-binding domains appeared in the same reading frame as the Gal4 DNA-
binding domain as expected.
7.3.2 Steroid-binding assays
Ligand-binding affinities of Gal4-GR1, Gal4-GR2 and MR for dexamethasone and
cortisol was assessed using whole cell binding assays using COS-7 cells transiently
expressing Gal4 constructs. Specific binding of the tritiated hormone to the Gal4
constructs were obtained as the difference between total binding and non-specific
binding, as exemplified in Figure 7-1. A comparison of hormone binding in transfected
and non-transfected cells revealed total binding in non-transfected cells to be equivelant
to the non-specific binding in transfected cells for both dexamethasone and cortisol,
confirming the absence of endogenous corticosteroid receptors in the COS-7 cell line
(Figure 7-1(A) and (B)).
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Figure 7-1. Binding of [3H] Dexamethasone (A) and Cortisol (B) to Gal4-GR2 construct and in cells
transfected with empty pBIND plasmid only. COS-7 cells transiently expressing Gal4-GR2 or
pBIND were treated with 1.56 - 50 nM [3H]-Dexamethasone or 0.28–69nM [3H]-Cortisol either in
the presence of (non-specific binding) or the absence of (specific binding) a 500-fold excess of
unlabelled hormone. Specific binding was calculated as the total binding minus the non-specific
binding.
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Binding data followed Michaelis-Menten kinetics in accordance with the presence of a
single binding site. Figure 7-2 shows typical binding results, expressed as linearized
scatchard plots, from cells transfected with Gal4-GR1, Gal4-GR2 and Gal4-MR in the
presence of both [3H]-dexamethasone and [3H]-cortisol.
For all Gal4-flounder CR constructs, specific binding followed saturation kinetics
allowing a dissociation constant (Kd) and an estimate of the number of binding sites
(Bmax) (Table 7-3). Bmax varied between transfections but did not differ between
receptors. Thus, Gal4 construct expression was similar between all receptors.
In terms of hormone affinity, Gal4-GR1 and Gal4-GR2 had a higher affinity for
dexamethasone than cortisol, while Gal4-MR had a similar affinity for both hormones.
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Figure 7-2. Typical results of [3H]-dexamethasone and [3H]-cortisol binding assays for Gal4-GR1
(A), Gal4-GR2 (B) and Gal4-MR (C) represented as scatchard plots.
- 266 -
Table 7-3. Binding affinity (Kd with 95% confidence intervals in brackets) and number of binding
sites (Bmax ± S.D.) estimated from whole cell binding assays with Gal4-GR1, Gal4-GR2 and Gal4-
MR constructs.
7.3.3 Activation of corticosteroid receptors by model agonists
Each of the constructs described in 7.3.1 were used in transient transfection assays to
assess the ability of model activators of corticosteroid receptors to activate the
mineralocorticoid receptor and the two glucocorticoid receptors from European
flounder. The potent synthetic glucocorticoid hormone dexamethasone, as well as the
naturally occurring glucocorticoid hormone cortisol, was able to activate all three
corticosteroid receptors, indicated by an increase in luciferase activity (Figure 7-3). The
mineralocorticoid aldosterone failed to activate the glucocorticoid receptors of
European flounder, but as expected had an agonistic effect on the mineralocorticoid
receptor.
Receptor Construct Hormone Kd (nM) Bmax (nMol/well)
Gal4-GR1 Cortisol 70.9 (51.6-103.0) 1.45 ± 0.94Gal4-GR2 63.8 (50.6-82.7) 1.08 ± 0.53
Gal4-MR 11.9 (10.5-13.5) 1.33 ± 0.45
Gal4-GR1 Dexamethasone 19.0 (15.9-22.9) 3.79 ± 0.02Gal4-GR2 17.5(14.5-21.2) 1.82 ± 0.32
Gal4-MR 13.1 (10.0-17.4) 0.71 ± 0.67
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Figure 7-3. Activation of Gal4-GR1 (A), Gal4-GR2 (B) and Gal4-MR (C) ligand-binding domain
constructs by dexamethasone, cortisol and aldosterone. FHM cells were transfected as described in
7.2.3.1 and treated with increasing concentrations of dexamethasone, cortisol or aldosterone before
being assayed for luciferase activity as previously described. Data are represented as the fold-
activation in luciferase activity, relative to treatment with ethanol vehicle only. The mean ± SEM of
three independent experiments are shown for each receptor construct. Asterisks represent
luciferase activities significantly different to control (* P<0.05; ** P<0.01).
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Cortisol appears to exhibit similar potencies on the two glucocorticoid receptor
constructs, with luciferase increasing at a concentration of 1×10-7 M for both receptors.
Dexamethasone, a highly potent synthetic glucocorticoid receptor, was a more potent
agonist of both GR1 and GR2 compared to cortisol, as indicated by a shift of the curve
to the left for dexamethasone as compared to cortisol. Aldosterone failed to activate
either of the glucocorticoid receptors at any of the concentrations tested.
All three corticosteroids tested were able to activate the transcriptional activity of the
mineralocorticoid receptor. Both cortisol and dexamethasone were more potent
activators of the mineralocorticoid receptor than the glucocorticoid receptor, indicated
by their effectiveness at lower concentrations. Aldosterone was the most potent
activator of mineralocorticoid receptor transactivation.
7.3.4 Antagonsim of corticosteroid receptors by model
antagonists
Antagonism of the Gal4 corticosteroid constructs was assessed using Gal4-CR
constructs activated by either 10-6M dexamethasone (Gal4-GR1 and Gal4-GR2) or 10-
6M aldosterone (Gal4-MR) both alone and in the presence of increasing concentrations
of an antagonist.
Mifepristone (RU486), an anti-progesterone and an anti-glucocorticoid almost
completely abolished dexamethasone-induction of GR1 and GR2 when at equimolar
concentrations with dexamethasone (10-6M) (Figure 7-4(A) & (B)). In contrast to the
effects of mifepristone on the glucocorticoid receptors, this compound had no effect on
the aldosterone-induction of the mineralocorticoid receptor (Figure 7-4(C))
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Spironolactone is a compound which has been shown to inhibit the mineralocorticoid
receptor. Spironolactone failed to inhibit dexamethasone-activated GR1 and although a
slight inhibition of GR2 appeared to occur, this inhibition was statistically not
significant (Figure 7-4(A) & (B)). Spironolactone partially inhibited aldosterone-
activated MR when at equimolar concentrations with aldosterone (Figure 7-4(C)).
Figure 7-4. Antagonism of GR1 (A), GR2 (B) and MR (C) of European flounder by mifepristone
and spironolactone. FHM cells were transfected as described in 7.2.3.1 and treated with increasing
concentrations of antagonist in the presence of 1 × 10-6M dexamethasone (GR1 & GR2 transfected
cells) or 1 × 10-6M aldosterone (MR transfected cells) before being assayed for luciferase activity as
previously described. Data are expressed as a percentage of the GR1, GR2 or MR activities
measured in the presence of 10-6M dexamethasone or aldosterone only. The mean ± SEM of three
independent experiments are shown for each receptor construct with asterisks representing
statistical significance (* p<0.05 & ** p<0.01; one way ANOVA with Dunnett’s post hoc test).
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7.3.5 Response of corticosteroid receptors to Pollutants
It has been reported previously that the ligand selectivity of corticosteroid receptors is
conserved in Gal4 constructs (Bridgham et al, 2006). In experiments with model
agonists and antagonists Gal4-MR and Gal4-GR showed specificities very similar to
those previously described from teleost and tetrapod GR and MR. The constructs thus
appear suitable to identify agonist and antagonist compounds amongst environmental
chemicals. An environmental contaminant, bis(tributyl tin) oxide (TBTO), shown to
interact with other nuclear hormone receptors was tested for its ability to both activate
and inhibit the corticosteroid receptors of European flounder.
Bis(tributyl tin) Oxide (TBTO)7.3.5.1
TBTO caused no increase in luciferase activity, indicating that TBTO does not act as an
agonist of CRs (Figure 7-5). At 250 nM TBTO a significant drop in luciferase activity
compared to ethanol treatment was observed, which may have been due to cell toxicity.
In antagonism experiments, an inhibition of Gal4-GR1, Gal4-GR2 and Gal4-MR was
observed and this occurred in a dose dependent manner with statistically significant
inhibition at concentrations above 100nM (Figure 7-6), although similar to the agonism
experiment, at 250nm, the inhibition may have occurred due to cell toxicity. At 100 nM
the activity of dexamethasone-activated constructs was inhibited by 63%, 88% and 82%
for Gal4-GR1, Gal4-GR2 and Gal4-MR, respectively.
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Figure 7-5. TBTO as a potential agonist of Gal4-CR constructs. FHM cells transiently expressing
Gal4-GR1, Gal4-GR2 or Gal4-MR constructs were treated with increasing concentrations of TBTO
(1-250 nM). Luciferase activity is expressed relative to treatment with ethanol vehicle only
(control). The graph shows the mean ± SEM of three independent experiments. Asterisks represent
values which differ significantly from the control treatment (* P<0.05, ** P<0.01).
Figure 7-6. Antagonism of Gal4-GR constructs with an environmental contaminant. FHM cells
transiently expressing Gal4-GR1, Gal4-GR2 or Gal4-MR constructs were treated with 10-6M
dexamethasone in combination with concentrations of TBTO between 1 and 250nM. Luciferase
activity are expressed as a percent of a control treatment of 10-6M dexamethasone only, which was
assigned the arbitrary value of 100%. The graph shows the mean ± SEM of three independent
experiments. Asterisks represent values which differ significantly from the control treatment
(P<0.01).
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Bisphenol A and Phthalate compounds7.3.5.2
Bisphenol A and phthalate compounds are used in the manufacturing industry as
plasticisers. In the present study bisphenol A (BPA), benzylbutylphthalate (BBP) and
dimethylphthalate (DMP) were tested as agonists and antagonists with the Gal4-CR
constructs. None of the compounds were agonists for Gal4-CR transactivation (Figure
7-7).
While dimethylphthalate had no antagonistic activity, bisphenol A and
benzylbutylphthalate were partial antagonists of Gal4-GR1 and Gal4-GR2, although
antagonism by the latter compound with Gal4-GR2 was not significant (Figure 7-8).
Figure 7-7. Agonism of Gal4-CR constructs by bisphenol A (BPA), benzylbutylphthalate (BBP) and
dimethylphthalate (DMP) at 10 µM or 25 µM. FHM cells were transiently transfected with Gal4-
CR constructs and reporter plasmids as described in materials and methods. Cells were then
treated with either 10 µM or 25 µM of each compound and transactivation activities determined by
measuring firefly luciferase normalised to internal Renilla luciferase controls. Data are expressed
as the fold activation over ethanol vehicle controls and are the mean and SEM of at least three
independent experiments.
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Figure 7-8. Antagonism of Gal4-CR constructs by bisphenol A (BPA), benzylbutylphthalate (BBP)
and dimethylphthalate (DMP) at 10 µM or 25 µM. FHM cells were transiently transfected with
Gal4-CR constructs and reporter plasmids as described in materials and methods. Cells were then
treated with either 10 µM or 25 µM of each compound in combination with 10-6M (Gal4-GR1 and
Gal4-GR2) or 10-8M (Gal4-MR) cortisol and transactivation activities determined by measuring
firefly luciferase normalised to internal Renilla luciferase controls. Data are expressed as
transactivation as a percentage of that observed with cortisol alone and are the mean and SEM of
at least three independent experiments. Treatments which are significantly different to cortisol only
controls are indicated by asterisks (*, P<0.05; **, P<0.01).
7.4 Discussion
In order to generate a reporter gene assay suitable for detecting interactions of
environmental pollutants with the corticosteroid receptors from European flounder,
recombinant fusion proteins were made linking the ligand-binding domains of the
corticosteroid receptors to the DNA binding domain of the yeast transcription factor
Gal4, and a reporter gene assay based on these constructs was developed. The assay was
validated by testing the effects of well-known hormonal and pharmacological agonists
and antagonists of corticosteroid receptors. The assay was further used to analyse the in
vitro effects of selected common water pollutants. The persistent aquatic pollutant
TBTO was shown to be a potent antagonist of all flounder corticosteroid receptors,
- 274 -
while two of three studied plasticisers were moderately active antagonists of GR1, one
of which was also an antagonist of GR2. The possibility that these common
environmental contaminants might interfere with corticosteroid signalling in wild fish
from polluted environment, and consequently might adversely affect the biological
processes under the control of corticosteroid signalling, deserves further enquiry.
In agreement with previous studies (Colombe et al, 2000; Greenwood et al, 2003; Bury
et al, 2003; Pippal et al, 2011) cortisol and dexamethasone were able to activate both
the glucocorticoid receptors and mineralocorticoid receptor of European flounder while
the mineralocorticoid aldosterone, was an agonist of the mineralocorticoid receptor
only. Furthermore cortisol stimulated activity of the mineralocorticoid receptor of
European flounder at lower levels than required to elicit effects on either of the two
glucocorticoid receptors. A similar situation has been described for Burton’s
mouthbrooder (H.burtoni) in which the concentration of cortisol required for half
maximal activation of the mineralocorticoid receptor was approximately 180-fold less
than for the GR1 and 270-fold and 105-fold less for the GR2a and GR2b receptors,
respectively (Greenwood et al, 2003). These findings parallel those in mammals in
which mineralocorticoid receptors are activated by cortisol at lower concentrations than
are required by glucocorticoid receptors (Rogerson and Fuller, 2000).
Aldosterone, the mineralocorticoid hormone found in mammals, is thought to be absent
in most teleosts, who are thought to lack the P450 11β-hydroxylase (P450(11β)) enzyme
that results in aldosterone biosynthesis (Jiang et al, 1998). Cortisol is the most abundant
corticosteroid in circulation in teleost species, and has been reported to function as both
a mineralocorticoid and glucocorticoid hormone. Current research has hypothesised that
11-deoxycorticosterone could function as a mineralocorticoid in fish species (Sturm et
- 275 -
al, 2005; Kiilerich et al, 2011) but further research and evidence is required before a
definitive conclusion can be drawn. Despite the lack of aldosterone in teleost’s it has
previously been found that this hormone retains the ability to activate the
mineralocorticoid receptor in zebrafish (Pippal et al, 2011) and rainbow trout (Sturm et
al, 2005). In agreement with these previous studies and reminiscent of the human
mineralocorticoid receptor (Hellal-Levy et al, 1999), aldosterone was found to activate
the transactivation properties of the Gal4-MR receptor with greater potency than either
of the glucocorticoid hormones, but with no effect on the glucocorticoid receptor
constructs and thus it appears the Gal4-corticosteroid receptor ligand-binding domain
constructs retains the ligand specificity previously observed with full-length fish
corticosteroid receptors.
As well as classical agonists, two well characterised corticosteroid antagonists were
tested with the Gal4-CR constructs. Spironolactone has been shown to be an antagonist
of the human mineralocorticoid receptor and is used as an MR antagonist in the
treatment of patients with cardiac failure (Fuller and Young, 2005). In contrast to the
mammalian mineralocorticoid receptor, spironolactone has been demonstrated to be an
agonist of teleost mineralocorticoid receptors (Sturm et al, 2005; Pippal et al, 2011).
Spironolactone was not tested as an agonist of the European flounder mineralocorticoid
receptor but was shown to antagonise the MR significantly at an equimolar
concentration (10-6M) with aldosterone. It is possible that spironolactone acts as a
partial agonist of the European flounder below 10-6M, since no inhibition was seen at
these concentrations but further work would be required to confirm this. Importantly
spironolactone was specific for the MR receptor, having no antagonistic effect on the
glucocorticoid receptors of European flounder.
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Mifepristone (RU486) is a glucocorticoid receptor-specific inhibitor, having been
shown to inhibit the actions of glucocorticoids both in mammals and fish (Bury et al,
2003; Lee et al, 2009). The ligand-binding domain of the glucocorticoid receptor has
previously been shown to be important in RU486-induced antagonism, with binding of
RU486 to this domain inducing a conformational change in which helix 12 of the
ligand-binding domain covers the coactivator binding site, preventing receptor
activation (Kauppi et al, 2003). Additionally the C-terminal AF1 region of the
glucocorticoid receptor has also been shown to be important in RU486-induced GR
antagonism (Lee et al, 2009). Here we have demonstrated that the presence of the
ligand-binding domain is enough for RU486-induced antagonism of the European
flounder GRs. Similar to spironolactone-inhibition of the mineralocorticoid receptor,
inhibition by RU486 was specific for the glucocorticoid receptors.
The above results from these transactivation and repression studies reveal the Gal4-
corticosteroid constructs to retain their expected ligand-specificity, with dexamethasone
and cortisol activating both the glucocorticoid and mineralocorticoid receptors, with
greater potency for the latter receptor, while aldosterone increases the transactivation
function of the mineralocorticoid receptor with no effect on the glucocorticoid
receptors. Spironolactone and RU486 were specific inhibitors of the mineralocorticoid
and the glucocorticoid receptors, respectively. Since they retained ligand specificity, the
Gal4 receptor constructs were considered suitable to study the activation and repression
of corticosteroid receptors by several environmental pollutants.
Organotin compounds have already been demonstrated to interfere with the
glucocorticoid receptor α of humans, with interactions between dibutyltin and the
ligand-binding domain having an inhibitory effect at concentrations of 250nM and
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above (Gumy et al, 2008). The inhibitory effects of TBTO on European flounder
corticosteroid receptors was observed at concentrations within the range of 100-250nM,
a similar concentration at which dibutyltin was observed to bind to the human
glucocorticoid receptor. Thus organotins are inhibitory to both GR1 and GR2 at similar
concentrations to the model anatagonist, RU486, while inhibition of the MR by TBTO
occurs at concentrations lower than that observed with spironolactone.
As well as interactions directly with the glucocorticoid receptor a disruption of the
human 11β-HSD2 enzyme by organotins, including tributyltins, has been reported
(Hellal-Levy et al, 1999; Atanasov et al, 2005), suggesting the ability of organotin
compounds to disrupt corticosteroid signalling at various levels. 11β-HSD2 functions in
mineralocorticoid-specific tissues to convert active cortisol into the inactive 11-keto
form cortisone, protecting the MR from activation by glucocorticoids and rendering the
specificity of the receptor for aldosterone. More recently, this enzyme has been isolated
from fish species in which aldosterone is absent and has been postulated to protect
tissues expressing this enzyme from the effects of stress-induced cortisol during key
developmental stages (Kusakabe et al, 2003; Jiang et al, 2003). With the discovery of
this enzyme in fish species it is possible that organotin compounds may inhibit this
enzyme in teleosts as well as mammals, leading to an overexposure of 11β-HSD2-
expressing tissues to cortisol.
The inhibitory effects of TBTO on the corticosteroid receptors in European flounder are
observed at concentrations greater than 100nM. Despite the ban on the use of organotin
compounds, TBT still persists within the aquatic environment due to its slow
degradation in sediments (Stewart and de Mora, 1990; de Mora et al, 1995; Viglino et
al, 2004). Organotin compounds have been found to accumulate to high concentrations
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within tissues of aquatic organisms; 35 ng TBT/g has been detected in the liver of
European flounder (Albalat et al, 2002), while 67 ng TBT/g wet weight has been
detected in Korean mackerel (Oh, 2009). These concentrations equate approximately to
59 nM and 112 nM, respectively, the latter of which is above the level in which effects
were observed in the present study.
As well as TBTO, three compounds used as plasticizers in the manufacturing industry
were tested in transfection assays for their ability to alter transcriptional activities of the
corticosteroid receptors. Two of these compounds, bisphenol A (BPA) and
benzylbutylphthalate (BBP) were able to antagonise GR1 of European flounder, while
GR2 was antagonised by BPA. Previously the ability of BPA to bind to the human
glucocorticoid receptor has been reported (Prasanth et al, 2010) and the high sequence
similarity seen between the ligand-binding domain of human GR and teleost GRs makes
it likely that BPA will also bind to GRs of the latter. As a receptor antagonist BPA is
not very potent, with antagonism observed only at concentrations of 25 µM. Within the
environment, BPA is not considered a persistent pollutant due to its rapid
biodegradation in wastewater treatment plants and receiving wasters, with a reported
half-life of 2.5 to 4 days (Staples et al, 1998). Reported concentrations of BPA in water
samples are typically well below the 25 µM concentration at which an antagonistic
effect on GR was observed in the transient transfection assay; Fromme et al (2002)
found levels of BPA in surface waters of rivers, lakes and channels across Germany of
between 0.0005 µg/L to 0.229 µg/L (2.19 pM – 1nM). While isolated examples of
higher BPA concentrations (up to 21 µg/L, equivalent to ~92nM) have been reported in
the Netherlands (Belfroid et al, 2002), these concentrations are still well below 25 µM.
Nevertheless, with the ever-increasing demand for bisphenol A (global demand is
predicted to grow from 3.9 million tons in 2006 to approximately 5 million tons in 2010
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(Tsai, 2006)), and the detection of bisphenol A in fish tissues (Mita et al, 2011) the
chronic input of this compound into receiving waters and its accumulation in the tissues
of fish species warrants consideration.
Previously, benzylbutyl phthalate has been shown to have estrogenic effects in fathead
minnow (Pimephales promelas) exposed to the phthalate compound at 100 µg/L
(Harries et al, 2000), consistent with the mode of action in vitro in which benzylbutyl
phthalate was able to bind weakly to the estrogen receptor in fish cell cultures, eliciting
weak estrogenic activity (Jobling et al, 1995). These studies used very high phthalate
exposure concentrations, which are unlikely to be present within the water column.
Indeed, concentrations of BBP have been reported in the river Rhine at concentrations
up to 10 µg/L (approx. 32nM) and therefore well below the concentrations at which
estrogenic effects in fathead minnow and inhibition of the GRs of European flounder
were observed. Within the muscle of different fish species, levels of different phthalate
compounds have been measured and benzylbutylphthalate levels found to reach up to
9.4mg/kg dw (Huang et al, 2008), equating to a concentration of approximately 30 µM.
Thus BBP is able to accumulate within the tissues of fish species and may lead to
concentrations at which BBP was observed to antagonise GRs of European flounder.
7.5 Conclusion
A reporter gene assay has been developed to screen aquatic contaminants for their
potential to cause endocrine disruption by interactions with the ligand-binding domains
of the corticosteroid receptors in European flounder. The ligand-binding domains, using
classical agonists, have been shown to confer ligand specificity with the Gal4-GR
ligand-binding domain constructs being activated only by glucocorticoids (cortisol and
dexamethasone) and the Gal4-MR construct being activated by both glucocorticoids and
the mineralocorticoid hormone present in mammalian species (aldosterone). Thus, these
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constructs are suitable for identifying interactions between corticosteroid receptors and
potential ligands, such as environmental pollutants. Several phthalate compounds,
namely bisphenol A and benzylbutylphthalate were observed to antagonise one or both
of the GRs of European flounder at concentrations of 25 µM. Such a high
concentrations is unlikely to be found within aquatic environments but BBP may
accumulate to such levels in the tissues of fish species. Of more environmental
relevance bis(tributyl tin) oxide was shown to inhibit all three corticosteroid receptors
of European flounder at concentrations above 100 nM. To further confirm the
interaction between TBTO and corticosteroid receptors and to determine the likely
effects of such an interaction further studies are warranted at an organisational level
higher than the in cellulo level (such as ex vivo or in vivo) in order to elucidate the
impact of exposure in whole organisms.
- 281 -
Chapter 8. General Discussion
8.1 Key Findings
In the current thesis a cell-based reporter gene assay system has been developed and
used to the study of the potential for aquatic pollutants to disrupt endocrine signalling in
fish via interactions with two NHRs - the peroxisome proliferator activated receptors
and the corticosteroid receptors. To this end three corticosteroid receptors have been
cloned for the first time from European flounder and, together with PPARα, β and γ
previously cloned from the closely related European plaice, were used to construct
receptor plasmid constructs. The ligand-binding domains (LBDs) of each receptor was
ligated downstream of the DNA-binding domain of yeast Gal4, and when co-transfected
into a fish cell line (FHM) with a reporter plasmid, containing the upstream activating
sequence (UAS) of yeast Gal4 ligated upstream of the firefly luciferase reporter gene,
could be used to detect pollutant-receptor LBD interactions in cells to which pollutants
of interest were administered. Using cells transfected with PPAR and corticosteroid
receptor constructs, the system was demonstrated to respond in a predictable fashion to
known agonists and was therefore considered a suitable method in which to study
pollutant-nuclear hormone receptor interactions.
The transient transfection assay identified bis(tributyl)tin oxide (TBTO) as an inhibitor
of both PPARα and corticosteroid receptors at low nanomolar concentrations. In a very
preliminary study to attempt to appreciate the wider consequences of the former
inhibition, a cDNA microarray analysis was undertaken using hepatocyte cells of
European flounder to which a PPARα agonist was administered, either alone or in
combination with TBTO, and gene expression profiles compared. Despite failing to
provide definitive conclusions, the results of the microarray analysis hinted at possible
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effects on proteasomal pathways, mitochondrial oxidative phosphorylation, immune
functions and lipid homeostasis.
The newly cloned European flounder corticosteroid receptors were studied further with
sequencing, tissue expression profiles and transactivation assays allowing the
characterisation of each receptor. Cortisol, the endogenous fish glucocorticoid, and
dexamethasone activated the transcriptional activities of all three corticosteroid
receptors while aldosterone, the tetrapod mineralocorticoid hormone, was specific for
the mineralocorticoid receptor. Additionally the abilities of RU486 and spironolactone
to function as an anti-glucocorticoid and anti-mineralocorticoid respectively, was
demonstrated. Steroid binding assays demonstrated a direct binding of cortisol and
dexamethasone to the Gal4-CR constructs.
8.2 In vitro versus In vivo studies
In the context of environmental screening, a shift towards the use of in vitro assay
systems to further understand the molecular and pathway perturbations caused by
chemical pollutants is occurring. Knowledge from such assay systems may be used to
prioritise chemicals for in vivo screening. Indeed such methods are being initiated by
the OECD and  the US environmental protection agency (EPA), the latter of which has
introduced the ToxCast programme, with the aims of (a) identifying in vitro assays that
can reliably indicate perturbations in biological processes relevant to in vivo toxicity, (b)
develop prediction models based on multiple assays and chemical properties, a
combination of which can achieve higher predictive power than each of these methods
alone and (c) use the combination of in silico and in vitro assay-based signatures to
screen large numbers of untested environmental chemicals (Judson et al, 2010).
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The use of in vitro transactivation assays to screen chemical pollutants presents both
advantages and disadvantages compared to in vivo methods of screening. One major
advantage is the ability to screen many chemicals in a cost effective and timely manner,
compared to in vivo screening which can be both time-consuming and costly. The use of
in vitro assays also provides the ability to study individual pathways and their
perturbation by chemicals of interest, thus indicating a chemicals mode-of-action.
However, compared to in vivo methods, cell-based systems may be over simplistic and
ultimately it is the emergent properties of tissues and organisms which are key
determinants of whether a compound will elicit endocrine-disrupting or toxic effects.
Furthermore difficulties also arise when considering the timescale of in vitro assays,
which usually run over hours to days, and how this relates to processes which can lead
to in vivo toxicity end point, such as cancer, over longer timescales of months to years.
Finally, the production of metabolite compounds which occurs upon parent compound
biotransformation, and which can be more or less active than the parent compound
clearly must be considered in the assay or modeling treatment. Indeed within the present
study, while the parent phthalate compounds had no effect on PPAR signalling, the
monoesther metabolites were able to activate PPAR constructs (Chapter 4). It is clear
therefore that the development of assays in which realistic levels of biotransformation
occur in vitro may be required in order to assess the complete suite of active
metabolites, otherwise the testing of metabolites will have to be a consideration. Despite
these drawbacks in comparison to in vivo testing, assay-based sceening methods can be
useful in providing a first tier approach to screening, allowing chemicals which show
the highest likelihood of disruptive effects in vivo to be prioritised for screening. This
tiered screening approach will reduce the number of organisms required for in vivo
screening and thus is in keeping with the three Rs concept (Flecknell, 2002).
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8.3 TBTO as an inhibitor of PPARs and CRs
Using the transient transfection assay developed in this study (Chapter 3) several
environmental pollutants were found to agonise or antagonise the PPAR and
corticosteroid receptor constructs, resulting in increased or decreased luciferase activity,
respectively. Most of the compounds were only effective at concentrations unlikely to
be encountered in the aquatic environment. Fibrates have been measured in sewage
effluents at concentrations between 20-200 nM (Krey et al, 1997; Ternes, 1998; Buser
and Müller, 1998; Andreozzi et al, 2003; Sanderson et al, 2003), phthalate metabolites
have been detected at concentrations of <5 nM (Suzuki et al, 2001) and concentrations
of bisphenol A are generally at concentrations of <1nM (Fromme et al, 2002). Effects
of these compounds in transfected cells were not seen at concentrations of less than 10
µM and therefore, in an environmental context, were considered insignificant.
8.3.1 PPARα
TBTO significantly inhibited PPARα at concentrations as low as 1nM and inhibited the
transcriptional activities of the corticosteroid receptors at 100nM and above. Within the
environment levels of TBT have been reported at concentrations of 200ng/L (0.34 nM)
to 3.2 µg/L (5.4 nM) in the water column (Michel et al, 2001; Basheer et al, 2002), and
at higher concentrations in sediments (44 nM in coastal environment of Xiamen, China
(Wang et al, 2008); up to 1.42 µg in São Paulo, Brazil (Godoi et al, 2003) and 961 nM
in the Gulf of Cádiz, Spain (Garg et al, 2009)). Moreover, due to the lipophilic nature of
tributyl tin compounds, these are readily accumulated in the tissues of aquatic
organisms with concentrations of 35ng/g (58.71 nM TBTO), 114ng/g (191.24 nM TBT)
and 30ng/g (50.33 nM) having been reported in the liver, digestive tract and gills of
European flounder, respectively, suggesting multiple routes of uptake including the diet
- 285 -
and directly from the water and accumulation at concentrations which could potentially
affect both PPAR and CR signalling.
In response to the recognised impacts of organotins on gastropod species, many
countries, including the USA, France, and the UK, banned the use of tributyltin-based
antifouling paints on smaller shipping vessels in the late 1980s, and the International
Maritime Organization (IMO) called for a complete ban in the application of such
antifoulants by 2008. Despite this legislation it is thought that TBT may persist in the
aquatic environment for tens of decades (Dowson et al, 1996) due to their being
retained in sediments, their slow rates of degradation, their continued  use as material
and wood preservatives and their continued use by countries not covered by IMO
regulation. Therefore, due to the likelihood that TBTO will remain as a relevant
environmental pollutant for the foreseeable future, it is important to decipher its effects
and modes of actions in aquatic organisms. Previously the main focus of TBTO has
been as an endocrine disruptor in female gastropods, due to the disruptive effects of this
compound on the reproductive system of females, inducing the development of male
reproductive organs resulting in sterility (Rilov et al, 2000; Blackmore, 2000; Camillo
et al, 2004; Nishikawa, 2006; Gravel et al, 2006; Garaventa et al, 2007; Lima et al,
2011). A proposed target for TBTO in gastropods is the retinoid X receptor, the
heterodimeric partner of PPARs. TBT binds covalently to human RXRα and in a stable
transfection assay was shown to activate all three RXRα-PPARα, β and γ heterodimers,
via interactions with RXRα (le Maire et al, 2009), although several studies have also
reported TBT to be an agonist of human PPARγ in vitro, but showed no agonist effect
on human PPARα and PPARβ (Kanayama et al, 2005; Grün et al, 2006). Despite being
an agonist of human PPARγ, TBTO was unable to activate the transcriptional activity of
plaice PPARγ, although this is not necessarily surprising given that PPARγ of fish
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species appears to be relatively insensitive to compounds which activate mammalian
PPARγ (Leaver et al, 2005). In agreement with the studies with human PPARα and
PPARβ, TBTO was not an agonist of PPARα or PPARβ from plaice. The finding that
TBT activates the RXR-PPAR heterodimers via interactions with the RXR partner in
humans provides an interesting quandary, since it is demonstrated in the present study
that TBTO significantly inhibits PPARα of plaice. Further investigations into the effects
of TBTO on RXR in fish species may prove interesting and would provide a more
thorough understanding into the likely effects of TBTO in vivo with regards to PPAR
signalling, and signalling via other RXR heterodimers.
As a preliminary experiment to investigate effects of TBTO on PPARα-target gene
expression, a microarray analysis was carried out using hepatocyte cells of European
flounder (Chapter 5). PPARα is highly expressed in the liver of fish species, including
sea bream and plaice (Leaver et al, 2005), making it an ideal tissue in which to study
PPARs. One of the main functions of PPARα-target genes is in mitochondrial and
peroxisomal fatty acid β-oxidation, thus it was predicted that such genes which are
upregulated upon activation of PPARα may be downregulated upon inhibition of
PPARα by TBTO. As discussed in Chapter 5 genes which have previously been
identified to function in lipid metabolism were both downregulated and upregulated by
the presence of TBTO and the PPARα activator, Wy14643. Although the
downregulation is in keeping with the predicted outcome, an upregulation of PPARα
target genes was unexpected and suggests other factors to function in the regulation of
these genes. Roles for other NHRs in regulating PPARα-target genes have been
reported which, along with the as yet untested possibility of TBTO affecting fish RXRs,
may complicate these analyses. For example, a role for the liver X receptor (LXR) in
hepatic peroxisomal β-oxidation has been described for rodents in response to an LXR
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activator in PPARα-null mice, indicating LXR regulatory mechanisms, independent of
PPARα (Hu et al, 2005). Three genes, acyl CoA oxidase (ACO), L-3-hydroxyacyl-
Coenzyme A dehydrogenase and 3-ketoacyl-CoA thiolase, all previously identified as
PPARα target genes, were upregulated in mice hepatocytes in response to the LXR
agonist T0901317. A similar role for the LXR in fatty acid metabolism has been
described in Atlantic salmon after cholesterol was found to simultaneously increase the
expression of acyl CoA oxidase (ACO) and LXR in Salmon head kidney (SHK) cells
(Minghetti et al, 2011). The ACO enzyme is the first, and rate-limiting, step in the β-
oxidation pathway and has previously been cloned from humans and rodents (Tugwood
et al, 1992; Varanasi et al, 1996; Lambe et al, 1999). Analysis of the promoter region of
the ACO gene reveals a DR-1 PPRE, which is functional in the rodent gene, being
activated by the potent PPARα ligand, Wy14643. An upregulation in the expression of
the ACO gene following treatment of human hepatocytes with Wy14643 was detected
using microarray analysis (Rakhshandehroo et al, 2009), suggesting PPARα may also
regulate the transcription of the human ACO gene. Functional PPREs have also been
characterised in the enzymes participating in the second (enoyl-CoA hydratase/3-
hydroxyacyl Co-A dehydrogenase bifunctional enzyme) and third steps (ketoacyl-CoA)
of the peroxisomal β-oxidation pathway (Zhang et al, 1992; Hansmannel et al, 2003).
The LXR response element (LXRE) typically consists of a direct repeat of the sequence
TGACCT separated by 4 nucleotides (DR-4), and a search of each of these three genes
from rodents described above revealed a putative LXRE sequence, further implicating
the LXR in mitochondrial β-oxidation (Hu et al, 2005).
As well as fatty acid homeostasis, genes with functions in proteasome maintenance
were observed to be downregulated by TBTO. In response to chemical and physical
stressors, proteins can become damaged or misfolded caused, in part, by the effects of
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oxidative stress. Several pathways are activated in response to stress to restore cellular
homeostasis including the stabilisation of unfolded proteins and removal of damaged
proteins. The proteasome prevents the accumulation of non-functional or potentially
toxic proteins through their ubiquitin-dependent degradation (Goldberg, 2003).
Previously genes encoding proteins which function in the maintenance of a healthy
proteome, including components of the proteasomal protein degradation pathway, have
been reported to be upregulated in response to PPARα agonists in rodents and primates
(Anderson et al, 2004; Cariello et al, 2005), suggesting a PPARα-dependent regulation
of protein associated with the proteasome. The hypothesis that PPARα is important in
the regulation of proteasome maintenance genes was strengthened by the finding that
PPARα-null mice display defects in the expression of proteins that protect the proteome
from chemical damage. A role for PPARα in the regulation of proteasomal proteins is
also indicated in the results of the microarray presented in Chapter 5, in which multiple
genes encoding subunits of the proteasome are upregulated by the PPARα agonist
Wy14643, while being downregulated by treatment with TBTO in Wy14643, consistent
with an inhibition of PPARα. A direct binding of organotin compounds to the
proteasome has been reported previously (Shi et al, 2008), indicating that organotins
can inhibit the proteasome by (i) inhibiting PPARα-dependent regulation of proteasome
subunit expression and (ii) direct binding to the assembled proteasome complex, thus
inhibiting its cellular activity.
8.3.2 Corticosteroid Receptors
In accordance with several other teleost species, European flounder appear to express
three corticosteroid receptors, having two glucocorticoid receptors and a single
mineralocorticoid receptor (Chapter 6). The presence of two GRs is unique to fish
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species, being absent in other vertebrate lineages. The success of the vertebrate lineage
is thought to have been driven by two rounds of whole genome duplications early in
their evolution (Dehal and Boore, 2005; Kasahara, 2007). A consensus has emerged in
support of a third whole genome duplication event in fish species, following the
divergence of the teleostomi into the actinopterygii and sarcopterygii lineages, the
European flounder belonging to the former group (Jaillon et al, 2004; Meyer and Van
de Peer, 2005).  The result of this additional whole genome duplication is the presence
of duplicated genes, present only in fish. Whole genome duplication can give rise to
duplicated copies of genes which can be lost (non-functionalisation), undergo neo-
functionalisation  in which the duplicated copy acquires a new function, or sub-
functionalisation in which both copies of the duplicated gene loses part of the ancestral
function and both are required to maintain the full function. The presence of two
glucocorticoid receptors within European flounder, although not proven, is likely to
have arisen following the actinopterygii-specific genome duplication. Both
glucocorticoid receptors were found to be responsive to cortisol, the endogenous ligand
of corticosteroid receptors in fish, with similar affinities and concentrations being
required to stimulate transactivation of both Gal4-GR1 and Gal4-GR2 constructs,
suggesting a sub-functionalisation event occurred in the European flounder to result in
the maintenance of two glucocorticoid receptors. Previously neo-functionalisation has
been reported for the duplicated glucocorticoid receptors from the midshipman fish
(Porichthys notatus), on the basis of the responsiveness of the GR2 to aldosterone,
which was absent in GR1 of the same species (Arterbery et al, 2011). Neither of the
European flounder GRs was activated by aldosterone and the sensitivity of
glucocorticoid receptors to mineralocorticoid hormone is not consistent with their
phylogenetic relationship; midshipman fish GR2 is aldosterone sensitive, in contrast to
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GR1 of the same species, while the GR1 of the daffodil chichlid is responsive to
aldosterone while the GR2 is not (Arterbery et al, 2011), leading the authors to suggest
that novel amino acid substitutions permit aldosterone binding to otherwise cortisol
specific receptors. Nine amino acid residues within the ligand-binding domains of
mineralocorticoid-sensitive and insensitive glucocorticoid receptors were suggested to
function in mineralocorticoid sensitivity, due to their differing in aldosterone-sensitive
and insensitive GRs. Two of these residues proved to be particularly strong candidates
due to their proximity to bound corticosteroids, or due to the predicted structural
changes induced in the receptor protein. Both GR1 and GR2 of European flounder had a
serine residue at position 49, consistent with the serine residue at the same position in
aldosterone-insensitive GRs of other species. At the position of the second residue
however (amino acid 204), GR1 of European flounder matched that of the other
aldosterone-insensitive GRs while the equivalent residue in GR2 was the same as that in
aldosterone-sensitive GRs. Since GR2 showed no sensitivity to aldosterone it may be
that the substitution at amino acid 49 is more influential in conferring aldosterone
sensitivity than that at position 204, or a double substitution at both positions 49 and
204 may be necessary to confer transcriptional activation by aldosterone.
In the search for aquatic pollutants with the potential to interfere with transcriptional
activities of corticosteroid receptors, TBTO was identified as a potential antagonist at
concentrations greater than 100 nM. Antagonism of the human glucocorticoid receptor
by dibutyltin has previously been reported, blocking access of glucocorticoid hormone
to the ligand-binding site and inhibiting transcriptional activation (Gumy et al, 2008).
Furthermore tributyltin can inhibit the 11β-HSD2 enzyme, leading to a disruption in
11β-HSD2-dependent glucocorticoid inactivation (Atanasov et al, 2005). This
inhibitory action of organotin compounds is likely to increase glucocorticoid hormone
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concentrations in aldosterone-sensitive tissues where 11β-HSD2 is highly expressed
and, during pregnancy, increase the exposure of the foetus to maternal glucocorticoids.
The effects of corticosteroid receptor inhibition in response to TBTO in vivo requires
further investigation but as the corticosteroid receptors function in the stress response,
osmoregulation, energy homeostasis, the immune system and inflammatory response, it
might be assumed that numerous harmful effects will be observed.
8.4 Predicted in vivo effects of TBTO exposure in fish species
Having observed a TBTO-mediated inhibition of PPARα and corticosteroid receptors
and having preliminarily identified genes whose altered expression in response to
TBTO may impact on particular physiological functions in European flounder, a final
concluding discussion on the possible impacts of TBTO exposure in fish species is
presented below.
The microarray experiment in Chapter 5 identified several genes with functions in lipid
metabolism and fatty acid β-oxidation which may be altered in response to TBTO. In
vivo, alterations in the obesogen response of chinook salmon to TBT exposure have
previously been described (Meador et al, 2011). Consistent with the obesogen response,
an increase in body mass, plasma triacylglycerols, cholesterol and lipase were found in
the salmonid species. However other parameters associated with the obesogen response
in small mammals differed in the fish species upon exposure to TBT, including an
increase in serum glucose, free fatty acids and triglyglycerids. Although intuitively
enhanced growth and lipid storage may appear beneficial, Meador et al (2011)
described numerous potentially negative consequences for fast growing salmon,
including inappropriately timed migration patterns (early smolting during outmigration
and an early return to streams and rivers), inapporopriate seasonal behaviours (e.g. an
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increase in appetite during winter) and increased activity resulting in higher metabolic
demands.
From previous studies involving the inhibition of proteasome complexes, several in vivo
effects may be predicted upon exposure of plaice to TBTO. An inhibition of proteasome
functions through a decrease in the expression of proteasome subunits may result in an
accumulation of misfolded and non-functional proteins. In addition inhibition of
proteasome may lead to inappropriate levels of apoptosis as demonstrated in cells to
which a proteasome inhibitor is added (Shinohara et al, 1996).  Within fish species a
proteasome complex has been detected in the flagella of sperm, the inhibition of which
reduces sperm motility (Inaba et al, 1993; Inaba et al, 1998). Similarly the proteasome
is involved in female oocyte maturation in many species, including fish and amphibians.
It has been found that the meiotic cell cycle of mature oocytes of many species is
arrested in metaphase II until eggs are fertilised, after which progression into anaphase
is dependent on the degradation of cyclin B protein in a ubiquitin-dependent proteolytic
manner which involves the 26S proteasome (Josefsberg et al, 2000; Horiguchi et al,
2006). A disruption of the proteasome complex has been demonstrated to prevent
germinal vesicle breakdown (GVBD), disrupt meiotic apparatus organisation, prevent
cell cycle progression and inhibit entry of the sperm into the oocyte (Sun et al, 2004).
Taken together these results suggest that an inhibition of proteasome functions may
reduce gamete quality by interfering with sperm motility and fertilisation ability while
preventing the final maturation of oocytes.
Results from the microarray also revealed a downregulation in genes which encode
proteins with roles in immune functions following treatment with TBTO. There are
many examples within the literature which document the immunosuppressive effects of
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organotin compounds in fish species and since both PPARs and corticosteroid receptors
have roles in immune responses and an in vitro inhibition of both receptors was
observed in the present work some of the immunosuppressive effects observed in fish
species may be due to interactions of TBT with these receptors. A dose-dependent
lymphocytic depletion in the spleen has been reported in rainbow trout exposed to
TBTO (Schwaiger et al, 1994), and a significantly reduced resistance to a bacterial
Aeromonas hydrophila challenge has been reported in rainbow trout yolk fry exposed to
both TBT and dibutyltin (De Vries et al, 1991). Using medaka and guppy, a
comparative study showed the induction of thymus atrophy in the guppy (Wester and
Canton, 1987; Wester et al., 1990), while a dose dependent decrease in phagocyte
activity has been reported in Atlantic croaker (Micropogonias undulatus), hogchoaker
(Trinectes maculatus) and oyster toadfish (Opsanus tau) exposed to TBT at 0.04 to 400
µg/L (Wishkovsky et al., 1989). Similarly TBT and dibutyltin have been shown to
reduce lymphocyte number in Murray cod (Maccullochella peelii) and rainbow trout
with a reduction in phagocytic activity also reported in the former species (O'Halloran et
al, 1998; Harford et al, 2007). A suppressive effect on the non-specific immune system,
indicated by a decrease in non-specific cytotoxic cells (NCC), and a deleterious effects
on the thymus have been described in European flounder exposed to TBTO, leading to
the possibility of a TBTO-induced immunocompetence (Grinwis et al, 1998; Grinwis et
al, 2000; Grinwis et al, 2009).
In addition to immune functions, one of the major functions of corticosteroid hormones
in fish species is in osmoregulatory functions. Evidence from previous literature
suggests the disruption of corticosteroid signalling impacts the osmoregulatory capacity
of fish species.  For example the survival of summer flounder (Paralichthys dentatus)
larvae in saltwater (30ppt) was significantly reduced when immersed into the
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glucocorticoid receptor blocker RU486, compared to larvae in which no RU486 was
present, indicative of a role for cortisol and the glucocorticoid receptors in the seawater
tolerance of larval marine teleosts (Veillette et al, 2007). European flounder share a
similar life cycle to that of summer flounder in that they hatch in offshore waters and
therefore must tolerate hyperosmotic conditions. From the results described for summer
flounder, an inhibition of the glucocorticoid receptors of European flounder, for
example by the pollutant compounds in the present study, is likely to impact on the
survival of larvae and thus has the potential to impact population numbers in heavily
contaminated areas. A further example of the impact of organotin compounds on the
osmoregulatory capacity of flounder was provided by Hartl et al (2001) who measured
alterations in mechanisms which maintain osmotic homeostasis, including membrane
permeability and hydromineral fluxes, in freshwater-adapted juvenile European
flounder exposed to sediment-associated organotins. While an unexposed control group
of flounder demonstrated behaviours of healthy freshwater-acclimated osmoregulators,
producing large volumes of dilute urine and drinking only occasionally in order to
maintain blood osmolality, flounder exposed to organotins demonstrated behaviours
more similar to seawater-adapted organisms, increasing their drinking rates and
reducing urine production. The authors hypothesised that these alterations in behaviour
were to compensate for increased blood osmolality, caused by organotin-dependent
reductions in membrane water permeability and increased passive sodium efflux (Hartl
et al, 2001). Thus exposure of flounder to organotin compounds may exhibit significant
disruptions in osmoregulatory capacity.
The corticosteroid receptors also have a role in the stress response in fish. A study of
brook charr (Salvelinus fontinalis) in which the glucocorticoid receptor was blocked by
RU486 found the stressor-related increase in plasma glucose concentrations, which was
- 295 -
seen in groups of brook charr in which RU486 was not administered, was absent
(Vijayan and Leatherland, 1992). Conversely rainbow trout show little evidence of an
altered stress response following RU486-mediated glucocorticoid blockade, but the
post-stressor cortisol profiles in RU486 treated trout were more erratic than control fish
in which RU486 was not administered leading authors to suggest a disturbance of
normal interactions of components of the HPI axis (Reddy et al, 1995). Alterations in
the stress responses in fish have previously manifested in an altered response to
secondary stressors. For example a stress response has been shown to occur in response
to exposure of rainbow trout to municipal wastewater effluents, which results in an
inhibited response to a further stress event, such as handling (Ings et al, 2012). This
inhibition of a secondary response may result in a greater susceptibility to disease as
shown in Atlantic salmon exposed to hyperoxygenation which had increased
susceptibility to infectious pancreatic necrosis virus (IPNV) (Sundh et al, 2009) and
decreased predator-avoidance behaviour, demonstrated in rainbow trout exposed to
cadmium (Scott et al, 2003). Thus, in response to TBTO an impaired stress response
may be expected, which might then further impact on the normal behaviour of exposed
organisms to further stressors such as predation or pathogens.
8.5 Conclusions
In summary the results of the present work indicate that:
1. The peroxisome proliferator-activated receptor and corticosteroid receptor
ligand-binding domains, in the presence of previously identified agonists, are
able to adopt a transcriptionally active conformation resulting in a change in
luciferase reporter expression. Therefore, the assay developed using these
constructs is considered a suitable system in which to screen pollutants
present in the aquatic environment which disrupt PPAR and CR functions of
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European flounder (Platichthys flesus). The adoption of an in vitro assay
system is in keeping with recent trends to reduce the use of live animal
models for environmental toxicological screening.
2. The European flounder contains three distinct corticosteroid receptors (two
glucocorticoid receptors and a single mineralocorticoid receptor), each most
likely expressed by a separate gene. Both GR1 and GR2 are responsive to
cortisol, the endogenous teleost corticosteroid hormone, and dexamethasone
while the mineralocorticoid receptor is responsive to cortisol,
dexamethasone and the mammalian mineralocorticoid hormone, aldosterone.
Transfection of COS-7 cells with the Gal4-CR ligand-binding domain
constructs, and treatment with tritiated hormones confirmed the expression
of Gal4-CR protein and the binding of corticosteroid hormones.
3. The transient transfection assay identified several environmental compounds
which act as PPAR and CR ligands. Fibrate compounds were both
transcriptional activators (Gemfibrozil, Ciprofibrate) and inhibitors
(Fenofibrate, Bezafibrate) of PPARα, while Bezafibrate activated PPARβ. In
response to phthalate monoesters, mono-1-methylhexyl phthalate and 1-
monobenzylphthalate, an increase in transcriptional activation was observed
with both PPARα and PPARβ. 1-monobenzylphthalate was the only
compound found to illicit any increase in transcriptional response from
PPARγ throughout the research presented here. Bisphenol A was
demonstrated as an inhibitor of GR1 and GR2 while benzylbutyl phthalate
inhibited GR1 only. The above responses generally required between 10 and
- 297 -
100 µM of compound before a change in reporter gene activity was observed
and thus were considered irrelevant in an environmental context.
4. TBTO at low (up to 10 - 100 nM) concentrations is an inhibitor of PPARα
and all three corticosteroid receptors. Inhibition occurs in a dose dependent
and receptor-dependent manner; no inhibition was observed when the
transcriptionally active pBIND ID-pACTmyoD complex was transfected and
treated with up to 50nM TBTO, indicating that the effect was specific for the
transfected NHR
5. A comparison of the gene expression profiles of hepatocytes exposed to
Wy14643 either in the presence or absence of TBTO suggested differential
expression of genes previously shown to be PPARα-targets in mammals.
These genes encode proteins with functions in lipid metabolism/homeostasis,
immune functions, mitochondrial functions and proteasome maintenance.
The presence of TBTO resulted in a significant downregulation of several of
these genes, consistent with an inhibition of PPARα by Wy14643. The
conclusions drawn from this microarray experiment are made tentatively,
however, since the study was done on hepatocytes from a single fish only
and with false discovery correction omitted, and thus false positive results
are likely to be present.
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